data_2mpi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mpi _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.466 ' N ' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 1 N--CA 1.53 4.923 0 N-CA-C 119.457 2.543 . . . . 0.0 119.457 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.581 ' CG2' ' CE2' ' A' ' 19' ' ' TYR . 12.6 mt -93.29 -34.01 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.129 -1.218 . . . . 0.0 109.577 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 4.3 m -65.94 -28.01 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.375 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 1' ' ' GLY . 4.9 mt-10 -80.58 2.18 26.63 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.487 -0.758 . . . . 0.0 109.666 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.25 -45.69 4.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.58 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 56.0 m -97.99 -33.11 11.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.912 . . . . 0.0 109.815 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -73.07 -12.97 61.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.947 . . . . 0.0 109.808 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.3 t -100.38 -34.3 10.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.079 -1.013 . . . . 0.0 108.922 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -136.97 159.23 42.49 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.457 HG22 ' O ' ' B' ' 25' ' ' GLN . 23.7 mm -79.41 96.62 2.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 109.513 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.458 ' O ' HG23 ' B' ' 23' ' ' VAL . 9.1 p -76.97 159.58 29.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -0.818 . . . . 0.0 109.794 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.539 ' HA ' HG22 ' B' ' 23' ' ' VAL . 59.1 p -89.03 144.69 25.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 109.338 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.517 HD13 ' CG1' ' B' ' 39' ' ' VAL . 1.4 tp -46.82 -24.89 0.65 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.283 -0.886 . . . . 0.0 109.108 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 6.5 t80 -71.72 -32.62 67.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -0.927 . . . . 0.0 109.135 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 12' ' ' SER . 5.4 mm100 -66.53 -35.79 81.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.188 -0.945 . . . . 0.0 108.456 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.623 ' CD1' ' CE2' ' A' ' 19' ' ' TYR . 3.2 mm? -66.19 -35.17 79.75 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -48.46 -36.21 14.53 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -74.7 -21.51 59.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.428 -0.795 . . . . 0.0 109.329 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.623 ' CE2' ' CD1' ' A' ' 16' ' ' LEU . 3.2 m-30 -60.04 -19.37 52.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.341 -0.85 . . . . 0.0 109.27 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.3 m -97.44 52.05 1.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.387 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.486 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' B' ' 22' ' ' PHE . 38.5 p90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.226 0.536 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 12' ' ' SER . 4.7 p -114.08 -170.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 108.981 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.525 ' ND2' HG12 ' B' ' 23' ' ' VAL . 33.3 m-20 82.84 36.28 0.05 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.697 -0.627 . . . . 0.0 109.495 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.457 ' O ' HG22 ' A' ' 10' ' ' ILE . 2.5 mt-30 -140.95 175.7 9.41 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -133.54 176.34 8.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.868 -1.145 . . . . 0.0 109.066 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.581 ' O ' ' HB2' ' B' ' 28' ' ' CYS . 0.1 OUTLIER -160.28 -164.93 1.35 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.763 -1.21 . . . . 0.0 111.072 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.581 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 146.16 153.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.45 -119.06 4.54 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -64.47 -52.47 57.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.3 -1.118 . . . . 0.0 110.115 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' B' ' 30' ' ' SER . 17.1 m-20 -43.55 -38.83 3.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.077 -1.015 . . . . 0.0 109.63 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -71.06 0.22 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.096 -1.003 . . . . 0.0 108.956 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' B' ' 30' ' ' SER . 32.2 m -47.9 -27.56 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.098 -1.001 . . . . 0.0 108.602 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 9.4 mt-10 -74.65 -59.57 2.67 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.505 -0.747 . . . . 0.0 109.087 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.526 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -58.92 -41.96 88.54 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.532 HD11 ' CD2' ' A' ' 19' ' ' TYR . 1.1 mm? -60.27 -29.03 68.54 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.674 0.75 . . . . 0.0 109.027 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 39.8 t80 -83.09 -13.51 55.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.68 -0.638 . . . . 0.0 110.247 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -90.02 -44.22 10.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.063 -1.023 . . . . 0.0 108.803 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.517 ' CG1' HD13 ' A' ' 13' ' ' LEU . 1.9 m -66.27 -37.69 80.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.558 -0.714 . . . . 0.0 109.314 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.481 ' N ' HG21 ' B' ' 39' ' ' VAL . 1.3 m -105.5 17.51 23.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.796 . . . . 0.0 109.439 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -56.96 -85.96 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.494 ' HG2' ' N ' ' B' ' 43' ' ' ARG . 28.2 tt0 -55.11 -88.47 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -1.152 . . . . 0.0 109.357 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.494 ' N ' ' HG2' ' B' ' 42' ' ' GLU . 0.4 OUTLIER -46.83 174.33 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.543 -0.723 . . . . 0.0 109.379 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.31 -92.64 1.73 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 30.97 6.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.63 -155.0 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -1.143 . . . . 0.0 109.648 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 9.8 t80 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 0.0 109.526 -179.779 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.799 0 N-CA-C 119.273 2.469 . . . . 0.0 119.273 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.542 HG23 ' CD2' ' B' ' 32' ' ' LEU . 18.2 mm -78.69 -62.18 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -1.108 . . . . 0.0 109.208 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.3 -13.79 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.17 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -89.11 -8.32 54.05 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.411 ' O ' HG22 ' A' ' 8' ' ' THR . 0.5 OUTLIER -97.52 -51.57 4.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 109.277 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.519 ' O ' ' O ' ' A' ' 9' ' ' SER . 17.3 m -85.94 -69.84 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.887 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 2.4 t -41.56 -25.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.033 . . . . 0.0 110.724 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.7 t -72.42 -27.08 62.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.86 -1.15 . . . . 0.0 109.238 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 6' ' ' CYS . 18.0 m -156.61 -157.66 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 mm -107.07 116.02 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.462 -1.399 . . . . 0.0 109.231 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.431 ' O ' HG22 ' B' ' 23' ' ' VAL . 2.5 p -99.05 172.84 7.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 109.649 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.2 p -106.87 150.78 26.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.806 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.481 ' HG ' HG11 ' B' ' 39' ' ' VAL . 0.3 OUTLIER -46.52 -28.24 1.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.686 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 14.9 t80 -61.82 -45.46 93.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 108.808 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.58 -54.13 47.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.368 -0.833 . . . . 0.0 109.418 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.58 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 1.6 mm? -51.33 -38.64 54.18 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.17 -0.956 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -49.36 -34.06 15.07 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.13 -21.81 58.6 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.602 ' CD2' HD12 ' B' ' 36' ' ' LEU . 3.3 m-85 -68.02 -16.93 64.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 0.0 109.435 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.3 m -82.21 51.26 1.75 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 0.0 109.564 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.48 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.252 0.548 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.58 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 0.8 OUTLIER -126.15 -155.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.0 109.631 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.58 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 2.5 t-20 86.68 4.72 0.39 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.287 0.565 . . . . 0.0 109.568 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -121.37 153.77 37.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.822 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -77.86 164.87 24.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.542 HD13 ' O ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -161.76 132.93 5.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.339 -1.475 . . . . 0.0 112.807 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.453 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -138.38 155.9 48.1 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 37.17 -115.2 0.29 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.442 ' HA ' HG22 ' B' ' 33' ' ' VAL . 4.1 m -47.75 -65.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.455 -1.027 . . . . 0.0 110.842 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' B' ' 30' ' ' SER . 5.6 m-20 -42.48 -39.11 2.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 109.418 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.542 ' CD2' HG23 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -65.99 -73.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 108.945 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.512 HG21 ' N ' ' B' ' 34' ' ' GLU . 15.9 m -43.86 -28.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.146 -0.971 . . . . 0.0 108.69 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.519 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -78.18 -61.63 1.94 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.528 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -56.67 -39.42 73.73 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.602 HD12 ' CD2' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -64.14 -34.13 77.35 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.942 0.877 . . . . 0.0 108.806 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.413 ' O ' ' HA2' ' B' ' 41' ' ' GLY . 20.4 t80 -75.97 -22.33 56.0 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.742 -0.599 . . . . 0.0 110.077 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.528 ' HG ' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -76.5 -53.41 8.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.944 -1.097 . . . . 0.0 108.484 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 16' ' ' LEU . 2.6 m -54.1 -32.24 22.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.515 ' HB3' ' CD ' ' B' ' 43' ' ' ARG . 1.3 m -122.83 39.59 3.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.506 -0.746 . . . . 0.0 109.713 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' B' ' 37' ' ' TYR . . . -53.45 -32.3 45.13 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.73 7.65 9.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -1.181 . . . . 0.0 109.94 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.515 ' CD ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -116.05 139.75 49.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 108.947 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.08 153.73 17.29 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.34 -151.95 6.18 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.22 31.81 0.24 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.233 -1.157 . . . . 0.0 109.636 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.447 -179.735 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.2 mt -92.55 -28.94 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.941 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 1.4 m -62.22 -37.41 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.369 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 3.0 mt-10 -76.06 -1.17 24.63 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.362 -0.836 . . . . 0.0 109.644 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -43.4 4.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.108 -0.995 . . . . 0.0 110.045 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 9' ' ' SER . 95.6 m -103.72 -29.35 11.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.103 -0.998 . . . . 0.0 110.093 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 2.5 t -69.26 -6.98 32.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.042 -1.036 . . . . 0.0 109.349 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -99.6 -31.3 11.66 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.943 . . . . 0.0 108.526 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 6' ' ' CYS . 4.2 m -147.45 165.24 30.84 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 10' ' ' ILE . 3.9 mm -80.15 110.42 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.104 -0.997 . . . . 0.0 109.548 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 78.4 m -74.8 -170.71 1.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.662 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 13' ' ' LEU . 87.5 p -121.13 136.04 55.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -42.81 -26.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.168 -0.957 . . . . 0.0 109.776 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -62.79 -49.34 75.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.125 -0.984 . . . . 0.0 108.888 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -65.07 -44.94 87.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 0.0 108.865 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.601 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 3.3 mp -55.65 -37.16 67.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.107 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 7.0 mm-40 -54.03 -34.5 60.17 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.286 -0.884 . . . . 0.0 108.749 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -21.98 61.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.414 -0.804 . . . . 0.0 109.485 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.601 ' CD2' ' HA ' ' A' ' 16' ' ' LEU . 5.0 m-30 -62.44 -29.41 70.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.7 m -82.57 53.79 2.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.891 . . . . 0.0 109.276 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.4 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.538 ' O ' ' CD2' ' B' ' 22' ' ' PHE . 52.4 p90 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.59 ' O ' ' HB3' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -143.53 171.15 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.041 -1.037 . . . . 0.0 110.008 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.59 ' HB3' ' O ' ' B' ' 23' ' ' VAL . 2.2 p-10 167.5 -29.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.56 -171.04 3.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.536 -0.728 . . . . 0.0 109.932 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -118.79 -169.82 1.79 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -0.846 . . . . 0.0 109.022 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.606 ' O ' ' HB2' ' B' ' 28' ' ' CYS . 0.3 OUTLIER -160.77 -159.27 0.66 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.751 -1.218 . . . . 0.0 110.415 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.606 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 145.9 141.9 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 123.558 0.743 . . . . 0.0 109.17 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 35.64 -118.19 0.35 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.485 ' O ' HG23 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -42.61 -62.83 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.427 -1.043 . . . . 0.0 110.177 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -43.99 -31.63 0.95 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.048 -1.033 . . . . 0.0 109.166 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.472 HD13 ' CA ' ' B' ' 28' ' ' CYS . 0.3 OUTLIER -68.69 -66.9 0.51 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.221 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.519 HG23 ' N ' ' B' ' 34' ' ' GLU . 30.6 m -51.52 -28.64 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.995 -1.066 . . . . 0.0 108.489 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.519 ' N ' HG23 ' B' ' 33' ' ' VAL . 1.1 mp0 -76.0 -58.77 3.08 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.541 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.55 -47.31 82.38 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.489 HD12 ' HB3' ' A' ' 19' ' ' TYR . 1.1 mm? -56.49 -29.01 61.29 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.781 0.8 . . . . 0.0 108.959 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' B' ' 33' ' ' VAL . 70.7 t80 -82.41 -15.09 53.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.828 -0.545 . . . . 0.0 109.988 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.541 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.4 OUTLIER -87.32 -46.64 9.5 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.476 HG23 ' N ' ' B' ' 40' ' ' CYS . 2.7 m -65.95 -21.37 28.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' B' ' 43' ' ' ARG . 1.3 m -119.9 27.09 8.89 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.451 -0.781 . . . . 0.0 109.235 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' B' ' 40' ' ' CYS . . . -43.45 -26.9 0.71 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' B' ' 40' ' ' CYS . 25.9 tt0 -90.92 -23.05 20.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -1.175 . . . . 0.0 109.644 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' B' ' 40' ' ' CYS . 2.0 ttt180 -110.25 159.37 17.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.406 -0.809 . . . . 0.0 109.222 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -178.45 142.57 5.53 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 47' ' ' TYR . . . 115.94 -67.59 0.29 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 60.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 0.0 109.529 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . 0.439 ' N ' ' O ' ' B' ' 45' ' ' GLY . 72.1 t80 . . . . . 0 C--N 1.297 -1.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.346 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.872 0 N-CA-C 119.369 2.508 . . . . 0.0 119.369 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.58 HG22 ' CE2' ' A' ' 19' ' ' TYR . 22.3 mt -89.06 -31.73 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -1.139 . . . . 0.0 109.399 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 1.6 m -47.09 -40.14 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.22 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 6.4 mt-10 -56.47 -16.32 5.67 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.641 -0.662 . . . . 0.0 110.103 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -105.34 -31.08 9.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 110.303 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.449 ' HB3' HD11 ' B' ' 27' ' ' LEU . 7.3 m -103.01 -31.2 10.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.039 . . . . 0.0 110.127 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 1.5 m -84.84 -13.82 49.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.32 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.8 -13.29 15.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.037 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.5 m -150.65 158.36 44.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.354 -0.841 . . . . 0.0 109.07 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.457 ' HA ' HD12 ' A' ' 10' ' ' ILE . 20.4 mm -80.86 97.99 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 0.0 109.622 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.457 ' SG ' HD11 ' A' ' 16' ' ' LEU . 3.7 p -82.06 171.46 14.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 109.373 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 13' ' ' LEU . 59.3 p -111.03 148.49 32.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.239 -0.913 . . . . 0.0 109.828 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' HG ' HG11 ' B' ' 39' ' ' VAL . 0.6 OUTLIER -45.45 -28.94 0.98 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.058 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -59.08 -53.41 58.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.368 -0.832 . . . . 0.0 109.024 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 27.5 mm-40 -61.43 -29.11 69.73 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.286 -0.884 . . . . 0.0 109.048 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.525 ' CD2' HD13 ' B' ' 36' ' ' LEU . 6.9 mp -71.22 -38.92 72.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.258 -0.901 . . . . 0.0 108.7 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.45 -32.75 63.02 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -73.38 -26.87 61.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.433 -0.792 . . . . 0.0 109.277 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.58 ' CE2' HG22 ' A' ' 2' ' ' ILE . 6.2 m-30 -58.79 -19.79 44.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 108.814 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.67 51.75 1.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -0.768 . . . . 0.0 109.247 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.333 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.397 0.618 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -157.4 -158.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.368 -0.832 . . . . 0.0 109.865 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' B' ' 23' ' ' VAL . 30.3 m-20 74.07 30.23 1.27 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -127.86 154.23 45.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.386 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.524 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -100.76 -178.35 3.75 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -161.0 -159.6 0.68 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.787 -1.195 . . . . 0.0 110.225 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.577 ' CB ' ' O ' ' B' ' 27' ' ' LEU . 1.2 m 149.35 150.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.49 -127.86 27.09 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.439 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.9 OUTLIER -58.34 -51.08 71.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.286 -1.126 . . . . 0.0 109.83 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 30' ' ' SER . 3.2 m-20 -43.35 -42.87 4.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 109.26 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.518 ' CD1' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -63.09 -76.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.918 . . . . 0.0 109.502 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.527 HG12 ' CE1' ' B' ' 47' ' ' TYR . 14.4 m -44.45 -33.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.029 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.527 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 2.5 mm-40 -62.97 -52.71 61.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.477 -0.764 . . . . 0.0 109.151 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -55.9 -52.96 62.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.535 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -57.37 -29.96 64.46 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.892 -1.13 . . . . 0.0 107.955 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.48 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 86.3 t80 -73.27 -11.95 60.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.558 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -97.06 -51.2 4.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.979 . . . . 0.0 108.74 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.472 HG11 ' HG ' ' A' ' 13' ' ' LEU . 2.3 m -48.33 -36.66 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.517 ' CB ' ' HB3' ' B' ' 43' ' ' ARG . 0.9 OUTLIER -93.71 -53.37 4.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.389 -0.819 . . . . 0.0 109.157 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.72 -50.42 3.58 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -116.86 22.36 12.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.186 . . . . 0.0 110.058 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.517 ' HB3' ' CB ' ' B' ' 40' ' ' CYS . 0.2 OUTLIER -56.31 -176.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.0 . . . . 0.0 109.15 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.68 155.35 49.69 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.12 56.5 4.35 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -147.05 140.2 25.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.527 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . 0.527 ' CE1' HG12 ' B' ' 33' ' ' VAL . 32.4 t80 . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.432 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.883 0 N-CA-C 119.388 2.515 . . . . 0.0 119.388 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.426 ' O ' HG21 ' A' ' 2' ' ' ILE . 39.7 mt -74.49 -25.98 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.567 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.46 HG13 HD22 ' B' ' 32' ' ' LEU . 1.3 m -71.3 -30.58 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.67 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.13 -10.73 53.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.619 -0.675 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -31.3 9.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.868 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' SER . 95.5 m -105.01 -34.53 7.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.982 -1.074 . . . . 0.0 110.076 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.538 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 1.8 t -63.44 -10.99 19.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.015 -1.053 . . . . 0.0 109.65 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.426 ' CG2' ' N ' ' A' ' 9' ' ' SER . 14.6 t -104.99 -37.9 6.8 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 6' ' ' CYS . 7.9 m -127.2 147.8 50.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.489 ' CG1' ' O ' ' B' ' 25' ' ' GLN . 0.9 OUTLIER -78.87 91.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.993 -1.067 . . . . 0.0 109.212 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.509 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 59.7 m -54.74 172.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.434 -0.791 . . . . 0.0 109.498 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.558 ' HA ' HG22 ' B' ' 23' ' ' VAL . 85.6 p -106.81 155.34 19.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 109.531 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.513 ' HG ' HG11 ' B' ' 39' ' ' VAL . 0.8 OUTLIER -45.51 -26.81 0.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.244 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -67.27 -44.35 79.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 10.0 mt-30 -65.47 -43.35 90.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' B' ' 36' ' ' LEU . 6.8 mp -61.72 -34.03 75.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.014 -1.054 . . . . 0.0 109.081 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.87 -23.61 61.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.3 m-80 -75.62 -24.37 56.49 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.53 -0.731 . . . . 0.0 109.615 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.632 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.6 m-30 -77.83 3.75 13.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.016 -1.052 . . . . 0.0 109.478 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 13.6 m -123.27 69.1 1.01 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 109.794 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 20' ' ' CYS . 17.4 p30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.421 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.465 ' HA ' HD11 ' A' ' 13' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 12' ' ' SER . 1.3 p -95.44 -159.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.213 -0.929 . . . . 0.0 108.603 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 6.5 t-20 78.08 30.44 0.44 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.489 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -155.54 162.62 40.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.436 -0.79 . . . . 0.0 109.127 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.538 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -110.74 179.93 3.93 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.519 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -160.24 -168.35 2.16 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.343 -1.473 . . . . 0.0 111.968 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.523 ' HA ' ' CD1' ' B' ' 32' ' ' LEU . 0.5 OUTLIER 151.38 147.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.66 -115.58 2.66 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 68.0 m -63.74 -57.58 9.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -1.132 . . . . 0.0 110.047 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' B' ' 30' ' ' SER . 6.6 m-20 -43.83 -36.23 2.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.205 -0.935 . . . . 0.0 109.437 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.545 ' O ' ' CD2' ' B' ' 36' ' ' LEU . 0.1 OUTLIER -67.85 -76.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.215 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.457 HG21 ' N ' ' B' ' 34' ' ' GLU . 3.5 m -44.51 -29.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 108.673 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.53 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 7.1 mt-10 -66.07 -55.58 15.86 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.511 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -55.17 -55.21 33.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.347 -0.846 . . . . 0.0 108.787 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' B' ' 32' ' ' LEU . 0.5 OUTLIER -58.3 -18.44 27.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 108.637 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 23.3 t80 -86.12 -14.49 44.03 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -89.47 -42.11 11.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 108.805 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.513 HG11 ' HG ' ' A' ' 13' ' ' LEU . 2.3 m -75.62 -20.81 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.485 -0.759 . . . . 0.0 109.261 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.422 ' SG ' HG23 ' B' ' 39' ' ' VAL . 55.6 m -111.2 6.04 20.4 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.324 -0.86 . . . . 0.0 109.757 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.34 -12.29 83.67 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -82.24 -72.11 0.45 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -1.12 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -175.01 1.84 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.464 -0.772 . . . . 0.0 109.617 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.01 -94.08 1.69 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.94 -119.63 5.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.94 27.42 0.79 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -1.132 . . . . 0.0 109.383 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.63 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.914 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.448 HD12 HD11 ' B' ' 36' ' ' LEU . 6.7 tt -102.99 -13.14 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.232 -1.158 . . . . 0.0 109.659 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.558 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 10.9 m -99.65 -30.46 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 109.17 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.489 ' O ' ' CG2' ' A' ' 8' ' ' THR . 10.1 mt-10 -82.68 -4.95 58.55 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.308 -0.87 . . . . 0.0 109.958 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.55 -34.93 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -0.991 . . . . 0.0 110.01 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.406 ' SG ' ' OH ' ' A' ' 19' ' ' TYR . 82.0 m -105.42 -30.31 9.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 110.412 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.558 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 4.5 t -71.57 -6.76 43.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.147 -0.97 . . . . 0.0 109.821 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -119.86 -14.33 8.98 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.234 -0.916 . . . . 0.0 108.815 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 68.0 m -136.88 -165.68 1.78 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mm -120.99 92.35 2.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 109.548 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.431 ' O ' HG21 ' B' ' 23' ' ' VAL . 28.0 m -71.66 171.68 11.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.482 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 13' ' ' LEU . 25.4 p -116.12 153.42 31.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.875 . . . . 0.0 108.861 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' B' ' 22' ' ' PHE . 0.8 OUTLIER -44.44 -29.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.101 -0.999 . . . . 0.0 109.083 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.32 -50.42 73.68 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.254 -0.904 . . . . 0.0 108.694 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.436 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 3.6 mm-40 -65.45 -35.58 81.34 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.59 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 3.4 mp -65.69 -33.91 76.98 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -25.25 63.98 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.88 -34.5 62.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.427 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.4 m-30 -59.4 -20.08 52.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 108.78 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.18 54.31 2.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.362 -0.836 . . . . 0.0 109.469 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.479 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.465 ' HA ' ' CD1' ' A' ' 13' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.554 HG11 ' N ' ' B' ' 24' ' ' ASN . 1.4 p -82.56 -166.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.422 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.554 ' N ' HG11 ' B' ' 23' ' ' VAL . 8.2 t30 46.47 38.66 5.65 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.559 -0.713 . . . . 0.0 109.308 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.17 169.11 24.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.881 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.538 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 1.1 t60 -125.98 172.01 10.29 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.574 ' CD1' ' CD1' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -161.29 -166.84 1.62 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.327 -1.483 . . . . 0.0 111.639 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 150.78 153.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 123.419 0.688 . . . . 0.0 109.265 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.79 -117.54 2.2 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.446 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.4 OUTLIER -60.84 -57.59 12.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -1.072 . . . . 0.0 110.28 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' B' ' 30' ' ' SER . 13.5 m-20 -42.28 -31.5 0.4 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.236 -0.915 . . . . 0.0 109.68 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.574 ' CD1' ' CD1' ' B' ' 27' ' ' LEU . 1.0 OUTLIER -70.46 -68.46 0.42 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.156 -0.965 . . . . 0.0 108.87 179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.48 HG21 ' N ' ' B' ' 34' ' ' GLU . 33.5 m -51.74 -35.26 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.125 -0.985 . . . . 0.0 108.733 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.536 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 4.7 mt-10 -69.68 -52.94 21.17 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.376 -0.828 . . . . 0.0 108.982 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.53 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -62.99 -42.97 99.99 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.448 HD11 HD12 ' A' ' 2' ' ' ILE . 1.6 mm? -60.32 -30.5 69.55 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.894 0.854 . . . . 0.0 108.698 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.414 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 13.3 t80 -77.37 -14.1 59.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.671 -0.643 . . . . 0.0 109.882 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.536 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -88.27 -53.7 4.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 108.609 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.522 HG11 ' CD2' ' A' ' 16' ' ' LEU . 2.2 m -54.57 -27.11 17.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . . . . . . . . . 55.7 m -119.61 35.45 4.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.467 -0.771 . . . . 0.0 109.558 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.16 51.2 3.53 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -172.91 -34.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -1.116 . . . . 0.0 109.481 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 44' ' ' GLY . 7.0 ttt85 -92.71 153.13 19.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.493 -0.754 . . . . 0.0 109.311 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' B' ' 43' ' ' ARG . . . -54.67 -106.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.66 145.18 1.05 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.6 -156.24 0.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -1.177 . . . . 0.0 109.632 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 0.0 109.777 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.813 0 N-CA-C 119.313 2.485 . . . . 0.0 119.313 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.407 HG22 HD21 ' B' ' 32' ' ' LEU . 7.9 mt -102.34 -45.66 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -1.16 . . . . 0.0 109.607 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.4 m -49.76 -34.47 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.703 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.457 ' O ' ' OG1' ' A' ' 8' ' ' THR . 2.6 mt-10 -77.38 -7.6 56.35 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 109.851 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -40.72 5.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 110.142 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 9' ' ' SER . 69.0 m -99.98 -34.69 9.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 0.0 110.509 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.581 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 6.1 t -71.96 -40.42 68.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.849 -1.157 . . . . 0.0 109.594 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 55.0 p -77.85 -31.9 51.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.114 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 10' ' ' ILE . 2.5 p -124.62 -150.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -0.81 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.493 ' N ' ' OG ' ' A' ' 9' ' ' SER . 5.5 mm -133.53 112.1 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.143 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.7 m -86.93 170.17 11.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 109.661 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' LEU . 79.4 p -102.76 140.23 37.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 109.383 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.563 HD13 ' CE2' ' B' ' 22' ' ' PHE . 0.8 OUTLIER -42.85 -31.3 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -62.97 -51.19 67.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.94 . . . . 0.0 109.373 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -37.56 74.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.058 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.58 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 6.2 mp -64.93 -38.91 92.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 108.868 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.56 -26.25 63.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -74.87 -32.79 61.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.348 -0.845 . . . . 0.0 108.929 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 4.3 m-30 -57.59 -20.58 33.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.31 -0.869 . . . . 0.0 109.219 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.6 m -87.81 50.62 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.55 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.563 ' CE2' HD13 ' A' ' 13' ' ' LEU . 11.8 t80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.4 0.619 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' B' ' 24' ' ' ASN . 1.1 p -161.8 -153.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.756 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.548 ' N ' ' CG1' ' B' ' 23' ' ' VAL . 6.2 m-20 81.88 55.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.69 166.44 18.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.63 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -124.97 146.56 49.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.588 ' CD1' ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -160.91 145.05 13.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.294 -1.503 . . . . 0.0 112.679 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.46 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -133.91 155.07 50.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.523 -0.736 . . . . 0.0 109.447 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 34.35 -126.12 0.52 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.449 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.2 OUTLIER -39.0 -63.8 0.5 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.937 . . . . 0.0 110.715 -179.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' B' ' 30' ' ' SER . 10.3 m-20 -41.31 -32.14 0.28 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.825 . . . . 0.0 109.354 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.538 ' O ' ' CD2' ' B' ' 36' ' ' LEU . 0.3 OUTLIER -69.15 -71.69 0.21 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.312 -0.867 . . . . 0.0 108.808 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.495 HG23 ' N ' ' B' ' 34' ' ' GLU . 29.0 m -43.05 -39.15 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.262 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.514 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -63.19 -50.44 70.29 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.311 -0.868 . . . . 0.0 108.954 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.503 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -53.36 -57.69 9.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.458 -0.776 . . . . 0.0 109.443 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.572 ' CD1' ' CD2' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -56.59 -22.73 35.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.047 -1.033 . . . . 0.0 108.526 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 11.1 t80 -82.5 -14.88 54.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.648 -0.657 . . . . 0.0 109.477 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -85.51 -45.31 11.91 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.478 HG22 ' N ' ' B' ' 40' ' ' CYS . 2.7 m -67.86 -21.63 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.535 -0.728 . . . . 0.0 109.173 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.478 ' N ' HG22 ' B' ' 39' ' ' VAL . 96.2 m -113.45 16.02 18.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.404 -0.81 . . . . 0.0 109.353 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -44.04 -39.94 5.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.95 17.0 6.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -1.174 . . . . 0.0 109.422 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' B' ' 40' ' ' CYS . 1.8 tpt85 -132.85 111.37 11.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.323 -0.86 . . . . 0.0 109.367 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.43 -122.88 6.93 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.9 40.11 1.9 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.502 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 29.6 t80 -108.88 -0.88 19.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -1.127 . . . . 0.0 109.507 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.823 -179.788 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.409 2.523 . . . . 0.0 119.409 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.449 HG23 ' CZ ' ' A' ' 19' ' ' TYR . 62.0 mt -81.49 -32.94 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.265 -1.138 . . . . 0.0 109.65 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 m -60.58 -30.33 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.584 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' O ' HG21 ' A' ' 8' ' ' THR . 1.1 mt-10 -78.73 1.79 21.85 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.565 -0.71 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 9' ' ' SER . 3.0 tp60 -105.24 -40.84 5.72 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.217 -0.927 . . . . 0.0 109.688 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 9' ' ' SER . 85.3 m -106.05 -36.87 6.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 110.667 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.564 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 8.8 t -68.97 -15.28 63.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.876 -1.14 . . . . 0.0 110.076 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 4' ' ' GLU . 11.2 t -113.34 -27.72 7.84 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 18.2 m -126.65 156.76 40.5 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' B' ' 24' ' ' ASN . 5.5 mm -81.14 146.61 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.735 -1.228 . . . . 0.0 109.516 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.7 m -124.91 -169.19 1.94 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.363 -0.835 . . . . 0.0 109.768 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -137.47 143.1 41.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -40.84 -33.32 0.29 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 109.66 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.469 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 75.1 t80 -65.93 -50.35 64.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.953 . . . . 0.0 108.616 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -60.98 -36.54 79.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.157 -0.964 . . . . 0.0 108.568 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.603 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 5.2 mp -69.37 -32.47 71.55 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 2.5 mt-10 -56.98 -28.5 62.4 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -31.57 69.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.477 -0.764 . . . . 0.0 109.294 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.603 ' CD2' ' HA ' ' A' ' 16' ' ' LEU . 23.2 m-30 -58.68 -14.84 9.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -0.963 . . . . 0.0 109.547 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.4 m -99.73 57.64 1.01 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.964 . . . . 0.0 109.532 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.472 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.482 0.658 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -144.37 -159.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.392 -0.818 . . . . 0.0 109.885 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.585 ' N ' ' CG1' ' B' ' 23' ' ' VAL . 15.4 t-20 62.08 68.25 0.69 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.399 0.619 . . . . 0.0 109.667 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.27 173.45 11.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.209 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.564 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -121.14 150.86 40.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' B' ' 27' ' ' LEU . 1.2 pt? -160.98 141.51 11.29 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.223 -1.548 . . . . 0.0 112.85 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.9 OUTLIER -139.54 167.9 21.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.381 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 40.71 -121.6 1.94 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.459 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.7 OUTLIER -53.1 -59.35 4.66 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.342 -1.093 . . . . 0.0 110.572 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.597 ' CB ' ' HB2' ' B' ' 27' ' ' LEU . 13.8 m-20 -40.09 -35.92 0.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.873 . . . . 0.0 109.765 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.533 ' HA ' ' CD1' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -67.61 -72.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 108.622 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -49.15 -27.98 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.941 . . . . 0.0 108.476 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.52 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -72.38 -56.29 5.7 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.55 ' CB ' ' CD1' ' B' ' 27' ' ' LEU . . . -60.21 -45.53 92.86 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' B' ' 36' ' ' LEU . 0.1 OUTLIER -59.9 -27.09 66.43 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.513 ' O ' ' CA ' ' B' ' 41' ' ' GLY . 76.9 t80 -80.22 -11.9 59.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.75 -0.593 . . . . 0.0 109.822 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.6 OUTLIER -90.79 -48.51 6.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.979 . . . . 0.0 108.713 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' A' ' 16' ' ' LEU . 2.4 m -62.22 -29.47 46.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.484 -0.76 . . . . 0.0 108.963 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . . . . . . . . . 19.1 m -119.49 13.71 12.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.45 -0.781 . . . . 0.0 109.526 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' B' ' 37' ' ' TYR . . . -55.86 -40.87 82.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -105.34 -11.32 16.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.46 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.14 138.31 41.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.601 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.95 -144.29 12.77 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . 0.557 ' C ' ' CG ' ' B' ' 46' ' ' PHE . . . 163.81 165.84 21.67 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.557 ' CG ' ' C ' ' B' ' 45' ' ' GLY . 0.8 OUTLIER 39.29 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.523 -0.987 . . . . 0.0 109.77 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.578 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 mt -80.35 -23.13 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -1.111 . . . . 0.0 109.38 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.1 m -60.97 -27.63 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.611 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -83.41 4.74 26.28 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.47 -0.769 . . . . 0.0 109.458 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.75 -49.36 3.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.169 -0.957 . . . . 0.0 110.455 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' SER . 62.0 m -104.97 -34.08 8.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 110.752 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.537 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 4.2 t -61.65 -12.06 14.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.774 -1.204 . . . . 0.0 109.553 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 9' ' ' SER . 4.1 t -99.13 -32.81 11.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 108.446 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.582 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 5.7 t -120.71 -156.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' CYS . 25.1 mm -109.98 -4.71 10.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.835 -1.166 . . . . 0.0 109.567 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' ILE . 1.5 m 45.41 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 110.24 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.6 p -150.58 149.84 30.42 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HG ' HG11 ' B' ' 39' ' ' VAL . 0.2 OUTLIER -47.74 -25.33 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.07 -1.019 . . . . 0.0 109.625 -179.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -61.82 -55.05 34.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.162 -0.961 . . . . 0.0 109.173 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 -46.8 84.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.311 -0.868 . . . . 0.0 109.331 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.453 HD11 ' N ' ' A' ' 16' ' ' LEU . 8.3 mp -61.47 -35.61 78.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.109 -0.994 . . . . 0.0 108.737 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -56.83 -23.36 43.37 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.96 -25.2 58.69 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.589 -0.695 . . . . 0.0 109.305 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.556 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.8 m-30 -74.81 -3.77 33.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.943 -1.098 . . . . 0.0 109.183 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.461 ' HB3' ' HA3' ' B' ' 45' ' ' GLY . 61.0 m -78.38 51.97 1.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.219 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 t30 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.601 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 3.8 p90 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.585 0.707 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.581 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 1.1 p -160.93 -153.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.579 -0.7 . . . . 0.0 109.422 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 28.0 t-20 87.73 74.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.5 0.667 . . . . 0.0 109.558 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -158.24 154.37 27.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.582 ' CE1' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -105.16 174.54 5.83 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.642 ' O ' ' HB2' ' B' ' 28' ' ' CYS . 0.0 OUTLIER -153.69 -157.17 0.75 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.485 -1.385 . . . . 0.0 111.335 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.642 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.6 OUTLIER 139.24 146.14 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 124.127 0.971 . . . . 0.0 108.53 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.21 -131.02 19.67 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.477 ' HA ' ' CG2' ' B' ' 33' ' ' VAL . 7.3 m -55.62 -38.95 70.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.718 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.503 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 7.4 m-20 -52.1 -40.04 60.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 109.005 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.522 HD13 ' N ' ' B' ' 28' ' ' CYS . 0.1 OUTLIER -67.17 -72.49 0.16 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 108.96 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' B' ' 30' ' ' SER . 27.7 m -42.89 -40.3 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.106 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.543 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -54.67 -51.88 64.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.223 -0.923 . . . . 0.0 109.046 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.502 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -59.1 -54.33 48.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.039 -1.038 . . . . 0.0 108.822 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.502 ' CD2' ' O ' ' B' ' 32' ' ' LEU . 0.8 OUTLIER -54.33 -20.15 6.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.138 -0.976 . . . . 0.0 108.881 179.297 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.447 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 33.1 t80 -86.09 -10.61 54.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.408 -0.807 . . . . 0.0 109.373 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -98.68 -40.54 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.038 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.503 HG22 ' N ' ' B' ' 40' ' ' CYS . 2.3 m -78.86 -27.17 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.422 -0.798 . . . . 0.0 109.409 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.503 ' N ' HG22 ' B' ' 39' ' ' VAL . 7.4 m -103.98 -1.01 28.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.15 -36.18 51.68 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.78 -15.04 25.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.156 -1.203 . . . . 0.0 109.641 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.507 ' HG2' ' N ' ' B' ' 44' ' ' GLY . 8.5 ttt180 -123.76 161.93 24.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.44 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.507 ' N ' ' HG2' ' B' ' 43' ' ' ARG . . . -48.91 164.94 0.31 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 20' ' ' CYS . . . 116.71 -10.61 16.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' B' ' 45' ' ' GLY . 2.0 t80 -43.16 124.7 3.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -1.088 . . . . 0.0 109.204 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . 0.472 ' OH ' ' O ' ' B' ' 33' ' ' VAL . 4.9 p90 . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.896 0 N-CA-C 119.336 2.494 . . . . 0.0 119.336 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.584 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -104.91 -9.69 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -1.156 . . . . 0.0 108.997 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.47 HG12 HD21 ' B' ' 32' ' ' LEU . 2.9 m -76.81 -35.3 24.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.359 -0.838 . . . . 0.0 109.893 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' HG22 ' A' ' 8' ' ' THR . 3.6 mt-10 -61.69 -10.87 9.6 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.707 -0.621 . . . . 0.0 110.641 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.452 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -105.46 -34.24 7.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.907 -1.12 . . . . 0.0 110.126 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.3 m -98.76 -18.49 17.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.678 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.543 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 13.3 t -86.2 -34.95 20.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 4' ' ' GLU . 6.2 t -89.67 -30.1 18.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 m -128.71 165.29 21.16 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.477 HG13 ' O ' ' B' ' 25' ' ' GLN . 0.5 OUTLIER -94.23 128.11 45.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.116 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.439 ' HB2' HD12 ' A' ' 16' ' ' LEU . 66.1 m -96.88 175.28 6.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 109.61 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 29.4 p -106.61 148.03 28.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 109.281 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -43.42 -30.17 0.52 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.119 -0.988 . . . . 0.0 109.81 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -62.21 -56.57 17.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.366 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.484 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 1.2 mp0 -57.88 -38.33 75.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.184 -0.947 . . . . 0.0 109.128 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.571 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 6.8 mp -67.07 -39.97 86.96 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.184 -0.948 . . . . 0.0 108.838 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.54 -25.94 53.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -70.95 -32.18 68.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.468 -0.77 . . . . 0.0 109.095 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.613 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.6 m-30 -68.71 -31.67 70.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.139 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -60.63 -98.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.988 0.899 . . . . 0.0 109.923 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 . . . . . 0 C--N 1.278 -2.513 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.34 -179.485 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' B' ' 22' ' ' PHE . 2.2 t80 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.393 0.616 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.59 ' CG1' ' N ' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -160.58 -162.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.239 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.59 ' N ' ' CG1' ' B' ' 23' ' ' VAL . 0.8 OUTLIER 73.28 68.94 0.11 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.523 -0.736 . . . . 0.0 109.566 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.477 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.1 tp60 -141.59 156.24 45.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 109.517 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.543 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -115.21 164.07 14.76 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.579 ' HG ' ' CD1' ' B' ' 32' ' ' LEU . 0.1 OUTLIER -161.41 -156.37 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 119.951 -1.718 . . . . 0.0 112.901 -178.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.567 ' N ' ' HB2' ' B' ' 31' ' ' ASP . 0.3 OUTLIER 150.93 140.78 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.725 0 C-N-CA 123.557 0.743 . . . . 0.0 110.271 -178.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' B' ' 32' ' ' LEU . . . 43.88 -128.99 6.51 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.464 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.3 OUTLIER -47.2 -39.46 14.02 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.156 -1.202 . . . . 0.0 108.821 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.567 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 80.8 m-20 -59.28 -29.83 67.87 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.208 -0.933 . . . . 0.0 108.704 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.579 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -68.7 -57.39 5.73 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.6 ' O ' ' CG ' ' B' ' 37' ' ' TYR . 4.8 m -55.63 -35.58 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.538 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -59.58 -59.53 5.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.532 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -61.29 -46.76 88.98 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.548 ' CD1' ' HB2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -57.89 -33.63 68.94 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.6 ' CG ' ' O ' ' B' ' 33' ' ' VAL . 5.5 m-30 -71.45 -21.94 61.9 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.671 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -81.26 -58.11 3.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 108.895 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.461 HG22 ' O ' ' B' ' 36' ' ' LEU . 2.5 m -47.27 -32.92 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.49 -0.756 . . . . 0.0 109.416 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' B' ' 43' ' ' ARG . 0.9 OUTLIER -100.09 -27.38 13.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 109.807 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.506 ' O ' ' CG ' ' B' ' 42' ' ' GLU . . . 41.24 65.81 1.04 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' B' ' 41' ' ' GLY . 10.6 pt-20 39.36 29.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -1.008 . . . . 0.0 110.115 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' B' ' 40' ' ' CYS . 0.8 OUTLIER -90.32 135.99 33.33 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.295 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 49.06 66.42 2.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.65 175.91 35.57 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.566 ' HB3' ' CD1' ' B' ' 47' ' ' TYR . 1.7 m-30 -79.75 -100.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.122 -1.223 . . . . 0.0 109.961 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . 0.589 ' CE1' ' OH ' ' B' ' 37' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 120.846 -1.159 . . . . 0.0 109.027 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.809 0 N-CA-C 119.414 2.526 . . . . 0.0 119.414 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.449 HG22 HD21 ' B' ' 32' ' ' LEU . 19.6 mt -89.22 -25.64 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -1.103 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 2.5 m -56.96 -30.55 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 109.724 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -78.37 1.68 21.16 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.496 -0.752 . . . . 0.0 109.706 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -105.63 -42.74 5.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 0.0 109.545 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 9' ' ' SER . 98.7 m -105.65 -39.99 5.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 0.0 110.065 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.595 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 2.2 t -58.28 -54.02 51.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.757 -1.214 . . . . 0.0 108.248 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.1 p -64.03 -68.97 0.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.065 . . . . 0.0 108.368 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 3.3 m -95.27 141.0 29.37 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.3 113.65 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.863 -1.148 . . . . 0.0 109.953 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.461 ' O ' HG13 ' B' ' 23' ' ' VAL . 22.7 m -77.96 -168.08 1.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.177 -0.952 . . . . 0.0 109.606 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 13' ' ' LEU . 6.3 p -122.34 142.1 50.85 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -43.11 -27.2 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.006 . . . . 0.0 109.644 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' SER . 86.9 t80 -62.53 -60.86 2.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.179 -0.951 . . . . 0.0 108.879 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -55.54 -41.71 73.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.305 -0.872 . . . . 0.0 109.044 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.582 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 1.6 mp -56.34 -45.99 80.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.186 -0.946 . . . . 0.0 108.787 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.81 -23.86 3.07 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -71.21 -38.67 72.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.57 -0.706 . . . . 0.0 109.159 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.582 ' CD2' ' HA ' ' A' ' 16' ' ' LEU . 23.1 m-85 -50.91 -32.81 21.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.077 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.456 ' SG ' ' HG3' ' B' ' 43' ' ' ARG . 1.7 m -85.78 52.32 2.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.407 -0.808 . . . . 0.0 109.394 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 t30 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.656 -179.794 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.586 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -79.77 -168.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.242 -0.911 . . . . 0.0 109.679 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 6.6 t30 87.86 -11.07 0.51 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -104.55 144.71 31.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.198 -0.939 . . . . 0.0 109.257 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -91.23 159.5 16.02 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.554 ' CD1' ' O ' ' B' ' 27' ' ' LEU . 0.3 OUTLIER -160.77 136.54 8.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.28 -1.512 . . . . 0.0 112.27 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.506 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -131.77 145.89 51.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.772 . . . . 0.0 109.009 178.244 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 28.34 -103.35 0.01 OUTLIER Glycine 0 N--CA 1.501 3.006 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.417 ' O ' HG23 ' B' ' 33' ' ' VAL . 16.1 t -41.21 -63.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.434 -1.039 . . . . 0.0 109.881 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.92 -33.74 18.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 108.64 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' B' ' 29' ' ' GLY . 0.3 OUTLIER -60.22 -65.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -0.861 . . . . 0.0 109.045 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.508 HG22 ' N ' ' B' ' 34' ' ' GLU . 35.4 m -49.49 -31.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 108.41 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.526 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 7.9 mt-10 -72.69 -59.0 2.93 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.537 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -60.7 -41.88 96.09 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.569 HD11 ' CD2' ' A' ' 19' ' ' TYR . 2.2 mm? -59.51 -30.4 68.55 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -80.12 -13.56 59.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.715 -0.615 . . . . 0.0 110.065 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -91.04 -47.08 7.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 108.609 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -63.49 -22.06 29.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.445 -0.785 . . . . 0.0 109.138 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' B' ' 43' ' ' ARG . 84.3 m -101.68 -41.63 6.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.26 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.54 -50.18 3.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' B' ' 43' ' ' ARG . 5.3 pt-20 -174.89 34.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -1.223 . . . . 0.0 109.797 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.513 ' HD3' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -43.03 150.03 0.18 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.559 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.93 -26.65 70.6 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.09 103.3 0.99 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.453 ' CG ' ' N ' ' B' ' 47' ' ' TYR . 0.1 OUTLIER -71.88 -156.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -1.127 . . . . 0.0 109.744 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . 0.453 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.425 -0.797 . . . . 0.0 109.626 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 1 N--CA 1.529 4.873 0 N-CA-C 119.436 2.534 . . . . 0.0 119.436 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.502 HG21 ' CD2' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -99.64 -27.82 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -1.19 . . . . 0.0 109.145 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 1.4 m -46.69 -29.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.941 . . . . 0.0 108.765 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 1' ' ' GLY . 0.9 OUTLIER -55.18 -19.65 8.43 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.55 -75.48 0.57 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.8 . . . . 0.0 109.795 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.558 ' O ' ' CD1' ' B' ' 32' ' ' LEU . 9.4 m -97.93 96.37 8.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.44 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 8.0 t 161.33 -33.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -3.36 21.97 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.544 ' C ' ' CE1' ' B' ' 26' ' ' HIS . 0.6 OUTLIER -156.06 -173.78 4.66 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.3 mm -91.9 142.09 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.019 -1.051 . . . . 0.0 109.396 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.4 -168.87 1.6 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.891 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.41 ' O ' HD11 ' A' ' 16' ' ' LEU . 23.5 p -145.75 144.8 30.55 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -43.58 -27.44 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 109.655 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -63.51 -53.16 56.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.658 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 4.1 mt-30 -58.48 -32.93 69.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 109.75 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.592 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 6.1 mp -67.85 -35.36 78.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.076 -1.015 . . . . 0.0 109.104 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.37 -22.12 62.93 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 25.3 m-80 -74.39 -37.51 63.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.571 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -67.84 -15.57 63.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 109.413 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 m -104.5 51.02 0.78 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.298 -0.876 . . . . 0.0 109.456 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.6 t30 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.462 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.609 0.718 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.57 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -154.8 173.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 121.645 -0.659 . . . . 0.0 109.562 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 10.0 p-10 153.37 49.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.27 151.59 30.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.41 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.544 ' CE1' ' C ' ' A' ' 9' ' ' SER . 2.2 t60 -72.4 -164.35 0.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.414 -0.804 . . . . 0.0 109.673 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.583 ' O ' ' CB ' ' B' ' 28' ' ' CYS . 0.4 OUTLIER -155.81 -171.38 3.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.583 ' CB ' ' O ' ' B' ' 27' ' ' LEU . 1.3 m 149.09 139.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.474 0.654 . . . . 0.0 109.792 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 34.57 -126.61 0.57 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.8 m -41.57 -53.43 3.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.405 -1.056 . . . . 0.0 109.71 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.505 ' O ' ' CD2' ' B' ' 27' ' ' LEU . 17.0 m-20 -44.41 -31.14 0.98 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.897 . . . . 0.0 109.17 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.558 ' CD1' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -74.49 -77.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.214 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.458 HG23 ' N ' ' B' ' 34' ' ' GLU . 9.4 m -41.6 -35.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.621 -0.674 . . . . 0.0 109.336 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.561 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 2.2 mp0 -70.28 -54.02 14.43 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.519 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -53.69 -56.41 17.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.16 -0.962 . . . . 0.0 109.462 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.551 ' CD1' ' CD2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -57.08 -20.88 27.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.97 -1.081 . . . . 0.0 108.162 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 89.3 t80 -84.96 -9.96 57.54 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.711 -0.618 . . . . 0.0 109.724 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -97.23 -42.62 7.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.085 -1.009 . . . . 0.0 108.961 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.426 HG21 ' SG ' ' B' ' 40' ' ' CYS . 1.7 m -72.52 -26.01 23.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.507 -0.745 . . . . 0.0 109.662 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.426 ' SG ' HG21 ' B' ' 39' ' ' VAL . 59.3 m -103.33 -11.84 17.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.181 -0.949 . . . . 0.0 109.786 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' B' ' 42' ' ' GLU . . . 49.76 25.44 6.98 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' B' ' 41' ' ' GLY . 0.2 OUTLIER 76.72 10.76 2.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -1.136 . . . . 0.0 109.259 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.12 154.95 5.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 0.0 109.418 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.28 -127.22 7.79 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.77 -91.02 2.2 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.89 -127.52 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -1.183 . . . . 0.0 109.188 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 120.752 -1.217 . . . . 0.0 109.378 179.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.894 0 N-CA-C 119.48 2.552 . . . . 0.0 119.48 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.9 mt -81.8 -46.03 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -1.111 . . . . 0.0 109.604 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 4.4 m -54.36 -18.82 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.78 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -92.21 -7.71 47.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.646 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.45 -31.31 9.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.13 -0.982 . . . . 0.0 110.114 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 9' ' ' SER . 83.5 m -105.3 -62.26 1.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.061 -1.025 . . . . 0.0 110.374 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 48.6 t -47.26 -28.58 2.0 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.388 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 t -69.88 -20.17 63.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.972 -1.08 . . . . 0.0 108.92 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.527 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 4.6 t -150.56 -151.24 0.38 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.42 128.32 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.945 -1.097 . . . . 0.0 109.498 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -111.4 164.84 12.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.849 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.491 ' CA ' HG13 ' B' ' 23' ' ' VAL . 14.5 p -108.17 141.92 39.18 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.54 ' CD2' HG11 ' B' ' 39' ' ' VAL . 0.1 OUTLIER -46.14 -28.28 1.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.827 -1.171 . . . . 0.0 109.151 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -53.52 -47.38 69.97 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.189 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.439 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 48.5 mm-40 -65.6 -40.86 93.13 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.6 ' HG ' ' CE2' ' A' ' 19' ' ' TYR . 7.9 mp -63.51 -34.68 78.32 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 4.1 mt-10 -54.95 -32.5 61.46 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -30.29 70.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.607 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -63.59 -41.92 98.3 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.18 -0.95 . . . . 0.0 108.695 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 m -91.11 53.7 2.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.777 . . . . 0.0 109.652 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.4 t30 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.466 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.491 HG13 ' CA ' ' A' ' 12' ' ' SER . 33.6 m -87.85 -158.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 122.059 0.933 . . . . 0.0 109.802 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.71 64.96 0.97 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.699 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.49 -177.19 5.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 109.233 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.537 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 1.2 t60 -138.02 169.06 18.44 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.696 ' O ' ' HB2' ' B' ' 28' ' ' CYS . 0.4 OUTLIER -161.13 -137.84 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.716 -1.24 . . . . 0.0 109.644 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.696 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.8 OUTLIER 137.13 134.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 33.54 -113.55 0.09 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -48.27 -56.23 8.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -1.032 . . . . 0.0 109.926 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.55 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 4.1 m-20 -44.36 -33.65 1.71 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -0.932 . . . . 0.0 109.095 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' B' ' 27' ' ' LEU . 0.8 OUTLIER -65.87 -71.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 108.943 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.509 HG23 ' N ' ' B' ' 34' ' ' GLU . 14.3 m -48.83 -24.47 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.518 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 5.4 mt-10 -75.34 -61.85 1.76 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.454 -0.779 . . . . 0.0 108.995 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.531 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.35 -44.0 83.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.519 HD11 ' CB ' ' A' ' 19' ' ' TYR . 2.4 mm? -57.31 -33.32 67.58 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.967 0.889 . . . . 0.0 108.725 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.423 ' CD2' HD22 ' B' ' 38' ' ' LEU . 11.8 t80 -77.3 -16.83 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.248 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -90.95 -33.55 15.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.111 -0.993 . . . . 0.0 108.904 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.54 HG11 ' CD2' ' A' ' 13' ' ' LEU . 1.4 m -88.93 -14.48 9.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.505 -0.747 . . . . 0.0 109.443 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' B' ' 43' ' ' ARG . 93.4 m -114.68 -10.58 12.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.375 -0.828 . . . . 0.0 109.364 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' B' ' 42' ' ' GLU . . . 46.29 67.74 1.27 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' B' ' 41' ' ' GLY . 2.0 pt-20 37.48 38.98 0.16 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.705 -0.88 . . . . 0.0 110.483 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' B' ' 40' ' ' CYS . 2.1 ttt85 -64.86 147.55 53.05 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 108.983 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.41 158.82 12.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.77 -1.62 87.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.84 -144.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -1.2 . . . . 0.0 109.388 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 6.8 t80 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 109.282 -179.817 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.816 0 N-CA-C 119.447 2.539 . . . . 0.0 119.447 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.584 HG23 ' CZ ' ' A' ' 19' ' ' TYR . 12.3 mt -89.85 -36.42 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -1.166 . . . . 0.0 109.554 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.437 HG11 ' N ' ' B' ' 29' ' ' GLY . 2.4 m -39.19 -31.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.63 -0.669 . . . . 0.0 110.534 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.456 ' O ' HG22 ' A' ' 8' ' ' THR . 4.8 mt-10 -68.93 -7.68 37.29 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.376 -0.828 . . . . 0.0 110.238 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.75 -35.42 7.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.065 -1.022 . . . . 0.0 110.251 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 9' ' ' SER . 96.7 m -105.36 -60.84 1.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.964 -1.085 . . . . 0.0 110.944 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.539 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 2.6 t -40.11 -60.31 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.022 -1.049 . . . . 0.0 109.946 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 4' ' ' GLU . 1.8 t -42.6 -29.31 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.169 -0.957 . . . . 0.0 109.248 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.617 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 18.3 m -142.47 -137.33 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.456 -0.777 . . . . 0.0 108.983 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.475 HG13 ' ND1' ' B' ' 26' ' ' HIS . 1.4 mt -146.85 113.61 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.589 -1.319 . . . . 0.0 109.299 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.446 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . 21.4 m -88.29 -167.26 1.82 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.42 -0.8 . . . . 0.0 110.096 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 p -115.02 159.28 20.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.098 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -50.85 -23.58 2.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.976 -1.077 . . . . 0.0 109.232 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 44.4 t80 -65.37 -48.34 73.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 108.812 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.446 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -57.82 -39.14 76.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 108.587 179.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.583 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 6.2 mp -65.16 -35.69 81.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.376 -0.828 . . . . 0.0 108.8 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 1.8 mm-40 -55.96 -27.53 52.98 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.08 -17.17 60.51 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.496 -0.753 . . . . 0.0 109.318 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.591 ' CD2' HD11 ' B' ' 36' ' ' LEU . 1.3 m-85 -72.81 -29.75 63.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 108.465 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.9 m -85.89 52.11 2.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 0.0 109.614 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.506 179.878 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.508 ' CZ ' HD21 ' A' ' 13' ' ' LEU . 12.2 p90 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.306 0.574 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.522 ' CG1' ' N ' ' B' ' 24' ' ' ASN . 0.7 OUTLIER -148.74 -159.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.428 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.522 ' N ' ' CG1' ' B' ' 23' ' ' VAL . 11.4 t-20 77.74 57.96 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.449 0.642 . . . . 0.0 109.347 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.57 142.92 39.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.323 -0.861 . . . . 0.0 109.299 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.617 ' CE1' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -90.92 144.1 26.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.568 ' CD1' ' O ' ' B' ' 27' ' ' LEU . 0.4 OUTLIER -154.07 145.7 23.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.348 -1.47 . . . . 0.0 112.133 -178.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' B' ' 32' ' ' LEU . 0.8 OUTLIER -124.92 -162.79 1.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.437 ' N ' HG11 ' A' ' 3' ' ' VAL . . . -37.47 -63.02 0.87 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.212 -0.93 . . . . 0.0 111.679 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.513 ' O ' HG21 ' B' ' 33' ' ' VAL . 1.4 p -69.77 -40.29 76.17 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.9 -1.353 . . . . 0.0 111.25 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.545 ' HB2' ' CA ' ' B' ' 27' ' ' LEU . 0.3 OUTLIER -70.71 -20.95 62.61 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.475 -1.391 . . . . 0.0 108.276 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.549 ' O ' ' CD2' ' B' ' 36' ' ' LEU . 0.6 OUTLIER -69.06 -70.22 0.29 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.513 HG21 ' O ' ' B' ' 30' ' ' SER . 33.2 m -43.66 -31.35 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.4 mt-10 -68.94 -54.61 14.49 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.42 -55.06 39.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 108.777 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.591 HD11 ' CD2' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -54.21 -21.94 10.22 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.041 -1.037 . . . . 0.0 108.248 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.511 ' O ' ' HA2' ' B' ' 41' ' ' GLY . 13.4 t80 -84.53 -6.43 59.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.543 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -105.76 -50.4 3.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.066 -1.021 . . . . 0.0 108.963 179.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.428 HG22 ' N ' ' B' ' 40' ' ' CYS . 1.8 m -67.03 -25.76 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.443 -0.786 . . . . 0.0 109.78 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.48 ' O ' ' C ' ' B' ' 41' ' ' GLY . 20.1 m -122.91 -21.13 5.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.921 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' B' ' 37' ' ' TYR . . . 40.52 29.72 0.27 Allowed Glycine 0 N--CA 1.496 2.637 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.517 ' HG2' ' N ' ' B' ' 46' ' ' PHE . 16.4 tp10 49.42 91.74 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.483 -1.01 . . . . 0.0 108.34 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 51.81 0.88 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.645 -0.659 . . . . 0.0 109.707 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.94 63.73 0.01 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . 0.466 ' C ' ' HG2' ' B' ' 42' ' ' GLU . . . 109.07 -140.98 15.85 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.517 ' N ' ' HG2' ' B' ' 42' ' ' GLU . 0.5 OUTLIER -120.15 177.9 4.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -1.191 . . . . 0.0 109.117 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . 0.539 ' OH ' ' CB ' ' B' ' 36' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.955 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 mm -104.82 -32.14 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -1.208 . . . . 0.0 109.617 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.568 ' CG1' ' CD2' ' B' ' 32' ' ' LEU . 0.9 OUTLIER -85.41 -41.33 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.614 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 5.9 mt-10 -70.44 -19.86 62.94 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.599 -0.688 . . . . 0.0 110.219 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -89.31 -34.79 16.44 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.125 -0.984 . . . . 0.0 109.48 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.5 m -105.83 -42.43 5.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 110.452 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.556 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 9.1 t -63.14 -18.12 63.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.934 -1.104 . . . . 0.0 110.062 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 4' ' ' GLU . 16.0 p -104.77 -38.5 6.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.077 -1.014 . . . . 0.0 108.516 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.7 -155.89 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.6 mm -129.75 83.34 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.979 -1.076 . . . . 0.0 109.57 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.1 m -59.71 171.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.291 -0.881 . . . . 0.0 109.61 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 13' ' ' LEU . 94.5 p -112.99 145.14 41.37 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -43.52 -27.48 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 108.966 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 28.5 t80 -62.54 -46.13 89.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.4 -0.813 . . . . 0.0 108.903 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -66.32 -49.37 67.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 109.007 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.589 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 9.0 mp -56.19 -31.98 63.94 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.311 -0.868 . . . . 0.0 109.118 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' OE1' ' CD ' ' B' ' 43' ' ' ARG . 1.3 mm-40 -58.65 -35.2 72.17 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.87 . . . . 0.0 108.745 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -75.09 -22.76 58.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.437 -0.789 . . . . 0.0 109.291 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.589 ' CD2' ' HA ' ' A' ' 16' ' ' LEU . 7.3 m-30 -60.28 -14.61 19.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.128 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -91.64 53.64 2.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.927 . . . . 0.0 109.385 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 p30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.417 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.582 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 0.8 OUTLIER -160.36 -157.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.907 . . . . 0.0 109.697 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 37.2 t-20 89.19 79.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.395 0.617 . . . . 0.0 109.835 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -161.0 -176.2 5.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.402 -0.811 . . . . 0.0 109.771 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.556 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -144.59 149.64 36.13 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -162.04 149.83 14.52 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.353 -1.467 . . . . 0.0 112.567 -178.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.505 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -135.38 158.67 43.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.518 -0.739 . . . . 0.0 109.264 177.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 25.49 -119.66 0.03 OUTLIER Glycine 0 N--CA 1.5 2.962 0 CA-C-O 121.62 0.567 . . . . 0.0 112.149 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.52 ' O ' ' CG2' ' B' ' 33' ' ' VAL . 54.5 m -35.77 -57.5 0.66 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.544 -0.974 . . . . 0.0 110.884 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.7 OUTLIER -45.31 -44.01 11.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.915 -1.116 . . . . 0.0 109.087 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.568 ' CD2' ' CG1' ' A' ' 3' ' ' VAL . 3.1 mp -54.14 -65.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.194 -0.941 . . . . 0.0 108.979 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' B' ' 30' ' ' SER . 18.1 m -51.36 -25.4 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.121 -0.987 . . . . 0.0 108.746 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.508 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.3 mt-10 -79.26 -58.41 3.24 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.557 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -60.65 -38.77 85.95 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.518 ' CD1' ' CB ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -61.32 -33.93 74.42 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.933 0.873 . . . . 0.0 108.745 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -74.91 -31.73 61.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.783 -0.573 . . . . 0.0 109.897 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.557 ' HG ' ' HA ' ' B' ' 35' ' ' ALA . 0.2 OUTLIER -70.49 -63.2 1.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.217 -0.927 . . . . 0.0 108.578 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -45.41 -27.24 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.45 ' O ' ' C ' ' B' ' 41' ' ' GLY . 1.3 m -118.93 36.56 4.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.739 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' B' ' 40' ' ' CYS . . . -41.35 -63.96 1.46 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -122.66 -22.95 5.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.069 -1.253 . . . . 0.0 109.946 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.493 ' CD ' ' OE1' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -81.53 111.47 17.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.451 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.14 91.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.02 110.06 0.72 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.52 23.4 0.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -1.096 . . . . 0.0 109.406 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.345 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.827 0 N-CA-C 119.433 2.533 . . . . 0.0 119.433 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.527 HD13 ' CE2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -91.74 -26.04 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -1.168 . . . . 0.0 109.182 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.499 HG12 ' CD2' ' B' ' 32' ' ' LEU . 4.7 m -75.7 -9.35 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.64 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.441 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.9 mt-10 -98.25 -10.89 23.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -105.34 -34.2 7.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.562 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.454 ' O ' ' C ' ' A' ' 7' ' ' CYS . 64.1 m -93.94 -66.23 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 109.704 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 18.6 t -41.42 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 9' ' ' SER . 2.1 t -66.31 135.05 53.85 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.557 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 1.5 m 75.65 -161.07 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 9' ' ' SER . 39.0 mm -128.5 130.67 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.61 -1.306 . . . . 0.0 110.248 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -166.54 1.62 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.476 -0.765 . . . . 0.0 109.593 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' C ' ' A' ' 13' ' ' LEU . 88.7 p -140.16 129.13 23.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -39.25 -33.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 109.781 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' SER . 27.8 t80 -57.7 -51.63 68.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.17 -0.956 . . . . 0.0 108.95 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.437 ' HG2' ' OG ' ' A' ' 12' ' ' SER . 15.4 mm100 -55.47 -44.96 76.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.873 . . . . 0.0 109.231 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.571 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 6.2 mp -57.05 -48.85 77.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -0.93 . . . . 0.0 109.247 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.471 ' OE2' ' CG2' ' B' ' 39' ' ' VAL . 0.9 OUTLIER -52.8 -23.32 6.68 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.108 -0.995 . . . . 0.0 108.399 179.322 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -75.49 -29.81 59.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.484 -0.76 . . . . 0.0 109.005 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.614 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.7 m-30 -72.63 -11.84 60.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 0.0 109.182 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 m -89.86 51.34 2.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 109.433 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.487 -179.927 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 8.0 p90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.165 0.507 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.59 ' CG1' ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -154.99 -158.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.935 . . . . 0.0 109.99 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.59 ' N ' ' CG1' ' B' ' 23' ' ' VAL . 25.4 m-20 69.64 102.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -153.48 152.22 30.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.702 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 9' ' ' SER . 1.4 t60 -121.69 149.05 43.79 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.595 ' CD2' ' CB ' ' B' ' 35' ' ' ALA . 0.0 OUTLIER -153.88 -158.59 0.88 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.469 -1.394 . . . . 0.0 110.95 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 148.77 146.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.77 -134.01 39.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.518 ' HA ' ' CG2' ' B' ' 33' ' ' VAL . 1.3 p -55.99 -46.25 78.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -1.131 . . . . 0.0 109.669 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' B' ' 30' ' ' SER . 9.0 m-20 -45.14 -43.27 9.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 108.555 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.533 ' O ' ' CD2' ' B' ' 36' ' ' LEU . 0.3 OUTLIER -60.1 -72.61 0.1 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.518 ' CG2' ' HA ' ' B' ' 30' ' ' SER . 14.8 m -45.12 -50.76 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.101 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.524 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.5 mp0 -56.06 -44.42 78.85 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.301 -0.874 . . . . 0.0 109.075 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.595 ' CB ' ' CD2' ' B' ' 27' ' ' LEU . . . -55.12 -58.95 5.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.362 -0.836 . . . . 0.0 109.255 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.558 ' CD1' ' CD2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -56.0 -24.01 36.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.046 -1.034 . . . . 0.0 108.32 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 72.6 t80 -79.94 -15.78 56.6 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' B' ' 35' ' ' ALA . 1.4 mt -83.74 -54.82 4.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 108.645 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.489 HG23 ' N ' ' B' ' 40' ' ' CYS . 2.5 m -54.16 -40.93 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.485 -0.759 . . . . 0.0 109.115 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.489 ' N ' HG23 ' B' ' 39' ' ' VAL . 79.0 m -99.31 17.41 20.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.338 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.06 -10.02 66.88 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -75.56 -26.06 57.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -1.22 . . . . 0.0 109.36 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.25 -172.65 2.31 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.446 -0.783 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.15 130.25 28.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.41 131.59 47.42 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' B' ' 47' ' ' TYR . 0.8 OUTLIER -161.4 -74.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -1.11 . . . . 0.0 109.329 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . 0.465 ' C ' ' O ' ' B' ' 46' ' ' PHE . 53.2 t80 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.577 -0.702 . . . . 0.0 110.267 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.784 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.7 mt -101.61 -17.42 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -1.095 . . . . 0.0 108.997 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.12 -11.4 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.491 -0.756 . . . . 0.0 110.502 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -101.94 -4.92 25.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.027 -1.045 . . . . 0.0 110.425 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.451 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 5.3 mm100 -105.33 -42.26 5.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.009 -1.057 . . . . 0.0 110.266 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' THR . 29.0 m -105.66 -57.9 1.98 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.184 -0.948 . . . . 0.0 110.901 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.558 ' HA ' ' CD2' ' B' ' 26' ' ' HIS . 0.9 OUTLIER -37.15 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.218 -0.926 . . . . 0.0 111.411 -178.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.3 t -68.83 -20.14 64.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.662 -1.274 . . . . 0.0 109.328 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.581 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 11.7 t -158.15 -170.69 3.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.685 ' HA ' ' ND1' ' B' ' 26' ' ' HIS . 0.8 OUTLIER -103.26 94.77 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.702 -1.249 . . . . 0.0 110.546 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 67.9 m -55.54 168.75 0.37 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 p -88.2 143.7 26.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.898 -1.126 . . . . 0.0 109.409 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -49.79 -24.09 2.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.978 . . . . 0.0 109.683 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -70.74 -38.79 73.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.182 -0.948 . . . . 0.0 109.072 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -66.6 -48.46 69.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.618 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.542 ' CD2' ' CD1' ' B' ' 36' ' ' LEU . 6.5 mp -55.71 -34.12 64.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.098 . . . . 0.0 108.567 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -63.13 -18.79 63.82 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -76.21 -28.87 57.38 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.485 -0.759 . . . . 0.0 109.059 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.9 m-30 -69.81 -5.49 25.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HA ' ' HA3' ' B' ' 45' ' ' GLY . 8.3 m -83.89 51.32 2.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -0.965 . . . . 0.0 109.603 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.91 -1.043 . . . . 0.0 109.484 179.874 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.553 0.692 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.618 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 2.3 p -160.7 -158.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.629 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 34.2 m120 109.32 32.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.979 0.895 . . . . 0.0 108.622 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.499 ' O ' HD12 ' A' ' 10' ' ' ILE . 6.2 tp-100 -160.65 160.97 32.24 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.685 ' ND1' ' HA ' ' A' ' 10' ' ' ILE . 5.3 t60 -126.63 161.92 26.95 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 116.889 -1.924 . . . . 0.0 114.503 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.586 ' O ' ' CB ' ' B' ' 28' ' ' CYS . 0.1 OUTLIER -97.39 -155.73 0.5 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 113.582 -1.644 . . . . 0.0 110.734 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.586 ' CB ' ' O ' ' B' ' 27' ' ' LEU . 2.2 m 141.05 143.96 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.35 -132.71 49.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 2.9 m -52.5 -46.37 66.59 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.91 -1.347 . . . . 0.0 108.039 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' B' ' 27' ' ' LEU . 23.3 m-20 -49.39 -31.1 8.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.406 -0.808 . . . . 0.0 109.201 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.585 ' HA ' ' CD1' ' B' ' 27' ' ' LEU . 0.4 OUTLIER -67.8 -68.04 0.42 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.249 -0.907 . . . . 0.0 108.875 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.556 ' HB ' ' CZ ' ' B' ' 47' ' ' TYR . 18.9 m -54.57 -36.64 36.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.365 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.541 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -64.28 -52.19 59.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.521 -0.737 . . . . 0.0 109.405 179.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.555 ' CB ' HD12 ' B' ' 27' ' ' LEU . . . -47.66 -61.28 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.052 . . . . 0.0 109.251 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.542 ' CD1' ' CD2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -55.39 -21.69 16.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.897 -1.127 . . . . 0.0 108.346 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 84.5 t80 -84.97 -11.26 55.9 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.656 -0.653 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -95.45 -54.29 3.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.147 -0.971 . . . . 0.0 108.582 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.471 HG21 ' N ' ' B' ' 40' ' ' CYS . 2.3 m -59.57 -26.7 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.471 ' N ' HG21 ' B' ' 39' ' ' VAL . 3.9 m -124.59 34.85 4.92 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.464 -0.773 . . . . 0.0 109.35 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.3 72.61 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -97.61 -20.52 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -1.214 . . . . 0.0 109.575 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -122.04 117.88 27.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -0.822 . . . . 0.0 109.495 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.39 173.62 19.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 20' ' ' CYS . . . -165.5 -124.55 0.71 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -82.62 -57.98 3.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 109.453 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . 0.556 ' CZ ' ' HB ' ' B' ' 33' ' ' VAL . 10.2 t80 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 109.419 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.818 0 N-CA-C 119.239 2.456 . . . . 0.0 119.239 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.577 HG23 ' CE2' ' A' ' 19' ' ' TYR . 0.5 OUTLIER -76.16 -31.57 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -1.135 . . . . 0.0 109.143 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 4.4 m -66.38 -33.09 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.453 ' O ' HG23 ' A' ' 8' ' ' THR . 0.9 OUTLIER -78.63 5.45 11.0 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 109.896 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -104.73 -43.4 5.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.115 -0.991 . . . . 0.0 109.207 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 9' ' ' SER . 89.3 m -105.63 -23.61 12.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 109.966 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.588 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 8.3 t -76.4 -28.37 56.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.902 -1.124 . . . . 0.0 109.262 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 4' ' ' GLU . 6.9 t -87.01 -32.49 20.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 1.1 t -134.74 147.56 50.06 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' B' ' 25' ' ' GLN . 1.1 mp -79.27 123.1 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.93 -1.106 . . . . 0.0 109.501 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.9 m -90.6 -167.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -0.797 . . . . 0.0 109.704 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.469 ' O ' HD11 ' A' ' 16' ' ' LEU . 52.5 p -122.68 150.24 42.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.475 -0.766 . . . . 0.0 109.148 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.646 ' CD1' ' CD2' ' B' ' 22' ' ' PHE . 2.4 tt -44.12 -28.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.895 . . . . 0.0 109.238 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.402 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 10.6 m-85 -64.14 -55.18 23.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.861 . . . . 0.0 109.118 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -41.78 77.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.959 . . . . 0.0 109.071 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.469 HD11 ' O ' ' A' ' 12' ' ' SER . 6.8 mp -61.82 -36.47 81.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.154 -0.966 . . . . 0.0 108.978 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 8.3 mt-10 -56.58 -30.45 63.2 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.249 -0.907 . . . . 0.0 108.641 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.5 -31.13 69.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.582 ' CD2' HD12 ' B' ' 36' ' ' LEU . 2.6 m-85 -54.65 -41.75 70.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 108.668 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.3 50.92 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.47 -0.769 . . . . 0.0 109.387 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.626 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.646 ' CD2' ' CD1' ' A' ' 13' ' ' LEU . 41.3 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -151.18 -172.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.935 -1.103 . . . . 0.0 109.374 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER 40.07 49.29 2.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 110.049 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLN . . . . . 0.521 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 1.4 mt-30 -160.05 155.75 25.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.8 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' HIS . . . . . 0.547 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -121.34 171.97 8.37 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.588 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -160.89 -142.53 0.08 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.351 -1.468 . . . . 0.0 110.863 -179.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 148.4 131.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 123.824 0.85 . . . . 0.0 108.996 -178.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' B' ' 32' ' ' LEU . . . 37.06 -116.9 0.4 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.467 ' O ' HG23 ' B' ' 33' ' ' VAL . 0.3 OUTLIER -43.2 -61.4 1.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.439 -1.036 . . . . 0.0 109.401 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.484 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 7.2 m-20 -45.37 -27.39 0.68 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -0.938 . . . . 0.0 108.984 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' B' ' 29' ' ' GLY . 0.2 OUTLIER -80.34 -72.24 0.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.848 . . . . 0.0 109.328 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 30' ' ' SER . 16.8 m -44.66 -29.35 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 108.87 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.533 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.0 OUTLIER -69.79 -60.33 2.38 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.553 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -60.61 -43.37 97.53 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.582 HD12 ' CD2' ' A' ' 19' ' ' TYR . 3.7 mm? -59.08 -29.27 67.21 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.468 -0.77 . . . . 0.0 109.162 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 37' ' ' TYR . 13.8 t80 -78.76 -10.64 59.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.593 -0.692 . . . . 0.0 109.597 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -95.24 -36.87 11.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.0 109.253 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 16' ' ' LEU . 3.4 m -72.46 -28.49 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.277 -0.889 . . . . 0.0 109.438 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' CYS . . . . . 0.539 ' HB3' ' CB ' ' B' ' 43' ' ' ARG . 72.5 m -79.84 -37.24 35.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.106 -0.996 . . . . 0.0 109.259 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' GLY . . . . . 0.495 ' C ' ' CG ' ' B' ' 42' ' ' GLU . . . 77.52 98.23 0.2 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.495 ' CG ' ' C ' ' B' ' 41' ' ' GLY . 2.5 pt-20 37.99 37.75 0.16 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.61 -0.935 . . . . 0.0 110.407 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.539 ' CB ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -93.86 -170.97 2.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.085 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 43' ' ' ARG . . . -43.58 112.37 0.55 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.26 -6.3 88.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.41 -168.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.407 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' N ' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 1 N--CA 1.53 4.923 0 N-CA-C 119.457 2.543 . . . . 0.0 119.457 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.581 ' CG2' ' CE2' ' A' ' 19' ' ' TYR . 12.6 mt -93.29 -34.01 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.129 -1.218 . . . . 0.0 109.577 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 4.3 m -65.94 -28.01 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.375 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 1' ' ' GLY . 4.9 mt-10 -80.58 2.18 26.63 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.487 -0.758 . . . . 0.0 109.666 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.25 -45.69 4.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.58 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 56.0 m -97.99 -33.11 11.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.912 . . . . 0.0 109.815 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -73.07 -12.97 61.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.947 . . . . 0.0 109.808 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.3 t -100.38 -34.3 10.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.079 -1.013 . . . . 0.0 108.922 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -136.97 159.23 42.49 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.457 HG22 ' O ' ' B' ' 25' ' ' GLN . 23.7 mm -79.41 96.62 2.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 109.513 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.458 ' O ' HG23 ' B' ' 23' ' ' VAL . 9.1 p -76.97 159.58 29.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -0.818 . . . . 0.0 109.794 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.539 ' HA ' HG22 ' B' ' 23' ' ' VAL . 59.1 p -89.03 144.69 25.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 109.338 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.517 HD13 ' CG1' ' B' ' 39' ' ' VAL . 1.4 tp -46.82 -24.89 0.65 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.283 -0.886 . . . . 0.0 109.108 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 6.5 t80 -71.72 -32.62 67.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -0.927 . . . . 0.0 109.135 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 12' ' ' SER . 5.4 mm100 -66.53 -35.79 81.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.188 -0.945 . . . . 0.0 108.456 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.623 ' CD1' ' CE2' ' A' ' 19' ' ' TYR . 3.2 mm? -66.19 -35.17 79.75 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -48.46 -36.21 14.53 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -74.7 -21.51 59.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.428 -0.795 . . . . 0.0 109.329 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.623 ' CE2' ' CD1' ' A' ' 16' ' ' LEU . 3.2 m-30 -60.04 -19.37 52.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.341 -0.85 . . . . 0.0 109.27 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.3 m -97.44 52.05 1.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.387 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.486 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' B' ' 22' ' ' PHE . 38.5 p90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.226 0.536 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 12' ' ' SER . 4.7 p -114.08 -170.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 108.981 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.525 ' ND2' HG12 ' B' ' 23' ' ' VAL . 33.3 m-20 82.84 36.28 0.05 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.697 -0.627 . . . . 0.0 109.495 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.457 ' O ' HG22 ' A' ' 10' ' ' ILE . 2.5 mt-30 -140.95 175.7 9.41 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -133.54 176.34 8.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.868 -1.145 . . . . 0.0 109.066 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.581 ' O ' ' HB2' ' B' ' 28' ' ' CYS . 0.1 OUTLIER -160.28 -164.93 1.35 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.763 -1.21 . . . . 0.0 111.072 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.581 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 146.16 153.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.45 -119.06 4.54 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -64.47 -52.47 57.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.3 -1.118 . . . . 0.0 110.115 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' B' ' 30' ' ' SER . 17.1 m-20 -43.55 -38.83 3.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.077 -1.015 . . . . 0.0 109.63 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -71.06 0.22 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.096 -1.003 . . . . 0.0 108.956 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' B' ' 30' ' ' SER . 32.2 m -47.9 -27.56 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.098 -1.001 . . . . 0.0 108.602 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 9.4 mt-10 -74.65 -59.57 2.67 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.505 -0.747 . . . . 0.0 109.087 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.526 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -58.92 -41.96 88.54 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.532 HD11 ' CD2' ' A' ' 19' ' ' TYR . 1.1 mm? -60.27 -29.03 68.54 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.674 0.75 . . . . 0.0 109.027 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 39.8 t80 -83.09 -13.51 55.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.68 -0.638 . . . . 0.0 110.247 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -90.02 -44.22 10.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.063 -1.023 . . . . 0.0 108.803 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.517 ' CG1' HD13 ' A' ' 13' ' ' LEU . 1.9 m -66.27 -37.69 80.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.558 -0.714 . . . . 0.0 109.314 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.481 ' N ' HG21 ' B' ' 39' ' ' VAL . 1.3 m -105.5 17.51 23.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.796 . . . . 0.0 109.439 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -56.96 -85.96 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.494 ' HG2' ' N ' ' B' ' 43' ' ' ARG . 28.2 tt0 -55.11 -88.47 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -1.152 . . . . 0.0 109.357 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.494 ' N ' ' HG2' ' B' ' 42' ' ' GLU . 0.4 OUTLIER -46.83 174.33 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.543 -0.723 . . . . 0.0 109.379 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.31 -92.64 1.73 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 30.97 6.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.63 -155.0 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -1.143 . . . . 0.0 109.648 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' B' ' 48' ' ' THR . 9.8 t80 -144.64 -93.39 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 0.0 109.526 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.498 ' N ' ' CG ' ' B' ' 47' ' ' TYR . 22.8 m -169.68 -35.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.598 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tttp 69.14 74.18 0.29 Allowed Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.476 -0.765 . . . . 0.0 109.368 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.494 ' HD3' ' CE2' ' B' ' 47' ' ' TYR . 34.5 Cg_endo -76.87 176.17 10.46 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.696 2.264 . . . . 0.0 110.58 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' B' ' 51' ' ' THR . 20.2 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.489 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.799 0 N-CA-C 119.273 2.469 . . . . 0.0 119.273 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.542 HG23 ' CD2' ' B' ' 32' ' ' LEU . 18.2 mm -78.69 -62.18 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -1.108 . . . . 0.0 109.208 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m -72.3 -13.79 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.17 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -89.11 -8.32 54.05 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.411 ' O ' HG22 ' A' ' 8' ' ' THR . 0.5 OUTLIER -97.52 -51.57 4.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 109.277 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.519 ' O ' ' O ' ' A' ' 9' ' ' SER . 17.3 m -85.94 -69.84 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.887 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 2.4 t -41.56 -25.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.033 . . . . 0.0 110.724 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.7 t -72.42 -27.08 62.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.86 -1.15 . . . . 0.0 109.238 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 6' ' ' CYS . 18.0 m -156.61 -157.66 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 mm -107.07 116.02 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.462 -1.399 . . . . 0.0 109.231 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.431 ' O ' HG22 ' B' ' 23' ' ' VAL . 2.5 p -99.05 172.84 7.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 109.649 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.2 p -106.87 150.78 26.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.806 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.481 ' HG ' HG11 ' B' ' 39' ' ' VAL . 0.3 OUTLIER -46.52 -28.24 1.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.686 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 14.9 t80 -61.82 -45.46 93.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 108.808 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.58 -54.13 47.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.368 -0.833 . . . . 0.0 109.418 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.58 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 1.6 mm? -51.33 -38.64 54.18 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.17 -0.956 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -49.36 -34.06 15.07 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.13 -21.81 58.6 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.602 ' CD2' HD12 ' B' ' 36' ' ' LEU . 3.3 m-85 -68.02 -16.93 64.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 0.0 109.435 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.3 m -82.21 51.26 1.75 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 0.0 109.564 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.48 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.252 0.548 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.58 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 0.8 OUTLIER -126.15 -155.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.0 109.631 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.58 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 2.5 t-20 86.68 4.72 0.39 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.287 0.565 . . . . 0.0 109.568 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -121.37 153.77 37.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.822 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -77.86 164.87 24.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.542 HD13 ' O ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -161.76 132.93 5.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.339 -1.475 . . . . 0.0 112.807 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.453 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -138.38 155.9 48.1 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 37.17 -115.2 0.29 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.442 ' HA ' HG22 ' B' ' 33' ' ' VAL . 4.1 m -47.75 -65.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.455 -1.027 . . . . 0.0 110.842 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' B' ' 30' ' ' SER . 5.6 m-20 -42.48 -39.11 2.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 109.418 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.542 ' CD2' HG23 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -65.99 -73.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 108.945 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.512 HG21 ' N ' ' B' ' 34' ' ' GLU . 15.9 m -43.86 -28.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.146 -0.971 . . . . 0.0 108.69 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.519 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -78.18 -61.63 1.94 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.528 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -56.67 -39.42 73.73 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.602 HD12 ' CD2' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -64.14 -34.13 77.35 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.942 0.877 . . . . 0.0 108.806 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.413 ' O ' ' HA2' ' B' ' 41' ' ' GLY . 20.4 t80 -75.97 -22.33 56.0 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.742 -0.599 . . . . 0.0 110.077 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.528 ' HG ' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -76.5 -53.41 8.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.944 -1.097 . . . . 0.0 108.484 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.492 HG22 ' HB3' ' A' ' 16' ' ' LEU . 2.6 m -54.1 -32.24 22.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.515 ' HB3' ' CD ' ' B' ' 43' ' ' ARG . 1.3 m -122.83 39.59 3.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.506 -0.746 . . . . 0.0 109.713 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' B' ' 37' ' ' TYR . . . -53.45 -32.3 45.13 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.73 7.65 9.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -1.181 . . . . 0.0 109.94 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.515 ' CD ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -116.05 139.75 49.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 108.947 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.08 153.73 17.29 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.34 -151.95 6.18 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.22 31.81 0.24 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.233 -1.157 . . . . 0.0 109.636 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.63 -18.4 11.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.447 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 5.8 m -62.19 -27.1 68.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 109.577 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -154.79 87.51 3.37 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.412 -0.805 . . . . 0.0 109.2 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.28 170.5 19.88 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.705 2.27 . . . . 0.0 110.651 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.49 -179.864 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.2 mt -92.55 -28.94 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.941 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 1.4 m -62.22 -37.41 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.369 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 3.0 mt-10 -76.06 -1.17 24.63 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.362 -0.836 . . . . 0.0 109.644 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -43.4 4.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.108 -0.995 . . . . 0.0 110.045 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 9' ' ' SER . 95.6 m -103.72 -29.35 11.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.103 -0.998 . . . . 0.0 110.093 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 2.5 t -69.26 -6.98 32.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.042 -1.036 . . . . 0.0 109.349 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -99.6 -31.3 11.66 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.943 . . . . 0.0 108.526 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 6' ' ' CYS . 4.2 m -147.45 165.24 30.84 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 10' ' ' ILE . 3.9 mm -80.15 110.42 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.104 -0.997 . . . . 0.0 109.548 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 78.4 m -74.8 -170.71 1.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.662 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 13' ' ' LEU . 87.5 p -121.13 136.04 55.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -42.81 -26.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.168 -0.957 . . . . 0.0 109.776 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -62.79 -49.34 75.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.125 -0.984 . . . . 0.0 108.888 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -65.07 -44.94 87.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 0.0 108.865 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.601 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 3.3 mp -55.65 -37.16 67.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.107 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 7.0 mm-40 -54.03 -34.5 60.17 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.286 -0.884 . . . . 0.0 108.749 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -21.98 61.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.414 -0.804 . . . . 0.0 109.485 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.601 ' CD2' ' HA ' ' A' ' 16' ' ' LEU . 5.0 m-30 -62.44 -29.41 70.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.7 m -82.57 53.79 2.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.891 . . . . 0.0 109.276 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.4 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.538 ' O ' ' CD2' ' B' ' 22' ' ' PHE . 52.4 p90 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.59 ' O ' ' HB3' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -143.53 171.15 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.041 -1.037 . . . . 0.0 110.008 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.59 ' HB3' ' O ' ' B' ' 23' ' ' VAL . 2.2 p-10 167.5 -29.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.56 -171.04 3.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.536 -0.728 . . . . 0.0 109.932 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -118.79 -169.82 1.79 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -0.846 . . . . 0.0 109.022 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.606 ' O ' ' HB2' ' B' ' 28' ' ' CYS . 0.3 OUTLIER -160.77 -159.27 0.66 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.751 -1.218 . . . . 0.0 110.415 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.606 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 145.9 141.9 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 123.558 0.743 . . . . 0.0 109.17 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 35.64 -118.19 0.35 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.485 ' O ' HG23 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -42.61 -62.83 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.427 -1.043 . . . . 0.0 110.177 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -43.99 -31.63 0.95 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.048 -1.033 . . . . 0.0 109.166 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.472 HD13 ' CA ' ' B' ' 28' ' ' CYS . 0.3 OUTLIER -68.69 -66.9 0.51 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.221 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.519 HG23 ' N ' ' B' ' 34' ' ' GLU . 30.6 m -51.52 -28.64 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.995 -1.066 . . . . 0.0 108.489 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.519 ' N ' HG23 ' B' ' 33' ' ' VAL . 1.1 mp0 -76.0 -58.77 3.08 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.541 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.55 -47.31 82.38 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.489 HD12 ' HB3' ' A' ' 19' ' ' TYR . 1.1 mm? -56.49 -29.01 61.29 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.781 0.8 . . . . 0.0 108.959 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' B' ' 33' ' ' VAL . 70.7 t80 -82.41 -15.09 53.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.828 -0.545 . . . . 0.0 109.988 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.541 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.4 OUTLIER -87.32 -46.64 9.5 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.476 HG23 ' N ' ' B' ' 40' ' ' CYS . 2.7 m -65.95 -21.37 28.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' B' ' 43' ' ' ARG . 1.3 m -119.9 27.09 8.89 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.451 -0.781 . . . . 0.0 109.235 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' B' ' 40' ' ' CYS . . . -43.45 -26.9 0.71 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' B' ' 40' ' ' CYS . 25.9 tt0 -90.92 -23.05 20.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -1.175 . . . . 0.0 109.644 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' B' ' 40' ' ' CYS . 2.0 ttt180 -110.25 159.37 17.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.406 -0.809 . . . . 0.0 109.222 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -178.45 142.57 5.53 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 47' ' ' TYR . . . 115.94 -67.59 0.29 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 60.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 0.0 109.529 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.496 ' O ' ' OG1' ' B' ' 48' ' ' THR . 72.1 t80 -114.73 -17.36 11.63 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.346 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' B' ' 47' ' ' TYR . 4.3 m -174.27 -18.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.219 -0.925 . . . . 0.0 111.381 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -113.01 85.57 8.11 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.647 -1.283 . . . . 0.0 109.465 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' B' ' 48' ' ' THR . 35.9 Cg_endo -76.42 -179.58 5.44 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.599 2.199 . . . . 0.0 110.695 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' B' ' 50' ' ' PRO . 41.8 p . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.345 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.872 0 N-CA-C 119.369 2.508 . . . . 0.0 119.369 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.58 HG22 ' CE2' ' A' ' 19' ' ' TYR . 22.3 mt -89.06 -31.73 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -1.139 . . . . 0.0 109.399 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 1.6 m -47.09 -40.14 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.22 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 6.4 mt-10 -56.47 -16.32 5.67 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.641 -0.662 . . . . 0.0 110.103 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -105.34 -31.08 9.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 110.303 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.449 ' HB3' HD11 ' B' ' 27' ' ' LEU . 7.3 m -103.01 -31.2 10.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.039 . . . . 0.0 110.127 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 1.5 m -84.84 -13.82 49.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.32 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.8 -13.29 15.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.037 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.5 m -150.65 158.36 44.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.354 -0.841 . . . . 0.0 109.07 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.457 ' HA ' HD12 ' A' ' 10' ' ' ILE . 20.4 mm -80.86 97.99 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 0.0 109.622 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.457 ' SG ' HD11 ' A' ' 16' ' ' LEU . 3.7 p -82.06 171.46 14.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 109.373 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 13' ' ' LEU . 59.3 p -111.03 148.49 32.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.239 -0.913 . . . . 0.0 109.828 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' HG ' HG11 ' B' ' 39' ' ' VAL . 0.6 OUTLIER -45.45 -28.94 0.98 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.058 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -59.08 -53.41 58.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.368 -0.832 . . . . 0.0 109.024 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 27.5 mm-40 -61.43 -29.11 69.73 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.286 -0.884 . . . . 0.0 109.048 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.525 ' CD2' HD13 ' B' ' 36' ' ' LEU . 6.9 mp -71.22 -38.92 72.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.258 -0.901 . . . . 0.0 108.7 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.45 -32.75 63.02 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -73.38 -26.87 61.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.433 -0.792 . . . . 0.0 109.277 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.58 ' CE2' HG22 ' A' ' 2' ' ' ILE . 6.2 m-30 -58.79 -19.79 44.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 108.814 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.67 51.75 1.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -0.768 . . . . 0.0 109.247 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.333 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.397 0.618 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -157.4 -158.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.368 -0.832 . . . . 0.0 109.865 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' B' ' 23' ' ' VAL . 30.3 m-20 74.07 30.23 1.27 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -127.86 154.23 45.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.386 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.524 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -100.76 -178.35 3.75 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.592 ' CD1' ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -161.0 -159.6 0.68 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.787 -1.195 . . . . 0.0 110.225 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.577 ' CB ' ' O ' ' B' ' 27' ' ' LEU . 1.2 m 149.35 150.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.49 -127.86 27.09 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.439 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.9 OUTLIER -58.34 -51.08 71.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.286 -1.126 . . . . 0.0 109.83 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 30' ' ' SER . 3.2 m-20 -43.35 -42.87 4.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 109.26 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.518 ' CD1' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -63.09 -76.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.918 . . . . 0.0 109.502 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.527 HG12 ' CE1' ' B' ' 47' ' ' TYR . 14.4 m -44.45 -33.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.029 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.527 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 2.5 mm-40 -62.97 -52.71 61.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.477 -0.764 . . . . 0.0 109.151 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -55.9 -52.96 62.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.535 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -57.37 -29.96 64.46 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.892 -1.13 . . . . 0.0 107.955 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.48 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 86.3 t80 -73.27 -11.95 60.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.558 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -97.06 -51.2 4.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.979 . . . . 0.0 108.74 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.472 HG11 ' HG ' ' A' ' 13' ' ' LEU . 2.3 m -48.33 -36.66 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.517 ' CB ' ' HB3' ' B' ' 43' ' ' ARG . 0.9 OUTLIER -93.71 -53.37 4.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.389 -0.819 . . . . 0.0 109.157 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.72 -50.42 3.58 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -116.86 22.36 12.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.186 . . . . 0.0 110.058 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.517 ' HB3' ' CB ' ' B' ' 40' ' ' CYS . 0.2 OUTLIER -56.31 -176.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.0 . . . . 0.0 109.15 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.68 155.35 49.69 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.12 56.5 4.35 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -147.05 140.2 25.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.527 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.527 ' CE1' HG12 ' B' ' 33' ' ' VAL . 32.4 t80 -175.27 88.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.432 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.502 ' O ' ' CB ' ' B' ' 49' ' ' LYS . 3.1 m -112.04 -50.51 2.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' B' ' 50' ' ' PRO . 2.1 tttp 165.37 -55.5 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.526 -0.734 . . . . 0.0 109.328 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 35.6 Cg_endo -76.45 -177.88 4.05 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.379 2.052 . . . . 0.0 110.744 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.561 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.883 0 N-CA-C 119.388 2.515 . . . . 0.0 119.388 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.426 ' O ' HG21 ' A' ' 2' ' ' ILE . 39.7 mt -74.49 -25.98 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.567 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG13 HD22 ' B' ' 32' ' ' LEU . 1.3 m -71.3 -30.58 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.67 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.13 -10.73 53.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.619 -0.675 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -31.3 9.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.868 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 9' ' ' SER . 95.5 m -105.01 -34.53 7.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.982 -1.074 . . . . 0.0 110.076 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.538 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 1.8 t -63.44 -10.99 19.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.015 -1.053 . . . . 0.0 109.65 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.426 ' CG2' ' N ' ' A' ' 9' ' ' SER . 14.6 t -104.99 -37.9 6.8 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 6' ' ' CYS . 7.9 m -127.2 147.8 50.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.489 ' CG1' ' O ' ' B' ' 25' ' ' GLN . 0.9 OUTLIER -78.87 91.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.993 -1.067 . . . . 0.0 109.212 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.509 ' O ' ' CG2' ' B' ' 23' ' ' VAL . 59.7 m -54.74 172.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.434 -0.791 . . . . 0.0 109.498 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.558 ' HA ' HG22 ' B' ' 23' ' ' VAL . 85.6 p -106.81 155.34 19.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 109.531 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.513 ' HG ' HG11 ' B' ' 39' ' ' VAL . 0.8 OUTLIER -45.51 -26.81 0.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.244 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -67.27 -44.35 79.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 10.0 mt-30 -65.47 -43.35 90.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' B' ' 36' ' ' LEU . 6.8 mp -61.72 -34.03 75.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.014 -1.054 . . . . 0.0 109.081 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.87 -23.61 61.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.3 m-80 -75.62 -24.37 56.49 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.53 -0.731 . . . . 0.0 109.615 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.632 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.6 m-30 -77.83 3.75 13.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.016 -1.052 . . . . 0.0 109.478 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 13.6 m -123.27 69.1 1.01 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 109.794 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 20' ' ' CYS . 17.4 p30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.421 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.465 ' HA ' HD11 ' A' ' 13' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 12' ' ' SER . 1.3 p -95.44 -159.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.213 -0.929 . . . . 0.0 108.603 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 6.5 t-20 78.08 30.44 0.44 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.489 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -155.54 162.62 40.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.436 -0.79 . . . . 0.0 109.127 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.538 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -110.74 179.93 3.93 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.519 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -160.24 -168.35 2.16 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.343 -1.473 . . . . 0.0 111.968 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.523 ' HA ' ' CD1' ' B' ' 32' ' ' LEU . 0.5 OUTLIER 151.38 147.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.66 -115.58 2.66 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 68.0 m -63.74 -57.58 9.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -1.132 . . . . 0.0 110.047 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' B' ' 30' ' ' SER . 6.6 m-20 -43.83 -36.23 2.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.205 -0.935 . . . . 0.0 109.437 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.545 ' O ' ' CD2' ' B' ' 36' ' ' LEU . 0.1 OUTLIER -67.85 -76.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.215 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.457 HG21 ' N ' ' B' ' 34' ' ' GLU . 3.5 m -44.51 -29.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 108.673 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.53 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 7.1 mt-10 -66.07 -55.58 15.86 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.511 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -55.17 -55.21 33.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.347 -0.846 . . . . 0.0 108.787 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' B' ' 32' ' ' LEU . 0.5 OUTLIER -58.3 -18.44 27.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 108.637 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 23.3 t80 -86.12 -14.49 44.03 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -89.47 -42.11 11.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 108.805 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.513 HG11 ' HG ' ' A' ' 13' ' ' LEU . 2.3 m -75.62 -20.81 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.485 -0.759 . . . . 0.0 109.261 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.422 ' SG ' HG23 ' B' ' 39' ' ' VAL . 55.6 m -111.2 6.04 20.4 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.324 -0.86 . . . . 0.0 109.757 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.34 -12.29 83.67 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -82.24 -72.11 0.45 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -1.12 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -175.01 1.84 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.464 -0.772 . . . . 0.0 109.617 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.01 -94.08 1.69 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.94 -119.63 5.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' B' ' 51' ' ' THR . 0.7 OUTLIER -149.94 27.42 0.79 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -1.132 . . . . 0.0 109.383 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.19 21.45 2.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.63 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 2.5 m -90.17 -13.97 34.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.375 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.566 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 2.5 tttt -168.32 -62.23 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.674 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 33.8 Cg_endo -72.94 172.96 14.36 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.948 1.765 . . . . 0.0 110.504 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.433 ' C ' ' O ' ' B' ' 50' ' ' PRO . 24.2 p . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.612 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.914 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.448 HD12 HD11 ' B' ' 36' ' ' LEU . 6.7 tt -102.99 -13.14 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.232 -1.158 . . . . 0.0 109.659 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.558 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 10.9 m -99.65 -30.46 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 109.17 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.489 ' O ' ' CG2' ' A' ' 8' ' ' THR . 10.1 mt-10 -82.68 -4.95 58.55 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.308 -0.87 . . . . 0.0 109.958 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.55 -34.93 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -0.991 . . . . 0.0 110.01 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.406 ' SG ' ' OH ' ' A' ' 19' ' ' TYR . 82.0 m -105.42 -30.31 9.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 110.412 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.558 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 4.5 t -71.57 -6.76 43.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.147 -0.97 . . . . 0.0 109.821 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -119.86 -14.33 8.98 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.234 -0.916 . . . . 0.0 108.815 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 68.0 m -136.88 -165.68 1.78 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mm -120.99 92.35 2.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 109.548 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.431 ' O ' HG21 ' B' ' 23' ' ' VAL . 28.0 m -71.66 171.68 11.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.482 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 13' ' ' LEU . 25.4 p -116.12 153.42 31.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.875 . . . . 0.0 108.861 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' B' ' 22' ' ' PHE . 0.8 OUTLIER -44.44 -29.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.101 -0.999 . . . . 0.0 109.083 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.32 -50.42 73.68 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.254 -0.904 . . . . 0.0 108.694 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.436 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 3.6 mm-40 -65.45 -35.58 81.34 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.59 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 3.4 mp -65.69 -33.91 76.98 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -25.25 63.98 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.88 -34.5 62.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.427 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.4 m-30 -59.4 -20.08 52.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 108.78 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.18 54.31 2.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.362 -0.836 . . . . 0.0 109.469 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.479 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.465 ' HA ' ' CD1' ' A' ' 13' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.554 HG11 ' N ' ' B' ' 24' ' ' ASN . 1.4 p -82.56 -166.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.422 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.554 ' N ' HG11 ' B' ' 23' ' ' VAL . 8.2 t30 46.47 38.66 5.65 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.559 -0.713 . . . . 0.0 109.308 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.17 169.11 24.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.881 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.538 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 1.1 t60 -125.98 172.01 10.29 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.574 ' CD1' ' CD1' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -161.29 -166.84 1.62 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.327 -1.483 . . . . 0.0 111.639 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 150.78 153.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 123.419 0.688 . . . . 0.0 109.265 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.79 -117.54 2.2 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.446 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.4 OUTLIER -60.84 -57.59 12.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -1.072 . . . . 0.0 110.28 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' B' ' 30' ' ' SER . 13.5 m-20 -42.28 -31.5 0.4 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.236 -0.915 . . . . 0.0 109.68 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.574 ' CD1' ' CD1' ' B' ' 27' ' ' LEU . 1.0 OUTLIER -70.46 -68.46 0.42 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.156 -0.965 . . . . 0.0 108.87 179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.48 HG21 ' N ' ' B' ' 34' ' ' GLU . 33.5 m -51.74 -35.26 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.125 -0.985 . . . . 0.0 108.733 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.536 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 4.7 mt-10 -69.68 -52.94 21.17 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.376 -0.828 . . . . 0.0 108.982 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.53 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -62.99 -42.97 99.99 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.448 HD11 HD12 ' A' ' 2' ' ' ILE . 1.6 mm? -60.32 -30.5 69.55 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.894 0.854 . . . . 0.0 108.698 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.414 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 13.3 t80 -77.37 -14.1 59.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.671 -0.643 . . . . 0.0 109.882 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.536 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -88.27 -53.7 4.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 108.609 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.522 HG11 ' CD2' ' A' ' 16' ' ' LEU . 2.2 m -54.57 -27.11 17.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . . . . . . . . . 55.7 m -119.61 35.45 4.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.467 -0.771 . . . . 0.0 109.558 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.16 51.2 3.53 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -172.91 -34.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -1.116 . . . . 0.0 109.481 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 44' ' ' GLY . 7.0 ttt85 -92.71 153.13 19.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.493 -0.754 . . . . 0.0 109.311 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' B' ' 43' ' ' ARG . . . -54.67 -106.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.66 145.18 1.05 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.6 -156.24 0.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -1.177 . . . . 0.0 109.632 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.58 44.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 0.0 109.777 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.22 -74.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.301 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.37 104.13 0.34 Allowed Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -76.01 157.15 38.64 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.443 2.095 . . . . 0.0 110.666 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.439 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.813 0 N-CA-C 119.313 2.485 . . . . 0.0 119.313 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.407 HG22 HD21 ' B' ' 32' ' ' LEU . 7.9 mt -102.34 -45.66 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -1.16 . . . . 0.0 109.607 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.4 m -49.76 -34.47 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.703 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.457 ' O ' ' OG1' ' A' ' 8' ' ' THR . 2.6 mt-10 -77.38 -7.6 56.35 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 109.851 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -40.72 5.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 110.142 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 9' ' ' SER . 69.0 m -99.98 -34.69 9.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 0.0 110.509 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.581 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 6.1 t -71.96 -40.42 68.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.849 -1.157 . . . . 0.0 109.594 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 55.0 p -77.85 -31.9 51.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.114 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 10' ' ' ILE . 2.5 p -124.62 -150.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -0.81 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.493 ' N ' ' OG ' ' A' ' 9' ' ' SER . 5.5 mm -133.53 112.1 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.143 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.7 m -86.93 170.17 11.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 109.661 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' LEU . 79.4 p -102.76 140.23 37.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 109.383 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.563 HD13 ' CE2' ' B' ' 22' ' ' PHE . 0.8 OUTLIER -42.85 -31.3 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -62.97 -51.19 67.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.94 . . . . 0.0 109.373 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -37.56 74.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.058 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.58 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 6.2 mp -64.93 -38.91 92.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 108.868 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.56 -26.25 63.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -74.87 -32.79 61.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.348 -0.845 . . . . 0.0 108.929 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 4.3 m-30 -57.59 -20.58 33.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.31 -0.869 . . . . 0.0 109.219 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.6 m -87.81 50.62 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.55 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.563 ' CE2' HD13 ' A' ' 13' ' ' LEU . 11.8 t80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.4 0.619 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' B' ' 24' ' ' ASN . 1.1 p -161.8 -153.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.756 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.548 ' N ' ' CG1' ' B' ' 23' ' ' VAL . 6.2 m-20 81.88 55.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.69 166.44 18.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.63 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -124.97 146.56 49.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.588 ' CD1' ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -160.91 145.05 13.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.294 -1.503 . . . . 0.0 112.679 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.46 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -133.91 155.07 50.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.523 -0.736 . . . . 0.0 109.447 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 34.35 -126.12 0.52 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.449 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.2 OUTLIER -39.0 -63.8 0.5 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.937 . . . . 0.0 110.715 -179.026 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' B' ' 30' ' ' SER . 10.3 m-20 -41.31 -32.14 0.28 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.825 . . . . 0.0 109.354 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.538 ' O ' ' CD2' ' B' ' 36' ' ' LEU . 0.3 OUTLIER -69.15 -71.69 0.21 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.312 -0.867 . . . . 0.0 108.808 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.495 HG23 ' N ' ' B' ' 34' ' ' GLU . 29.0 m -43.05 -39.15 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.262 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.514 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -63.19 -50.44 70.29 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.311 -0.868 . . . . 0.0 108.954 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.503 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -53.36 -57.69 9.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.458 -0.776 . . . . 0.0 109.443 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.572 ' CD1' ' CD2' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -56.59 -22.73 35.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.047 -1.033 . . . . 0.0 108.526 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 11.1 t80 -82.5 -14.88 54.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.648 -0.657 . . . . 0.0 109.477 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -85.51 -45.31 11.91 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.478 HG22 ' N ' ' B' ' 40' ' ' CYS . 2.7 m -67.86 -21.63 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.535 -0.728 . . . . 0.0 109.173 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.478 ' N ' HG22 ' B' ' 39' ' ' VAL . 96.2 m -113.45 16.02 18.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.404 -0.81 . . . . 0.0 109.353 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -44.04 -39.94 5.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.95 17.0 6.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -1.174 . . . . 0.0 109.422 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' B' ' 40' ' ' CYS . 1.8 tpt85 -132.85 111.37 11.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.323 -0.86 . . . . 0.0 109.367 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.43 -122.88 6.93 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.9 40.11 1.9 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.502 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 29.6 t80 -108.88 -0.88 19.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -1.127 . . . . 0.0 109.507 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -78.69 50.84 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.823 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' B' ' 49' ' ' LYS . 11.4 m -113.21 -70.18 0.82 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.063 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' B' ' 48' ' ' THR . 8.2 tttp 69.5 96.15 0.05 OUTLIER Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.502 -0.748 . . . . 0.0 109.772 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.73 175.36 11.33 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.607 2.204 . . . . 0.0 110.524 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.459 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.409 2.523 . . . . 0.0 119.409 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.449 HG23 ' CZ ' ' A' ' 19' ' ' TYR . 62.0 mt -81.49 -32.94 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.265 -1.138 . . . . 0.0 109.65 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 m -60.58 -30.33 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.584 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' O ' HG21 ' A' ' 8' ' ' THR . 1.1 mt-10 -78.73 1.79 21.85 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.565 -0.71 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 9' ' ' SER . 3.0 tp60 -105.24 -40.84 5.72 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.217 -0.927 . . . . 0.0 109.688 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 9' ' ' SER . 85.3 m -106.05 -36.87 6.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 110.667 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.564 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 8.8 t -68.97 -15.28 63.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.876 -1.14 . . . . 0.0 110.076 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 4' ' ' GLU . 11.2 t -113.34 -27.72 7.84 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 18.2 m -126.65 156.76 40.5 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' B' ' 24' ' ' ASN . 5.5 mm -81.14 146.61 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.735 -1.228 . . . . 0.0 109.516 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.7 m -124.91 -169.19 1.94 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.363 -0.835 . . . . 0.0 109.768 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -137.47 143.1 41.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.9 OUTLIER -40.84 -33.32 0.29 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 109.66 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.469 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 75.1 t80 -65.93 -50.35 64.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.953 . . . . 0.0 108.616 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -60.98 -36.54 79.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.157 -0.964 . . . . 0.0 108.568 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.603 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 5.2 mp -69.37 -32.47 71.55 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 2.5 mt-10 -56.98 -28.5 62.4 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -31.57 69.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.477 -0.764 . . . . 0.0 109.294 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.603 ' CD2' ' HA ' ' A' ' 16' ' ' LEU . 23.2 m-30 -58.68 -14.84 9.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -0.963 . . . . 0.0 109.547 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.4 m -99.73 57.64 1.01 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.964 . . . . 0.0 109.532 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.472 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.482 0.658 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -144.37 -159.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.392 -0.818 . . . . 0.0 109.885 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.585 ' N ' ' CG1' ' B' ' 23' ' ' VAL . 15.4 t-20 62.08 68.25 0.69 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.399 0.619 . . . . 0.0 109.667 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.27 173.45 11.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.209 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.564 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -121.14 150.86 40.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' B' ' 27' ' ' LEU . 1.2 pt? -160.98 141.51 11.29 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.223 -1.548 . . . . 0.0 112.85 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.9 OUTLIER -139.54 167.9 21.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.381 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 40.71 -121.6 1.94 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.459 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.7 OUTLIER -53.1 -59.35 4.66 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.342 -1.093 . . . . 0.0 110.572 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.597 ' CB ' ' HB2' ' B' ' 27' ' ' LEU . 13.8 m-20 -40.09 -35.92 0.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.873 . . . . 0.0 109.765 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.533 ' HA ' ' CD1' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -67.61 -72.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 108.622 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -49.15 -27.98 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.941 . . . . 0.0 108.476 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.52 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -72.38 -56.29 5.7 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.55 ' CB ' ' CD1' ' B' ' 27' ' ' LEU . . . -60.21 -45.53 92.86 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' B' ' 36' ' ' LEU . 0.1 OUTLIER -59.9 -27.09 66.43 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.513 ' O ' ' CA ' ' B' ' 41' ' ' GLY . 76.9 t80 -80.22 -11.9 59.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.75 -0.593 . . . . 0.0 109.822 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.6 OUTLIER -90.79 -48.51 6.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.979 . . . . 0.0 108.713 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.475 HG23 ' HB3' ' A' ' 16' ' ' LEU . 2.4 m -62.22 -29.47 46.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.484 -0.76 . . . . 0.0 108.963 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . . . . . . . . . 19.1 m -119.49 13.71 12.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.45 -0.781 . . . . 0.0 109.526 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' B' ' 37' ' ' TYR . . . -55.86 -40.87 82.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -105.34 -11.32 16.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.46 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.14 138.31 41.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.601 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.95 -144.29 12.77 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . 0.557 ' C ' ' CG ' ' B' ' 46' ' ' PHE . . . 163.81 165.84 21.67 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.557 ' CG ' ' C ' ' B' ' 45' ' ' GLY . 0.8 OUTLIER 39.29 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.523 -0.987 . . . . 0.0 109.77 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -75.63 3.18 10.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -55.22 -20.55 11.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.067 -1.021 . . . . 0.0 109.349 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt 57.02 92.71 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.33 158.59 33.14 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.67 2.246 . . . . 0.0 110.56 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 91.5 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.554 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.5 mt -80.35 -23.13 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -1.111 . . . . 0.0 109.38 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.1 m -60.97 -27.63 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.611 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -83.41 4.74 26.28 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.47 -0.769 . . . . 0.0 109.458 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.75 -49.36 3.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.169 -0.957 . . . . 0.0 110.455 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' SER . 62.0 m -104.97 -34.08 8.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 110.752 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 4.2 t -61.65 -12.06 14.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.774 -1.204 . . . . 0.0 109.553 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 9' ' ' SER . 4.1 t -99.13 -32.81 11.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 108.446 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.582 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 5.7 t -120.71 -156.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 11' ' ' CYS . 25.1 mm -109.98 -4.71 10.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.835 -1.166 . . . . 0.0 109.567 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' ILE . 1.5 m 45.41 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 110.24 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.6 p -150.58 149.84 30.42 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HG ' HG11 ' B' ' 39' ' ' VAL . 0.2 OUTLIER -47.74 -25.33 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.07 -1.019 . . . . 0.0 109.625 -179.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -61.82 -55.05 34.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.162 -0.961 . . . . 0.0 109.173 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 -46.8 84.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.311 -0.868 . . . . 0.0 109.331 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.453 HD11 ' N ' ' A' ' 16' ' ' LEU . 8.3 mp -61.47 -35.61 78.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.109 -0.994 . . . . 0.0 108.737 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -56.83 -23.36 43.37 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.96 -25.2 58.69 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.589 -0.695 . . . . 0.0 109.305 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.556 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.8 m-30 -74.81 -3.77 33.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.943 -1.098 . . . . 0.0 109.183 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.461 ' HB3' ' HA3' ' B' ' 45' ' ' GLY . 61.0 m -78.38 51.97 1.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.219 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 t30 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.601 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 3.8 p90 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.585 0.707 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.581 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 1.1 p -160.93 -153.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.579 -0.7 . . . . 0.0 109.422 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 28.0 t-20 87.73 74.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.5 0.667 . . . . 0.0 109.558 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -158.24 154.37 27.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.582 ' CE1' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -105.16 174.54 5.83 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.642 ' O ' ' HB2' ' B' ' 28' ' ' CYS . 0.0 OUTLIER -153.69 -157.17 0.75 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.485 -1.385 . . . . 0.0 111.335 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.642 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.6 OUTLIER 139.24 146.14 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 124.127 0.971 . . . . 0.0 108.53 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.21 -131.02 19.67 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.477 ' HA ' ' CG2' ' B' ' 33' ' ' VAL . 7.3 m -55.62 -38.95 70.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.718 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.503 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 7.4 m-20 -52.1 -40.04 60.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 109.005 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.522 HD13 ' N ' ' B' ' 28' ' ' CYS . 0.1 OUTLIER -67.17 -72.49 0.16 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 108.96 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' B' ' 30' ' ' SER . 27.7 m -42.89 -40.3 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.106 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.543 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -54.67 -51.88 64.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.223 -0.923 . . . . 0.0 109.046 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.502 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -59.1 -54.33 48.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.039 -1.038 . . . . 0.0 108.822 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.502 ' CD2' ' O ' ' B' ' 32' ' ' LEU . 0.8 OUTLIER -54.33 -20.15 6.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.138 -0.976 . . . . 0.0 108.881 179.297 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.447 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 33.1 t80 -86.09 -10.61 54.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.408 -0.807 . . . . 0.0 109.373 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -98.68 -40.54 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.038 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.503 HG22 ' N ' ' B' ' 40' ' ' CYS . 2.3 m -78.86 -27.17 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.422 -0.798 . . . . 0.0 109.409 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.503 ' N ' HG22 ' B' ' 39' ' ' VAL . 7.4 m -103.98 -1.01 28.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.15 -36.18 51.68 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.78 -15.04 25.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.156 -1.203 . . . . 0.0 109.641 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.507 ' HG2' ' N ' ' B' ' 44' ' ' GLY . 8.5 ttt180 -123.76 161.93 24.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.44 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.507 ' N ' ' HG2' ' B' ' 43' ' ' ARG . . . -48.91 164.94 0.31 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 20' ' ' CYS . . . 116.71 -10.61 16.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' B' ' 45' ' ' GLY . 2.0 t80 -43.16 124.7 3.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -1.088 . . . . 0.0 109.204 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.52 ' O ' ' OG1' ' B' ' 48' ' ' THR . 4.9 p90 -122.09 -134.48 0.3 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' B' ' 47' ' ' TYR . 1.1 m 162.59 -53.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.312 -0.868 . . . . 0.0 108.837 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -174.14 109.64 0.3 Allowed Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.589 -0.695 . . . . 0.0 109.452 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.3 -178.18 4.24 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.366 2.044 . . . . 0.0 110.455 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 58.9 p . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.495 179.955 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.896 0 N-CA-C 119.336 2.494 . . . . 0.0 119.336 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.584 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -104.91 -9.69 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -1.156 . . . . 0.0 108.997 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.47 HG12 HD21 ' B' ' 32' ' ' LEU . 2.9 m -76.81 -35.3 24.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.359 -0.838 . . . . 0.0 109.893 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' HG22 ' A' ' 8' ' ' THR . 3.6 mt-10 -61.69 -10.87 9.6 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.707 -0.621 . . . . 0.0 110.641 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.452 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -105.46 -34.24 7.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.907 -1.12 . . . . 0.0 110.126 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.3 m -98.76 -18.49 17.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.678 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.543 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 13.3 t -86.2 -34.95 20.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 4' ' ' GLU . 6.2 t -89.67 -30.1 18.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 m -128.71 165.29 21.16 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.477 HG13 ' O ' ' B' ' 25' ' ' GLN . 0.5 OUTLIER -94.23 128.11 45.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.116 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.439 ' HB2' HD12 ' A' ' 16' ' ' LEU . 66.1 m -96.88 175.28 6.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 109.61 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 29.4 p -106.61 148.03 28.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 109.281 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -43.42 -30.17 0.52 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.119 -0.988 . . . . 0.0 109.81 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -62.21 -56.57 17.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.366 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.484 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 1.2 mp0 -57.88 -38.33 75.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.184 -0.947 . . . . 0.0 109.128 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.571 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 6.8 mp -67.07 -39.97 86.96 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.184 -0.948 . . . . 0.0 108.838 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.54 -25.94 53.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -70.95 -32.18 68.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.468 -0.77 . . . . 0.0 109.095 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.613 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.6 m-30 -68.71 -31.67 70.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.139 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -60.63 -98.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.988 0.899 . . . . 0.0 109.923 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 . . . . . 0 C--N 1.278 -2.513 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.34 -179.485 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' B' ' 22' ' ' PHE . 2.2 t80 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.393 0.616 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.59 ' CG1' ' N ' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -160.58 -162.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.239 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.59 ' N ' ' CG1' ' B' ' 23' ' ' VAL . 0.8 OUTLIER 73.28 68.94 0.11 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.523 -0.736 . . . . 0.0 109.566 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.477 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.1 tp60 -141.59 156.24 45.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 109.517 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.543 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -115.21 164.07 14.76 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.579 ' HG ' ' CD1' ' B' ' 32' ' ' LEU . 0.1 OUTLIER -161.41 -156.37 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 119.951 -1.718 . . . . 0.0 112.901 -178.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.567 ' N ' ' HB2' ' B' ' 31' ' ' ASP . 0.3 OUTLIER 150.93 140.78 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.725 0 C-N-CA 123.557 0.743 . . . . 0.0 110.271 -178.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' B' ' 32' ' ' LEU . . . 43.88 -128.99 6.51 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.464 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.3 OUTLIER -47.2 -39.46 14.02 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.156 -1.202 . . . . 0.0 108.821 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.567 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 80.8 m-20 -59.28 -29.83 67.87 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.208 -0.933 . . . . 0.0 108.704 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.579 ' CD1' ' HG ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -68.7 -57.39 5.73 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.6 ' O ' ' CG ' ' B' ' 37' ' ' TYR . 4.8 m -55.63 -35.58 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.538 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -59.58 -59.53 5.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.532 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -61.29 -46.76 88.98 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.548 ' CD1' ' HB2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -57.89 -33.63 68.94 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.6 ' CG ' ' O ' ' B' ' 33' ' ' VAL . 5.5 m-30 -71.45 -21.94 61.9 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.671 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -81.26 -58.11 3.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 108.895 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.461 HG22 ' O ' ' B' ' 36' ' ' LEU . 2.5 m -47.27 -32.92 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.49 -0.756 . . . . 0.0 109.416 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' B' ' 43' ' ' ARG . 0.9 OUTLIER -100.09 -27.38 13.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 109.807 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.506 ' O ' ' CG ' ' B' ' 42' ' ' GLU . . . 41.24 65.81 1.04 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' B' ' 41' ' ' GLY . 10.6 pt-20 39.36 29.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -1.008 . . . . 0.0 110.115 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' B' ' 40' ' ' CYS . 0.8 OUTLIER -90.32 135.99 33.33 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.295 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 49.06 66.42 2.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.65 175.91 35.57 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.566 ' HB3' ' CD1' ' B' ' 47' ' ' TYR . 1.7 m-30 -79.75 -100.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.122 -1.223 . . . . 0.0 109.961 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.589 ' CE1' ' OH ' ' B' ' 37' ' ' TYR . 0.1 OUTLIER -107.15 -99.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.846 -1.159 . . . . 0.0 109.027 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' B' ' 47' ' ' TYR . 2.7 m -178.26 -50.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.922 . . . . 0.0 109.155 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.67 77.38 0.45 Allowed Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.565 -0.709 . . . . 0.0 109.209 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.09 -177.44 3.82 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.803 2.336 . . . . 0.0 110.786 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.341 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.809 0 N-CA-C 119.414 2.526 . . . . 0.0 119.414 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.449 HG22 HD21 ' B' ' 32' ' ' LEU . 19.6 mt -89.22 -25.64 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -1.103 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 2.5 m -56.96 -30.55 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 109.724 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -78.37 1.68 21.16 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.496 -0.752 . . . . 0.0 109.706 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -105.63 -42.74 5.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 0.0 109.545 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 9' ' ' SER . 98.7 m -105.65 -39.99 5.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 0.0 110.065 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.595 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 2.2 t -58.28 -54.02 51.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.757 -1.214 . . . . 0.0 108.248 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.1 p -64.03 -68.97 0.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.065 . . . . 0.0 108.368 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 3.3 m -95.27 141.0 29.37 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.3 113.65 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.863 -1.148 . . . . 0.0 109.953 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.461 ' O ' HG13 ' B' ' 23' ' ' VAL . 22.7 m -77.96 -168.08 1.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.177 -0.952 . . . . 0.0 109.606 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.447 ' O ' ' C ' ' A' ' 13' ' ' LEU . 6.3 p -122.34 142.1 50.85 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -43.11 -27.2 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.006 . . . . 0.0 109.644 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' SER . 86.9 t80 -62.53 -60.86 2.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.179 -0.951 . . . . 0.0 108.879 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -55.54 -41.71 73.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.305 -0.872 . . . . 0.0 109.044 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.582 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 1.6 mp -56.34 -45.99 80.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.186 -0.946 . . . . 0.0 108.787 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.81 -23.86 3.07 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -71.21 -38.67 72.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.57 -0.706 . . . . 0.0 109.159 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.582 ' CD2' ' HA ' ' A' ' 16' ' ' LEU . 23.1 m-85 -50.91 -32.81 21.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.077 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.456 ' SG ' ' HG3' ' B' ' 43' ' ' ARG . 1.7 m -85.78 52.32 2.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.407 -0.808 . . . . 0.0 109.394 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 t30 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.656 -179.794 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.586 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -79.77 -168.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.242 -0.911 . . . . 0.0 109.679 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 6.6 t30 87.86 -11.07 0.51 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -104.55 144.71 31.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.198 -0.939 . . . . 0.0 109.257 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -91.23 159.5 16.02 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.554 ' CD1' ' O ' ' B' ' 27' ' ' LEU . 0.3 OUTLIER -160.77 136.54 8.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.28 -1.512 . . . . 0.0 112.27 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.506 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -131.77 145.89 51.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.772 . . . . 0.0 109.009 178.244 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 28.34 -103.35 0.01 OUTLIER Glycine 0 N--CA 1.501 3.006 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.417 ' O ' HG23 ' B' ' 33' ' ' VAL . 16.1 t -41.21 -63.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.434 -1.039 . . . . 0.0 109.881 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.92 -33.74 18.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 108.64 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' B' ' 29' ' ' GLY . 0.3 OUTLIER -60.22 -65.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -0.861 . . . . 0.0 109.045 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.508 HG22 ' N ' ' B' ' 34' ' ' GLU . 35.4 m -49.49 -31.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 108.41 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.526 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 7.9 mt-10 -72.69 -59.0 2.93 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.537 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -60.7 -41.88 96.09 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.569 HD11 ' CD2' ' A' ' 19' ' ' TYR . 2.2 mm? -59.51 -30.4 68.55 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -80.12 -13.56 59.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.715 -0.615 . . . . 0.0 110.065 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -91.04 -47.08 7.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 108.609 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -63.49 -22.06 29.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.445 -0.785 . . . . 0.0 109.138 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' B' ' 43' ' ' ARG . 84.3 m -101.68 -41.63 6.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.26 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.54 -50.18 3.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' B' ' 43' ' ' ARG . 5.3 pt-20 -174.89 34.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -1.223 . . . . 0.0 109.797 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.513 ' HD3' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -43.03 150.03 0.18 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.559 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.93 -26.65 70.6 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.09 103.3 0.99 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.453 ' CG ' ' N ' ' B' ' 47' ' ' TYR . 0.1 OUTLIER -71.88 -156.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -1.127 . . . . 0.0 109.744 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.609 ' O ' ' HB ' ' B' ' 48' ' ' THR . 0.7 OUTLIER -42.65 -68.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -0.797 . . . . 0.0 109.626 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' B' ' 47' ' ' TYR . 2.5 m 74.1 -9.2 1.3 Allowed 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.052 0.454 . . . . 0.0 110.464 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp 51.45 90.7 0.08 OUTLIER Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 121.043 -1.036 . . . . 0.0 109.438 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.86 150.14 30.08 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.691 2.261 . . . . 0.0 110.689 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.374 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 1 N--CA 1.529 4.873 0 N-CA-C 119.436 2.534 . . . . 0.0 119.436 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.502 HG21 ' CD2' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -99.64 -27.82 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -1.19 . . . . 0.0 109.145 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 1.4 m -46.69 -29.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.941 . . . . 0.0 108.765 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 1' ' ' GLY . 0.9 OUTLIER -55.18 -19.65 8.43 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.55 -75.48 0.57 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.8 . . . . 0.0 109.795 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.558 ' O ' ' CD1' ' B' ' 32' ' ' LEU . 9.4 m -97.93 96.37 8.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.44 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 6' ' ' CYS . 8.0 t 161.33 -33.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -3.36 21.97 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.544 ' C ' ' CE1' ' B' ' 26' ' ' HIS . 0.6 OUTLIER -156.06 -173.78 4.66 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.3 mm -91.9 142.09 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.019 -1.051 . . . . 0.0 109.396 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.4 -168.87 1.6 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.891 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.41 ' O ' HD11 ' A' ' 16' ' ' LEU . 23.5 p -145.75 144.8 30.55 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -43.58 -27.44 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 109.655 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -63.51 -53.16 56.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.658 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 4.1 mt-30 -58.48 -32.93 69.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 109.75 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.592 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 6.1 mp -67.85 -35.36 78.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.076 -1.015 . . . . 0.0 109.104 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.37 -22.12 62.93 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 25.3 m-80 -74.39 -37.51 63.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.571 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -67.84 -15.57 63.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 109.413 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 m -104.5 51.02 0.78 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.298 -0.876 . . . . 0.0 109.456 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.6 t30 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.462 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.609 0.718 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.57 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -154.8 173.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 121.645 -0.659 . . . . 0.0 109.562 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 10.0 p-10 153.37 49.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.27 151.59 30.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.41 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.544 ' CE1' ' C ' ' A' ' 9' ' ' SER . 2.2 t60 -72.4 -164.35 0.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.414 -0.804 . . . . 0.0 109.673 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.583 ' O ' ' CB ' ' B' ' 28' ' ' CYS . 0.4 OUTLIER -155.81 -171.38 3.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.583 ' CB ' ' O ' ' B' ' 27' ' ' LEU . 1.3 m 149.09 139.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.474 0.654 . . . . 0.0 109.792 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 34.57 -126.61 0.57 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.8 m -41.57 -53.43 3.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.405 -1.056 . . . . 0.0 109.71 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.505 ' O ' ' CD2' ' B' ' 27' ' ' LEU . 17.0 m-20 -44.41 -31.14 0.98 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.897 . . . . 0.0 109.17 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.558 ' CD1' ' O ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -74.49 -77.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.214 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.458 HG23 ' N ' ' B' ' 34' ' ' GLU . 9.4 m -41.6 -35.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.621 -0.674 . . . . 0.0 109.336 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.561 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 2.2 mp0 -70.28 -54.02 14.43 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.519 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -53.69 -56.41 17.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.16 -0.962 . . . . 0.0 109.462 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.551 ' CD1' ' CD2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -57.08 -20.88 27.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.97 -1.081 . . . . 0.0 108.162 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 89.3 t80 -84.96 -9.96 57.54 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.711 -0.618 . . . . 0.0 109.724 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -97.23 -42.62 7.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.085 -1.009 . . . . 0.0 108.961 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.426 HG21 ' SG ' ' B' ' 40' ' ' CYS . 1.7 m -72.52 -26.01 23.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.507 -0.745 . . . . 0.0 109.662 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.426 ' SG ' HG21 ' B' ' 39' ' ' VAL . 59.3 m -103.33 -11.84 17.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.181 -0.949 . . . . 0.0 109.786 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' B' ' 42' ' ' GLU . . . 49.76 25.44 6.98 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' B' ' 41' ' ' GLY . 0.2 OUTLIER 76.72 10.76 2.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -1.136 . . . . 0.0 109.259 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.12 154.95 5.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 0.0 109.418 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.28 -127.22 7.79 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.77 -91.02 2.2 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.89 -127.52 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -1.183 . . . . 0.0 109.188 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.66 -88.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.752 -1.217 . . . . 0.0 109.378 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 94.1 m -111.82 -77.06 0.59 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.364 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 59.57 93.71 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 109.615 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.38 146.09 24.44 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.614 2.209 . . . . 0.0 110.552 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.4 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.894 0 N-CA-C 119.48 2.552 . . . . 0.0 119.48 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.9 mt -81.8 -46.03 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -1.111 . . . . 0.0 109.604 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 4.4 m -54.36 -18.82 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.78 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -92.21 -7.71 47.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.646 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.45 -31.31 9.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.13 -0.982 . . . . 0.0 110.114 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 9' ' ' SER . 83.5 m -105.3 -62.26 1.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.061 -1.025 . . . . 0.0 110.374 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 48.6 t -47.26 -28.58 2.0 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.388 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 t -69.88 -20.17 63.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.972 -1.08 . . . . 0.0 108.92 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.527 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 4.6 t -150.56 -151.24 0.38 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.42 128.32 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.945 -1.097 . . . . 0.0 109.498 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -111.4 164.84 12.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.849 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.491 ' CA ' HG13 ' B' ' 23' ' ' VAL . 14.5 p -108.17 141.92 39.18 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.54 ' CD2' HG11 ' B' ' 39' ' ' VAL . 0.1 OUTLIER -46.14 -28.28 1.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.827 -1.171 . . . . 0.0 109.151 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -53.52 -47.38 69.97 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.189 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.439 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 48.5 mm-40 -65.6 -40.86 93.13 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.6 ' HG ' ' CE2' ' A' ' 19' ' ' TYR . 7.9 mp -63.51 -34.68 78.32 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 4.1 mt-10 -54.95 -32.5 61.46 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -30.29 70.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.607 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -63.59 -41.92 98.3 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.18 -0.95 . . . . 0.0 108.695 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 m -91.11 53.7 2.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.777 . . . . 0.0 109.652 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.4 t30 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.466 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.491 HG13 ' CA ' ' A' ' 12' ' ' SER . 33.6 m -87.85 -158.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 122.059 0.933 . . . . 0.0 109.802 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.71 64.96 0.97 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.699 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.49 -177.19 5.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 109.233 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.537 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 1.2 t60 -138.02 169.06 18.44 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.696 ' O ' ' HB2' ' B' ' 28' ' ' CYS . 0.4 OUTLIER -161.13 -137.84 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.716 -1.24 . . . . 0.0 109.644 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.696 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.8 OUTLIER 137.13 134.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 33.54 -113.55 0.09 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' VAL . 0.1 OUTLIER -48.27 -56.23 8.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -1.032 . . . . 0.0 109.926 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.55 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 4.1 m-20 -44.36 -33.65 1.71 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -0.932 . . . . 0.0 109.095 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' B' ' 27' ' ' LEU . 0.8 OUTLIER -65.87 -71.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 108.943 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.509 HG23 ' N ' ' B' ' 34' ' ' GLU . 14.3 m -48.83 -24.47 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.518 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 5.4 mt-10 -75.34 -61.85 1.76 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.454 -0.779 . . . . 0.0 108.995 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.531 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.35 -44.0 83.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.519 HD11 ' CB ' ' A' ' 19' ' ' TYR . 2.4 mm? -57.31 -33.32 67.58 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.967 0.889 . . . . 0.0 108.725 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.423 ' CD2' HD22 ' B' ' 38' ' ' LEU . 11.8 t80 -77.3 -16.83 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.248 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -90.95 -33.55 15.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.111 -0.993 . . . . 0.0 108.904 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.54 HG11 ' CD2' ' A' ' 13' ' ' LEU . 1.4 m -88.93 -14.48 9.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.505 -0.747 . . . . 0.0 109.443 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' B' ' 43' ' ' ARG . 93.4 m -114.68 -10.58 12.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.375 -0.828 . . . . 0.0 109.364 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' B' ' 42' ' ' GLU . . . 46.29 67.74 1.27 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' B' ' 41' ' ' GLY . 2.0 pt-20 37.48 38.98 0.16 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.705 -0.88 . . . . 0.0 110.483 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' B' ' 40' ' ' CYS . 2.1 ttt85 -64.86 147.55 53.05 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 108.983 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.41 158.82 12.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.77 -1.62 87.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.84 -144.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -1.2 . . . . 0.0 109.388 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -115.67 -16.4 11.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 109.282 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -159.4 -39.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.403 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -118.44 86.33 28.04 Favored Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 121.501 -0.75 . . . . 0.0 109.164 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.71 175.25 11.61 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.692 2.262 . . . . 0.0 110.696 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.444 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.816 0 N-CA-C 119.447 2.539 . . . . 0.0 119.447 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.584 HG23 ' CZ ' ' A' ' 19' ' ' TYR . 12.3 mt -89.85 -36.42 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -1.166 . . . . 0.0 109.554 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.437 HG11 ' N ' ' B' ' 29' ' ' GLY . 2.4 m -39.19 -31.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.63 -0.669 . . . . 0.0 110.534 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.456 ' O ' HG22 ' A' ' 8' ' ' THR . 4.8 mt-10 -68.93 -7.68 37.29 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.376 -0.828 . . . . 0.0 110.238 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.75 -35.42 7.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.065 -1.022 . . . . 0.0 110.251 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 9' ' ' SER . 96.7 m -105.36 -60.84 1.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.964 -1.085 . . . . 0.0 110.944 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.539 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 2.6 t -40.11 -60.31 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.022 -1.049 . . . . 0.0 109.946 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 4' ' ' GLU . 1.8 t -42.6 -29.31 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.169 -0.957 . . . . 0.0 109.248 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.617 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 18.3 m -142.47 -137.33 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.456 -0.777 . . . . 0.0 108.983 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.475 HG13 ' ND1' ' B' ' 26' ' ' HIS . 1.4 mt -146.85 113.61 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.589 -1.319 . . . . 0.0 109.299 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.446 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . 21.4 m -88.29 -167.26 1.82 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.42 -0.8 . . . . 0.0 110.096 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 p -115.02 159.28 20.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.098 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' B' ' 22' ' ' PHE . 0.4 OUTLIER -50.85 -23.58 2.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.976 -1.077 . . . . 0.0 109.232 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 44.4 t80 -65.37 -48.34 73.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 108.812 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.446 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -57.82 -39.14 76.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 108.587 179.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.583 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 6.2 mp -65.16 -35.69 81.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.376 -0.828 . . . . 0.0 108.8 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 1.8 mm-40 -55.96 -27.53 52.98 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.08 -17.17 60.51 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.496 -0.753 . . . . 0.0 109.318 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.591 ' CD2' HD11 ' B' ' 36' ' ' LEU . 1.3 m-85 -72.81 -29.75 63.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 108.465 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.9 m -85.89 52.11 2.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 0.0 109.614 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.506 179.878 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.508 ' CZ ' HD21 ' A' ' 13' ' ' LEU . 12.2 p90 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.306 0.574 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.522 ' CG1' ' N ' ' B' ' 24' ' ' ASN . 0.7 OUTLIER -148.74 -159.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.428 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.522 ' N ' ' CG1' ' B' ' 23' ' ' VAL . 11.4 t-20 77.74 57.96 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.449 0.642 . . . . 0.0 109.347 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.57 142.92 39.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.323 -0.861 . . . . 0.0 109.299 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.617 ' CE1' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -90.92 144.1 26.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.568 ' CD1' ' O ' ' B' ' 27' ' ' LEU . 0.4 OUTLIER -154.07 145.7 23.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.348 -1.47 . . . . 0.0 112.133 -178.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' B' ' 32' ' ' LEU . 0.8 OUTLIER -124.92 -162.79 1.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.437 ' N ' HG11 ' A' ' 3' ' ' VAL . . . -37.47 -63.02 0.87 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.212 -0.93 . . . . 0.0 111.679 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.513 ' O ' HG21 ' B' ' 33' ' ' VAL . 1.4 p -69.77 -40.29 76.17 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.9 -1.353 . . . . 0.0 111.25 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.545 ' HB2' ' CA ' ' B' ' 27' ' ' LEU . 0.3 OUTLIER -70.71 -20.95 62.61 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.475 -1.391 . . . . 0.0 108.276 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.549 ' O ' ' CD2' ' B' ' 36' ' ' LEU . 0.6 OUTLIER -69.06 -70.22 0.29 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.513 HG21 ' O ' ' B' ' 30' ' ' SER . 33.2 m -43.66 -31.35 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.4 mt-10 -68.94 -54.61 14.49 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.42 -55.06 39.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 108.777 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.591 HD11 ' CD2' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -54.21 -21.94 10.22 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.041 -1.037 . . . . 0.0 108.248 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.511 ' O ' ' HA2' ' B' ' 41' ' ' GLY . 13.4 t80 -84.53 -6.43 59.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.543 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -105.76 -50.4 3.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.066 -1.021 . . . . 0.0 108.963 179.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.428 HG22 ' N ' ' B' ' 40' ' ' CYS . 1.8 m -67.03 -25.76 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.443 -0.786 . . . . 0.0 109.78 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.48 ' O ' ' C ' ' B' ' 41' ' ' GLY . 20.1 m -122.91 -21.13 5.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.921 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' B' ' 37' ' ' TYR . . . 40.52 29.72 0.27 Allowed Glycine 0 N--CA 1.496 2.637 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.517 ' HG2' ' N ' ' B' ' 46' ' ' PHE . 16.4 tp10 49.42 91.74 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.483 -1.01 . . . . 0.0 108.34 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 51.81 0.88 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.645 -0.659 . . . . 0.0 109.707 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.94 63.73 0.01 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . 0.466 ' C ' ' HG2' ' B' ' 42' ' ' GLU . . . 109.07 -140.98 15.85 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.517 ' N ' ' HG2' ' B' ' 42' ' ' GLU . 0.5 OUTLIER -120.15 177.9 4.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -1.191 . . . . 0.0 109.117 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.613 ' O ' ' HB ' ' B' ' 48' ' ' THR . 0.1 OUTLIER -40.37 -75.86 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.345 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' B' ' 47' ' ' TYR . 86.5 m 85.59 -22.73 0.18 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.418 0.628 . . . . 0.0 110.201 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.454 ' HG2' ' HD2' ' B' ' 50' ' ' PRO . 2.3 tttt 177.16 129.35 0.19 Allowed Pre-proline 0 C--N 1.292 -1.896 0 O-C-N 121.48 -0.762 . . . . 0.0 109.032 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.589 ' HA ' ' CE2' ' B' ' 47' ' ' TYR . 36.4 Cg_endo -77.05 143.29 22.7 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.276 1.984 . . . . 0.0 110.523 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.593 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.955 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 mm -104.82 -32.14 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -1.208 . . . . 0.0 109.617 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.568 ' CG1' ' CD2' ' B' ' 32' ' ' LEU . 0.9 OUTLIER -85.41 -41.33 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.614 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 5.9 mt-10 -70.44 -19.86 62.94 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.599 -0.688 . . . . 0.0 110.219 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -89.31 -34.79 16.44 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.125 -0.984 . . . . 0.0 109.48 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.5 m -105.83 -42.43 5.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 110.452 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.556 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 9.1 t -63.14 -18.12 63.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.934 -1.104 . . . . 0.0 110.062 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 4' ' ' GLU . 16.0 p -104.77 -38.5 6.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.077 -1.014 . . . . 0.0 108.516 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.7 -155.89 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.6 mm -129.75 83.34 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.979 -1.076 . . . . 0.0 109.57 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.1 m -59.71 171.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.291 -0.881 . . . . 0.0 109.61 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 13' ' ' LEU . 94.5 p -112.99 145.14 41.37 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -43.52 -27.48 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 108.966 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 28.5 t80 -62.54 -46.13 89.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.4 -0.813 . . . . 0.0 108.903 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -66.32 -49.37 67.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 109.007 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.589 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 9.0 mp -56.19 -31.98 63.94 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.311 -0.868 . . . . 0.0 109.118 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' OE1' ' CD ' ' B' ' 43' ' ' ARG . 1.3 mm-40 -58.65 -35.2 72.17 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.87 . . . . 0.0 108.745 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -75.09 -22.76 58.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.437 -0.789 . . . . 0.0 109.291 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.589 ' CD2' ' HA ' ' A' ' 16' ' ' LEU . 7.3 m-30 -60.28 -14.61 19.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.128 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -91.64 53.64 2.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.927 . . . . 0.0 109.385 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 p30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.417 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.582 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 0.8 OUTLIER -160.36 -157.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.907 . . . . 0.0 109.697 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 37.2 t-20 89.19 79.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.395 0.617 . . . . 0.0 109.835 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -161.0 -176.2 5.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.402 -0.811 . . . . 0.0 109.771 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.556 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -144.59 149.64 36.13 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.542 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -162.04 149.83 14.52 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.353 -1.467 . . . . 0.0 112.567 -178.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.505 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -135.38 158.67 43.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.518 -0.739 . . . . 0.0 109.264 177.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 25.49 -119.66 0.03 OUTLIER Glycine 0 N--CA 1.5 2.962 0 CA-C-O 121.62 0.567 . . . . 0.0 112.149 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.52 ' O ' ' CG2' ' B' ' 33' ' ' VAL . 54.5 m -35.77 -57.5 0.66 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.544 -0.974 . . . . 0.0 110.884 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.7 OUTLIER -45.31 -44.01 11.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.915 -1.116 . . . . 0.0 109.087 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.568 ' CD2' ' CG1' ' A' ' 3' ' ' VAL . 3.1 mp -54.14 -65.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.194 -0.941 . . . . 0.0 108.979 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' B' ' 30' ' ' SER . 18.1 m -51.36 -25.4 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.121 -0.987 . . . . 0.0 108.746 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.508 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.3 mt-10 -79.26 -58.41 3.24 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.557 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -60.65 -38.77 85.95 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.518 ' CD1' ' CB ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -61.32 -33.93 74.42 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.933 0.873 . . . . 0.0 108.745 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -74.91 -31.73 61.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.783 -0.573 . . . . 0.0 109.897 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.557 ' HG ' ' HA ' ' B' ' 35' ' ' ALA . 0.2 OUTLIER -70.49 -63.2 1.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.217 -0.927 . . . . 0.0 108.578 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -45.41 -27.24 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.45 ' O ' ' C ' ' B' ' 41' ' ' GLY . 1.3 m -118.93 36.56 4.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.739 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' B' ' 40' ' ' CYS . . . -41.35 -63.96 1.46 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -122.66 -22.95 5.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.069 -1.253 . . . . 0.0 109.946 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.493 ' CD ' ' OE1' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -81.53 111.47 17.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.451 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.14 91.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.02 110.06 0.72 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.52 23.4 0.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -1.096 . . . . 0.0 109.406 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -76.46 -16.71 59.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.345 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' B' ' 49' ' ' LYS . 40.0 m -162.16 -73.9 0.05 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.701 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' B' ' 48' ' ' THR . 2.9 tptt 178.28 97.88 0.15 Allowed Pre-proline 0 C--N 1.298 -1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.5 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.49 150.29 31.78 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.539 2.159 . . . . 0.0 110.531 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.556 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.827 0 N-CA-C 119.433 2.533 . . . . 0.0 119.433 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.527 HD13 ' CE2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -91.74 -26.04 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -1.168 . . . . 0.0 109.182 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.499 HG12 ' CD2' ' B' ' 32' ' ' LEU . 4.7 m -75.7 -9.35 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.64 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.441 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.9 mt-10 -98.25 -10.89 23.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -105.34 -34.2 7.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.562 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.454 ' O ' ' C ' ' A' ' 7' ' ' CYS . 64.1 m -93.94 -66.23 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 109.704 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 18.6 t -41.42 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 9' ' ' SER . 2.1 t -66.31 135.05 53.85 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.557 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 1.5 m 75.65 -161.07 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 9' ' ' SER . 39.0 mm -128.5 130.67 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.61 -1.306 . . . . 0.0 110.248 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -166.54 1.62 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.476 -0.765 . . . . 0.0 109.593 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' C ' ' A' ' 13' ' ' LEU . 88.7 p -140.16 129.13 23.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -39.25 -33.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 109.781 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' SER . 27.8 t80 -57.7 -51.63 68.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.17 -0.956 . . . . 0.0 108.95 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.437 ' HG2' ' OG ' ' A' ' 12' ' ' SER . 15.4 mm100 -55.47 -44.96 76.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.873 . . . . 0.0 109.231 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.571 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 6.2 mp -57.05 -48.85 77.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -0.93 . . . . 0.0 109.247 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.471 ' OE2' ' CG2' ' B' ' 39' ' ' VAL . 0.9 OUTLIER -52.8 -23.32 6.68 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.108 -0.995 . . . . 0.0 108.399 179.322 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -75.49 -29.81 59.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.484 -0.76 . . . . 0.0 109.005 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.614 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.7 m-30 -72.63 -11.84 60.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 0.0 109.182 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 m -89.86 51.34 2.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 109.433 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.487 -179.927 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 8.0 p90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.165 0.507 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.59 ' CG1' ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -154.99 -158.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.935 . . . . 0.0 109.99 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.59 ' N ' ' CG1' ' B' ' 23' ' ' VAL . 25.4 m-20 69.64 102.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -153.48 152.22 30.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.702 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 9' ' ' SER . 1.4 t60 -121.69 149.05 43.79 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.595 ' CD2' ' CB ' ' B' ' 35' ' ' ALA . 0.0 OUTLIER -153.88 -158.59 0.88 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.469 -1.394 . . . . 0.0 110.95 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 148.77 146.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.77 -134.01 39.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.518 ' HA ' ' CG2' ' B' ' 33' ' ' VAL . 1.3 p -55.99 -46.25 78.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -1.131 . . . . 0.0 109.669 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' B' ' 30' ' ' SER . 9.0 m-20 -45.14 -43.27 9.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 108.555 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.533 ' O ' ' CD2' ' B' ' 36' ' ' LEU . 0.3 OUTLIER -60.1 -72.61 0.1 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.518 ' CG2' ' HA ' ' B' ' 30' ' ' SER . 14.8 m -45.12 -50.76 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.101 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.524 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.5 mp0 -56.06 -44.42 78.85 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.301 -0.874 . . . . 0.0 109.075 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.595 ' CB ' ' CD2' ' B' ' 27' ' ' LEU . . . -55.12 -58.95 5.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.362 -0.836 . . . . 0.0 109.255 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.558 ' CD1' ' CD2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -56.0 -24.01 36.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.046 -1.034 . . . . 0.0 108.32 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 72.6 t80 -79.94 -15.78 56.6 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' B' ' 35' ' ' ALA . 1.4 mt -83.74 -54.82 4.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 108.645 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.489 HG23 ' N ' ' B' ' 40' ' ' CYS . 2.5 m -54.16 -40.93 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.485 -0.759 . . . . 0.0 109.115 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.489 ' N ' HG23 ' B' ' 39' ' ' VAL . 79.0 m -99.31 17.41 20.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.338 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.06 -10.02 66.88 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -75.56 -26.06 57.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -1.22 . . . . 0.0 109.36 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.25 -172.65 2.31 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.446 -0.783 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.15 130.25 28.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.41 131.59 47.42 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' B' ' 47' ' ' TYR . 0.8 OUTLIER -161.4 -74.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -1.11 . . . . 0.0 109.329 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.465 ' C ' ' O ' ' B' ' 46' ' ' PHE . 53.2 t80 37.0 61.91 0.85 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.577 -0.702 . . . . 0.0 110.267 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' B' ' 46' ' ' PHE . 3.4 m -160.87 -54.62 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.47 ' N ' ' HD3' ' B' ' 50' ' ' PRO . 1.3 mttm -145.94 64.19 9.89 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.557 -0.714 . . . . 0.0 109.451 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' B' ' 49' ' ' LYS . 34.3 Cg_endo -76.95 -171.51 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.768 2.312 . . . . 0.0 110.683 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.456 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.784 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.7 mt -101.61 -17.42 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -1.095 . . . . 0.0 108.997 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 m -62.12 -11.4 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.491 -0.756 . . . . 0.0 110.502 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -101.94 -4.92 25.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.027 -1.045 . . . . 0.0 110.425 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.451 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 5.3 mm100 -105.33 -42.26 5.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.009 -1.057 . . . . 0.0 110.266 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' THR . 29.0 m -105.66 -57.9 1.98 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.184 -0.948 . . . . 0.0 110.901 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.558 ' HA ' ' CD2' ' B' ' 26' ' ' HIS . 0.9 OUTLIER -37.15 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.218 -0.926 . . . . 0.0 111.411 -178.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.3 t -68.83 -20.14 64.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.662 -1.274 . . . . 0.0 109.328 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.581 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 11.7 t -158.15 -170.69 3.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.685 ' HA ' ' ND1' ' B' ' 26' ' ' HIS . 0.8 OUTLIER -103.26 94.77 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.702 -1.249 . . . . 0.0 110.546 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 67.9 m -55.54 168.75 0.37 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 p -88.2 143.7 26.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.898 -1.126 . . . . 0.0 109.409 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 tt -49.79 -24.09 2.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.978 . . . . 0.0 109.683 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -70.74 -38.79 73.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.182 -0.948 . . . . 0.0 109.072 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -66.6 -48.46 69.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.618 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.542 ' CD2' ' CD1' ' B' ' 36' ' ' LEU . 6.5 mp -55.71 -34.12 64.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.098 . . . . 0.0 108.567 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -63.13 -18.79 63.82 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -76.21 -28.87 57.38 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.485 -0.759 . . . . 0.0 109.059 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.9 m-30 -69.81 -5.49 25.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HA ' ' HA3' ' B' ' 45' ' ' GLY . 8.3 m -83.89 51.32 2.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -0.965 . . . . 0.0 109.603 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.91 -1.043 . . . . 0.0 109.484 179.874 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.553 0.692 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.618 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 2.3 p -160.7 -158.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.629 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 34.2 m120 109.32 32.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.979 0.895 . . . . 0.0 108.622 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.499 ' O ' HD12 ' A' ' 10' ' ' ILE . 6.2 tp-100 -160.65 160.97 32.24 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.685 ' ND1' ' HA ' ' A' ' 10' ' ' ILE . 5.3 t60 -126.63 161.92 26.95 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 116.889 -1.924 . . . . 0.0 114.503 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.586 ' O ' ' CB ' ' B' ' 28' ' ' CYS . 0.1 OUTLIER -97.39 -155.73 0.5 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 113.582 -1.644 . . . . 0.0 110.734 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.586 ' CB ' ' O ' ' B' ' 27' ' ' LEU . 2.2 m 141.05 143.96 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.35 -132.71 49.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 2.9 m -52.5 -46.37 66.59 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.91 -1.347 . . . . 0.0 108.039 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.507 ' HB3' ' HA ' ' B' ' 27' ' ' LEU . 23.3 m-20 -49.39 -31.1 8.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.406 -0.808 . . . . 0.0 109.201 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.585 ' HA ' ' CD1' ' B' ' 27' ' ' LEU . 0.4 OUTLIER -67.8 -68.04 0.42 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.249 -0.907 . . . . 0.0 108.875 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.556 ' HB ' ' CZ ' ' B' ' 47' ' ' TYR . 18.9 m -54.57 -36.64 36.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.365 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.541 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -64.28 -52.19 59.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.521 -0.737 . . . . 0.0 109.405 179.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.555 ' CB ' HD12 ' B' ' 27' ' ' LEU . . . -47.66 -61.28 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.052 . . . . 0.0 109.251 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.542 ' CD1' ' CD2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -55.39 -21.69 16.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.897 -1.127 . . . . 0.0 108.346 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 84.5 t80 -84.97 -11.26 55.9 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.656 -0.653 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -95.45 -54.29 3.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.147 -0.971 . . . . 0.0 108.582 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.471 HG21 ' N ' ' B' ' 40' ' ' CYS . 2.3 m -59.57 -26.7 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.471 ' N ' HG21 ' B' ' 39' ' ' VAL . 3.9 m -124.59 34.85 4.92 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.464 -0.773 . . . . 0.0 109.35 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.3 72.61 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -97.61 -20.52 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -1.214 . . . . 0.0 109.575 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -122.04 117.88 27.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -0.822 . . . . 0.0 109.495 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.39 173.62 19.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 20' ' ' CYS . . . -165.5 -124.55 0.71 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -82.62 -57.98 3.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 109.453 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . 0.611 ' O ' ' HB ' ' B' ' 48' ' ' THR . 10.2 t80 -43.99 -83.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 109.419 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.611 ' HB ' ' O ' ' B' ' 47' ' ' TYR . 11.6 m 78.35 -14.66 0.83 Allowed 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 121.123 0.487 . . . . 0.0 110.61 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.551 ' HA ' ' CZ ' ' B' ' 47' ' ' TYR . 15.1 tttp 57.47 96.48 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.608 0 O-C-N 121.052 -1.03 . . . . 0.0 109.293 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.54 172.62 15.96 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.475 2.116 . . . . 0.0 110.429 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.534 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.818 0 N-CA-C 119.239 2.456 . . . . 0.0 119.239 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.577 HG23 ' CE2' ' A' ' 19' ' ' TYR . 0.5 OUTLIER -76.16 -31.57 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -1.135 . . . . 0.0 109.143 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 4.4 m -66.38 -33.09 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.453 ' O ' HG23 ' A' ' 8' ' ' THR . 0.9 OUTLIER -78.63 5.45 11.0 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 109.896 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -104.73 -43.4 5.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.115 -0.991 . . . . 0.0 109.207 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 9' ' ' SER . 89.3 m -105.63 -23.61 12.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 109.966 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.588 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 8.3 t -76.4 -28.37 56.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.902 -1.124 . . . . 0.0 109.262 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 4' ' ' GLU . 6.9 t -87.01 -32.49 20.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 1.1 t -134.74 147.56 50.06 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' B' ' 25' ' ' GLN . 1.1 mp -79.27 123.1 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.93 -1.106 . . . . 0.0 109.501 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.9 m -90.6 -167.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -0.797 . . . . 0.0 109.704 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.469 ' O ' HD11 ' A' ' 16' ' ' LEU . 52.5 p -122.68 150.24 42.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.475 -0.766 . . . . 0.0 109.148 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.646 ' CD1' ' CD2' ' B' ' 22' ' ' PHE . 2.4 tt -44.12 -28.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.895 . . . . 0.0 109.238 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.402 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 10.6 m-85 -64.14 -55.18 23.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.861 . . . . 0.0 109.118 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -41.78 77.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.959 . . . . 0.0 109.071 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.469 HD11 ' O ' ' A' ' 12' ' ' SER . 6.8 mp -61.82 -36.47 81.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.154 -0.966 . . . . 0.0 108.978 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 8.3 mt-10 -56.58 -30.45 63.2 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.249 -0.907 . . . . 0.0 108.641 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.5 -31.13 69.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.582 ' CD2' HD12 ' B' ' 36' ' ' LEU . 2.6 m-85 -54.65 -41.75 70.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 108.668 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.3 50.92 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.47 -0.769 . . . . 0.0 109.387 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.46 ' O ' ' HG3' ' B' ' 50' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.626 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.646 ' CD2' ' CD1' ' A' ' 13' ' ' LEU . 41.3 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -151.18 -172.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.935 -1.103 . . . . 0.0 109.374 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER 40.07 49.29 2.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 110.049 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLN . . . . . 0.521 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 1.4 mt-30 -160.05 155.75 25.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.8 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' HIS . . . . . 0.547 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -121.34 171.97 8.37 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.588 ' O ' ' SG ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -160.89 -142.53 0.08 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.351 -1.468 . . . . 0.0 110.863 -179.071 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 148.4 131.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 123.824 0.85 . . . . 0.0 108.996 -178.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' B' ' 32' ' ' LEU . . . 37.06 -116.9 0.4 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.467 ' O ' HG23 ' B' ' 33' ' ' VAL . 0.3 OUTLIER -43.2 -61.4 1.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.439 -1.036 . . . . 0.0 109.401 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.484 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 7.2 m-20 -45.37 -27.39 0.68 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -0.938 . . . . 0.0 108.984 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' B' ' 29' ' ' GLY . 0.2 OUTLIER -80.34 -72.24 0.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.848 . . . . 0.0 109.328 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 30' ' ' SER . 16.8 m -44.66 -29.35 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 108.87 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.533 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.0 OUTLIER -69.79 -60.33 2.38 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.553 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -60.61 -43.37 97.53 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.582 HD12 ' CD2' ' A' ' 19' ' ' TYR . 3.7 mm? -59.08 -29.27 67.21 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.468 -0.77 . . . . 0.0 109.162 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 37' ' ' TYR . 13.8 t80 -78.76 -10.64 59.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.593 -0.692 . . . . 0.0 109.597 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -95.24 -36.87 11.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.0 109.253 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 16' ' ' LEU . 3.4 m -72.46 -28.49 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.277 -0.889 . . . . 0.0 109.438 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' CYS . . . . . 0.539 ' HB3' ' CB ' ' B' ' 43' ' ' ARG . 72.5 m -79.84 -37.24 35.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.106 -0.996 . . . . 0.0 109.259 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . 0.495 ' C ' ' CG ' ' B' ' 42' ' ' GLU . . . 77.52 98.23 0.2 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.495 ' CG ' ' C ' ' B' ' 41' ' ' GLY . 2.5 pt-20 37.99 37.75 0.16 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.61 -0.935 . . . . 0.0 110.407 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.539 ' CB ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -93.86 -170.97 2.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.085 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 43' ' ' ARG . . . -43.58 112.37 0.55 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.26 -6.3 88.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.41 -168.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.65 43.06 1.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.407 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 99.0 m -148.45 -37.45 0.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 109.777 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER -167.21 116.65 0.7 Allowed Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 109.572 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.46 ' HG3' ' O ' ' A' ' 21' ' ' ASN . 34.5 Cg_endo -77.5 -170.09 0.87 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.227 1.952 . . . . 0.0 110.261 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.2 p . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.471 -179.901 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.465 ' N ' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 1 N--CA 1.53 4.923 0 N-CA-C 119.457 2.543 . . . . 0.0 119.457 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.685 HG23 ' CE2' ' A' ' 19' ' ' TYR . 12.6 mt -93.29 -34.01 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.129 -1.218 . . . . 0.0 109.577 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 4.3 m -65.94 -28.01 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.375 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 1' ' ' GLY . 4.9 mt-10 -80.58 2.18 26.63 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.487 -0.758 . . . . 0.0 109.666 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.25 -45.69 4.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.985 ' HB3' HD11 ' B' ' 27' ' ' LEU . 56.0 m -97.99 -33.11 11.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.912 . . . . 0.0 109.815 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -73.07 -12.97 61.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.947 . . . . 0.0 109.808 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.3 t -100.38 -34.3 10.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.079 -1.013 . . . . 0.0 108.922 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -136.97 159.23 42.49 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.638 HG23 ' O ' ' B' ' 25' ' ' GLN . 23.7 mm -79.41 96.62 2.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 109.513 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.724 ' O ' HG23 ' B' ' 23' ' ' VAL . 9.1 p -76.97 159.58 29.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -0.818 . . . . 0.0 109.794 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.476 ' HA ' HG23 ' B' ' 23' ' ' VAL . 59.1 p -89.03 144.69 25.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 109.338 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.966 HD11 HG12 ' B' ' 39' ' ' VAL . 1.4 tp -46.82 -24.89 0.65 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.283 -0.886 . . . . 0.0 109.108 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 6.5 t80 -71.72 -32.62 67.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -0.927 . . . . 0.0 109.135 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 12' ' ' SER . 5.4 mm100 -66.53 -35.79 81.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.188 -0.945 . . . . 0.0 108.456 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.682 ' N ' HD22 ' A' ' 16' ' ' LEU . 3.2 mm? -66.19 -35.17 79.75 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -48.46 -36.21 14.53 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -74.7 -21.51 59.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.428 -0.795 . . . . 0.0 109.329 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.925 ' HD2' HD11 ' B' ' 36' ' ' LEU . 3.2 m-30 -60.04 -19.37 52.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.341 -0.85 . . . . 0.0 109.27 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.3 m -97.44 52.05 1.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.387 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.486 -179.919 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' B' ' 22' ' ' PHE . 38.5 p90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.226 0.536 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.829 HG22 ' H ' ' B' ' 24' ' ' ASN . 4.7 p -114.08 -170.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 108.981 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.829 ' H ' HG22 ' B' ' 23' ' ' VAL . 33.3 m-20 82.84 36.28 0.05 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.697 -0.627 . . . . 0.0 109.495 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.638 ' O ' HG23 ' A' ' 10' ' ' ILE . 2.5 mt-30 -140.95 175.7 9.41 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -133.54 176.34 8.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.868 -1.145 . . . . 0.0 109.066 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.985 HD11 ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -160.28 -164.93 1.35 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.763 -1.21 . . . . 0.0 111.072 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 146.16 153.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.45 -119.06 4.54 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.462 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -64.47 -52.47 57.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.3 -1.118 . . . . 0.0 110.115 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' B' ' 30' ' ' SER . 17.1 m-20 -43.55 -38.83 3.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.077 -1.015 . . . . 0.0 109.63 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.494 HD12 HD13 ' B' ' 27' ' ' LEU . 0.2 OUTLIER -67.73 -71.06 0.22 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.096 -1.003 . . . . 0.0 108.956 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.539 HG12 ' OH ' ' B' ' 47' ' ' TYR . 32.2 m -47.9 -27.56 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.098 -1.001 . . . . 0.0 108.602 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 9.4 mt-10 -74.65 -59.57 2.67 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.505 -0.747 . . . . 0.0 109.087 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.572 ' O ' HG13 ' B' ' 39' ' ' VAL . . . -58.92 -41.96 88.54 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.925 HD11 ' HD2' ' A' ' 19' ' ' TYR . 1.1 mm? -60.27 -29.03 68.54 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.674 0.75 . . . . 0.0 109.027 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 39.8 t80 -83.09 -13.51 55.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.68 -0.638 . . . . 0.0 110.247 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -90.02 -44.22 10.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.063 -1.023 . . . . 0.0 108.803 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.966 HG12 HD11 ' A' ' 13' ' ' LEU . 1.9 m -66.27 -37.69 80.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.558 -0.714 . . . . 0.0 109.314 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.421 ' N ' ' CG2' ' B' ' 39' ' ' VAL . 1.3 m -105.5 17.51 23.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.796 . . . . 0.0 109.439 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -56.96 -85.96 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.486 ' HG2' ' N ' ' B' ' 43' ' ' ARG . 28.2 tt0 -55.11 -88.47 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -1.152 . . . . 0.0 109.357 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.486 ' N ' ' HG2' ' B' ' 42' ' ' GLU . 0.4 OUTLIER -46.83 174.33 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.543 -0.723 . . . . 0.0 109.379 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.31 -92.64 1.73 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 30.97 6.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.63 -155.0 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -1.143 . . . . 0.0 109.648 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' TYR . . . . . 0.539 ' OH ' HG12 ' B' ' 33' ' ' VAL . 9.8 t80 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 0.0 109.526 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.799 0 N-CA-C 119.273 2.469 . . . . 0.0 119.273 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.655 HG22 ' CD2' ' B' ' 32' ' ' LEU . 18.2 mm -78.69 -62.18 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -1.108 . . . . 0.0 109.208 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.792 HG12 HD22 ' B' ' 32' ' ' LEU . 2.4 m -72.3 -13.79 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.17 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -89.11 -8.32 54.05 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.637 ' O ' HG22 ' A' ' 8' ' ' THR . 2.9 mm-40 -97.52 -51.57 4.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 109.277 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.628 ' SG ' HD11 ' A' ' 16' ' ' LEU . 17.3 m -85.94 -69.84 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.887 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 2.4 t -41.56 -25.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.033 . . . . 0.0 110.724 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 5' ' ' GLN . 3.7 t -72.42 -27.08 62.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.86 -1.15 . . . . 0.0 109.238 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 6' ' ' CYS . 18.0 m -156.61 -157.66 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 mm -107.07 116.02 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.462 -1.399 . . . . 0.0 109.231 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.463 ' O ' HG21 ' B' ' 23' ' ' VAL . 2.5 p -99.05 172.84 7.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 109.649 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.2 p -106.87 150.78 26.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.806 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -46.52 -28.24 1.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.686 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 14.9 t80 -61.82 -45.46 93.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 108.808 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.58 -54.13 47.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.368 -0.833 . . . . 0.0 109.418 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 16' ' ' LEU . 1.6 mm? -51.33 -38.64 54.18 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.17 -0.956 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -49.36 -34.06 15.07 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.13 -21.81 58.6 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.884 ' CD2' HD11 ' B' ' 36' ' ' LEU . 3.3 m-85 -68.02 -16.93 64.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 0.0 109.435 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.3 m -82.21 51.26 1.75 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 0.0 109.564 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.48 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.252 0.548 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.832 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.8 OUTLIER -126.15 -155.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.0 109.631 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.832 ' N ' HG13 ' B' ' 23' ' ' VAL . 0.5 OUTLIER 86.68 4.72 0.39 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.287 0.565 . . . . 0.0 109.568 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -121.37 153.77 37.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.822 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -77.86 164.87 24.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.716 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -161.76 132.93 5.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.339 -1.475 . . . . 0.0 112.807 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.453 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -138.38 155.9 48.1 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.376 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 37.17 -115.2 0.29 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.446 ' O ' HG22 ' B' ' 33' ' ' VAL . 4.1 m -47.75 -65.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.455 -1.027 . . . . 0.0 110.842 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' B' ' 30' ' ' SER . 5.6 m-20 -42.48 -39.11 2.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 109.418 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.792 HD22 HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -65.99 -73.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 108.945 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.752 HG12 ' CD2' ' B' ' 47' ' ' TYR . 15.9 m -43.86 -28.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.146 -0.971 . . . . 0.0 108.69 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.519 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -78.18 -61.63 1.94 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.541 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -56.67 -39.42 73.73 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.884 HD11 ' CD2' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -64.14 -34.13 77.35 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.942 0.877 . . . . 0.0 108.806 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.418 ' O ' ' HA2' ' B' ' 41' ' ' GLY . 20.4 t80 -75.97 -22.33 56.0 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.742 -0.599 . . . . 0.0 110.077 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.537 HD23 ' N ' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -76.5 -53.41 8.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.944 -1.097 . . . . 0.0 108.484 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 16' ' ' LEU . 2.6 m -54.1 -32.24 22.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.534 ' HB3' ' CD ' ' B' ' 43' ' ' ARG . 1.3 m -122.83 39.59 3.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.506 -0.746 . . . . 0.0 109.713 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' B' ' 37' ' ' TYR . . . -53.45 -32.3 45.13 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.73 7.65 9.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -1.181 . . . . 0.0 109.94 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.534 ' CD ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -116.05 139.75 49.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 108.947 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.08 153.73 17.29 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.34 -151.95 6.18 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.22 31.81 0.24 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.233 -1.157 . . . . 0.0 109.636 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' TYR . . . . . 0.752 ' CD2' HG12 ' B' ' 33' ' ' VAL . 1.2 t80 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.447 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.751 HG22 HD21 ' B' ' 32' ' ' LEU . 62.2 mt -92.55 -28.94 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.941 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 1.4 m -62.22 -37.41 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.369 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 3.0 mt-10 -76.06 -1.17 24.63 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.362 -0.836 . . . . 0.0 109.644 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -43.4 4.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.108 -0.995 . . . . 0.0 110.045 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 9' ' ' SER . 95.6 m -103.72 -29.35 11.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.103 -0.998 . . . . 0.0 110.093 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 2.5 t -69.26 -6.98 32.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.042 -1.036 . . . . 0.0 109.349 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -99.6 -31.3 11.66 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.943 . . . . 0.0 108.526 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 6' ' ' CYS . 4.2 m -147.45 165.24 30.84 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 10' ' ' ILE . 3.9 mm -80.15 110.42 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.104 -0.997 . . . . 0.0 109.548 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 78.4 m -74.8 -170.71 1.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.662 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 13' ' ' LEU . 87.5 p -121.13 136.04 55.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -42.81 -26.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.168 -0.957 . . . . 0.0 109.776 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -62.79 -49.34 75.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.125 -0.984 . . . . 0.0 108.888 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -65.07 -44.94 87.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 0.0 108.865 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.616 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 3.3 mp -55.65 -37.16 67.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.107 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 7.0 mm-40 -54.03 -34.5 60.17 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.286 -0.884 . . . . 0.0 108.749 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -21.98 61.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.414 -0.804 . . . . 0.0 109.485 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.779 ' HD2' HD11 ' B' ' 36' ' ' LEU . 5.0 m-30 -62.44 -29.41 70.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.7 m -82.57 53.79 2.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.891 . . . . 0.0 109.276 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.4 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' B' ' 22' ' ' PHE . 52.4 p90 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.592 ' O ' ' HB3' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -143.53 171.15 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.041 -1.037 . . . . 0.0 110.008 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.592 ' HB3' ' O ' ' B' ' 23' ' ' VAL . 10.6 p30 167.5 -29.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -85.56 -171.04 3.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.536 -0.728 . . . . 0.0 109.932 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -118.79 -169.82 1.79 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -0.846 . . . . 0.0 109.022 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' B' ' 28' ' ' CYS . 0.3 OUTLIER -160.77 -159.27 0.66 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.751 -1.218 . . . . 0.0 110.415 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.616 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 145.9 141.9 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 123.558 0.743 . . . . 0.0 109.17 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 35.64 -118.19 0.35 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.1 OUTLIER -42.61 -62.83 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.427 -1.043 . . . . 0.0 110.177 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -43.99 -31.63 0.95 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.048 -1.033 . . . . 0.0 109.166 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.751 HD21 HG22 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -68.69 -66.9 0.51 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.221 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.452 HG23 ' OE2' ' B' ' 34' ' ' GLU . 30.6 m -51.52 -28.64 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.995 -1.066 . . . . 0.0 108.489 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.503 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.1 mp0 -76.0 -58.77 3.08 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.545 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.55 -47.31 82.38 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.779 HD11 ' HD2' ' A' ' 19' ' ' TYR . 1.1 mm? -56.49 -29.01 61.29 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.781 0.8 . . . . 0.0 108.959 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' B' ' 33' ' ' VAL . 70.7 t80 -82.41 -15.09 53.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.828 -0.545 . . . . 0.0 109.988 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.4 OUTLIER -87.32 -46.64 9.5 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 16' ' ' LEU . 2.7 m -65.95 -21.37 28.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' B' ' 43' ' ' ARG . 1.3 m -119.9 27.09 8.89 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.451 -0.781 . . . . 0.0 109.235 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' B' ' 40' ' ' CYS . . . -43.45 -26.9 0.71 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' B' ' 40' ' ' CYS . 25.9 tt0 -90.92 -23.05 20.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -1.175 . . . . 0.0 109.644 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' B' ' 40' ' ' CYS . 2.0 ttt180 -110.25 159.37 17.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.406 -0.809 . . . . 0.0 109.222 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -178.45 142.57 5.53 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' B' ' 47' ' ' TYR . . . 115.94 -67.59 0.29 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 60.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 0.0 109.529 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' B' ' 45' ' ' GLY . 72.1 t80 . . . . . 0 C--N 1.297 -1.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.346 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.872 0 N-CA-C 119.369 2.508 . . . . 0.0 119.369 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.566 HG21 ' CE2' ' A' ' 19' ' ' TYR . 22.3 mt -89.06 -31.73 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -1.139 . . . . 0.0 109.399 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.621 HG12 HD22 ' B' ' 32' ' ' LEU . 1.6 m -47.09 -40.14 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.22 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 6.4 mt-10 -56.47 -16.32 5.67 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.641 -0.662 . . . . 0.0 110.103 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -105.34 -31.08 9.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 110.303 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.617 ' HB3' HD11 ' B' ' 27' ' ' LEU . 7.3 m -103.01 -31.2 10.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.039 . . . . 0.0 110.127 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 1.5 m -84.84 -13.82 49.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.32 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.8 -13.29 15.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.037 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.5 m -150.65 158.36 44.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.354 -0.841 . . . . 0.0 109.07 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 10' ' ' ILE . 20.4 mm -80.86 97.99 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 0.0 109.622 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 16' ' ' LEU . 3.7 p -82.06 171.46 14.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 109.373 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.678 ' HA ' HG21 ' B' ' 23' ' ' VAL . 59.3 p -111.03 148.49 32.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.239 -0.913 . . . . 0.0 109.828 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.637 ' CD1' HG12 ' B' ' 39' ' ' VAL . 0.6 OUTLIER -45.45 -28.94 0.98 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.058 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -59.08 -53.41 58.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.368 -0.832 . . . . 0.0 109.024 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 27.5 mm-40 -61.43 -29.11 69.73 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.286 -0.884 . . . . 0.0 109.048 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.883 HD23 HD13 ' B' ' 36' ' ' LEU . 6.9 mp -71.22 -38.92 72.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.258 -0.901 . . . . 0.0 108.7 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.45 -32.75 63.02 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -73.38 -26.87 61.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.433 -0.792 . . . . 0.0 109.277 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' A' ' 2' ' ' ILE . 6.2 m-30 -58.79 -19.79 44.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 108.814 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.67 51.75 1.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -0.768 . . . . 0.0 109.247 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.333 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.397 0.618 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.819 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -157.4 -158.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.368 -0.832 . . . . 0.0 109.865 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.819 ' N ' HG13 ' B' ' 23' ' ' VAL . 30.3 m-20 74.07 30.23 1.27 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -127.86 154.23 45.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.386 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.524 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -100.76 -178.35 3.75 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.782 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -161.0 -159.6 0.68 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.787 -1.195 . . . . 0.0 110.225 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.577 ' CB ' ' O ' ' B' ' 27' ' ' LEU . 1.2 m 149.35 150.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.49 -127.86 27.09 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.439 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.9 OUTLIER -58.34 -51.08 71.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.286 -1.126 . . . . 0.0 109.83 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 30' ' ' SER . 3.2 m-20 -43.35 -42.87 4.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 109.26 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.853 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -63.09 -76.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.918 . . . . 0.0 109.502 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.803 HG12 ' CE1' ' B' ' 47' ' ' TYR . 14.4 m -44.45 -33.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.029 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.528 ' O ' ' HG ' ' B' ' 38' ' ' LEU . 2.5 mm-40 -62.97 -52.71 61.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.477 -0.764 . . . . 0.0 109.151 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -55.9 -52.96 62.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.535 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.883 HD13 HD23 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -57.37 -29.96 64.46 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.892 -1.13 . . . . 0.0 107.955 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 86.3 t80 -73.27 -11.95 60.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.567 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -97.06 -51.2 4.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.979 . . . . 0.0 108.74 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.815 HG11 ' HB3' ' A' ' 16' ' ' LEU . 2.3 m -48.33 -36.66 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.509 ' CB ' ' HB3' ' B' ' 43' ' ' ARG . 0.9 OUTLIER -93.71 -53.37 4.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.389 -0.819 . . . . 0.0 109.157 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.72 -50.42 3.58 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -116.86 22.36 12.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.186 . . . . 0.0 110.058 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.509 ' HB3' ' CB ' ' B' ' 40' ' ' CYS . 0.2 OUTLIER -56.31 -176.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.0 . . . . 0.0 109.15 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.68 155.35 49.69 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.12 56.5 4.35 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -147.05 140.2 25.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.527 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' TYR . . . . . 0.803 ' CE1' HG12 ' B' ' 33' ' ' VAL . 32.4 t80 . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.432 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.883 0 N-CA-C 119.388 2.515 . . . . 0.0 119.388 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.7 mt -74.49 -25.98 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.567 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.732 HG12 HD22 ' B' ' 32' ' ' LEU . 1.3 m -71.3 -30.58 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.67 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.13 -10.73 53.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.619 -0.675 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -31.3 9.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.868 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.551 ' HB3' HD11 ' B' ' 27' ' ' LEU . 95.5 m -105.01 -34.53 7.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.982 -1.074 . . . . 0.0 110.076 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.538 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 1.8 t -63.44 -10.99 19.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.015 -1.053 . . . . 0.0 109.65 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 9' ' ' SER . 14.6 t -104.99 -37.9 6.8 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.469 ' N ' HG23 ' A' ' 8' ' ' THR . 7.9 m -127.2 147.8 50.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.702 ' CG2' HG22 ' B' ' 23' ' ' VAL . 0.9 OUTLIER -78.87 91.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.993 -1.067 . . . . 0.0 109.212 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.625 ' O ' HG23 ' B' ' 23' ' ' VAL . 59.7 m -54.74 172.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.434 -0.791 . . . . 0.0 109.498 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 13' ' ' LEU . 85.6 p -106.81 155.34 19.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 109.531 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.75 HD11 HG12 ' B' ' 39' ' ' VAL . 0.8 OUTLIER -45.51 -26.81 0.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.244 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -67.27 -44.35 79.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 10.0 mt-30 -65.47 -43.35 90.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.923 HD23 HD13 ' B' ' 36' ' ' LEU . 6.8 mp -61.72 -34.03 75.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.014 -1.054 . . . . 0.0 109.081 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.87 -23.61 61.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.3 m-80 -75.62 -24.37 56.49 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.53 -0.731 . . . . 0.0 109.615 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.632 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.6 m-30 -77.83 3.75 13.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.016 -1.052 . . . . 0.0 109.478 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 13.6 m -123.27 69.1 1.01 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 109.794 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 18' ' ' ASN . 17.4 p30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.421 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.498 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.71 HG13 ' N ' ' B' ' 24' ' ' ASN . 1.3 p -95.44 -159.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.213 -0.929 . . . . 0.0 108.603 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.71 ' N ' HG13 ' B' ' 23' ' ' VAL . 6.5 t-20 78.08 30.44 0.44 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.489 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -155.54 162.62 40.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.436 -0.79 . . . . 0.0 109.127 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.538 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -110.74 179.93 3.93 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.686 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -160.24 -168.35 2.16 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.343 -1.473 . . . . 0.0 111.968 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' B' ' 32' ' ' LEU . 0.5 OUTLIER 151.38 147.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.66 -115.58 2.66 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 68.0 m -63.74 -57.58 9.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -1.132 . . . . 0.0 110.047 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' B' ' 30' ' ' SER . 6.6 m-20 -43.83 -36.23 2.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.205 -0.935 . . . . 0.0 109.437 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.88 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -67.85 -76.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.215 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' B' ' 32' ' ' LEU . 3.5 m -44.51 -29.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 108.673 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.53 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 7.1 mt-10 -66.07 -55.58 15.86 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.505 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -55.17 -55.21 33.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.347 -0.846 . . . . 0.0 108.787 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.923 HD13 HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -58.3 -18.44 27.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 108.637 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 23.3 t80 -86.12 -14.49 44.03 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -89.47 -42.11 11.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 108.805 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.75 HG12 HD11 ' A' ' 13' ' ' LEU . 2.3 m -75.62 -20.81 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.485 -0.759 . . . . 0.0 109.261 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' B' ' 39' ' ' VAL . 55.6 m -111.2 6.04 20.4 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.324 -0.86 . . . . 0.0 109.757 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.34 -12.29 83.67 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -82.24 -72.11 0.45 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -1.12 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -175.01 1.84 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.464 -0.772 . . . . 0.0 109.617 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.01 -94.08 1.69 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.94 -119.63 5.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.94 27.42 0.79 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -1.132 . . . . 0.0 109.383 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.63 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.914 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 2' ' ' ILE . 6.7 tt -102.99 -13.14 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.232 -1.158 . . . . 0.0 109.659 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.836 HG12 HD22 ' B' ' 32' ' ' LEU . 10.9 m -99.65 -30.46 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 109.17 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.489 ' O ' ' CG2' ' A' ' 8' ' ' THR . 10.1 mt-10 -82.68 -4.95 58.55 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.308 -0.87 . . . . 0.0 109.958 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.55 -34.93 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -0.991 . . . . 0.0 110.01 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.519 ' CB ' HD11 ' B' ' 27' ' ' LEU . 82.0 m -105.42 -30.31 9.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 110.412 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.558 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 4.5 t -71.57 -6.76 43.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.147 -0.97 . . . . 0.0 109.821 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -119.86 -14.33 8.98 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.234 -0.916 . . . . 0.0 108.815 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.68 ' O ' HD13 ' A' ' 10' ' ' ILE . 68.0 m -136.88 -165.68 1.78 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 9' ' ' SER . 4.6 mm -120.99 92.35 2.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 109.548 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.788 ' O ' HG23 ' B' ' 23' ' ' VAL . 28.0 m -71.66 171.68 11.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.482 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 13' ' ' LEU . 25.4 p -116.12 153.42 31.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.875 . . . . 0.0 108.861 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.707 ' CD1' HG12 ' B' ' 39' ' ' VAL . 0.8 OUTLIER -44.44 -29.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.101 -0.999 . . . . 0.0 109.083 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.32 -50.42 73.68 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.254 -0.904 . . . . 0.0 108.694 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.436 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 3.6 mm-40 -65.45 -35.58 81.34 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.835 ' CD2' HG11 ' B' ' 39' ' ' VAL . 3.4 mp -65.69 -33.91 76.98 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -25.25 63.98 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.88 -34.5 62.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.427 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.72 ' HD2' HD11 ' B' ' 36' ' ' LEU . 1.4 m-30 -59.4 -20.08 52.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 108.78 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.18 54.31 2.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.362 -0.836 . . . . 0.0 109.469 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.479 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.513 ' HA ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 11' ' ' CYS . 1.4 p -82.56 -166.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.422 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.742 ' H ' HG22 ' B' ' 23' ' ' VAL . 8.2 t30 46.47 38.66 5.65 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.559 -0.713 . . . . 0.0 109.308 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.17 169.11 24.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.881 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.538 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 1.1 t60 -125.98 172.01 10.29 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 1.136 HD13 ' CD1' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -161.29 -166.84 1.62 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.327 -1.483 . . . . 0.0 111.639 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 150.78 153.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 123.419 0.688 . . . . 0.0 109.265 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.79 -117.54 2.2 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.446 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.4 OUTLIER -60.84 -57.59 12.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -1.072 . . . . 0.0 110.28 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' B' ' 30' ' ' SER . 13.5 m-20 -42.28 -31.5 0.4 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.236 -0.915 . . . . 0.0 109.68 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 1.136 ' CD1' HD13 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -70.46 -68.46 0.42 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.156 -0.965 . . . . 0.0 108.87 179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.422 HG23 ' N ' ' B' ' 34' ' ' GLU . 33.5 m -51.74 -35.26 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.125 -0.985 . . . . 0.0 108.733 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.536 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 4.7 mt-10 -69.68 -52.94 21.17 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.376 -0.828 . . . . 0.0 108.982 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.539 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -62.99 -42.97 99.99 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.72 HD11 ' HD2' ' A' ' 19' ' ' TYR . 1.6 mm? -60.32 -30.5 69.55 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.894 0.854 . . . . 0.0 108.698 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.414 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 13.3 t80 -77.37 -14.1 59.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.671 -0.643 . . . . 0.0 109.882 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.5 OUTLIER -88.27 -53.7 4.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 108.609 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.835 HG11 ' CD2' ' A' ' 16' ' ' LEU . 2.2 m -54.57 -27.11 17.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' CYS . . . . . . . . . . . . . 55.7 m -119.61 35.45 4.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.467 -0.771 . . . . 0.0 109.558 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.16 51.2 3.53 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -172.91 -34.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -1.116 . . . . 0.0 109.481 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 44' ' ' GLY . 7.0 ttt85 -92.71 153.13 19.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.493 -0.754 . . . . 0.0 109.311 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' B' ' 43' ' ' ARG . . . -54.67 -106.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.66 145.18 1.05 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.6 -156.24 0.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -1.177 . . . . 0.0 109.632 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 0.0 109.777 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.813 0 N-CA-C 119.313 2.485 . . . . 0.0 119.313 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' B' ' 32' ' ' LEU . 7.9 mt -102.34 -45.66 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -1.16 . . . . 0.0 109.607 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.4 m -49.76 -34.47 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.703 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 3' ' ' VAL . 2.6 mt-10 -77.38 -7.6 56.35 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 109.851 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -40.72 5.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 110.142 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 9' ' ' SER . 69.0 m -99.98 -34.69 9.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 0.0 110.509 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.581 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 6.1 t -71.96 -40.42 68.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.849 -1.157 . . . . 0.0 109.594 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 55.0 p -77.85 -31.9 51.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.114 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.771 ' O ' HD13 ' A' ' 10' ' ' ILE . 2.5 p -124.62 -150.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -0.81 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 9' ' ' SER . 5.5 mm -133.53 112.1 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.143 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.7 m -86.93 170.17 11.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 109.661 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' LEU . 79.4 p -102.76 140.23 37.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 109.383 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.664 HD13 ' CE2' ' B' ' 22' ' ' PHE . 0.8 OUTLIER -42.85 -31.3 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -62.97 -51.19 67.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.94 . . . . 0.0 109.373 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -37.56 74.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.058 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.777 HD23 HD13 ' B' ' 36' ' ' LEU . 6.2 mp -64.93 -38.91 92.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 108.868 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.56 -26.25 63.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -74.87 -32.79 61.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.348 -0.845 . . . . 0.0 108.929 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.591 ' CD2' ' HA ' ' A' ' 16' ' ' LEU . 4.3 m-30 -57.59 -20.58 33.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.31 -0.869 . . . . 0.0 109.219 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.6 m -87.81 50.62 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.55 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.664 ' CE2' HD13 ' A' ' 13' ' ' LEU . 11.8 t80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.4 0.619 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.82 HG13 ' N ' ' B' ' 24' ' ' ASN . 1.1 p -161.8 -153.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.756 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.82 ' N ' HG13 ' B' ' 23' ' ' VAL . 6.2 m-20 81.88 55.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.69 166.44 18.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.63 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -124.97 146.56 49.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.611 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.813 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -160.91 145.05 13.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.294 -1.503 . . . . 0.0 112.679 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.46 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -133.91 155.07 50.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.523 -0.736 . . . . 0.0 109.447 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 34.35 -126.12 0.52 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.498 ' O ' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER -39.0 -63.8 0.5 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.937 . . . . 0.0 110.715 -179.026 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' B' ' 30' ' ' SER . 10.3 m-20 -41.31 -32.14 0.28 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.825 . . . . 0.0 109.354 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.948 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.3 OUTLIER -69.15 -71.69 0.21 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.312 -0.867 . . . . 0.0 108.808 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.498 HG22 ' O ' ' B' ' 30' ' ' SER . 29.0 m -43.05 -39.15 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.262 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.514 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -63.19 -50.44 70.29 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.311 -0.868 . . . . 0.0 108.954 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.722 ' HB2' HD23 ' B' ' 27' ' ' LEU . . . -53.36 -57.69 9.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.458 -0.776 . . . . 0.0 109.443 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.948 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.3 OUTLIER -56.59 -22.73 35.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.047 -1.033 . . . . 0.0 108.526 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 11.1 t80 -82.5 -14.88 54.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.648 -0.657 . . . . 0.0 109.477 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -85.51 -45.31 11.91 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -67.86 -21.63 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.535 -0.728 . . . . 0.0 109.173 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.444 ' HB3' ' O ' ' B' ' 43' ' ' ARG . 96.2 m -113.45 16.02 18.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.404 -0.81 . . . . 0.0 109.353 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -44.04 -39.94 5.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.95 17.0 6.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -1.174 . . . . 0.0 109.422 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' B' ' 40' ' ' CYS . 1.8 tpt85 -132.85 111.37 11.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.323 -0.86 . . . . 0.0 109.367 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.43 -122.88 6.93 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.9 40.11 1.9 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.502 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 29.6 t80 -108.88 -0.88 19.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -1.127 . . . . 0.0 109.507 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' TYR . . . . . 0.41 ' CE1' HG12 ' B' ' 33' ' ' VAL . 2.3 t80 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.823 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.409 2.523 . . . . 0.0 119.409 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.446 HG23 ' CZ ' ' A' ' 19' ' ' TYR . 62.0 mt -81.49 -32.94 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.265 -1.138 . . . . 0.0 109.65 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.954 HG12 HD22 ' B' ' 32' ' ' LEU . 2.9 m -60.58 -30.33 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.584 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.1 mt-10 -78.73 1.79 21.85 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.565 -0.71 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' SER . 3.0 tp60 -105.24 -40.84 5.72 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.217 -0.927 . . . . 0.0 109.688 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 9' ' ' SER . 85.3 m -106.05 -36.87 6.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 110.667 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.564 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 8.8 t -68.97 -15.28 63.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.876 -1.14 . . . . 0.0 110.076 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 11.2 t -113.34 -27.72 7.84 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 18.2 m -126.65 156.76 40.5 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.482 ' CG2' ' HA ' ' B' ' 24' ' ' ASN . 5.5 mm -81.14 146.61 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.735 -1.228 . . . . 0.0 109.516 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.435 ' HB2' HD11 ' A' ' 16' ' ' LEU . 82.7 m -124.91 -169.19 1.94 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.363 -0.835 . . . . 0.0 109.768 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -137.47 143.1 41.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.653 ' HG ' HG12 ' B' ' 39' ' ' VAL . 0.9 OUTLIER -40.84 -33.32 0.29 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 109.66 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 75.1 t80 -65.93 -50.35 64.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.953 . . . . 0.0 108.616 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -60.98 -36.54 79.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.157 -0.964 . . . . 0.0 108.568 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.835 HD23 HD22 ' B' ' 36' ' ' LEU . 5.2 mp -69.37 -32.47 71.55 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 2.5 mt-10 -56.98 -28.5 62.4 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -31.57 69.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.477 -0.764 . . . . 0.0 109.294 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.629 ' CD2' HD11 ' B' ' 36' ' ' LEU . 23.2 m-30 -58.68 -14.84 9.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -0.963 . . . . 0.0 109.547 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.4 m -99.73 57.64 1.01 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.964 . . . . 0.0 109.532 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.472 179.934 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.482 0.658 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.821 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -144.37 -159.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.392 -0.818 . . . . 0.0 109.885 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.821 ' N ' HG13 ' B' ' 23' ' ' VAL . 36.6 t30 62.08 68.25 0.69 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.399 0.619 . . . . 0.0 109.667 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.27 173.45 11.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.209 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.564 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -121.14 150.86 40.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.76 HD23 ' N ' ' B' ' 27' ' ' LEU . 1.2 pt? -160.98 141.51 11.29 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.223 -1.548 . . . . 0.0 112.85 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.9 OUTLIER -139.54 167.9 21.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.381 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 40.71 -121.6 1.94 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.459 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.7 OUTLIER -53.1 -59.35 4.66 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.342 -1.093 . . . . 0.0 110.572 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.614 ' CB ' ' HB2' ' B' ' 27' ' ' LEU . 13.8 m-20 -40.09 -35.92 0.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.873 . . . . 0.0 109.765 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.954 HD22 HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -67.61 -72.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 108.622 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -49.15 -27.98 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.941 . . . . 0.0 108.476 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.52 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -72.38 -56.29 5.7 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.704 ' HB3' ' CD1' ' B' ' 27' ' ' LEU . . . -60.21 -45.53 92.86 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.835 HD22 HD23 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -59.9 -27.09 66.43 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.513 ' O ' ' CA ' ' B' ' 41' ' ' GLY . 76.9 t80 -80.22 -11.9 59.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.75 -0.593 . . . . 0.0 109.822 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.541 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.6 OUTLIER -90.79 -48.51 6.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.979 . . . . 0.0 108.713 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.653 HG12 ' HG ' ' A' ' 13' ' ' LEU . 2.4 m -62.22 -29.47 46.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.484 -0.76 . . . . 0.0 108.963 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' CYS . . . . . . . . . . . . . 19.1 m -119.49 13.71 12.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.45 -0.781 . . . . 0.0 109.526 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' B' ' 37' ' ' TYR . . . -55.86 -40.87 82.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -105.34 -11.32 16.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.46 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.14 138.31 41.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.601 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.95 -144.29 12.77 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' GLY . . . . . 0.557 ' C ' ' CG ' ' B' ' 46' ' ' PHE . . . 163.81 165.84 21.67 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.557 ' CG ' ' C ' ' B' ' 45' ' ' GLY . 0.8 OUTLIER 39.29 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.523 -0.987 . . . . 0.0 109.77 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.578 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.738 HG22 HD21 ' B' ' 32' ' ' LEU . 10.5 mt -80.35 -23.13 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -1.111 . . . . 0.0 109.38 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.1 m -60.97 -27.63 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.611 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -83.41 4.74 26.28 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.47 -0.769 . . . . 0.0 109.458 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.75 -49.36 3.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.169 -0.957 . . . . 0.0 110.455 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' SER . 62.0 m -104.97 -34.08 8.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 110.752 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.537 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 4.2 t -61.65 -12.06 14.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.774 -1.204 . . . . 0.0 109.553 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -99.13 -32.81 11.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 108.446 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.582 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 5.7 t -120.71 -156.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' B' ' 24' ' ' ASN . 25.1 mm -109.98 -4.71 10.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.835 -1.166 . . . . 0.0 109.567 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' ILE . 1.5 m 45.41 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 110.24 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.6 p -150.58 149.84 30.42 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.74 -25.33 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.07 -1.019 . . . . 0.0 109.625 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -61.82 -55.05 34.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.162 -0.961 . . . . 0.0 109.173 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 -46.8 84.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.311 -0.868 . . . . 0.0 109.331 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.3 mp -61.47 -35.61 78.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.109 -0.994 . . . . 0.0 108.737 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -56.83 -23.36 43.37 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.96 -25.2 58.69 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.589 -0.695 . . . . 0.0 109.305 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.58 ' CD2' HD11 ' B' ' 36' ' ' LEU . 1.8 m-30 -74.81 -3.77 33.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.943 -1.098 . . . . 0.0 109.183 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.566 ' SG ' HG23 ' B' ' 39' ' ' VAL . 61.0 m -78.38 51.97 1.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.219 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 t30 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.601 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' B' ' 22' ' ' PHE . 3.8 p90 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.585 0.707 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.822 HG13 ' N ' ' B' ' 24' ' ' ASN . 1.1 p -160.93 -153.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.579 -0.7 . . . . 0.0 109.422 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.822 ' N ' HG13 ' B' ' 23' ' ' VAL . 28.0 t-20 87.73 74.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.5 0.667 . . . . 0.0 109.558 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -158.24 154.37 27.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.582 ' CE1' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -105.16 174.54 5.83 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.806 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.0 OUTLIER -153.69 -157.17 0.75 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.485 -1.385 . . . . 0.0 111.335 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.653 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.6 OUTLIER 139.24 146.14 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 124.127 0.971 . . . . 0.0 108.53 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.21 -131.02 19.67 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.489 ' HA ' HG22 ' B' ' 33' ' ' VAL . 7.3 m -55.62 -38.95 70.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.718 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.517 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 7.4 m-20 -52.1 -40.04 60.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 109.005 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.795 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -67.17 -72.49 0.16 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 108.96 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.49 HG23 ' N ' ' B' ' 34' ' ' GLU . 27.7 m -42.89 -40.3 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.106 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.543 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -54.67 -51.88 64.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.223 -0.923 . . . . 0.0 109.046 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' B' ' 38' ' ' LEU . . . -59.1 -54.33 48.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.039 -1.038 . . . . 0.0 108.822 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.795 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.8 OUTLIER -54.33 -20.15 6.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.138 -0.976 . . . . 0.0 108.881 179.297 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 33.1 t80 -86.09 -10.61 54.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.408 -0.807 . . . . 0.0 109.373 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -98.68 -40.54 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.038 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.566 HG23 ' SG ' ' A' ' 20' ' ' CYS . 2.3 m -78.86 -27.17 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.422 -0.798 . . . . 0.0 109.409 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.524 ' SG ' HG23 ' B' ' 39' ' ' VAL . 7.4 m -103.98 -1.01 28.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.15 -36.18 51.68 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.78 -15.04 25.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.156 -1.203 . . . . 0.0 109.641 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' B' ' 44' ' ' GLY . 8.5 ttt180 -123.76 161.93 24.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.44 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.525 ' N ' ' HG2' ' B' ' 43' ' ' ARG . . . -48.91 164.94 0.31 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 20' ' ' CYS . . . 116.71 -10.61 16.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' B' ' 45' ' ' GLY . 2.0 t80 -43.16 124.7 3.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -1.088 . . . . 0.0 109.204 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' TYR . . . . . 0.472 ' OH ' ' O ' ' B' ' 33' ' ' VAL . 4.9 p90 . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.896 0 N-CA-C 119.336 2.494 . . . . 0.0 119.336 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.757 HD13 ' CE2' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -104.91 -9.69 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -1.156 . . . . 0.0 108.997 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.651 HG12 HD22 ' B' ' 32' ' ' LEU . 2.9 m -76.81 -35.3 24.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.359 -0.838 . . . . 0.0 109.893 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' THR . 3.6 mt-10 -61.69 -10.87 9.6 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.707 -0.621 . . . . 0.0 110.641 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -105.46 -34.24 7.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.907 -1.12 . . . . 0.0 110.126 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.3 m -98.76 -18.49 17.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.678 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.543 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 13.3 t -86.2 -34.95 20.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 4' ' ' GLU . 6.2 t -89.67 -30.1 18.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.45 ' OG ' HG23 ' A' ' 8' ' ' THR . 4.5 m -128.71 165.29 21.16 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.566 HG21 ' HA ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -94.23 128.11 45.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.116 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.615 ' HB2' HD11 ' A' ' 16' ' ' LEU . 66.1 m -96.88 175.28 6.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 109.61 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 29.4 p -106.61 148.03 28.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 109.281 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.575 ' HG ' HG12 ' B' ' 39' ' ' VAL . 0.2 OUTLIER -43.42 -30.17 0.52 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.119 -0.988 . . . . 0.0 109.81 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -62.21 -56.57 17.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.366 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.484 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 1.2 mp0 -57.88 -38.33 75.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.184 -0.947 . . . . 0.0 109.128 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.823 ' CB ' HG11 ' B' ' 39' ' ' VAL . 6.8 mp -67.07 -39.97 86.96 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.184 -0.948 . . . . 0.0 108.838 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.54 -25.94 53.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -70.95 -32.18 68.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.468 -0.77 . . . . 0.0 109.095 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.757 ' CE2' HD13 ' A' ' 2' ' ' ILE . 1.6 m-30 -68.71 -31.67 70.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.139 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -60.63 -98.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.988 0.899 . . . . 0.0 109.923 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 . . . . . 0 C--N 1.278 -2.513 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.34 -179.485 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' B' ' 22' ' ' PHE . 2.2 t80 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.393 0.616 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.802 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -160.58 -162.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.239 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.802 ' N ' HG13 ' B' ' 23' ' ' VAL . 0.8 OUTLIER 73.28 68.94 0.11 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.523 -0.736 . . . . 0.0 109.566 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.1 tp60 -141.59 156.24 45.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 109.517 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.543 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -115.21 164.07 14.76 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 1.022 ' HG ' HD12 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -161.41 -156.37 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 119.951 -1.718 . . . . 0.0 112.901 -178.513 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.592 ' N ' ' HB2' ' B' ' 31' ' ' ASP . 0.3 OUTLIER 150.93 140.78 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.725 0 C-N-CA 123.557 0.743 . . . . 0.0 110.271 -178.579 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' B' ' 32' ' ' LEU . . . 43.88 -128.99 6.51 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.454 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.3 OUTLIER -47.2 -39.46 14.02 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.156 -1.202 . . . . 0.0 108.821 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.592 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 80.8 m-20 -59.28 -29.83 67.87 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.208 -0.933 . . . . 0.0 108.704 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 1.022 HD12 ' HG ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -68.7 -57.39 5.73 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.6 ' O ' ' CG ' ' B' ' 37' ' ' TYR . 4.8 m -55.63 -35.58 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.538 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -59.58 -59.53 5.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.523 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -61.29 -46.76 88.98 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.599 HD11 ' HD2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -57.89 -33.63 68.94 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.6 ' CG ' ' O ' ' B' ' 33' ' ' VAL . 5.5 m-30 -71.45 -21.94 61.9 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.671 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -81.26 -58.11 3.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 108.895 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.823 HG11 ' CB ' ' A' ' 16' ' ' LEU . 2.5 m -47.27 -32.92 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.49 -0.756 . . . . 0.0 109.416 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' B' ' 43' ' ' ARG . 0.9 OUTLIER -100.09 -27.38 13.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 109.807 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.506 ' O ' ' CG ' ' B' ' 42' ' ' GLU . . . 41.24 65.81 1.04 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' B' ' 41' ' ' GLY . 10.6 pt-20 39.36 29.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -1.008 . . . . 0.0 110.115 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' B' ' 40' ' ' CYS . 0.8 OUTLIER -90.32 135.99 33.33 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.295 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 49.06 66.42 2.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.65 175.91 35.57 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.56 ' HB3' ' CD1' ' B' ' 47' ' ' TYR . 1.7 m-30 -79.75 -100.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.122 -1.223 . . . . 0.0 109.961 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' TYR . . . . . 0.562 ' CE1' ' OH ' ' B' ' 37' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 120.846 -1.159 . . . . 0.0 109.027 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.809 0 N-CA-C 119.414 2.526 . . . . 0.0 119.414 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.439 HG22 HD21 ' B' ' 32' ' ' LEU . 19.6 mt -89.22 -25.64 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -1.103 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 2.5 m -56.96 -30.55 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 109.724 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -78.37 1.68 21.16 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.496 -0.752 . . . . 0.0 109.706 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -105.63 -42.74 5.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 0.0 109.545 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 9' ' ' SER . 98.7 m -105.65 -39.99 5.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 0.0 110.065 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.595 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 2.2 t -58.28 -54.02 51.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.757 -1.214 . . . . 0.0 108.248 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.1 p -64.03 -68.97 0.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.065 . . . . 0.0 108.368 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 3.3 m -95.27 141.0 29.37 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.3 113.65 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.863 -1.148 . . . . 0.0 109.953 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.7 m -77.96 -168.08 1.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.177 -0.952 . . . . 0.0 109.606 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.608 ' HA ' HG11 ' B' ' 23' ' ' VAL . 6.3 p -122.34 142.1 50.85 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -43.11 -27.2 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.006 . . . . 0.0 109.644 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' SER . 86.9 t80 -62.53 -60.86 2.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.179 -0.951 . . . . 0.0 108.879 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -55.54 -41.71 73.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.305 -0.872 . . . . 0.0 109.044 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.697 ' HB3' HG21 ' B' ' 39' ' ' VAL . 1.6 mp -56.34 -45.99 80.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.186 -0.946 . . . . 0.0 108.787 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.81 -23.86 3.07 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -71.21 -38.67 72.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.57 -0.706 . . . . 0.0 109.159 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.838 ' CD2' HD11 ' B' ' 36' ' ' LEU . 23.1 m-85 -50.91 -32.81 21.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.077 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.441 ' SG ' ' HG3' ' B' ' 43' ' ' ARG . 1.7 m -85.78 52.32 2.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.407 -0.808 . . . . 0.0 109.394 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 t30 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.656 -179.794 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.608 HG11 ' HA ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -79.77 -168.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.242 -0.911 . . . . 0.0 109.679 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 6.6 t30 87.86 -11.07 0.51 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -104.55 144.71 31.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.198 -0.939 . . . . 0.0 109.257 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -91.23 159.5 16.02 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.678 ' O ' HD12 ' B' ' 27' ' ' LEU . 0.3 OUTLIER -160.77 136.54 8.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.28 -1.512 . . . . 0.0 112.27 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.506 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -131.77 145.89 51.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.772 . . . . 0.0 109.009 178.244 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 28.34 -103.35 0.01 OUTLIER Glycine 0 N--CA 1.501 3.006 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.668 ' O ' HG22 ' B' ' 33' ' ' VAL . 16.1 t -41.21 -63.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.434 -1.039 . . . . 0.0 109.881 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.92 -33.74 18.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 108.64 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' B' ' 29' ' ' GLY . 0.3 OUTLIER -60.22 -65.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -0.861 . . . . 0.0 109.045 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.668 HG22 ' O ' ' B' ' 30' ' ' SER . 35.4 m -49.49 -31.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 108.41 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.526 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 7.9 mt-10 -72.69 -59.0 2.93 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.564 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -60.7 -41.88 96.09 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.838 HD11 ' CD2' ' A' ' 19' ' ' TYR . 2.2 mm? -59.51 -30.4 68.55 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -80.12 -13.56 59.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.715 -0.615 . . . . 0.0 110.065 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.544 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -91.04 -47.08 7.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 108.609 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.697 HG21 ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -63.49 -22.06 29.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.445 -0.785 . . . . 0.0 109.138 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' B' ' 43' ' ' ARG . 84.3 m -101.68 -41.63 6.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.26 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.54 -50.18 3.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' B' ' 43' ' ' ARG . 5.3 pt-20 -174.89 34.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -1.223 . . . . 0.0 109.797 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.51 ' HD3' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -43.03 150.03 0.18 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.559 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.93 -26.65 70.6 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.09 103.3 0.99 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.453 ' CG ' ' N ' ' B' ' 47' ' ' TYR . 0.1 OUTLIER -71.88 -156.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -1.127 . . . . 0.0 109.744 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 47' ' ' TYR . . . . . 0.453 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.425 -0.797 . . . . 0.0 109.626 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 1 N--CA 1.529 4.873 0 N-CA-C 119.436 2.534 . . . . 0.0 119.436 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.488 HG22 ' CD2' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -99.64 -27.82 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -1.19 . . . . 0.0 109.145 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 1.4 m -46.69 -29.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.941 . . . . 0.0 108.765 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 1' ' ' GLY . 0.9 OUTLIER -55.18 -19.65 8.43 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.55 -75.48 0.57 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.8 . . . . 0.0 109.795 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 1.046 ' O ' HD11 ' B' ' 32' ' ' LEU . 9.4 m -97.93 96.37 8.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.44 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.706 ' HB2' HD11 ' B' ' 32' ' ' LEU . 8.0 t 161.33 -33.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -3.36 21.97 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.544 ' C ' ' CE1' ' B' ' 26' ' ' HIS . 0.6 OUTLIER -156.06 -173.78 4.66 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.614 HD13 ' ND1' ' B' ' 26' ' ' HIS . 23.3 mm -91.9 142.09 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.019 -1.051 . . . . 0.0 109.396 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.4 -168.87 1.6 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.891 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -145.75 144.8 30.55 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -43.58 -27.44 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 109.655 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -63.51 -53.16 56.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.658 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 4.1 mt-30 -58.48 -32.93 69.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 109.75 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.736 HD23 ' CD1' ' B' ' 36' ' ' LEU . 6.1 mp -67.85 -35.36 78.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.076 -1.015 . . . . 0.0 109.104 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.37 -22.12 62.93 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 25.3 m-80 -74.39 -37.51 63.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.571 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -67.84 -15.57 63.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 109.413 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 m -104.5 51.02 0.78 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.298 -0.876 . . . . 0.0 109.456 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.6 t30 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.462 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.429 ' HB3' HG22 ' B' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.609 0.718 . . . . 0.0 109.393 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.57 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -154.8 173.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 121.645 -0.659 . . . . 0.0 109.562 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 10.0 p-10 153.37 49.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.27 151.59 30.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.41 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.614 ' ND1' HD13 ' A' ' 10' ' ' ILE . 2.2 t60 -72.4 -164.35 0.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.414 -0.804 . . . . 0.0 109.673 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' B' ' 35' ' ' ALA . 0.4 OUTLIER -155.81 -171.38 3.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.687 ' N ' HD12 ' B' ' 32' ' ' LEU . 1.3 m 149.09 139.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.474 0.654 . . . . 0.0 109.792 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 34.57 -126.61 0.57 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.8 m -41.57 -53.43 3.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.405 -1.056 . . . . 0.0 109.71 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.544 ' O ' HD23 ' B' ' 27' ' ' LEU . 17.0 m-20 -44.41 -31.14 0.98 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.897 . . . . 0.0 109.17 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 1.072 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -74.49 -77.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.214 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' B' ' 37' ' ' TYR . 9.4 m -41.6 -35.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.621 -0.674 . . . . 0.0 109.336 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.561 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 2.2 mp0 -70.28 -54.02 14.43 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.832 ' HB2' HD21 ' B' ' 27' ' ' LEU . . . -53.69 -56.41 17.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.16 -0.962 . . . . 0.0 109.462 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 1.072 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.1 OUTLIER -57.08 -20.88 27.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.97 -1.081 . . . . 0.0 108.162 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 89.3 t80 -84.96 -9.96 57.54 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.711 -0.618 . . . . 0.0 109.724 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -97.23 -42.62 7.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.085 -1.009 . . . . 0.0 108.961 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.412 HG23 ' SG ' ' B' ' 40' ' ' CYS . 1.7 m -72.52 -26.01 23.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.507 -0.745 . . . . 0.0 109.662 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.412 ' SG ' HG23 ' B' ' 39' ' ' VAL . 59.3 m -103.33 -11.84 17.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.181 -0.949 . . . . 0.0 109.786 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' B' ' 42' ' ' GLU . . . 49.76 25.44 6.98 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' B' ' 41' ' ' GLY . 0.2 OUTLIER 76.72 10.76 2.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -1.136 . . . . 0.0 109.259 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.12 154.95 5.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 0.0 109.418 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.28 -127.22 7.79 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.77 -91.02 2.2 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.89 -127.52 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -1.183 . . . . 0.0 109.188 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 120.752 -1.217 . . . . 0.0 109.378 179.886 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.894 0 N-CA-C 119.48 2.552 . . . . 0.0 119.48 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.9 mt -81.8 -46.03 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -1.111 . . . . 0.0 109.604 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.914 HG12 HD22 ' B' ' 32' ' ' LEU . 4.4 m -54.36 -18.82 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.78 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' HG21 ' A' ' 8' ' ' THR . 4.3 mt-10 -92.21 -7.71 47.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.646 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.45 -31.31 9.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.13 -0.982 . . . . 0.0 110.114 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 9' ' ' SER . 83.5 m -105.3 -62.26 1.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.061 -1.025 . . . . 0.0 110.374 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 48.6 t -47.26 -28.58 2.0 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.388 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 4' ' ' GLU . 3.1 t -69.88 -20.17 63.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.972 -1.08 . . . . 0.0 108.92 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.527 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 4.6 t -150.56 -151.24 0.38 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.42 128.32 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.945 -1.097 . . . . 0.0 109.498 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -111.4 164.84 12.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.849 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 13' ' ' LEU . 14.5 p -108.17 141.92 39.18 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.93 HD13 ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -46.14 -28.28 1.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.827 -1.171 . . . . 0.0 109.151 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -53.52 -47.38 69.97 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.189 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.439 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 48.5 mm-40 -65.6 -40.86 93.13 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.93 ' HB2' HD13 ' A' ' 13' ' ' LEU . 7.9 mp -63.51 -34.68 78.32 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 4.1 mt-10 -54.95 -32.5 61.46 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -66.37 -30.29 70.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.862 ' HD2' HD11 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -63.59 -41.92 98.3 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.18 -0.95 . . . . 0.0 108.695 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 m -91.11 53.7 2.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.777 . . . . 0.0 109.652 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.4 t30 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.466 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.919 HG12 ' H ' ' A' ' 13' ' ' LEU . 33.6 m -87.85 -158.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 122.059 0.933 . . . . 0.0 109.802 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.71 64.96 0.97 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.699 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.49 -177.19 5.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 109.233 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.537 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 1.2 t60 -138.02 169.06 18.44 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 1.12 HD13 ' CD1' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -161.13 -137.84 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.716 -1.24 . . . . 0.0 109.644 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.715 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.8 OUTLIER 137.13 134.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 33.54 -113.55 0.09 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.1 OUTLIER -48.27 -56.23 8.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -1.032 . . . . 0.0 109.926 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.568 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 4.1 m-20 -44.36 -33.65 1.71 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -0.932 . . . . 0.0 109.095 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 1.12 ' CD1' HD13 ' B' ' 27' ' ' LEU . 0.8 OUTLIER -65.87 -71.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 108.943 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.416 HG22 ' O ' ' B' ' 30' ' ' SER . 14.3 m -48.83 -24.47 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.518 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 5.4 mt-10 -75.34 -61.85 1.76 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.454 -0.779 . . . . 0.0 108.995 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.535 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.35 -44.0 83.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.862 HD11 ' HD2' ' A' ' 19' ' ' TYR . 2.4 mm? -57.31 -33.32 67.58 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.967 0.889 . . . . 0.0 108.725 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.444 ' CD2' HD23 ' B' ' 38' ' ' LEU . 11.8 t80 -77.3 -16.83 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.248 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.535 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -90.95 -33.55 15.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.111 -0.993 . . . . 0.0 108.904 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.747 HG21 HD11 ' A' ' 13' ' ' LEU . 1.4 m -88.93 -14.48 9.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.505 -0.747 . . . . 0.0 109.443 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 43' ' ' ARG . 93.4 m -114.68 -10.58 12.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.375 -0.828 . . . . 0.0 109.364 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' B' ' 42' ' ' GLU . . . 46.29 67.74 1.27 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 41' ' ' GLY . 2.0 pt-20 37.48 38.98 0.16 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.705 -0.88 . . . . 0.0 110.483 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 40' ' ' CYS . 2.1 ttt85 -64.86 147.55 53.05 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 108.983 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.41 158.82 12.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.77 -1.62 87.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.84 -144.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -1.2 . . . . 0.0 109.388 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 6.8 t80 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 109.282 -179.817 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.816 0 N-CA-C 119.447 2.539 . . . . 0.0 119.447 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.763 HG21 ' CZ ' ' A' ' 19' ' ' TYR . 12.3 mt -89.85 -36.42 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -1.166 . . . . 0.0 109.554 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.691 HG12 HD13 ' B' ' 32' ' ' LEU . 2.4 m -39.19 -31.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.63 -0.669 . . . . 0.0 110.534 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 2' ' ' ILE . 4.8 mt-10 -68.93 -7.68 37.29 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.376 -0.828 . . . . 0.0 110.238 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.75 -35.42 7.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.065 -1.022 . . . . 0.0 110.251 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.666 ' HB3' HD11 ' B' ' 27' ' ' LEU . 96.7 m -105.36 -60.84 1.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.964 -1.085 . . . . 0.0 110.944 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.539 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 2.6 t -40.11 -60.31 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.022 -1.049 . . . . 0.0 109.946 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 7' ' ' CYS . 1.8 t -42.6 -29.31 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.169 -0.957 . . . . 0.0 109.248 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.617 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 18.3 m -142.47 -137.33 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.456 -0.777 . . . . 0.0 108.983 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.48 HG13 ' ND1' ' B' ' 26' ' ' HIS . 1.4 mt -146.85 113.61 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.589 -1.319 . . . . 0.0 109.299 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.451 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . 21.4 m -88.29 -167.26 1.82 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.42 -0.8 . . . . 0.0 110.096 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.546 ' HA ' HG21 ' B' ' 23' ' ' VAL . 39.1 p -115.02 159.28 20.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.098 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.508 HD11 HG12 ' B' ' 39' ' ' VAL . 0.4 OUTLIER -50.85 -23.58 2.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.976 -1.077 . . . . 0.0 109.232 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.473 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 44.4 t80 -65.37 -48.34 73.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 108.812 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.451 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -57.82 -39.14 76.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 108.587 179.257 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.64 ' CD2' ' HB1' ' B' ' 35' ' ' ALA . 6.2 mp -65.16 -35.69 81.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.376 -0.828 . . . . 0.0 108.8 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 1.8 mm-40 -55.96 -27.53 52.98 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.08 -17.17 60.51 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.496 -0.753 . . . . 0.0 109.318 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.763 ' CZ ' HG21 ' A' ' 2' ' ' ILE . 1.3 m-85 -72.81 -29.75 63.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 108.465 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.9 m -85.89 52.11 2.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 0.0 109.614 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.506 179.878 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' B' ' 22' ' ' PHE . 12.2 p90 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.306 0.574 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.797 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.7 OUTLIER -148.74 -159.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.428 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.797 ' N ' HG13 ' B' ' 23' ' ' VAL . 0.9 OUTLIER 77.74 57.96 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.449 0.642 . . . . 0.0 109.347 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -138.57 142.92 39.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.323 -0.861 . . . . 0.0 109.299 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.617 ' CE1' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -90.92 144.1 26.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.815 ' O ' HD12 ' B' ' 27' ' ' LEU . 0.4 OUTLIER -154.07 145.7 23.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.348 -1.47 . . . . 0.0 112.133 -178.601 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' B' ' 32' ' ' LEU . 0.8 OUTLIER -124.92 -162.79 1.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.492 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . -37.47 -63.02 0.87 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.212 -0.93 . . . . 0.0 111.679 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.402 ' O ' ' OE1' ' B' ' 34' ' ' GLU . 1.4 p -69.77 -40.29 76.17 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.9 -1.353 . . . . 0.0 111.25 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.568 ' HB2' ' CA ' ' B' ' 27' ' ' LEU . 0.3 OUTLIER -70.71 -20.95 62.61 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.475 -1.391 . . . . 0.0 108.276 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.99 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.6 OUTLIER -69.06 -70.22 0.29 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.549 HG12 ' CE2' ' B' ' 47' ' ' TYR . 33.2 m -43.66 -31.35 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.4 mt-10 -68.94 -54.61 14.49 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.64 ' HB1' ' CD2' ' A' ' 16' ' ' LEU . . . -57.42 -55.06 39.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 108.777 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.99 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -54.21 -21.94 10.22 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.041 -1.037 . . . . 0.0 108.248 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.525 ' O ' ' HA2' ' B' ' 41' ' ' GLY . 13.4 t80 -84.53 -6.43 59.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -105.76 -50.4 3.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.066 -1.021 . . . . 0.0 108.963 179.255 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.508 HG12 HD11 ' A' ' 13' ' ' LEU . 1.8 m -67.03 -25.76 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.443 -0.786 . . . . 0.0 109.78 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.48 ' O ' ' C ' ' B' ' 41' ' ' GLY . 20.1 m -122.91 -21.13 5.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.921 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' B' ' 37' ' ' TYR . . . 40.52 29.72 0.27 Allowed Glycine 0 N--CA 1.496 2.637 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.539 ' HG2' ' N ' ' B' ' 46' ' ' PHE . 16.4 tp10 49.42 91.74 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.483 -1.01 . . . . 0.0 108.34 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 51.81 0.88 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.645 -0.659 . . . . 0.0 109.707 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.94 63.73 0.01 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' GLY . . . . . 0.487 ' C ' ' HG2' ' B' ' 42' ' ' GLU . . . 109.07 -140.98 15.85 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.539 ' N ' ' HG2' ' B' ' 42' ' ' GLU . 0.5 OUTLIER -120.15 177.9 4.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -1.191 . . . . 0.0 109.117 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 47' ' ' TYR . . . . . 0.615 ' OH ' HD23 ' B' ' 36' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.955 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 mm -104.82 -32.14 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -1.208 . . . . 0.0 109.617 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.033 HG12 ' CD2' ' B' ' 32' ' ' LEU . 0.9 OUTLIER -85.41 -41.33 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.614 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 5.9 mt-10 -70.44 -19.86 62.94 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.599 -0.688 . . . . 0.0 110.219 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -89.31 -34.79 16.44 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.125 -0.984 . . . . 0.0 109.48 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.5 m -105.83 -42.43 5.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 110.452 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.556 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 9.1 t -63.14 -18.12 63.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.934 -1.104 . . . . 0.0 110.062 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 4' ' ' GLU . 16.0 p -104.77 -38.5 6.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.077 -1.014 . . . . 0.0 108.516 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.711 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -108.7 -155.89 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 9' ' ' SER . 9.6 mm -129.75 83.34 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.979 -1.076 . . . . 0.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' HB2' HD11 ' A' ' 16' ' ' LEU . 64.1 m -59.71 171.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.291 -0.881 . . . . 0.0 109.61 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.771 ' HA ' HG21 ' B' ' 23' ' ' VAL . 94.5 p -112.99 145.14 41.37 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -43.52 -27.48 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 108.966 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 28.5 t80 -62.54 -46.13 89.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.4 -0.813 . . . . 0.0 108.903 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -66.32 -49.37 67.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 109.007 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.601 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 9.0 mp -56.19 -31.98 63.94 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.311 -0.868 . . . . 0.0 109.118 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' OE1' ' CD ' ' B' ' 43' ' ' ARG . 1.3 mm-40 -58.65 -35.2 72.17 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.87 . . . . 0.0 108.745 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -75.09 -22.76 58.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.437 -0.789 . . . . 0.0 109.291 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.686 ' HD2' HD11 ' B' ' 36' ' ' LEU . 7.3 m-30 -60.28 -14.61 19.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.128 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -91.64 53.64 2.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.927 . . . . 0.0 109.385 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 p30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.417 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.817 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.8 OUTLIER -160.36 -157.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.907 . . . . 0.0 109.697 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.817 ' N ' HG13 ' B' ' 23' ' ' VAL . 37.2 t-20 89.19 79.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.395 0.617 . . . . 0.0 109.835 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -161.0 -176.2 5.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.402 -0.811 . . . . 0.0 109.771 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.556 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -144.59 149.64 36.13 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.783 HD13 HD11 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -162.04 149.83 14.52 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.353 -1.467 . . . . 0.0 112.567 -178.376 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.505 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -135.38 158.67 43.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.518 -0.739 . . . . 0.0 109.264 177.766 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 25.49 -119.66 0.03 OUTLIER Glycine 0 N--CA 1.5 2.962 0 CA-C-O 121.62 0.567 . . . . 0.0 112.149 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.579 ' O ' HG22 ' B' ' 33' ' ' VAL . 54.5 m -35.77 -57.5 0.66 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.544 -0.974 . . . . 0.0 110.884 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.7 OUTLIER -45.31 -44.01 11.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.915 -1.116 . . . . 0.0 109.087 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 1.033 ' CD2' HG12 ' A' ' 3' ' ' VAL . 3.1 mp -54.14 -65.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.194 -0.941 . . . . 0.0 108.979 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.579 HG22 ' O ' ' B' ' 30' ' ' SER . 18.1 m -51.36 -25.4 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.121 -0.987 . . . . 0.0 108.746 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.508 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.3 mt-10 -79.26 -58.41 3.24 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.686 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -60.65 -38.77 85.95 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.686 HD11 ' HD2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -61.32 -33.93 74.42 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.933 0.873 . . . . 0.0 108.745 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -74.91 -31.73 61.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.783 -0.573 . . . . 0.0 109.897 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.556 HD23 ' N ' ' B' ' 38' ' ' LEU . 0.2 OUTLIER -70.49 -63.2 1.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.217 -0.927 . . . . 0.0 108.578 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.572 HG13 ' O ' ' B' ' 35' ' ' ALA . 2.5 m -45.41 -27.24 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.45 ' O ' ' C ' ' B' ' 41' ' ' GLY . 1.3 m -118.93 36.56 4.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.739 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' B' ' 40' ' ' CYS . . . -41.35 -63.96 1.46 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -122.66 -22.95 5.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.069 -1.253 . . . . 0.0 109.946 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.493 ' CD ' ' OE1' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -81.53 111.47 17.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.451 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.14 91.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.02 110.06 0.72 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.52 23.4 0.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -1.096 . . . . 0.0 109.406 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.345 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.827 0 N-CA-C 119.433 2.533 . . . . 0.0 119.433 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.671 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -91.74 -26.04 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -1.168 . . . . 0.0 109.182 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.982 HG12 HD22 ' B' ' 32' ' ' LEU . 4.7 m -75.7 -9.35 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.64 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.441 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.9 mt-10 -98.25 -10.89 23.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -105.34 -34.2 7.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.562 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.761 ' HB3' HD11 ' B' ' 27' ' ' LEU . 64.1 m -93.94 -66.23 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 109.704 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 18.6 t -41.42 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 9' ' ' SER . 2.1 t -66.31 135.05 53.85 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.749 ' O ' HD13 ' A' ' 10' ' ' ILE . 1.5 m 75.65 -161.07 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 9' ' ' SER . 39.0 mm -128.5 130.67 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.61 -1.306 . . . . 0.0 110.248 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -166.54 1.62 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.476 -0.765 . . . . 0.0 109.593 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' C ' ' A' ' 13' ' ' LEU . 88.7 p -140.16 129.13 23.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' H ' HG23 ' B' ' 23' ' ' VAL . 0.4 OUTLIER -39.25 -33.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 109.781 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' SER . 27.8 t80 -57.7 -51.63 68.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.17 -0.956 . . . . 0.0 108.95 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.457 ' HG2' ' OG ' ' A' ' 12' ' ' SER . 15.4 mm100 -55.47 -44.96 76.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.873 . . . . 0.0 109.231 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.768 HD23 HD13 ' B' ' 36' ' ' LEU . 6.2 mp -57.05 -48.85 77.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -0.93 . . . . 0.0 109.247 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' OE2' ' HB ' ' B' ' 39' ' ' VAL . 0.9 OUTLIER -52.8 -23.32 6.68 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.108 -0.995 . . . . 0.0 108.399 179.322 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -75.49 -29.81 59.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.484 -0.76 . . . . 0.0 109.005 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.671 ' CE2' HD12 ' A' ' 2' ' ' ILE . 1.7 m-30 -72.63 -11.84 60.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 0.0 109.182 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 m -89.86 51.34 2.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 109.433 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.487 -179.927 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' B' ' 22' ' ' PHE . 8.0 p90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.165 0.507 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.837 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -154.99 -158.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.935 . . . . 0.0 109.99 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.837 ' N ' HG13 ' B' ' 23' ' ' VAL . 25.4 m-20 69.64 102.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -153.48 152.22 30.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.702 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 9' ' ' SER . 1.4 t60 -121.69 149.05 43.79 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.975 HD23 ' CB ' ' B' ' 35' ' ' ALA . 0.0 OUTLIER -153.88 -158.59 0.88 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.469 -1.394 . . . . 0.0 110.95 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.563 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 148.77 146.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.77 -134.01 39.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.524 ' HA ' ' CG2' ' B' ' 33' ' ' VAL . 1.3 p -55.99 -46.25 78.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -1.131 . . . . 0.0 109.669 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' B' ' 30' ' ' SER . 9.0 m-20 -45.14 -43.27 9.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 108.555 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.982 HD22 HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -60.1 -72.61 0.1 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.557 HG23 ' N ' ' B' ' 34' ' ' GLU . 14.8 m -45.12 -50.76 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.101 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.557 ' N ' HG23 ' B' ' 33' ' ' VAL . 1.5 mp0 -56.06 -44.42 78.85 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.301 -0.874 . . . . 0.0 109.075 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.975 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -55.12 -58.95 5.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.362 -0.836 . . . . 0.0 109.255 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.948 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -56.0 -24.01 36.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.046 -1.034 . . . . 0.0 108.32 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 72.6 t80 -79.94 -15.78 56.6 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' B' ' 35' ' ' ALA . 1.4 mt -83.74 -54.82 4.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 108.645 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.478 ' HB ' ' OE2' ' A' ' 17' ' ' GLU . 2.5 m -54.16 -40.93 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.485 -0.759 . . . . 0.0 109.115 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.477 ' N ' ' CG2' ' B' ' 39' ' ' VAL . 79.0 m -99.31 17.41 20.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.338 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.06 -10.02 66.88 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -75.56 -26.06 57.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -1.22 . . . . 0.0 109.36 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.25 -172.65 2.31 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.446 -0.783 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.15 130.25 28.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.41 131.59 47.42 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' B' ' 47' ' ' TYR . 0.8 OUTLIER -161.4 -74.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -1.11 . . . . 0.0 109.329 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 47' ' ' TYR . . . . . 0.465 ' C ' ' O ' ' B' ' 46' ' ' PHE . 53.2 t80 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.577 -0.702 . . . . 0.0 110.267 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.784 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.7 mt -101.61 -17.42 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -1.095 . . . . 0.0 108.997 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 3.5 m -62.12 -11.4 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.491 -0.756 . . . . 0.0 110.502 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -101.94 -4.92 25.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.027 -1.045 . . . . 0.0 110.425 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.448 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 5.3 mm100 -105.33 -42.26 5.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.009 -1.057 . . . . 0.0 110.266 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' THR . 29.0 m -105.66 -57.9 1.98 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.184 -0.948 . . . . 0.0 110.901 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.581 ' HA ' ' CD2' ' B' ' 26' ' ' HIS . 0.9 OUTLIER -37.15 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.218 -0.926 . . . . 0.0 111.411 -178.147 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.3 t -68.83 -20.14 64.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.662 -1.274 . . . . 0.0 109.328 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.581 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 11.7 t -158.15 -170.69 3.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.709 ' HA ' ' ND1' ' B' ' 26' ' ' HIS . 0.8 OUTLIER -103.26 94.77 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.702 -1.249 . . . . 0.0 110.546 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 67.9 m -55.54 168.75 0.37 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 p -88.2 143.7 26.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.898 -1.126 . . . . 0.0 109.409 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 13' ' ' LEU . 3.0 tt -49.79 -24.09 2.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.978 . . . . 0.0 109.683 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -70.74 -38.79 73.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.182 -0.948 . . . . 0.0 109.072 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -66.6 -48.46 69.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.618 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.893 HD23 HD13 ' B' ' 36' ' ' LEU . 6.5 mp -55.71 -34.12 64.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.098 . . . . 0.0 108.567 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -63.13 -18.79 63.82 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -76.21 -28.87 57.38 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.485 -0.759 . . . . 0.0 109.059 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.9 m-30 -69.81 -5.49 25.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.483 ' HA ' ' HA3' ' B' ' 45' ' ' GLY . 8.3 m -83.89 51.32 2.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -0.965 . . . . 0.0 109.603 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.91 -1.043 . . . . 0.0 109.484 179.874 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.553 0.692 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.798 HG22 ' H ' ' B' ' 24' ' ' ASN . 2.3 p -160.7 -158.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.629 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.798 ' H ' HG22 ' B' ' 23' ' ' VAL . 34.2 m120 109.32 32.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.979 0.895 . . . . 0.0 108.622 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.477 ' O ' HD13 ' A' ' 10' ' ' ILE . 6.2 tp-100 -160.65 160.97 32.24 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.778 ' CE1' HD22 ' B' ' 27' ' ' LEU . 5.3 t60 -126.63 161.92 26.95 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 116.889 -1.924 . . . . 0.0 114.503 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.831 HD23 ' C ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -97.39 -155.73 0.5 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 113.582 -1.644 . . . . 0.0 110.734 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.587 ' N ' ' HG ' ' B' ' 27' ' ' LEU . 2.2 m 141.05 143.96 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.35 -132.71 49.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 2.9 m -52.5 -46.37 66.59 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.91 -1.347 . . . . 0.0 108.039 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.536 ' HB3' ' HA ' ' B' ' 27' ' ' LEU . 23.3 m-20 -49.39 -31.1 8.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.406 -0.808 . . . . 0.0 109.201 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.978 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.4 OUTLIER -67.8 -68.04 0.42 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.249 -0.907 . . . . 0.0 108.875 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.565 ' HB ' ' CZ ' ' B' ' 47' ' ' TYR . 18.9 m -54.57 -36.64 36.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.365 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.541 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -64.28 -52.19 59.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.521 -0.737 . . . . 0.0 109.405 179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -47.66 -61.28 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.052 . . . . 0.0 109.251 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.978 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -55.39 -21.69 16.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.897 -1.127 . . . . 0.0 108.346 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 84.5 t80 -84.97 -11.26 55.9 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.656 -0.653 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -95.45 -54.29 3.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.147 -0.971 . . . . 0.0 108.582 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.437 ' H ' HG13 ' B' ' 39' ' ' VAL . 2.3 m -59.57 -26.7 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' B' ' 43' ' ' ARG . 3.9 m -124.59 34.85 4.92 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.464 -0.773 . . . . 0.0 109.35 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.3 72.61 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -97.61 -20.52 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -1.214 . . . . 0.0 109.575 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -122.04 117.88 27.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -0.822 . . . . 0.0 109.495 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.39 173.62 19.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 20' ' ' CYS . . . -165.5 -124.55 0.71 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -82.62 -57.98 3.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 109.453 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' TYR . . . . . 0.565 ' CZ ' ' HB ' ' B' ' 33' ' ' VAL . 10.2 t80 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 109.419 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.818 0 N-CA-C 119.239 2.456 . . . . 0.0 119.239 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.607 HG23 ' CE2' ' A' ' 19' ' ' TYR . 0.5 OUTLIER -76.16 -31.57 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -1.135 . . . . 0.0 109.143 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.603 HG23 ' HG2' ' A' ' 4' ' ' GLU . 4.4 m -66.38 -33.09 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.603 ' HG2' HG23 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -78.63 5.45 11.0 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 109.896 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -104.73 -43.4 5.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.115 -0.991 . . . . 0.0 109.207 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 9' ' ' SER . 89.3 m -105.63 -23.61 12.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 109.966 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.588 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 8.3 t -76.4 -28.37 56.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.902 -1.124 . . . . 0.0 109.262 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 6.9 t -87.01 -32.49 20.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 1.1 t -134.74 147.56 50.06 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' B' ' 25' ' ' GLN . 1.1 mp -79.27 123.1 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.93 -1.106 . . . . 0.0 109.501 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.9 m -90.6 -167.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -0.797 . . . . 0.0 109.704 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.509 ' HA ' HG13 ' B' ' 23' ' ' VAL . 52.5 p -122.68 150.24 42.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.475 -0.766 . . . . 0.0 109.148 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.847 HD12 ' CD2' ' B' ' 22' ' ' PHE . 2.4 tt -44.12 -28.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.895 . . . . 0.0 109.238 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.413 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 10.6 m-85 -64.14 -55.18 23.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.861 . . . . 0.0 109.118 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -41.78 77.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.959 . . . . 0.0 109.071 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.702 HD23 HD22 ' B' ' 36' ' ' LEU . 6.8 mp -61.82 -36.47 81.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.154 -0.966 . . . . 0.0 108.978 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 8.3 mt-10 -56.58 -30.45 63.2 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.249 -0.907 . . . . 0.0 108.641 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.5 -31.13 69.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.607 ' CE2' HG23 ' A' ' 2' ' ' ILE . 2.6 m-85 -54.65 -41.75 70.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 108.668 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.3 50.92 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.47 -0.769 . . . . 0.0 109.387 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.626 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.847 ' CD2' HD12 ' A' ' 13' ' ' LEU . 41.3 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -151.18 -172.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.935 -1.103 . . . . 0.0 109.374 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER 40.07 49.29 2.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 110.049 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLN . . . . . 0.521 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 1.4 mt-30 -160.05 155.75 25.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.8 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' HIS . . . . . 0.547 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -121.34 171.97 8.37 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.926 HD13 HD12 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -160.89 -142.53 0.08 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.351 -1.468 . . . . 0.0 110.863 -179.071 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 28' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 148.4 131.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 123.824 0.85 . . . . 0.0 108.996 -178.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' B' ' 32' ' ' LEU . . . 37.06 -116.9 0.4 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.447 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.3 OUTLIER -43.2 -61.4 1.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.439 -1.036 . . . . 0.0 109.401 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.497 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 7.2 m-20 -45.37 -27.39 0.68 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -0.938 . . . . 0.0 108.984 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.926 HD12 HD13 ' B' ' 27' ' ' LEU . 0.2 OUTLIER -80.34 -72.24 0.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.848 . . . . 0.0 109.328 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 33' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' B' ' 30' ' ' SER . 16.8 m -44.66 -29.35 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 108.87 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.533 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.0 OUTLIER -69.79 -60.33 2.38 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.562 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -60.61 -43.37 97.53 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.702 HD22 HD23 ' A' ' 16' ' ' LEU . 3.7 mm? -59.08 -29.27 67.21 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.468 -0.77 . . . . 0.0 109.162 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 37' ' ' TYR . 13.8 t80 -78.76 -10.64 59.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.593 -0.692 . . . . 0.0 109.597 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.562 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -95.24 -36.87 11.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.0 109.253 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 16' ' ' LEU . 3.4 m -72.46 -28.49 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.277 -0.889 . . . . 0.0 109.438 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' CYS . . . . . 0.565 ' HB3' ' CB ' ' B' ' 43' ' ' ARG . 72.5 m -79.84 -37.24 35.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.106 -0.996 . . . . 0.0 109.259 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' GLY . . . . . 0.495 ' C ' ' CG ' ' B' ' 42' ' ' GLU . . . 77.52 98.23 0.2 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.495 ' CG ' ' C ' ' B' ' 41' ' ' GLY . 2.5 pt-20 37.99 37.75 0.16 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.61 -0.935 . . . . 0.0 110.407 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.565 ' CB ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -93.86 -170.97 2.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.085 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 43' ' ' ARG . . . -43.58 112.37 0.55 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.26 -6.3 88.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.41 -168.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.407 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' N ' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 1 N--CA 1.53 4.923 0 N-CA-C 119.457 2.543 . . . . 0.0 119.457 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.685 HG23 ' CE2' ' A' ' 19' ' ' TYR . 12.6 mt -93.29 -34.01 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.129 -1.218 . . . . 0.0 109.577 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 4.3 m -65.94 -28.01 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.375 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 1' ' ' GLY . 4.9 mt-10 -80.58 2.18 26.63 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.487 -0.758 . . . . 0.0 109.666 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.25 -45.69 4.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.985 ' HB3' HD11 ' B' ' 27' ' ' LEU . 56.0 m -97.99 -33.11 11.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.912 . . . . 0.0 109.815 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -73.07 -12.97 61.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.947 . . . . 0.0 109.808 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.3 t -100.38 -34.3 10.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.079 -1.013 . . . . 0.0 108.922 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -136.97 159.23 42.49 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.638 HG23 ' O ' ' B' ' 25' ' ' GLN . 23.7 mm -79.41 96.62 2.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 109.513 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.724 ' O ' HG23 ' B' ' 23' ' ' VAL . 9.1 p -76.97 159.58 29.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -0.818 . . . . 0.0 109.794 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.476 ' HA ' HG23 ' B' ' 23' ' ' VAL . 59.1 p -89.03 144.69 25.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 109.338 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.966 HD11 HG12 ' B' ' 39' ' ' VAL . 1.4 tp -46.82 -24.89 0.65 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.283 -0.886 . . . . 0.0 109.108 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 6.5 t80 -71.72 -32.62 67.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -0.927 . . . . 0.0 109.135 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 12' ' ' SER . 5.4 mm100 -66.53 -35.79 81.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.188 -0.945 . . . . 0.0 108.456 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.682 ' N ' HD22 ' A' ' 16' ' ' LEU . 3.2 mm? -66.19 -35.17 79.75 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -48.46 -36.21 14.53 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -74.7 -21.51 59.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.428 -0.795 . . . . 0.0 109.329 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.925 ' HD2' HD11 ' B' ' 36' ' ' LEU . 3.2 m-30 -60.04 -19.37 52.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.341 -0.85 . . . . 0.0 109.27 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.3 m -97.44 52.05 1.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.387 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.486 -179.919 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' B' ' 22' ' ' PHE . 38.5 p90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.226 0.536 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.829 HG22 ' H ' ' B' ' 24' ' ' ASN . 4.7 p -114.08 -170.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 108.981 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.829 ' H ' HG22 ' B' ' 23' ' ' VAL . 33.3 m-20 82.84 36.28 0.05 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.697 -0.627 . . . . 0.0 109.495 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.638 ' O ' HG23 ' A' ' 10' ' ' ILE . 2.5 mt-30 -140.95 175.7 9.41 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -133.54 176.34 8.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.868 -1.145 . . . . 0.0 109.066 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.985 HD11 ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -160.28 -164.93 1.35 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.763 -1.21 . . . . 0.0 111.072 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 146.16 153.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.45 -119.06 4.54 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.462 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -64.47 -52.47 57.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.3 -1.118 . . . . 0.0 110.115 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' B' ' 30' ' ' SER . 17.1 m-20 -43.55 -38.83 3.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.077 -1.015 . . . . 0.0 109.63 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.494 HD12 HD13 ' B' ' 27' ' ' LEU . 0.2 OUTLIER -67.73 -71.06 0.22 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.096 -1.003 . . . . 0.0 108.956 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.539 HG12 ' OH ' ' B' ' 47' ' ' TYR . 32.2 m -47.9 -27.56 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.098 -1.001 . . . . 0.0 108.602 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 9.4 mt-10 -74.65 -59.57 2.67 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.505 -0.747 . . . . 0.0 109.087 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.572 ' O ' HG13 ' B' ' 39' ' ' VAL . . . -58.92 -41.96 88.54 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.925 HD11 ' HD2' ' A' ' 19' ' ' TYR . 1.1 mm? -60.27 -29.03 68.54 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.674 0.75 . . . . 0.0 109.027 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 39.8 t80 -83.09 -13.51 55.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.68 -0.638 . . . . 0.0 110.247 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -90.02 -44.22 10.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.063 -1.023 . . . . 0.0 108.803 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.966 HG12 HD11 ' A' ' 13' ' ' LEU . 1.9 m -66.27 -37.69 80.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.558 -0.714 . . . . 0.0 109.314 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.421 ' N ' ' CG2' ' B' ' 39' ' ' VAL . 1.3 m -105.5 17.51 23.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.796 . . . . 0.0 109.439 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -56.96 -85.96 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.486 ' HG2' ' N ' ' B' ' 43' ' ' ARG . 28.2 tt0 -55.11 -88.47 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -1.152 . . . . 0.0 109.357 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.486 ' N ' ' HG2' ' B' ' 42' ' ' GLU . 0.4 OUTLIER -46.83 174.33 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.543 -0.723 . . . . 0.0 109.379 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.31 -92.64 1.73 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 30.97 6.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.63 -155.0 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -1.143 . . . . 0.0 109.648 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.539 ' OH ' HG12 ' B' ' 33' ' ' VAL . 9.8 t80 -144.64 -93.39 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 0.0 109.526 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.498 ' N ' ' CG ' ' B' ' 47' ' ' TYR . 22.8 m -169.68 -35.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.598 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tttp 69.14 74.18 0.29 Allowed Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.476 -0.765 . . . . 0.0 109.368 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.514 ' HD3' ' CE2' ' B' ' 47' ' ' TYR . 34.5 Cg_endo -76.87 176.17 10.46 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.696 2.264 . . . . 0.0 110.58 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.434 ' O ' ' OG1' ' B' ' 51' ' ' THR . 20.2 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.489 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.799 0 N-CA-C 119.273 2.469 . . . . 0.0 119.273 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.655 HG22 ' CD2' ' B' ' 32' ' ' LEU . 18.2 mm -78.69 -62.18 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -1.108 . . . . 0.0 109.208 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.792 HG12 HD22 ' B' ' 32' ' ' LEU . 2.4 m -72.3 -13.79 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.17 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -89.11 -8.32 54.05 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.637 ' O ' HG22 ' A' ' 8' ' ' THR . 2.9 mm-40 -97.52 -51.57 4.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 109.277 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.628 ' SG ' HD11 ' A' ' 16' ' ' LEU . 17.3 m -85.94 -69.84 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.887 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 2.4 t -41.56 -25.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.033 . . . . 0.0 110.724 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 5' ' ' GLN . 3.7 t -72.42 -27.08 62.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.86 -1.15 . . . . 0.0 109.238 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 6' ' ' CYS . 18.0 m -156.61 -157.66 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 mm -107.07 116.02 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.462 -1.399 . . . . 0.0 109.231 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.463 ' O ' HG21 ' B' ' 23' ' ' VAL . 2.5 p -99.05 172.84 7.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 109.649 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.2 p -106.87 150.78 26.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.806 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -46.52 -28.24 1.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.686 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 14.9 t80 -61.82 -45.46 93.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 108.808 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.58 -54.13 47.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.368 -0.833 . . . . 0.0 109.418 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 16' ' ' LEU . 1.6 mm? -51.33 -38.64 54.18 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.17 -0.956 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -49.36 -34.06 15.07 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.13 -21.81 58.6 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.884 ' CD2' HD11 ' B' ' 36' ' ' LEU . 3.3 m-85 -68.02 -16.93 64.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 0.0 109.435 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.3 m -82.21 51.26 1.75 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 0.0 109.564 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.48 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.252 0.548 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.832 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.8 OUTLIER -126.15 -155.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.0 109.631 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.832 ' N ' HG13 ' B' ' 23' ' ' VAL . 0.5 OUTLIER 86.68 4.72 0.39 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.287 0.565 . . . . 0.0 109.568 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -121.37 153.77 37.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.822 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -77.86 164.87 24.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.716 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -161.76 132.93 5.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.339 -1.475 . . . . 0.0 112.807 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.453 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -138.38 155.9 48.1 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.376 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 37.17 -115.2 0.29 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.446 ' O ' HG22 ' B' ' 33' ' ' VAL . 4.1 m -47.75 -65.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.455 -1.027 . . . . 0.0 110.842 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' B' ' 30' ' ' SER . 5.6 m-20 -42.48 -39.11 2.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 109.418 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.792 HD22 HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -65.99 -73.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 108.945 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.752 HG12 ' CD2' ' B' ' 47' ' ' TYR . 15.9 m -43.86 -28.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.146 -0.971 . . . . 0.0 108.69 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.519 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -78.18 -61.63 1.94 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.541 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -56.67 -39.42 73.73 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.884 HD11 ' CD2' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -64.14 -34.13 77.35 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.942 0.877 . . . . 0.0 108.806 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.418 ' O ' ' HA2' ' B' ' 41' ' ' GLY . 20.4 t80 -75.97 -22.33 56.0 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.742 -0.599 . . . . 0.0 110.077 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.537 HD23 ' N ' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -76.5 -53.41 8.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.944 -1.097 . . . . 0.0 108.484 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 16' ' ' LEU . 2.6 m -54.1 -32.24 22.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.534 ' HB3' ' CD ' ' B' ' 43' ' ' ARG . 1.3 m -122.83 39.59 3.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.506 -0.746 . . . . 0.0 109.713 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' B' ' 37' ' ' TYR . . . -53.45 -32.3 45.13 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.73 7.65 9.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -1.181 . . . . 0.0 109.94 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.534 ' CD ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -116.05 139.75 49.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 108.947 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.08 153.73 17.29 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.34 -151.95 6.18 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.22 31.81 0.24 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.233 -1.157 . . . . 0.0 109.636 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.752 ' CD2' HG12 ' B' ' 33' ' ' VAL . 1.2 t80 -56.63 -18.4 11.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.447 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 5.8 m -62.19 -27.1 68.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 109.577 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -154.79 87.51 3.37 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.412 -0.805 . . . . 0.0 109.2 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.28 170.5 19.88 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.705 2.27 . . . . 0.0 110.651 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.49 -179.864 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.751 HG22 HD21 ' B' ' 32' ' ' LEU . 62.2 mt -92.55 -28.94 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.941 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 1.4 m -62.22 -37.41 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.369 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 3.0 mt-10 -76.06 -1.17 24.63 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.362 -0.836 . . . . 0.0 109.644 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -43.4 4.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.108 -0.995 . . . . 0.0 110.045 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 9' ' ' SER . 95.6 m -103.72 -29.35 11.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.103 -0.998 . . . . 0.0 110.093 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 2.5 t -69.26 -6.98 32.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.042 -1.036 . . . . 0.0 109.349 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -99.6 -31.3 11.66 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.943 . . . . 0.0 108.526 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 6' ' ' CYS . 4.2 m -147.45 165.24 30.84 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 10' ' ' ILE . 3.9 mm -80.15 110.42 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.104 -0.997 . . . . 0.0 109.548 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 78.4 m -74.8 -170.71 1.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.662 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 13' ' ' LEU . 87.5 p -121.13 136.04 55.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -42.81 -26.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.168 -0.957 . . . . 0.0 109.776 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -62.79 -49.34 75.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.125 -0.984 . . . . 0.0 108.888 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -65.07 -44.94 87.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 0.0 108.865 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.616 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 3.3 mp -55.65 -37.16 67.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.107 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 7.0 mm-40 -54.03 -34.5 60.17 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.286 -0.884 . . . . 0.0 108.749 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -21.98 61.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.414 -0.804 . . . . 0.0 109.485 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.779 ' HD2' HD11 ' B' ' 36' ' ' LEU . 5.0 m-30 -62.44 -29.41 70.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.7 m -82.57 53.79 2.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.891 . . . . 0.0 109.276 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.4 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' B' ' 22' ' ' PHE . 52.4 p90 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.592 ' O ' ' HB3' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -143.53 171.15 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.041 -1.037 . . . . 0.0 110.008 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.592 ' HB3' ' O ' ' B' ' 23' ' ' VAL . 10.6 p30 167.5 -29.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -85.56 -171.04 3.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.536 -0.728 . . . . 0.0 109.932 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -118.79 -169.82 1.79 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -0.846 . . . . 0.0 109.022 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' B' ' 28' ' ' CYS . 0.3 OUTLIER -160.77 -159.27 0.66 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.751 -1.218 . . . . 0.0 110.415 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.616 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 145.9 141.9 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 123.558 0.743 . . . . 0.0 109.17 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 35.64 -118.19 0.35 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.1 OUTLIER -42.61 -62.83 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.427 -1.043 . . . . 0.0 110.177 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -43.99 -31.63 0.95 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.048 -1.033 . . . . 0.0 109.166 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.751 HD21 HG22 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -68.69 -66.9 0.51 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.221 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.452 HG23 ' OE2' ' B' ' 34' ' ' GLU . 30.6 m -51.52 -28.64 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.995 -1.066 . . . . 0.0 108.489 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.503 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.1 mp0 -76.0 -58.77 3.08 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.545 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.55 -47.31 82.38 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.779 HD11 ' HD2' ' A' ' 19' ' ' TYR . 1.1 mm? -56.49 -29.01 61.29 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.781 0.8 . . . . 0.0 108.959 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' B' ' 33' ' ' VAL . 70.7 t80 -82.41 -15.09 53.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.828 -0.545 . . . . 0.0 109.988 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.4 OUTLIER -87.32 -46.64 9.5 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 16' ' ' LEU . 2.7 m -65.95 -21.37 28.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' B' ' 43' ' ' ARG . 1.3 m -119.9 27.09 8.89 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.451 -0.781 . . . . 0.0 109.235 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' B' ' 40' ' ' CYS . . . -43.45 -26.9 0.71 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' B' ' 40' ' ' CYS . 25.9 tt0 -90.92 -23.05 20.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -1.175 . . . . 0.0 109.644 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' B' ' 40' ' ' CYS . 2.0 ttt180 -110.25 159.37 17.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.406 -0.809 . . . . 0.0 109.222 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -178.45 142.57 5.53 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' B' ' 47' ' ' TYR . . . 115.94 -67.59 0.29 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 60.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 0.0 109.529 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' B' ' 45' ' ' GLY . 72.1 t80 -114.73 -17.36 11.63 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.346 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.532 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 4.3 m -174.27 -18.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.219 -0.925 . . . . 0.0 111.381 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -113.01 85.57 8.11 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.647 -1.283 . . . . 0.0 109.465 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' B' ' 48' ' ' THR . 35.9 Cg_endo -76.42 -179.58 5.44 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.599 2.199 . . . . 0.0 110.695 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' B' ' 50' ' ' PRO . 41.8 p . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.345 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.872 0 N-CA-C 119.369 2.508 . . . . 0.0 119.369 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.566 HG21 ' CE2' ' A' ' 19' ' ' TYR . 22.3 mt -89.06 -31.73 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -1.139 . . . . 0.0 109.399 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.621 HG12 HD22 ' B' ' 32' ' ' LEU . 1.6 m -47.09 -40.14 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.22 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 6.4 mt-10 -56.47 -16.32 5.67 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.641 -0.662 . . . . 0.0 110.103 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -105.34 -31.08 9.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 110.303 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.617 ' HB3' HD11 ' B' ' 27' ' ' LEU . 7.3 m -103.01 -31.2 10.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.039 . . . . 0.0 110.127 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 1.5 m -84.84 -13.82 49.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.32 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.8 -13.29 15.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.037 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.5 m -150.65 158.36 44.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.354 -0.841 . . . . 0.0 109.07 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 10' ' ' ILE . 20.4 mm -80.86 97.99 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 0.0 109.622 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 16' ' ' LEU . 3.7 p -82.06 171.46 14.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 109.373 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.678 ' HA ' HG21 ' B' ' 23' ' ' VAL . 59.3 p -111.03 148.49 32.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.239 -0.913 . . . . 0.0 109.828 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.637 ' CD1' HG12 ' B' ' 39' ' ' VAL . 0.6 OUTLIER -45.45 -28.94 0.98 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.058 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -59.08 -53.41 58.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.368 -0.832 . . . . 0.0 109.024 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 27.5 mm-40 -61.43 -29.11 69.73 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.286 -0.884 . . . . 0.0 109.048 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.883 HD23 HD13 ' B' ' 36' ' ' LEU . 6.9 mp -71.22 -38.92 72.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.258 -0.901 . . . . 0.0 108.7 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.45 -32.75 63.02 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -73.38 -26.87 61.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.433 -0.792 . . . . 0.0 109.277 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' A' ' 2' ' ' ILE . 6.2 m-30 -58.79 -19.79 44.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 108.814 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.67 51.75 1.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -0.768 . . . . 0.0 109.247 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.333 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.397 0.618 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.819 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -157.4 -158.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.368 -0.832 . . . . 0.0 109.865 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.819 ' N ' HG13 ' B' ' 23' ' ' VAL . 30.3 m-20 74.07 30.23 1.27 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -127.86 154.23 45.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.386 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.524 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -100.76 -178.35 3.75 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.782 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -161.0 -159.6 0.68 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.787 -1.195 . . . . 0.0 110.225 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.577 ' CB ' ' O ' ' B' ' 27' ' ' LEU . 1.2 m 149.35 150.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.49 -127.86 27.09 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.439 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.9 OUTLIER -58.34 -51.08 71.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.286 -1.126 . . . . 0.0 109.83 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 30' ' ' SER . 3.2 m-20 -43.35 -42.87 4.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 109.26 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.853 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -63.09 -76.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.918 . . . . 0.0 109.502 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.803 HG12 ' CE1' ' B' ' 47' ' ' TYR . 14.4 m -44.45 -33.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.029 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.528 ' O ' ' HG ' ' B' ' 38' ' ' LEU . 2.5 mm-40 -62.97 -52.71 61.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.477 -0.764 . . . . 0.0 109.151 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -55.9 -52.96 62.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.535 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.883 HD13 HD23 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -57.37 -29.96 64.46 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.892 -1.13 . . . . 0.0 107.955 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 86.3 t80 -73.27 -11.95 60.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.567 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -97.06 -51.2 4.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.979 . . . . 0.0 108.74 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.815 HG11 ' HB3' ' A' ' 16' ' ' LEU . 2.3 m -48.33 -36.66 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.509 ' CB ' ' HB3' ' B' ' 43' ' ' ARG . 0.9 OUTLIER -93.71 -53.37 4.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.389 -0.819 . . . . 0.0 109.157 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.72 -50.42 3.58 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -116.86 22.36 12.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.186 . . . . 0.0 110.058 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.509 ' HB3' ' CB ' ' B' ' 40' ' ' CYS . 0.2 OUTLIER -56.31 -176.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.0 . . . . 0.0 109.15 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.68 155.35 49.69 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.12 56.5 4.35 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -147.05 140.2 25.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.527 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.803 ' CE1' HG12 ' B' ' 33' ' ' VAL . 32.4 t80 -175.27 88.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.432 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' B' ' 50' ' ' PRO . 3.1 m -112.04 -50.51 2.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.549 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 2.1 tttp 165.37 -55.5 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.526 -0.734 . . . . 0.0 109.328 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 35.6 Cg_endo -76.45 -177.88 4.05 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.379 2.052 . . . . 0.0 110.744 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.561 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.883 0 N-CA-C 119.388 2.515 . . . . 0.0 119.388 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.7 mt -74.49 -25.98 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.567 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.732 HG12 HD22 ' B' ' 32' ' ' LEU . 1.3 m -71.3 -30.58 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.67 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.13 -10.73 53.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.619 -0.675 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -31.3 9.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.868 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.551 ' HB3' HD11 ' B' ' 27' ' ' LEU . 95.5 m -105.01 -34.53 7.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.982 -1.074 . . . . 0.0 110.076 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.538 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 1.8 t -63.44 -10.99 19.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.015 -1.053 . . . . 0.0 109.65 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 9' ' ' SER . 14.6 t -104.99 -37.9 6.8 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.469 ' N ' HG23 ' A' ' 8' ' ' THR . 7.9 m -127.2 147.8 50.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.702 ' CG2' HG22 ' B' ' 23' ' ' VAL . 0.9 OUTLIER -78.87 91.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.993 -1.067 . . . . 0.0 109.212 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.625 ' O ' HG23 ' B' ' 23' ' ' VAL . 59.7 m -54.74 172.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.434 -0.791 . . . . 0.0 109.498 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 13' ' ' LEU . 85.6 p -106.81 155.34 19.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 109.531 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.75 HD11 HG12 ' B' ' 39' ' ' VAL . 0.8 OUTLIER -45.51 -26.81 0.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.244 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -67.27 -44.35 79.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 10.0 mt-30 -65.47 -43.35 90.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.923 HD23 HD13 ' B' ' 36' ' ' LEU . 6.8 mp -61.72 -34.03 75.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.014 -1.054 . . . . 0.0 109.081 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.87 -23.61 61.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.3 m-80 -75.62 -24.37 56.49 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.53 -0.731 . . . . 0.0 109.615 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.632 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.6 m-30 -77.83 3.75 13.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.016 -1.052 . . . . 0.0 109.478 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 13.6 m -123.27 69.1 1.01 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 109.794 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 18' ' ' ASN . 17.4 p30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.421 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.498 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.71 HG13 ' N ' ' B' ' 24' ' ' ASN . 1.3 p -95.44 -159.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.213 -0.929 . . . . 0.0 108.603 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.71 ' N ' HG13 ' B' ' 23' ' ' VAL . 6.5 t-20 78.08 30.44 0.44 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.489 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -155.54 162.62 40.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.436 -0.79 . . . . 0.0 109.127 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.538 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -110.74 179.93 3.93 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.686 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -160.24 -168.35 2.16 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.343 -1.473 . . . . 0.0 111.968 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' B' ' 32' ' ' LEU . 0.5 OUTLIER 151.38 147.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.66 -115.58 2.66 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 68.0 m -63.74 -57.58 9.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -1.132 . . . . 0.0 110.047 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' B' ' 30' ' ' SER . 6.6 m-20 -43.83 -36.23 2.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.205 -0.935 . . . . 0.0 109.437 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.88 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -67.85 -76.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.215 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' B' ' 32' ' ' LEU . 3.5 m -44.51 -29.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 108.673 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.53 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 7.1 mt-10 -66.07 -55.58 15.86 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.505 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -55.17 -55.21 33.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.347 -0.846 . . . . 0.0 108.787 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.923 HD13 HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -58.3 -18.44 27.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 108.637 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 23.3 t80 -86.12 -14.49 44.03 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -89.47 -42.11 11.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 108.805 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.75 HG12 HD11 ' A' ' 13' ' ' LEU . 2.3 m -75.62 -20.81 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.485 -0.759 . . . . 0.0 109.261 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' B' ' 39' ' ' VAL . 55.6 m -111.2 6.04 20.4 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.324 -0.86 . . . . 0.0 109.757 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.34 -12.29 83.67 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -82.24 -72.11 0.45 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -1.12 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -175.01 1.84 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.464 -0.772 . . . . 0.0 109.617 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.01 -94.08 1.69 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.94 -119.63 5.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' B' ' 51' ' ' THR . 0.7 OUTLIER -149.94 27.42 0.79 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -1.132 . . . . 0.0 109.383 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.19 21.45 2.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.63 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 2.5 m -90.17 -13.97 34.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.375 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.603 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 2.5 tttt -168.32 -62.23 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.674 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 33.8 Cg_endo -72.94 172.96 14.36 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.948 1.765 . . . . 0.0 110.504 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.433 ' C ' ' O ' ' B' ' 50' ' ' PRO . 24.2 p . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.612 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.914 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.442 ' O ' HG12 ' A' ' 2' ' ' ILE . 6.7 tt -102.99 -13.14 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.232 -1.158 . . . . 0.0 109.659 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.836 HG12 HD22 ' B' ' 32' ' ' LEU . 10.9 m -99.65 -30.46 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 109.17 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.489 ' O ' ' CG2' ' A' ' 8' ' ' THR . 10.1 mt-10 -82.68 -4.95 58.55 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.308 -0.87 . . . . 0.0 109.958 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.55 -34.93 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -0.991 . . . . 0.0 110.01 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.519 ' CB ' HD11 ' B' ' 27' ' ' LEU . 82.0 m -105.42 -30.31 9.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 110.412 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.558 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 4.5 t -71.57 -6.76 43.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.147 -0.97 . . . . 0.0 109.821 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -119.86 -14.33 8.98 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.234 -0.916 . . . . 0.0 108.815 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.68 ' O ' HD13 ' A' ' 10' ' ' ILE . 68.0 m -136.88 -165.68 1.78 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 9' ' ' SER . 4.6 mm -120.99 92.35 2.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 109.548 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.788 ' O ' HG23 ' B' ' 23' ' ' VAL . 28.0 m -71.66 171.68 11.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.482 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 13' ' ' LEU . 25.4 p -116.12 153.42 31.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.875 . . . . 0.0 108.861 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.707 ' CD1' HG12 ' B' ' 39' ' ' VAL . 0.8 OUTLIER -44.44 -29.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.101 -0.999 . . . . 0.0 109.083 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.32 -50.42 73.68 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.254 -0.904 . . . . 0.0 108.694 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.436 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 3.6 mm-40 -65.45 -35.58 81.34 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.835 ' CD2' HG11 ' B' ' 39' ' ' VAL . 3.4 mp -65.69 -33.91 76.98 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -25.25 63.98 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.88 -34.5 62.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.427 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.72 ' HD2' HD11 ' B' ' 36' ' ' LEU . 1.4 m-30 -59.4 -20.08 52.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 108.78 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.18 54.31 2.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.362 -0.836 . . . . 0.0 109.469 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.479 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.513 ' HA ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 11' ' ' CYS . 1.4 p -82.56 -166.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.422 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.742 ' H ' HG22 ' B' ' 23' ' ' VAL . 8.2 t30 46.47 38.66 5.65 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.559 -0.713 . . . . 0.0 109.308 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.17 169.11 24.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.881 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.538 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 1.1 t60 -125.98 172.01 10.29 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 1.136 HD13 ' CD1' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -161.29 -166.84 1.62 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.327 -1.483 . . . . 0.0 111.639 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 150.78 153.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 123.419 0.688 . . . . 0.0 109.265 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.79 -117.54 2.2 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.446 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.4 OUTLIER -60.84 -57.59 12.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -1.072 . . . . 0.0 110.28 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' B' ' 30' ' ' SER . 13.5 m-20 -42.28 -31.5 0.4 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.236 -0.915 . . . . 0.0 109.68 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 1.136 ' CD1' HD13 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -70.46 -68.46 0.42 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.156 -0.965 . . . . 0.0 108.87 179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.422 HG23 ' N ' ' B' ' 34' ' ' GLU . 33.5 m -51.74 -35.26 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.125 -0.985 . . . . 0.0 108.733 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.536 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 4.7 mt-10 -69.68 -52.94 21.17 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.376 -0.828 . . . . 0.0 108.982 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.539 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -62.99 -42.97 99.99 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.72 HD11 ' HD2' ' A' ' 19' ' ' TYR . 1.6 mm? -60.32 -30.5 69.55 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.894 0.854 . . . . 0.0 108.698 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.414 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 13.3 t80 -77.37 -14.1 59.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.671 -0.643 . . . . 0.0 109.882 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.5 OUTLIER -88.27 -53.7 4.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 108.609 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.835 HG11 ' CD2' ' A' ' 16' ' ' LEU . 2.2 m -54.57 -27.11 17.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' CYS . . . . . . . . . . . . . 55.7 m -119.61 35.45 4.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.467 -0.771 . . . . 0.0 109.558 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.16 51.2 3.53 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -172.91 -34.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -1.116 . . . . 0.0 109.481 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 44' ' ' GLY . 7.0 ttt85 -92.71 153.13 19.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.493 -0.754 . . . . 0.0 109.311 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' B' ' 43' ' ' ARG . . . -54.67 -106.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.66 145.18 1.05 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.6 -156.24 0.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -1.177 . . . . 0.0 109.632 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.58 44.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 0.0 109.777 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.22 -74.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.301 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.37 104.13 0.34 Allowed Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -76.01 157.15 38.64 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.443 2.095 . . . . 0.0 110.666 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.439 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.813 0 N-CA-C 119.313 2.485 . . . . 0.0 119.313 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' B' ' 32' ' ' LEU . 7.9 mt -102.34 -45.66 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -1.16 . . . . 0.0 109.607 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.4 m -49.76 -34.47 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.703 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 3' ' ' VAL . 2.6 mt-10 -77.38 -7.6 56.35 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 109.851 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -40.72 5.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 110.142 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 9' ' ' SER . 69.0 m -99.98 -34.69 9.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 0.0 110.509 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.581 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 6.1 t -71.96 -40.42 68.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.849 -1.157 . . . . 0.0 109.594 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 55.0 p -77.85 -31.9 51.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.114 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.771 ' O ' HD13 ' A' ' 10' ' ' ILE . 2.5 p -124.62 -150.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -0.81 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 9' ' ' SER . 5.5 mm -133.53 112.1 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.143 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.7 m -86.93 170.17 11.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 109.661 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' LEU . 79.4 p -102.76 140.23 37.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 109.383 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.664 HD13 ' CE2' ' B' ' 22' ' ' PHE . 0.8 OUTLIER -42.85 -31.3 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -62.97 -51.19 67.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.94 . . . . 0.0 109.373 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -37.56 74.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.058 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.777 HD23 HD13 ' B' ' 36' ' ' LEU . 6.2 mp -64.93 -38.91 92.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 108.868 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.56 -26.25 63.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -74.87 -32.79 61.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.348 -0.845 . . . . 0.0 108.929 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.591 ' CD2' ' HA ' ' A' ' 16' ' ' LEU . 4.3 m-30 -57.59 -20.58 33.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.31 -0.869 . . . . 0.0 109.219 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.6 m -87.81 50.62 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.55 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.664 ' CE2' HD13 ' A' ' 13' ' ' LEU . 11.8 t80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.4 0.619 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.82 HG13 ' N ' ' B' ' 24' ' ' ASN . 1.1 p -161.8 -153.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.756 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.82 ' N ' HG13 ' B' ' 23' ' ' VAL . 6.2 m-20 81.88 55.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.69 166.44 18.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.63 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -124.97 146.56 49.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.611 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.813 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -160.91 145.05 13.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.294 -1.503 . . . . 0.0 112.679 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.46 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -133.91 155.07 50.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.523 -0.736 . . . . 0.0 109.447 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 34.35 -126.12 0.52 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.498 ' O ' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER -39.0 -63.8 0.5 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.937 . . . . 0.0 110.715 -179.026 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' B' ' 30' ' ' SER . 10.3 m-20 -41.31 -32.14 0.28 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.825 . . . . 0.0 109.354 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.948 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.3 OUTLIER -69.15 -71.69 0.21 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.312 -0.867 . . . . 0.0 108.808 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.498 HG22 ' O ' ' B' ' 30' ' ' SER . 29.0 m -43.05 -39.15 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.262 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.514 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -63.19 -50.44 70.29 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.311 -0.868 . . . . 0.0 108.954 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.722 ' HB2' HD23 ' B' ' 27' ' ' LEU . . . -53.36 -57.69 9.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.458 -0.776 . . . . 0.0 109.443 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.948 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.3 OUTLIER -56.59 -22.73 35.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.047 -1.033 . . . . 0.0 108.526 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 11.1 t80 -82.5 -14.88 54.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.648 -0.657 . . . . 0.0 109.477 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -85.51 -45.31 11.91 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -67.86 -21.63 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.535 -0.728 . . . . 0.0 109.173 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.444 ' HB3' ' O ' ' B' ' 43' ' ' ARG . 96.2 m -113.45 16.02 18.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.404 -0.81 . . . . 0.0 109.353 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -44.04 -39.94 5.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.95 17.0 6.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -1.174 . . . . 0.0 109.422 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' B' ' 40' ' ' CYS . 1.8 tpt85 -132.85 111.37 11.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.323 -0.86 . . . . 0.0 109.367 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.43 -122.88 6.93 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.9 40.11 1.9 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.502 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 29.6 t80 -108.88 -0.88 19.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -1.127 . . . . 0.0 109.507 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.41 ' CE1' HG12 ' B' ' 33' ' ' VAL . 2.3 t80 -78.69 50.84 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.823 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' B' ' 49' ' ' LYS . 11.4 m -113.21 -70.18 0.82 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.063 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' B' ' 48' ' ' THR . 8.2 tttp 69.5 96.15 0.05 OUTLIER Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.502 -0.748 . . . . 0.0 109.772 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.73 175.36 11.33 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.607 2.204 . . . . 0.0 110.524 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.459 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.409 2.523 . . . . 0.0 119.409 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.446 HG23 ' CZ ' ' A' ' 19' ' ' TYR . 62.0 mt -81.49 -32.94 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.265 -1.138 . . . . 0.0 109.65 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.954 HG12 HD22 ' B' ' 32' ' ' LEU . 2.9 m -60.58 -30.33 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.584 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.1 mt-10 -78.73 1.79 21.85 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.565 -0.71 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' SER . 3.0 tp60 -105.24 -40.84 5.72 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.217 -0.927 . . . . 0.0 109.688 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 9' ' ' SER . 85.3 m -106.05 -36.87 6.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 110.667 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.564 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 8.8 t -68.97 -15.28 63.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.876 -1.14 . . . . 0.0 110.076 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 11.2 t -113.34 -27.72 7.84 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 18.2 m -126.65 156.76 40.5 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.482 ' CG2' ' HA ' ' B' ' 24' ' ' ASN . 5.5 mm -81.14 146.61 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.735 -1.228 . . . . 0.0 109.516 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.435 ' HB2' HD11 ' A' ' 16' ' ' LEU . 82.7 m -124.91 -169.19 1.94 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.363 -0.835 . . . . 0.0 109.768 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -137.47 143.1 41.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.653 ' HG ' HG12 ' B' ' 39' ' ' VAL . 0.9 OUTLIER -40.84 -33.32 0.29 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 109.66 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 75.1 t80 -65.93 -50.35 64.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.953 . . . . 0.0 108.616 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -60.98 -36.54 79.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.157 -0.964 . . . . 0.0 108.568 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.835 HD23 HD22 ' B' ' 36' ' ' LEU . 5.2 mp -69.37 -32.47 71.55 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 2.5 mt-10 -56.98 -28.5 62.4 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -31.57 69.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.477 -0.764 . . . . 0.0 109.294 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.629 ' CD2' HD11 ' B' ' 36' ' ' LEU . 23.2 m-30 -58.68 -14.84 9.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -0.963 . . . . 0.0 109.547 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.4 m -99.73 57.64 1.01 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.964 . . . . 0.0 109.532 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.472 179.934 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.482 0.658 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.821 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -144.37 -159.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.392 -0.818 . . . . 0.0 109.885 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.821 ' N ' HG13 ' B' ' 23' ' ' VAL . 36.6 t30 62.08 68.25 0.69 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.399 0.619 . . . . 0.0 109.667 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.27 173.45 11.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.209 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.564 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -121.14 150.86 40.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.76 HD23 ' N ' ' B' ' 27' ' ' LEU . 1.2 pt? -160.98 141.51 11.29 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.223 -1.548 . . . . 0.0 112.85 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.9 OUTLIER -139.54 167.9 21.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.381 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 40.71 -121.6 1.94 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.459 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.7 OUTLIER -53.1 -59.35 4.66 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.342 -1.093 . . . . 0.0 110.572 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.614 ' CB ' ' HB2' ' B' ' 27' ' ' LEU . 13.8 m-20 -40.09 -35.92 0.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.873 . . . . 0.0 109.765 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.954 HD22 HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -67.61 -72.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 108.622 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -49.15 -27.98 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.941 . . . . 0.0 108.476 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.52 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -72.38 -56.29 5.7 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.704 ' HB3' ' CD1' ' B' ' 27' ' ' LEU . . . -60.21 -45.53 92.86 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.835 HD22 HD23 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -59.9 -27.09 66.43 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.513 ' O ' ' CA ' ' B' ' 41' ' ' GLY . 76.9 t80 -80.22 -11.9 59.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.75 -0.593 . . . . 0.0 109.822 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.541 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.6 OUTLIER -90.79 -48.51 6.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.979 . . . . 0.0 108.713 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.653 HG12 ' HG ' ' A' ' 13' ' ' LEU . 2.4 m -62.22 -29.47 46.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.484 -0.76 . . . . 0.0 108.963 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' CYS . . . . . . . . . . . . . 19.1 m -119.49 13.71 12.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.45 -0.781 . . . . 0.0 109.526 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' B' ' 37' ' ' TYR . . . -55.86 -40.87 82.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -105.34 -11.32 16.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.46 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.14 138.31 41.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.601 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.95 -144.29 12.77 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' GLY . . . . . 0.557 ' C ' ' CG ' ' B' ' 46' ' ' PHE . . . 163.81 165.84 21.67 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.557 ' CG ' ' C ' ' B' ' 45' ' ' GLY . 0.8 OUTLIER 39.29 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.523 -0.987 . . . . 0.0 109.77 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -75.63 3.18 10.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -55.22 -20.55 11.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.067 -1.021 . . . . 0.0 109.349 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt 57.02 92.71 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.33 158.59 33.14 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.67 2.246 . . . . 0.0 110.56 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 91.5 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.554 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.738 HG22 HD21 ' B' ' 32' ' ' LEU . 10.5 mt -80.35 -23.13 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -1.111 . . . . 0.0 109.38 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.1 m -60.97 -27.63 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.611 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -83.41 4.74 26.28 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.47 -0.769 . . . . 0.0 109.458 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.75 -49.36 3.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.169 -0.957 . . . . 0.0 110.455 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' SER . 62.0 m -104.97 -34.08 8.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 110.752 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 4.2 t -61.65 -12.06 14.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.774 -1.204 . . . . 0.0 109.553 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -99.13 -32.81 11.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 108.446 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.582 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 5.7 t -120.71 -156.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' B' ' 24' ' ' ASN . 25.1 mm -109.98 -4.71 10.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.835 -1.166 . . . . 0.0 109.567 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' ILE . 1.5 m 45.41 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 110.24 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.6 p -150.58 149.84 30.42 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.74 -25.33 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.07 -1.019 . . . . 0.0 109.625 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -61.82 -55.05 34.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.162 -0.961 . . . . 0.0 109.173 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 -46.8 84.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.311 -0.868 . . . . 0.0 109.331 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.3 mp -61.47 -35.61 78.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.109 -0.994 . . . . 0.0 108.737 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -56.83 -23.36 43.37 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.96 -25.2 58.69 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.589 -0.695 . . . . 0.0 109.305 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.58 ' CD2' HD11 ' B' ' 36' ' ' LEU . 1.8 m-30 -74.81 -3.77 33.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.943 -1.098 . . . . 0.0 109.183 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.566 ' SG ' HG23 ' B' ' 39' ' ' VAL . 61.0 m -78.38 51.97 1.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.219 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 t30 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.601 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' B' ' 22' ' ' PHE . 3.8 p90 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.585 0.707 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.822 HG13 ' N ' ' B' ' 24' ' ' ASN . 1.1 p -160.93 -153.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.579 -0.7 . . . . 0.0 109.422 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.822 ' N ' HG13 ' B' ' 23' ' ' VAL . 28.0 t-20 87.73 74.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.5 0.667 . . . . 0.0 109.558 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -158.24 154.37 27.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.582 ' CE1' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -105.16 174.54 5.83 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.806 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.0 OUTLIER -153.69 -157.17 0.75 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.485 -1.385 . . . . 0.0 111.335 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.653 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.6 OUTLIER 139.24 146.14 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 124.127 0.971 . . . . 0.0 108.53 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.21 -131.02 19.67 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.489 ' HA ' HG22 ' B' ' 33' ' ' VAL . 7.3 m -55.62 -38.95 70.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.718 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.517 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 7.4 m-20 -52.1 -40.04 60.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 109.005 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.795 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -67.17 -72.49 0.16 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 108.96 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.49 HG23 ' N ' ' B' ' 34' ' ' GLU . 27.7 m -42.89 -40.3 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.106 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.543 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -54.67 -51.88 64.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.223 -0.923 . . . . 0.0 109.046 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' B' ' 38' ' ' LEU . . . -59.1 -54.33 48.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.039 -1.038 . . . . 0.0 108.822 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.795 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.8 OUTLIER -54.33 -20.15 6.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.138 -0.976 . . . . 0.0 108.881 179.297 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 33.1 t80 -86.09 -10.61 54.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.408 -0.807 . . . . 0.0 109.373 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -98.68 -40.54 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.038 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.566 HG23 ' SG ' ' A' ' 20' ' ' CYS . 2.3 m -78.86 -27.17 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.422 -0.798 . . . . 0.0 109.409 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.524 ' SG ' HG23 ' B' ' 39' ' ' VAL . 7.4 m -103.98 -1.01 28.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.15 -36.18 51.68 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.78 -15.04 25.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.156 -1.203 . . . . 0.0 109.641 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' B' ' 44' ' ' GLY . 8.5 ttt180 -123.76 161.93 24.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.44 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.525 ' N ' ' HG2' ' B' ' 43' ' ' ARG . . . -48.91 164.94 0.31 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 20' ' ' CYS . . . 116.71 -10.61 16.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' B' ' 45' ' ' GLY . 2.0 t80 -43.16 124.7 3.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -1.088 . . . . 0.0 109.204 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.518 ' O ' ' CB ' ' B' ' 48' ' ' THR . 4.9 p90 -122.09 -134.48 0.3 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' B' ' 47' ' ' TYR . 1.1 m 162.59 -53.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.312 -0.868 . . . . 0.0 108.837 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -174.14 109.64 0.3 Allowed Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.589 -0.695 . . . . 0.0 109.452 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.3 -178.18 4.24 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.366 2.044 . . . . 0.0 110.455 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 58.9 p . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.495 179.955 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.896 0 N-CA-C 119.336 2.494 . . . . 0.0 119.336 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.757 HD13 ' CE2' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -104.91 -9.69 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -1.156 . . . . 0.0 108.997 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.651 HG12 HD22 ' B' ' 32' ' ' LEU . 2.9 m -76.81 -35.3 24.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.359 -0.838 . . . . 0.0 109.893 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' THR . 3.6 mt-10 -61.69 -10.87 9.6 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.707 -0.621 . . . . 0.0 110.641 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -105.46 -34.24 7.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.907 -1.12 . . . . 0.0 110.126 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.3 m -98.76 -18.49 17.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.678 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.543 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 13.3 t -86.2 -34.95 20.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 4' ' ' GLU . 6.2 t -89.67 -30.1 18.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.45 ' OG ' HG23 ' A' ' 8' ' ' THR . 4.5 m -128.71 165.29 21.16 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.566 HG21 ' HA ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -94.23 128.11 45.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.116 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.615 ' HB2' HD11 ' A' ' 16' ' ' LEU . 66.1 m -96.88 175.28 6.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 109.61 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 29.4 p -106.61 148.03 28.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 109.281 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.575 ' HG ' HG12 ' B' ' 39' ' ' VAL . 0.2 OUTLIER -43.42 -30.17 0.52 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.119 -0.988 . . . . 0.0 109.81 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -62.21 -56.57 17.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.366 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.484 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 1.2 mp0 -57.88 -38.33 75.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.184 -0.947 . . . . 0.0 109.128 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.823 ' CB ' HG11 ' B' ' 39' ' ' VAL . 6.8 mp -67.07 -39.97 86.96 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.184 -0.948 . . . . 0.0 108.838 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.54 -25.94 53.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -70.95 -32.18 68.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.468 -0.77 . . . . 0.0 109.095 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.757 ' CE2' HD13 ' A' ' 2' ' ' ILE . 1.6 m-30 -68.71 -31.67 70.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.139 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -60.63 -98.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.988 0.899 . . . . 0.0 109.923 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 . . . . . 0 C--N 1.278 -2.513 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.34 -179.485 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' B' ' 22' ' ' PHE . 2.2 t80 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.393 0.616 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.802 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -160.58 -162.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.239 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.802 ' N ' HG13 ' B' ' 23' ' ' VAL . 0.8 OUTLIER 73.28 68.94 0.11 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.523 -0.736 . . . . 0.0 109.566 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.1 tp60 -141.59 156.24 45.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 109.517 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.543 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -115.21 164.07 14.76 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 1.022 ' HG ' HD12 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -161.41 -156.37 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 119.951 -1.718 . . . . 0.0 112.901 -178.513 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.592 ' N ' ' HB2' ' B' ' 31' ' ' ASP . 0.3 OUTLIER 150.93 140.78 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.725 0 C-N-CA 123.557 0.743 . . . . 0.0 110.271 -178.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' B' ' 32' ' ' LEU . . . 43.88 -128.99 6.51 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.454 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.3 OUTLIER -47.2 -39.46 14.02 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.156 -1.202 . . . . 0.0 108.821 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.592 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 80.8 m-20 -59.28 -29.83 67.87 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.208 -0.933 . . . . 0.0 108.704 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 1.022 HD12 ' HG ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -68.7 -57.39 5.73 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.6 ' O ' ' CG ' ' B' ' 37' ' ' TYR . 4.8 m -55.63 -35.58 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.538 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -59.58 -59.53 5.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.523 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -61.29 -46.76 88.98 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.599 HD11 ' HD2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -57.89 -33.63 68.94 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.6 ' CG ' ' O ' ' B' ' 33' ' ' VAL . 5.5 m-30 -71.45 -21.94 61.9 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.671 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -81.26 -58.11 3.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 108.895 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.823 HG11 ' CB ' ' A' ' 16' ' ' LEU . 2.5 m -47.27 -32.92 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.49 -0.756 . . . . 0.0 109.416 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' B' ' 43' ' ' ARG . 0.9 OUTLIER -100.09 -27.38 13.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 109.807 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.506 ' O ' ' CG ' ' B' ' 42' ' ' GLU . . . 41.24 65.81 1.04 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' B' ' 41' ' ' GLY . 10.6 pt-20 39.36 29.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -1.008 . . . . 0.0 110.115 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' B' ' 40' ' ' CYS . 0.8 OUTLIER -90.32 135.99 33.33 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.295 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 49.06 66.42 2.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.65 175.91 35.57 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.56 ' HB3' ' CD1' ' B' ' 47' ' ' TYR . 1.7 m-30 -79.75 -100.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.122 -1.223 . . . . 0.0 109.961 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.562 ' CE1' ' OH ' ' B' ' 37' ' ' TYR . 0.1 OUTLIER -107.15 -99.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.846 -1.159 . . . . 0.0 109.027 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' B' ' 47' ' ' TYR . 2.7 m -178.26 -50.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.922 . . . . 0.0 109.155 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.67 77.38 0.45 Allowed Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.565 -0.709 . . . . 0.0 109.209 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.09 -177.44 3.82 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.803 2.336 . . . . 0.0 110.786 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.341 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.809 0 N-CA-C 119.414 2.526 . . . . 0.0 119.414 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.439 HG22 HD21 ' B' ' 32' ' ' LEU . 19.6 mt -89.22 -25.64 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -1.103 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 2.5 m -56.96 -30.55 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 109.724 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -78.37 1.68 21.16 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.496 -0.752 . . . . 0.0 109.706 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -105.63 -42.74 5.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 0.0 109.545 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 9' ' ' SER . 98.7 m -105.65 -39.99 5.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 0.0 110.065 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.595 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 2.2 t -58.28 -54.02 51.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.757 -1.214 . . . . 0.0 108.248 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.1 p -64.03 -68.97 0.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.065 . . . . 0.0 108.368 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 3.3 m -95.27 141.0 29.37 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.3 113.65 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.863 -1.148 . . . . 0.0 109.953 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.7 m -77.96 -168.08 1.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.177 -0.952 . . . . 0.0 109.606 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.608 ' HA ' HG11 ' B' ' 23' ' ' VAL . 6.3 p -122.34 142.1 50.85 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -43.11 -27.2 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.006 . . . . 0.0 109.644 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' SER . 86.9 t80 -62.53 -60.86 2.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.179 -0.951 . . . . 0.0 108.879 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -55.54 -41.71 73.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.305 -0.872 . . . . 0.0 109.044 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.697 ' HB3' HG21 ' B' ' 39' ' ' VAL . 1.6 mp -56.34 -45.99 80.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.186 -0.946 . . . . 0.0 108.787 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.81 -23.86 3.07 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -71.21 -38.67 72.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.57 -0.706 . . . . 0.0 109.159 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.838 ' CD2' HD11 ' B' ' 36' ' ' LEU . 23.1 m-85 -50.91 -32.81 21.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.077 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.441 ' SG ' ' HG3' ' B' ' 43' ' ' ARG . 1.7 m -85.78 52.32 2.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.407 -0.808 . . . . 0.0 109.394 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 t30 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.656 -179.794 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.608 HG11 ' HA ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -79.77 -168.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.242 -0.911 . . . . 0.0 109.679 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 6.6 t30 87.86 -11.07 0.51 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -104.55 144.71 31.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.198 -0.939 . . . . 0.0 109.257 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -91.23 159.5 16.02 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.678 ' O ' HD12 ' B' ' 27' ' ' LEU . 0.3 OUTLIER -160.77 136.54 8.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.28 -1.512 . . . . 0.0 112.27 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.506 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -131.77 145.89 51.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.772 . . . . 0.0 109.009 178.244 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 28.34 -103.35 0.01 OUTLIER Glycine 0 N--CA 1.501 3.006 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.668 ' O ' HG22 ' B' ' 33' ' ' VAL . 16.1 t -41.21 -63.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.434 -1.039 . . . . 0.0 109.881 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.92 -33.74 18.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 108.64 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' B' ' 29' ' ' GLY . 0.3 OUTLIER -60.22 -65.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -0.861 . . . . 0.0 109.045 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.668 HG22 ' O ' ' B' ' 30' ' ' SER . 35.4 m -49.49 -31.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 108.41 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.526 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 7.9 mt-10 -72.69 -59.0 2.93 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.564 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -60.7 -41.88 96.09 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.838 HD11 ' CD2' ' A' ' 19' ' ' TYR . 2.2 mm? -59.51 -30.4 68.55 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -80.12 -13.56 59.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.715 -0.615 . . . . 0.0 110.065 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.544 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -91.04 -47.08 7.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 108.609 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.697 HG21 ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -63.49 -22.06 29.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.445 -0.785 . . . . 0.0 109.138 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' B' ' 43' ' ' ARG . 84.3 m -101.68 -41.63 6.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.26 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.54 -50.18 3.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' B' ' 43' ' ' ARG . 5.3 pt-20 -174.89 34.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -1.223 . . . . 0.0 109.797 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.51 ' HD3' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -43.03 150.03 0.18 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.559 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.93 -26.65 70.6 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.09 103.3 0.99 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.453 ' CG ' ' N ' ' B' ' 47' ' ' TYR . 0.1 OUTLIER -71.88 -156.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -1.127 . . . . 0.0 109.744 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.624 ' O ' ' HB ' ' B' ' 48' ' ' THR . 0.7 OUTLIER -42.65 -68.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -0.797 . . . . 0.0 109.626 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.624 ' HB ' ' O ' ' B' ' 47' ' ' TYR . 2.5 m 74.1 -9.2 1.3 Allowed 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.052 0.454 . . . . 0.0 110.464 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp 51.45 90.7 0.08 OUTLIER Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 121.043 -1.036 . . . . 0.0 109.438 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.86 150.14 30.08 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.691 2.261 . . . . 0.0 110.689 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.374 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 1 N--CA 1.529 4.873 0 N-CA-C 119.436 2.534 . . . . 0.0 119.436 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.488 HG22 ' CD2' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -99.64 -27.82 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -1.19 . . . . 0.0 109.145 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 1.4 m -46.69 -29.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.941 . . . . 0.0 108.765 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 1' ' ' GLY . 0.9 OUTLIER -55.18 -19.65 8.43 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.55 -75.48 0.57 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.8 . . . . 0.0 109.795 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 1.046 ' O ' HD11 ' B' ' 32' ' ' LEU . 9.4 m -97.93 96.37 8.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.44 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.706 ' HB2' HD11 ' B' ' 32' ' ' LEU . 8.0 t 161.33 -33.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -3.36 21.97 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.544 ' C ' ' CE1' ' B' ' 26' ' ' HIS . 0.6 OUTLIER -156.06 -173.78 4.66 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.614 HD13 ' ND1' ' B' ' 26' ' ' HIS . 23.3 mm -91.9 142.09 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.019 -1.051 . . . . 0.0 109.396 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.4 -168.87 1.6 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.891 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -145.75 144.8 30.55 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -43.58 -27.44 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 109.655 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -63.51 -53.16 56.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.658 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 4.1 mt-30 -58.48 -32.93 69.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 109.75 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.736 HD23 ' CD1' ' B' ' 36' ' ' LEU . 6.1 mp -67.85 -35.36 78.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.076 -1.015 . . . . 0.0 109.104 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.37 -22.12 62.93 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 25.3 m-80 -74.39 -37.51 63.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.571 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -67.84 -15.57 63.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 109.413 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 m -104.5 51.02 0.78 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.298 -0.876 . . . . 0.0 109.456 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.6 t30 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.462 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.429 ' HB3' HG22 ' B' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.609 0.718 . . . . 0.0 109.393 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.57 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -154.8 173.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 121.645 -0.659 . . . . 0.0 109.562 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 10.0 p-10 153.37 49.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.27 151.59 30.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.41 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.614 ' ND1' HD13 ' A' ' 10' ' ' ILE . 2.2 t60 -72.4 -164.35 0.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.414 -0.804 . . . . 0.0 109.673 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' B' ' 35' ' ' ALA . 0.4 OUTLIER -155.81 -171.38 3.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.687 ' N ' HD12 ' B' ' 32' ' ' LEU . 1.3 m 149.09 139.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.474 0.654 . . . . 0.0 109.792 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 34.57 -126.61 0.57 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.8 m -41.57 -53.43 3.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.405 -1.056 . . . . 0.0 109.71 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.544 ' O ' HD23 ' B' ' 27' ' ' LEU . 17.0 m-20 -44.41 -31.14 0.98 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.897 . . . . 0.0 109.17 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 1.072 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -74.49 -77.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.214 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' B' ' 37' ' ' TYR . 9.4 m -41.6 -35.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.621 -0.674 . . . . 0.0 109.336 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.561 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 2.2 mp0 -70.28 -54.02 14.43 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.832 ' HB2' HD21 ' B' ' 27' ' ' LEU . . . -53.69 -56.41 17.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.16 -0.962 . . . . 0.0 109.462 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 1.072 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.1 OUTLIER -57.08 -20.88 27.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.97 -1.081 . . . . 0.0 108.162 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 89.3 t80 -84.96 -9.96 57.54 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.711 -0.618 . . . . 0.0 109.724 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -97.23 -42.62 7.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.085 -1.009 . . . . 0.0 108.961 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.412 HG23 ' SG ' ' B' ' 40' ' ' CYS . 1.7 m -72.52 -26.01 23.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.507 -0.745 . . . . 0.0 109.662 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.412 ' SG ' HG23 ' B' ' 39' ' ' VAL . 59.3 m -103.33 -11.84 17.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.181 -0.949 . . . . 0.0 109.786 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' B' ' 42' ' ' GLU . . . 49.76 25.44 6.98 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' B' ' 41' ' ' GLY . 0.2 OUTLIER 76.72 10.76 2.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -1.136 . . . . 0.0 109.259 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.12 154.95 5.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 0.0 109.418 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.28 -127.22 7.79 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.77 -91.02 2.2 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.89 -127.52 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -1.183 . . . . 0.0 109.188 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.66 -88.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.752 -1.217 . . . . 0.0 109.378 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 94.1 m -111.82 -77.06 0.59 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.364 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 59.57 93.71 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 109.615 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.38 146.09 24.44 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.614 2.209 . . . . 0.0 110.552 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.4 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.894 0 N-CA-C 119.48 2.552 . . . . 0.0 119.48 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.9 mt -81.8 -46.03 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -1.111 . . . . 0.0 109.604 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.914 HG12 HD22 ' B' ' 32' ' ' LEU . 4.4 m -54.36 -18.82 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.78 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' HG21 ' A' ' 8' ' ' THR . 4.3 mt-10 -92.21 -7.71 47.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.646 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.45 -31.31 9.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.13 -0.982 . . . . 0.0 110.114 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 9' ' ' SER . 83.5 m -105.3 -62.26 1.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.061 -1.025 . . . . 0.0 110.374 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 48.6 t -47.26 -28.58 2.0 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.388 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 4' ' ' GLU . 3.1 t -69.88 -20.17 63.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.972 -1.08 . . . . 0.0 108.92 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.527 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 4.6 t -150.56 -151.24 0.38 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.42 128.32 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.945 -1.097 . . . . 0.0 109.498 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -111.4 164.84 12.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.849 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 13' ' ' LEU . 14.5 p -108.17 141.92 39.18 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.93 HD13 ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -46.14 -28.28 1.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.827 -1.171 . . . . 0.0 109.151 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -53.52 -47.38 69.97 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.189 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.439 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 48.5 mm-40 -65.6 -40.86 93.13 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.93 ' HB2' HD13 ' A' ' 13' ' ' LEU . 7.9 mp -63.51 -34.68 78.32 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 4.1 mt-10 -54.95 -32.5 61.46 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -66.37 -30.29 70.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.862 ' HD2' HD11 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -63.59 -41.92 98.3 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.18 -0.95 . . . . 0.0 108.695 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 m -91.11 53.7 2.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.777 . . . . 0.0 109.652 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.4 t30 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.466 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.919 HG12 ' H ' ' A' ' 13' ' ' LEU . 33.6 m -87.85 -158.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 122.059 0.933 . . . . 0.0 109.802 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.71 64.96 0.97 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.699 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.49 -177.19 5.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 109.233 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.537 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 1.2 t60 -138.02 169.06 18.44 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 1.12 HD13 ' CD1' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -161.13 -137.84 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.716 -1.24 . . . . 0.0 109.644 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.715 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.8 OUTLIER 137.13 134.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 33.54 -113.55 0.09 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.1 OUTLIER -48.27 -56.23 8.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -1.032 . . . . 0.0 109.926 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.568 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 4.1 m-20 -44.36 -33.65 1.71 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -0.932 . . . . 0.0 109.095 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 1.12 ' CD1' HD13 ' B' ' 27' ' ' LEU . 0.8 OUTLIER -65.87 -71.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 108.943 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.416 HG22 ' O ' ' B' ' 30' ' ' SER . 14.3 m -48.83 -24.47 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.518 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 5.4 mt-10 -75.34 -61.85 1.76 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.454 -0.779 . . . . 0.0 108.995 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.535 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.35 -44.0 83.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.862 HD11 ' HD2' ' A' ' 19' ' ' TYR . 2.4 mm? -57.31 -33.32 67.58 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.967 0.889 . . . . 0.0 108.725 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.444 ' CD2' HD23 ' B' ' 38' ' ' LEU . 11.8 t80 -77.3 -16.83 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.248 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.535 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -90.95 -33.55 15.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.111 -0.993 . . . . 0.0 108.904 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.747 HG21 HD11 ' A' ' 13' ' ' LEU . 1.4 m -88.93 -14.48 9.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.505 -0.747 . . . . 0.0 109.443 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 43' ' ' ARG . 93.4 m -114.68 -10.58 12.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.375 -0.828 . . . . 0.0 109.364 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' B' ' 42' ' ' GLU . . . 46.29 67.74 1.27 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 41' ' ' GLY . 2.0 pt-20 37.48 38.98 0.16 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.705 -0.88 . . . . 0.0 110.483 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 40' ' ' CYS . 2.1 ttt85 -64.86 147.55 53.05 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 108.983 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.41 158.82 12.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.77 -1.62 87.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.84 -144.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -1.2 . . . . 0.0 109.388 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -115.67 -16.4 11.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 109.282 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -159.4 -39.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.403 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -118.44 86.33 28.04 Favored Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 121.501 -0.75 . . . . 0.0 109.164 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.71 175.25 11.61 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.692 2.262 . . . . 0.0 110.696 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.444 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.816 0 N-CA-C 119.447 2.539 . . . . 0.0 119.447 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.763 HG21 ' CZ ' ' A' ' 19' ' ' TYR . 12.3 mt -89.85 -36.42 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -1.166 . . . . 0.0 109.554 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.691 HG12 HD13 ' B' ' 32' ' ' LEU . 2.4 m -39.19 -31.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.63 -0.669 . . . . 0.0 110.534 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 2' ' ' ILE . 4.8 mt-10 -68.93 -7.68 37.29 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.376 -0.828 . . . . 0.0 110.238 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.75 -35.42 7.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.065 -1.022 . . . . 0.0 110.251 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.666 ' HB3' HD11 ' B' ' 27' ' ' LEU . 96.7 m -105.36 -60.84 1.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.964 -1.085 . . . . 0.0 110.944 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.539 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 2.6 t -40.11 -60.31 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.022 -1.049 . . . . 0.0 109.946 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 7' ' ' CYS . 1.8 t -42.6 -29.31 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.169 -0.957 . . . . 0.0 109.248 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.617 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 18.3 m -142.47 -137.33 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.456 -0.777 . . . . 0.0 108.983 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.48 HG13 ' ND1' ' B' ' 26' ' ' HIS . 1.4 mt -146.85 113.61 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.589 -1.319 . . . . 0.0 109.299 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.451 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . 21.4 m -88.29 -167.26 1.82 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.42 -0.8 . . . . 0.0 110.096 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.546 ' HA ' HG21 ' B' ' 23' ' ' VAL . 39.1 p -115.02 159.28 20.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.098 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.508 HD11 HG12 ' B' ' 39' ' ' VAL . 0.4 OUTLIER -50.85 -23.58 2.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.976 -1.077 . . . . 0.0 109.232 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.473 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 44.4 t80 -65.37 -48.34 73.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 108.812 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.451 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -57.82 -39.14 76.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 108.587 179.257 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.64 ' CD2' ' HB1' ' B' ' 35' ' ' ALA . 6.2 mp -65.16 -35.69 81.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.376 -0.828 . . . . 0.0 108.8 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 1.8 mm-40 -55.96 -27.53 52.98 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.08 -17.17 60.51 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.496 -0.753 . . . . 0.0 109.318 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.763 ' CZ ' HG21 ' A' ' 2' ' ' ILE . 1.3 m-85 -72.81 -29.75 63.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 108.465 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.9 m -85.89 52.11 2.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 0.0 109.614 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.506 179.878 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' B' ' 22' ' ' PHE . 12.2 p90 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.306 0.574 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.797 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.7 OUTLIER -148.74 -159.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.428 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.797 ' N ' HG13 ' B' ' 23' ' ' VAL . 0.9 OUTLIER 77.74 57.96 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.449 0.642 . . . . 0.0 109.347 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -138.57 142.92 39.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.323 -0.861 . . . . 0.0 109.299 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.617 ' CE1' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -90.92 144.1 26.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.815 ' O ' HD12 ' B' ' 27' ' ' LEU . 0.4 OUTLIER -154.07 145.7 23.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.348 -1.47 . . . . 0.0 112.133 -178.601 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' B' ' 32' ' ' LEU . 0.8 OUTLIER -124.92 -162.79 1.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . -37.47 -63.02 0.87 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.212 -0.93 . . . . 0.0 111.679 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.402 ' O ' ' OE1' ' B' ' 34' ' ' GLU . 1.4 p -69.77 -40.29 76.17 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.9 -1.353 . . . . 0.0 111.25 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.568 ' HB2' ' CA ' ' B' ' 27' ' ' LEU . 0.3 OUTLIER -70.71 -20.95 62.61 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.475 -1.391 . . . . 0.0 108.276 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.99 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.6 OUTLIER -69.06 -70.22 0.29 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.549 HG12 ' CE2' ' B' ' 47' ' ' TYR . 33.2 m -43.66 -31.35 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.4 mt-10 -68.94 -54.61 14.49 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.64 ' HB1' ' CD2' ' A' ' 16' ' ' LEU . . . -57.42 -55.06 39.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 108.777 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.99 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -54.21 -21.94 10.22 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.041 -1.037 . . . . 0.0 108.248 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.525 ' O ' ' HA2' ' B' ' 41' ' ' GLY . 13.4 t80 -84.53 -6.43 59.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -105.76 -50.4 3.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.066 -1.021 . . . . 0.0 108.963 179.255 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.508 HG12 HD11 ' A' ' 13' ' ' LEU . 1.8 m -67.03 -25.76 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.443 -0.786 . . . . 0.0 109.78 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.48 ' O ' ' C ' ' B' ' 41' ' ' GLY . 20.1 m -122.91 -21.13 5.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.921 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' B' ' 37' ' ' TYR . . . 40.52 29.72 0.27 Allowed Glycine 0 N--CA 1.496 2.637 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.539 ' HG2' ' N ' ' B' ' 46' ' ' PHE . 16.4 tp10 49.42 91.74 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.483 -1.01 . . . . 0.0 108.34 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 51.81 0.88 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.645 -0.659 . . . . 0.0 109.707 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.94 63.73 0.01 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' GLY . . . . . 0.487 ' C ' ' HG2' ' B' ' 42' ' ' GLU . . . 109.07 -140.98 15.85 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.539 ' N ' ' HG2' ' B' ' 42' ' ' GLU . 0.5 OUTLIER -120.15 177.9 4.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -1.191 . . . . 0.0 109.117 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.639 ' O ' ' HB ' ' B' ' 48' ' ' THR . 0.1 OUTLIER -40.37 -75.86 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.345 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.639 ' HB ' ' O ' ' B' ' 47' ' ' TYR . 86.5 m 85.59 -22.73 0.18 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.418 0.628 . . . . 0.0 110.201 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.469 ' HG2' ' HD2' ' B' ' 50' ' ' PRO . 2.3 tttt 177.16 129.35 0.19 Allowed Pre-proline 0 C--N 1.292 -1.896 0 O-C-N 121.48 -0.762 . . . . 0.0 109.032 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.541 ' HA ' ' CE2' ' B' ' 47' ' ' TYR . 36.4 Cg_endo -77.05 143.29 22.7 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.276 1.984 . . . . 0.0 110.523 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.593 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.955 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 mm -104.82 -32.14 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -1.208 . . . . 0.0 109.617 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.033 HG12 ' CD2' ' B' ' 32' ' ' LEU . 0.9 OUTLIER -85.41 -41.33 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.614 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 5.9 mt-10 -70.44 -19.86 62.94 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.599 -0.688 . . . . 0.0 110.219 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -89.31 -34.79 16.44 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.125 -0.984 . . . . 0.0 109.48 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.5 m -105.83 -42.43 5.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 110.452 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.556 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 9.1 t -63.14 -18.12 63.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.934 -1.104 . . . . 0.0 110.062 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 4' ' ' GLU . 16.0 p -104.77 -38.5 6.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.077 -1.014 . . . . 0.0 108.516 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.711 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -108.7 -155.89 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 9' ' ' SER . 9.6 mm -129.75 83.34 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.979 -1.076 . . . . 0.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' HB2' HD11 ' A' ' 16' ' ' LEU . 64.1 m -59.71 171.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.291 -0.881 . . . . 0.0 109.61 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.771 ' HA ' HG21 ' B' ' 23' ' ' VAL . 94.5 p -112.99 145.14 41.37 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -43.52 -27.48 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 108.966 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 28.5 t80 -62.54 -46.13 89.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.4 -0.813 . . . . 0.0 108.903 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -66.32 -49.37 67.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 109.007 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.601 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 9.0 mp -56.19 -31.98 63.94 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.311 -0.868 . . . . 0.0 109.118 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' OE1' ' CD ' ' B' ' 43' ' ' ARG . 1.3 mm-40 -58.65 -35.2 72.17 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.87 . . . . 0.0 108.745 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -75.09 -22.76 58.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.437 -0.789 . . . . 0.0 109.291 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.686 ' HD2' HD11 ' B' ' 36' ' ' LEU . 7.3 m-30 -60.28 -14.61 19.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.128 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -91.64 53.64 2.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.927 . . . . 0.0 109.385 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 p30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.417 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.817 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.8 OUTLIER -160.36 -157.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.907 . . . . 0.0 109.697 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.817 ' N ' HG13 ' B' ' 23' ' ' VAL . 37.2 t-20 89.19 79.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.395 0.617 . . . . 0.0 109.835 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -161.0 -176.2 5.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.402 -0.811 . . . . 0.0 109.771 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.556 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -144.59 149.64 36.13 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.783 HD13 HD11 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -162.04 149.83 14.52 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.353 -1.467 . . . . 0.0 112.567 -178.376 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.505 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -135.38 158.67 43.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.518 -0.739 . . . . 0.0 109.264 177.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 25.49 -119.66 0.03 OUTLIER Glycine 0 N--CA 1.5 2.962 0 CA-C-O 121.62 0.567 . . . . 0.0 112.149 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.579 ' O ' HG22 ' B' ' 33' ' ' VAL . 54.5 m -35.77 -57.5 0.66 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.544 -0.974 . . . . 0.0 110.884 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.7 OUTLIER -45.31 -44.01 11.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.915 -1.116 . . . . 0.0 109.087 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 1.033 ' CD2' HG12 ' A' ' 3' ' ' VAL . 3.1 mp -54.14 -65.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.194 -0.941 . . . . 0.0 108.979 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.579 HG22 ' O ' ' B' ' 30' ' ' SER . 18.1 m -51.36 -25.4 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.121 -0.987 . . . . 0.0 108.746 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.508 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.3 mt-10 -79.26 -58.41 3.24 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.686 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -60.65 -38.77 85.95 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.686 HD11 ' HD2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -61.32 -33.93 74.42 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.933 0.873 . . . . 0.0 108.745 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -74.91 -31.73 61.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.783 -0.573 . . . . 0.0 109.897 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.556 HD23 ' N ' ' B' ' 38' ' ' LEU . 0.2 OUTLIER -70.49 -63.2 1.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.217 -0.927 . . . . 0.0 108.578 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.572 HG13 ' O ' ' B' ' 35' ' ' ALA . 2.5 m -45.41 -27.24 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.45 ' O ' ' C ' ' B' ' 41' ' ' GLY . 1.3 m -118.93 36.56 4.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.739 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' B' ' 40' ' ' CYS . . . -41.35 -63.96 1.46 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -122.66 -22.95 5.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.069 -1.253 . . . . 0.0 109.946 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.493 ' CD ' ' OE1' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -81.53 111.47 17.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.451 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.14 91.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.02 110.06 0.72 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.52 23.4 0.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -1.096 . . . . 0.0 109.406 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -76.46 -16.71 59.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.345 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' B' ' 49' ' ' LYS . 40.0 m -162.16 -73.9 0.05 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.701 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' B' ' 48' ' ' THR . 2.9 tptt 178.28 97.88 0.15 Allowed Pre-proline 0 C--N 1.298 -1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.5 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.49 150.29 31.78 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.539 2.159 . . . . 0.0 110.531 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.556 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.827 0 N-CA-C 119.433 2.533 . . . . 0.0 119.433 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.671 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -91.74 -26.04 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -1.168 . . . . 0.0 109.182 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.982 HG12 HD22 ' B' ' 32' ' ' LEU . 4.7 m -75.7 -9.35 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.64 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.441 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.9 mt-10 -98.25 -10.89 23.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -105.34 -34.2 7.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.562 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.761 ' HB3' HD11 ' B' ' 27' ' ' LEU . 64.1 m -93.94 -66.23 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 109.704 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 18.6 t -41.42 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 9' ' ' SER . 2.1 t -66.31 135.05 53.85 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.749 ' O ' HD13 ' A' ' 10' ' ' ILE . 1.5 m 75.65 -161.07 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 9' ' ' SER . 39.0 mm -128.5 130.67 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.61 -1.306 . . . . 0.0 110.248 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -166.54 1.62 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.476 -0.765 . . . . 0.0 109.593 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' C ' ' A' ' 13' ' ' LEU . 88.7 p -140.16 129.13 23.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' H ' HG23 ' B' ' 23' ' ' VAL . 0.4 OUTLIER -39.25 -33.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 109.781 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' SER . 27.8 t80 -57.7 -51.63 68.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.17 -0.956 . . . . 0.0 108.95 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.457 ' HG2' ' OG ' ' A' ' 12' ' ' SER . 15.4 mm100 -55.47 -44.96 76.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.873 . . . . 0.0 109.231 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.768 HD23 HD13 ' B' ' 36' ' ' LEU . 6.2 mp -57.05 -48.85 77.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -0.93 . . . . 0.0 109.247 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' OE2' ' HB ' ' B' ' 39' ' ' VAL . 0.9 OUTLIER -52.8 -23.32 6.68 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.108 -0.995 . . . . 0.0 108.399 179.322 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -75.49 -29.81 59.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.484 -0.76 . . . . 0.0 109.005 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.671 ' CE2' HD12 ' A' ' 2' ' ' ILE . 1.7 m-30 -72.63 -11.84 60.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 0.0 109.182 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 m -89.86 51.34 2.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 109.433 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.487 -179.927 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' B' ' 22' ' ' PHE . 8.0 p90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.165 0.507 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.837 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -154.99 -158.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.935 . . . . 0.0 109.99 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.837 ' N ' HG13 ' B' ' 23' ' ' VAL . 25.4 m-20 69.64 102.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -153.48 152.22 30.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.702 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 9' ' ' SER . 1.4 t60 -121.69 149.05 43.79 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.975 HD23 ' CB ' ' B' ' 35' ' ' ALA . 0.0 OUTLIER -153.88 -158.59 0.88 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.469 -1.394 . . . . 0.0 110.95 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.563 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 148.77 146.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.77 -134.01 39.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.524 ' HA ' ' CG2' ' B' ' 33' ' ' VAL . 1.3 p -55.99 -46.25 78.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -1.131 . . . . 0.0 109.669 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' B' ' 30' ' ' SER . 9.0 m-20 -45.14 -43.27 9.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 108.555 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.982 HD22 HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -60.1 -72.61 0.1 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.557 HG23 ' N ' ' B' ' 34' ' ' GLU . 14.8 m -45.12 -50.76 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.101 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.557 ' N ' HG23 ' B' ' 33' ' ' VAL . 1.5 mp0 -56.06 -44.42 78.85 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.301 -0.874 . . . . 0.0 109.075 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.975 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -55.12 -58.95 5.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.362 -0.836 . . . . 0.0 109.255 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.948 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -56.0 -24.01 36.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.046 -1.034 . . . . 0.0 108.32 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 72.6 t80 -79.94 -15.78 56.6 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' B' ' 35' ' ' ALA . 1.4 mt -83.74 -54.82 4.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 108.645 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.478 ' HB ' ' OE2' ' A' ' 17' ' ' GLU . 2.5 m -54.16 -40.93 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.485 -0.759 . . . . 0.0 109.115 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.477 ' N ' ' CG2' ' B' ' 39' ' ' VAL . 79.0 m -99.31 17.41 20.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.338 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.06 -10.02 66.88 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -75.56 -26.06 57.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -1.22 . . . . 0.0 109.36 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.25 -172.65 2.31 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.446 -0.783 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.15 130.25 28.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.41 131.59 47.42 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' B' ' 47' ' ' TYR . 0.8 OUTLIER -161.4 -74.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -1.11 . . . . 0.0 109.329 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.465 ' C ' ' O ' ' B' ' 46' ' ' PHE . 53.2 t80 37.0 61.91 0.85 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.577 -0.702 . . . . 0.0 110.267 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' B' ' 46' ' ' PHE . 3.4 m -160.87 -54.62 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.478 ' N ' ' HD3' ' B' ' 50' ' ' PRO . 1.3 mttm -145.94 64.19 9.89 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.557 -0.714 . . . . 0.0 109.451 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' B' ' 49' ' ' LYS . 34.3 Cg_endo -76.95 -171.51 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.768 2.312 . . . . 0.0 110.683 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.456 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.784 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.7 mt -101.61 -17.42 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -1.095 . . . . 0.0 108.997 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 3.5 m -62.12 -11.4 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.491 -0.756 . . . . 0.0 110.502 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -101.94 -4.92 25.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.027 -1.045 . . . . 0.0 110.425 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.448 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 5.3 mm100 -105.33 -42.26 5.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.009 -1.057 . . . . 0.0 110.266 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' THR . 29.0 m -105.66 -57.9 1.98 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.184 -0.948 . . . . 0.0 110.901 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.581 ' HA ' ' CD2' ' B' ' 26' ' ' HIS . 0.9 OUTLIER -37.15 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.218 -0.926 . . . . 0.0 111.411 -178.147 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.3 t -68.83 -20.14 64.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.662 -1.274 . . . . 0.0 109.328 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.581 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 11.7 t -158.15 -170.69 3.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.709 ' HA ' ' ND1' ' B' ' 26' ' ' HIS . 0.8 OUTLIER -103.26 94.77 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.702 -1.249 . . . . 0.0 110.546 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 67.9 m -55.54 168.75 0.37 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 p -88.2 143.7 26.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.898 -1.126 . . . . 0.0 109.409 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 13' ' ' LEU . 3.0 tt -49.79 -24.09 2.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.978 . . . . 0.0 109.683 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -70.74 -38.79 73.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.182 -0.948 . . . . 0.0 109.072 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -66.6 -48.46 69.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.618 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.893 HD23 HD13 ' B' ' 36' ' ' LEU . 6.5 mp -55.71 -34.12 64.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.098 . . . . 0.0 108.567 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -63.13 -18.79 63.82 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -76.21 -28.87 57.38 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.485 -0.759 . . . . 0.0 109.059 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.9 m-30 -69.81 -5.49 25.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.483 ' HA ' ' HA3' ' B' ' 45' ' ' GLY . 8.3 m -83.89 51.32 2.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -0.965 . . . . 0.0 109.603 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.91 -1.043 . . . . 0.0 109.484 179.874 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.553 0.692 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.798 HG22 ' H ' ' B' ' 24' ' ' ASN . 2.3 p -160.7 -158.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.629 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.798 ' H ' HG22 ' B' ' 23' ' ' VAL . 34.2 m120 109.32 32.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.979 0.895 . . . . 0.0 108.622 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.477 ' O ' HD13 ' A' ' 10' ' ' ILE . 6.2 tp-100 -160.65 160.97 32.24 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.778 ' CE1' HD22 ' B' ' 27' ' ' LEU . 5.3 t60 -126.63 161.92 26.95 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 116.889 -1.924 . . . . 0.0 114.503 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.831 HD23 ' C ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -97.39 -155.73 0.5 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 113.582 -1.644 . . . . 0.0 110.734 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.587 ' N ' ' HG ' ' B' ' 27' ' ' LEU . 2.2 m 141.05 143.96 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.35 -132.71 49.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 2.9 m -52.5 -46.37 66.59 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.91 -1.347 . . . . 0.0 108.039 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.536 ' HB3' ' HA ' ' B' ' 27' ' ' LEU . 23.3 m-20 -49.39 -31.1 8.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.406 -0.808 . . . . 0.0 109.201 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.978 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.4 OUTLIER -67.8 -68.04 0.42 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.249 -0.907 . . . . 0.0 108.875 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.565 ' HB ' ' CZ ' ' B' ' 47' ' ' TYR . 18.9 m -54.57 -36.64 36.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.365 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.541 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -64.28 -52.19 59.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.521 -0.737 . . . . 0.0 109.405 179.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -47.66 -61.28 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.052 . . . . 0.0 109.251 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.978 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -55.39 -21.69 16.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.897 -1.127 . . . . 0.0 108.346 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 84.5 t80 -84.97 -11.26 55.9 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.656 -0.653 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -95.45 -54.29 3.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.147 -0.971 . . . . 0.0 108.582 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.437 ' H ' HG13 ' B' ' 39' ' ' VAL . 2.3 m -59.57 -26.7 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' B' ' 43' ' ' ARG . 3.9 m -124.59 34.85 4.92 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.464 -0.773 . . . . 0.0 109.35 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.3 72.61 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -97.61 -20.52 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -1.214 . . . . 0.0 109.575 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -122.04 117.88 27.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -0.822 . . . . 0.0 109.495 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.39 173.62 19.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 20' ' ' CYS . . . -165.5 -124.55 0.71 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -82.62 -57.98 3.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 109.453 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' TYR . . . . . 0.63 ' O ' ' HB ' ' B' ' 48' ' ' THR . 10.2 t80 -43.99 -83.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 109.419 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' B' ' 47' ' ' TYR . 11.6 m 78.35 -14.66 0.83 Allowed 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 121.123 0.487 . . . . 0.0 110.61 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.556 ' HA ' ' CZ ' ' B' ' 47' ' ' TYR . 15.1 tttp 57.47 96.48 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.608 0 O-C-N 121.052 -1.03 . . . . 0.0 109.293 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.54 172.62 15.96 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.475 2.116 . . . . 0.0 110.429 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.534 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.818 0 N-CA-C 119.239 2.456 . . . . 0.0 119.239 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.607 HG23 ' CE2' ' A' ' 19' ' ' TYR . 0.5 OUTLIER -76.16 -31.57 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -1.135 . . . . 0.0 109.143 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.603 HG23 ' HG2' ' A' ' 4' ' ' GLU . 4.4 m -66.38 -33.09 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.603 ' HG2' HG23 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -78.63 5.45 11.0 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 109.896 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -104.73 -43.4 5.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.115 -0.991 . . . . 0.0 109.207 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 9' ' ' SER . 89.3 m -105.63 -23.61 12.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 109.966 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.588 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 8.3 t -76.4 -28.37 56.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.902 -1.124 . . . . 0.0 109.262 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 6.9 t -87.01 -32.49 20.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 1.1 t -134.74 147.56 50.06 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' B' ' 25' ' ' GLN . 1.1 mp -79.27 123.1 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.93 -1.106 . . . . 0.0 109.501 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.9 m -90.6 -167.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -0.797 . . . . 0.0 109.704 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.509 ' HA ' HG13 ' B' ' 23' ' ' VAL . 52.5 p -122.68 150.24 42.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.475 -0.766 . . . . 0.0 109.148 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.847 HD12 ' CD2' ' B' ' 22' ' ' PHE . 2.4 tt -44.12 -28.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.895 . . . . 0.0 109.238 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.413 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 10.6 m-85 -64.14 -55.18 23.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.861 . . . . 0.0 109.118 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -41.78 77.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.959 . . . . 0.0 109.071 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.702 HD23 HD22 ' B' ' 36' ' ' LEU . 6.8 mp -61.82 -36.47 81.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.154 -0.966 . . . . 0.0 108.978 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 8.3 mt-10 -56.58 -30.45 63.2 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.249 -0.907 . . . . 0.0 108.641 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.5 -31.13 69.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.607 ' CE2' HG23 ' A' ' 2' ' ' ILE . 2.6 m-85 -54.65 -41.75 70.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 108.668 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.3 50.92 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.47 -0.769 . . . . 0.0 109.387 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.497 ' O ' ' HG3' ' B' ' 50' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.626 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.847 ' CD2' HD12 ' A' ' 13' ' ' LEU . 41.3 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -151.18 -172.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.935 -1.103 . . . . 0.0 109.374 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER 40.07 49.29 2.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 110.049 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLN . . . . . 0.521 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 1.4 mt-30 -160.05 155.75 25.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.8 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' HIS . . . . . 0.547 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -121.34 171.97 8.37 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.926 HD13 HD12 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -160.89 -142.53 0.08 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.351 -1.468 . . . . 0.0 110.863 -179.071 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 28' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 148.4 131.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 123.824 0.85 . . . . 0.0 108.996 -178.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' B' ' 32' ' ' LEU . . . 37.06 -116.9 0.4 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.447 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.3 OUTLIER -43.2 -61.4 1.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.439 -1.036 . . . . 0.0 109.401 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.497 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 7.2 m-20 -45.37 -27.39 0.68 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -0.938 . . . . 0.0 108.984 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.926 HD12 HD13 ' B' ' 27' ' ' LEU . 0.2 OUTLIER -80.34 -72.24 0.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.848 . . . . 0.0 109.328 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' B' ' 30' ' ' SER . 16.8 m -44.66 -29.35 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 108.87 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.533 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.0 OUTLIER -69.79 -60.33 2.38 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.562 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -60.61 -43.37 97.53 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.702 HD22 HD23 ' A' ' 16' ' ' LEU . 3.7 mm? -59.08 -29.27 67.21 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.468 -0.77 . . . . 0.0 109.162 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 37' ' ' TYR . 13.8 t80 -78.76 -10.64 59.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.593 -0.692 . . . . 0.0 109.597 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.562 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -95.24 -36.87 11.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.0 109.253 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 16' ' ' LEU . 3.4 m -72.46 -28.49 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.277 -0.889 . . . . 0.0 109.438 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' CYS . . . . . 0.565 ' HB3' ' CB ' ' B' ' 43' ' ' ARG . 72.5 m -79.84 -37.24 35.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.106 -0.996 . . . . 0.0 109.259 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' GLY . . . . . 0.495 ' C ' ' CG ' ' B' ' 42' ' ' GLU . . . 77.52 98.23 0.2 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.495 ' CG ' ' C ' ' B' ' 41' ' ' GLY . 2.5 pt-20 37.99 37.75 0.16 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.61 -0.935 . . . . 0.0 110.407 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.565 ' CB ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -93.86 -170.97 2.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.085 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 43' ' ' ARG . . . -43.58 112.37 0.55 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.26 -6.3 88.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.41 -168.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.65 43.06 1.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.407 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 99.0 m -148.45 -37.45 0.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 109.777 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER -167.21 116.65 0.7 Allowed Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 109.572 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.497 ' HG3' ' O ' ' A' ' 21' ' ' ASN . 34.5 Cg_endo -77.5 -170.09 0.87 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.227 1.952 . . . . 0.0 110.261 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.2 p . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.471 -179.901 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.465 ' N ' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 1 N--CA 1.53 4.923 0 N-CA-C 119.457 2.543 . . . . 0.0 119.457 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.685 HG23 ' CE2' ' A' ' 19' ' ' TYR . 12.6 mt -93.29 -34.01 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.129 -1.218 . . . . 0.0 109.577 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 4.3 m -65.94 -28.01 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.375 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 1' ' ' GLY . 4.9 mt-10 -80.58 2.18 26.63 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.487 -0.758 . . . . 0.0 109.666 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.25 -45.69 4.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.985 ' HB3' HD11 ' B' ' 27' ' ' LEU . 56.0 m -97.99 -33.11 11.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.912 . . . . 0.0 109.815 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -73.07 -12.97 61.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.947 . . . . 0.0 109.808 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.3 t -100.38 -34.3 10.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.079 -1.013 . . . . 0.0 108.922 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -136.97 159.23 42.49 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.638 HG23 ' O ' ' B' ' 25' ' ' GLN . 23.7 mm -79.41 96.62 2.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 109.513 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.724 ' O ' HG23 ' B' ' 23' ' ' VAL . 9.1 p -76.97 159.58 29.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -0.818 . . . . 0.0 109.794 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.476 ' HA ' HG23 ' B' ' 23' ' ' VAL . 59.1 p -89.03 144.69 25.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 109.338 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.966 HD11 HG12 ' B' ' 39' ' ' VAL . 1.4 tp -46.82 -24.89 0.65 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.283 -0.886 . . . . 0.0 109.108 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 6.5 t80 -71.72 -32.62 67.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -0.927 . . . . 0.0 109.135 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 12' ' ' SER . 5.4 mm100 -66.53 -35.79 81.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.188 -0.945 . . . . 0.0 108.456 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.682 HD22 ' N ' ' A' ' 16' ' ' LEU . 3.2 mm? -66.19 -35.17 79.75 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -48.46 -36.21 14.53 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -74.7 -21.51 59.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.428 -0.795 . . . . 0.0 109.329 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.925 ' HD2' HD11 ' B' ' 36' ' ' LEU . 3.2 m-30 -60.04 -19.37 52.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.341 -0.85 . . . . 0.0 109.27 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.3 m -97.44 52.05 1.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.387 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.486 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' B' ' 22' ' ' PHE . 38.5 p90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.226 0.536 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.829 HG22 ' H ' ' B' ' 24' ' ' ASN . 4.7 p -114.08 -170.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 108.981 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.829 ' H ' HG22 ' B' ' 23' ' ' VAL . 33.3 m-20 82.84 36.28 0.05 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.697 -0.627 . . . . 0.0 109.495 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.638 ' O ' HG23 ' A' ' 10' ' ' ILE . 2.5 mt-30 -140.95 175.7 9.41 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -133.54 176.34 8.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.868 -1.145 . . . . 0.0 109.066 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.985 HD11 ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -160.28 -164.93 1.35 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.763 -1.21 . . . . 0.0 111.072 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 146.16 153.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.45 -119.06 4.54 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.462 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -64.47 -52.47 57.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.3 -1.118 . . . . 0.0 110.115 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' B' ' 30' ' ' SER . 17.1 m-20 -43.55 -38.83 3.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.077 -1.015 . . . . 0.0 109.63 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.494 HD12 HD13 ' B' ' 27' ' ' LEU . 0.2 OUTLIER -67.73 -71.06 0.22 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.096 -1.003 . . . . 0.0 108.956 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.539 HG12 ' OH ' ' B' ' 47' ' ' TYR . 32.2 m -47.9 -27.56 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.098 -1.001 . . . . 0.0 108.602 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 9.4 mt-10 -74.65 -59.57 2.67 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.505 -0.747 . . . . 0.0 109.087 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.572 ' O ' HG13 ' B' ' 39' ' ' VAL . . . -58.92 -41.96 88.54 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.925 HD11 ' HD2' ' A' ' 19' ' ' TYR . 1.1 mm? -60.27 -29.03 68.54 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.674 0.75 . . . . 0.0 109.027 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 39.8 t80 -83.09 -13.51 55.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.68 -0.638 . . . . 0.0 110.247 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -90.02 -44.22 10.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.063 -1.023 . . . . 0.0 108.803 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.966 HG12 HD11 ' A' ' 13' ' ' LEU . 1.9 m -66.27 -37.69 80.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.558 -0.714 . . . . 0.0 109.314 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.421 ' N ' ' CG2' ' B' ' 39' ' ' VAL . 1.3 m -105.5 17.51 23.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.796 . . . . 0.0 109.439 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -56.96 -85.96 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.486 ' HG2' ' N ' ' B' ' 43' ' ' ARG . 28.2 tt0 -55.11 -88.47 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -1.152 . . . . 0.0 109.357 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.486 ' N ' ' HG2' ' B' ' 42' ' ' GLU . 0.4 OUTLIER -46.83 174.33 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.543 -0.723 . . . . 0.0 109.379 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.31 -92.64 1.73 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 30.97 6.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.63 -155.0 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -1.143 . . . . 0.0 109.648 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . 0.539 ' OH ' HG12 ' B' ' 33' ' ' VAL . 9.8 t80 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 0.0 109.526 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.799 0 N-CA-C 119.273 2.469 . . . . 0.0 119.273 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.655 HG22 ' CD2' ' B' ' 32' ' ' LEU . 18.2 mm -78.69 -62.18 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -1.108 . . . . 0.0 109.208 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.792 HG12 HD22 ' B' ' 32' ' ' LEU . 2.4 m -72.3 -13.79 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.17 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -89.11 -8.32 54.05 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.637 ' O ' HG22 ' A' ' 8' ' ' THR . 0.5 OUTLIER -97.52 -51.57 4.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 109.277 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.628 ' SG ' HD11 ' A' ' 16' ' ' LEU . 17.3 m -85.94 -69.84 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.887 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 2.4 t -41.56 -25.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.033 . . . . 0.0 110.724 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 5' ' ' GLN . 3.7 t -72.42 -27.08 62.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.86 -1.15 . . . . 0.0 109.238 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 6' ' ' CYS . 18.0 m -156.61 -157.66 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 mm -107.07 116.02 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.462 -1.399 . . . . 0.0 109.231 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.463 ' O ' HG21 ' B' ' 23' ' ' VAL . 2.5 p -99.05 172.84 7.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 109.649 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.2 p -106.87 150.78 26.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.806 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -46.52 -28.24 1.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.686 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 14.9 t80 -61.82 -45.46 93.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 108.808 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.58 -54.13 47.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.368 -0.833 . . . . 0.0 109.418 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 16' ' ' LEU . 1.6 mm? -51.33 -38.64 54.18 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.17 -0.956 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -49.36 -34.06 15.07 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.13 -21.81 58.6 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.884 ' CD2' HD11 ' B' ' 36' ' ' LEU . 3.3 m-85 -68.02 -16.93 64.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 0.0 109.435 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.3 m -82.21 51.26 1.75 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 0.0 109.564 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.48 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.252 0.548 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.832 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.8 OUTLIER -126.15 -155.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.0 109.631 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.832 ' N ' HG13 ' B' ' 23' ' ' VAL . 2.5 t-20 86.68 4.72 0.39 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.287 0.565 . . . . 0.0 109.568 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -121.37 153.77 37.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.822 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -77.86 164.87 24.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.716 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -161.76 132.93 5.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.339 -1.475 . . . . 0.0 112.807 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.453 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -138.38 155.9 48.1 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 37.17 -115.2 0.29 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.446 ' O ' HG22 ' B' ' 33' ' ' VAL . 4.1 m -47.75 -65.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.455 -1.027 . . . . 0.0 110.842 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' B' ' 30' ' ' SER . 5.6 m-20 -42.48 -39.11 2.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 109.418 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.792 HD22 HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -65.99 -73.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 108.945 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.752 HG12 ' CD2' ' B' ' 47' ' ' TYR . 15.9 m -43.86 -28.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.146 -0.971 . . . . 0.0 108.69 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.519 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -78.18 -61.63 1.94 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.541 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -56.67 -39.42 73.73 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.884 HD11 ' CD2' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -64.14 -34.13 77.35 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.942 0.877 . . . . 0.0 108.806 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.418 ' O ' ' HA2' ' B' ' 41' ' ' GLY . 20.4 t80 -75.97 -22.33 56.0 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.742 -0.599 . . . . 0.0 110.077 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.537 ' N ' HD23 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -76.5 -53.41 8.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.944 -1.097 . . . . 0.0 108.484 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 16' ' ' LEU . 2.6 m -54.1 -32.24 22.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.534 ' HB3' ' CD ' ' B' ' 43' ' ' ARG . 1.3 m -122.83 39.59 3.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.506 -0.746 . . . . 0.0 109.713 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' B' ' 37' ' ' TYR . . . -53.45 -32.3 45.13 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.73 7.65 9.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -1.181 . . . . 0.0 109.94 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.534 ' CD ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -116.05 139.75 49.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 108.947 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.08 153.73 17.29 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.34 -151.95 6.18 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.22 31.81 0.24 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.233 -1.157 . . . . 0.0 109.636 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . 0.752 ' CD2' HG12 ' B' ' 33' ' ' VAL . 1.2 t80 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.447 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.751 HG22 HD21 ' B' ' 32' ' ' LEU . 62.2 mt -92.55 -28.94 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.941 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 1.4 m -62.22 -37.41 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.369 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 3.0 mt-10 -76.06 -1.17 24.63 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.362 -0.836 . . . . 0.0 109.644 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -43.4 4.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.108 -0.995 . . . . 0.0 110.045 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 9' ' ' SER . 95.6 m -103.72 -29.35 11.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.103 -0.998 . . . . 0.0 110.093 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 2.5 t -69.26 -6.98 32.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.042 -1.036 . . . . 0.0 109.349 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -99.6 -31.3 11.66 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.943 . . . . 0.0 108.526 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 6' ' ' CYS . 4.2 m -147.45 165.24 30.84 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.486 ' N ' HD13 ' A' ' 10' ' ' ILE . 3.9 mm -80.15 110.42 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.104 -0.997 . . . . 0.0 109.548 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 78.4 m -74.8 -170.71 1.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.662 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 13' ' ' LEU . 87.5 p -121.13 136.04 55.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -42.81 -26.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.168 -0.957 . . . . 0.0 109.776 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -62.79 -49.34 75.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.125 -0.984 . . . . 0.0 108.888 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -65.07 -44.94 87.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 0.0 108.865 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.616 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 3.3 mp -55.65 -37.16 67.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.107 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 7.0 mm-40 -54.03 -34.5 60.17 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.286 -0.884 . . . . 0.0 108.749 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -21.98 61.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.414 -0.804 . . . . 0.0 109.485 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.779 ' HD2' HD11 ' B' ' 36' ' ' LEU . 5.0 m-30 -62.44 -29.41 70.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.7 m -82.57 53.79 2.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.891 . . . . 0.0 109.276 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.4 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.538 ' O ' ' CD2' ' B' ' 22' ' ' PHE . 52.4 p90 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.592 ' O ' ' HB3' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -143.53 171.15 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.041 -1.037 . . . . 0.0 110.008 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.592 ' HB3' ' O ' ' B' ' 23' ' ' VAL . 2.2 p-10 167.5 -29.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.56 -171.04 3.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.536 -0.728 . . . . 0.0 109.932 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -118.79 -169.82 1.79 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -0.846 . . . . 0.0 109.022 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' B' ' 28' ' ' CYS . 0.3 OUTLIER -160.77 -159.27 0.66 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.751 -1.218 . . . . 0.0 110.415 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.616 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 145.9 141.9 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 123.558 0.743 . . . . 0.0 109.17 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 35.64 -118.19 0.35 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.1 OUTLIER -42.61 -62.83 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.427 -1.043 . . . . 0.0 110.177 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -43.99 -31.63 0.95 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.048 -1.033 . . . . 0.0 109.166 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.751 HD21 HG22 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -68.69 -66.9 0.51 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.221 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.452 HG23 ' OE2' ' B' ' 34' ' ' GLU . 30.6 m -51.52 -28.64 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.995 -1.066 . . . . 0.0 108.489 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.503 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.1 mp0 -76.0 -58.77 3.08 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.545 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.55 -47.31 82.38 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.779 HD11 ' HD2' ' A' ' 19' ' ' TYR . 1.1 mm? -56.49 -29.01 61.29 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.781 0.8 . . . . 0.0 108.959 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' B' ' 33' ' ' VAL . 70.7 t80 -82.41 -15.09 53.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.828 -0.545 . . . . 0.0 109.988 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.4 OUTLIER -87.32 -46.64 9.5 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 16' ' ' LEU . 2.7 m -65.95 -21.37 28.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' B' ' 43' ' ' ARG . 1.3 m -119.9 27.09 8.89 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.451 -0.781 . . . . 0.0 109.235 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' B' ' 40' ' ' CYS . . . -43.45 -26.9 0.71 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' B' ' 40' ' ' CYS . 25.9 tt0 -90.92 -23.05 20.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -1.175 . . . . 0.0 109.644 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' B' ' 40' ' ' CYS . 2.0 ttt180 -110.25 159.37 17.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.406 -0.809 . . . . 0.0 109.222 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -178.45 142.57 5.53 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' B' ' 47' ' ' TYR . . . 115.94 -67.59 0.29 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 60.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 0.0 109.529 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' B' ' 45' ' ' GLY . 72.1 t80 . . . . . 0 C--N 1.297 -1.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.346 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.872 0 N-CA-C 119.369 2.508 . . . . 0.0 119.369 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.566 HG21 ' CE2' ' A' ' 19' ' ' TYR . 22.3 mt -89.06 -31.73 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -1.139 . . . . 0.0 109.399 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.621 HG12 HD22 ' B' ' 32' ' ' LEU . 1.6 m -47.09 -40.14 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.22 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 6.4 mt-10 -56.47 -16.32 5.67 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.641 -0.662 . . . . 0.0 110.103 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -105.34 -31.08 9.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 110.303 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.617 ' HB3' HD11 ' B' ' 27' ' ' LEU . 7.3 m -103.01 -31.2 10.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.039 . . . . 0.0 110.127 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.524 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 1.5 m -84.84 -13.82 49.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.32 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.8 -13.29 15.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.037 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.5 m -150.65 158.36 44.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.354 -0.841 . . . . 0.0 109.07 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.414 HD12 HG23 ' A' ' 10' ' ' ILE . 20.4 mm -80.86 97.99 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 0.0 109.622 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 16' ' ' LEU . 3.7 p -82.06 171.46 14.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 109.373 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.678 ' HA ' HG21 ' B' ' 23' ' ' VAL . 59.3 p -111.03 148.49 32.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.239 -0.913 . . . . 0.0 109.828 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.637 ' CD1' HG12 ' B' ' 39' ' ' VAL . 0.6 OUTLIER -45.45 -28.94 0.98 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.058 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -59.08 -53.41 58.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.368 -0.832 . . . . 0.0 109.024 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 27.5 mm-40 -61.43 -29.11 69.73 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.286 -0.884 . . . . 0.0 109.048 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.883 HD23 HD13 ' B' ' 36' ' ' LEU . 6.9 mp -71.22 -38.92 72.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.258 -0.901 . . . . 0.0 108.7 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.45 -32.75 63.02 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -73.38 -26.87 61.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.433 -0.792 . . . . 0.0 109.277 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' A' ' 2' ' ' ILE . 6.2 m-30 -58.79 -19.79 44.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 108.814 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.67 51.75 1.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -0.768 . . . . 0.0 109.247 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.333 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.397 0.618 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.819 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -157.4 -158.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.368 -0.832 . . . . 0.0 109.865 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.819 ' N ' HG13 ' B' ' 23' ' ' VAL . 30.3 m-20 74.07 30.23 1.27 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -127.86 154.23 45.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.386 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.524 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -100.76 -178.35 3.75 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.782 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -161.0 -159.6 0.68 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.787 -1.195 . . . . 0.0 110.225 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.577 ' CB ' ' O ' ' B' ' 27' ' ' LEU . 1.2 m 149.35 150.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.49 -127.86 27.09 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.439 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.9 OUTLIER -58.34 -51.08 71.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.286 -1.126 . . . . 0.0 109.83 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 30' ' ' SER . 3.2 m-20 -43.35 -42.87 4.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 109.26 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.853 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -63.09 -76.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.918 . . . . 0.0 109.502 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.803 HG12 ' CE1' ' B' ' 47' ' ' TYR . 14.4 m -44.45 -33.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.029 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.528 ' O ' ' HG ' ' B' ' 38' ' ' LEU . 2.5 mm-40 -62.97 -52.71 61.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.477 -0.764 . . . . 0.0 109.151 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -55.9 -52.96 62.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.535 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.883 HD13 HD23 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -57.37 -29.96 64.46 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.892 -1.13 . . . . 0.0 107.955 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 86.3 t80 -73.27 -11.95 60.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.567 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -97.06 -51.2 4.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.979 . . . . 0.0 108.74 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.815 HG11 ' HB3' ' A' ' 16' ' ' LEU . 2.3 m -48.33 -36.66 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.509 ' CB ' ' HB3' ' B' ' 43' ' ' ARG . 0.9 OUTLIER -93.71 -53.37 4.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.389 -0.819 . . . . 0.0 109.157 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.72 -50.42 3.58 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -116.86 22.36 12.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.186 . . . . 0.0 110.058 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.509 ' HB3' ' CB ' ' B' ' 40' ' ' CYS . 0.2 OUTLIER -56.31 -176.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.0 . . . . 0.0 109.15 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.68 155.35 49.69 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.12 56.5 4.35 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -147.05 140.2 25.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.527 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . 0.803 ' CE1' HG12 ' B' ' 33' ' ' VAL . 32.4 t80 . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.432 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.883 0 N-CA-C 119.388 2.515 . . . . 0.0 119.388 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.7 mt -74.49 -25.98 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.567 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.732 HG12 HD22 ' B' ' 32' ' ' LEU . 1.3 m -71.3 -30.58 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.67 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.13 -10.73 53.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.619 -0.675 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -31.3 9.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.868 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.551 ' HB3' HD11 ' B' ' 27' ' ' LEU . 95.5 m -105.01 -34.53 7.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.982 -1.074 . . . . 0.0 110.076 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.538 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 1.8 t -63.44 -10.99 19.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.015 -1.053 . . . . 0.0 109.65 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 9' ' ' SER . 14.6 t -104.99 -37.9 6.8 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.469 ' N ' HG23 ' A' ' 8' ' ' THR . 7.9 m -127.2 147.8 50.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.702 ' CG2' HG22 ' B' ' 23' ' ' VAL . 0.9 OUTLIER -78.87 91.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.993 -1.067 . . . . 0.0 109.212 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.625 ' O ' HG23 ' B' ' 23' ' ' VAL . 59.7 m -54.74 172.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.434 -0.791 . . . . 0.0 109.498 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 13' ' ' LEU . 85.6 p -106.81 155.34 19.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 109.531 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.75 HD11 HG12 ' B' ' 39' ' ' VAL . 0.8 OUTLIER -45.51 -26.81 0.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.244 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -67.27 -44.35 79.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 10.0 mt-30 -65.47 -43.35 90.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.923 HD23 HD13 ' B' ' 36' ' ' LEU . 6.8 mp -61.72 -34.03 75.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.014 -1.054 . . . . 0.0 109.081 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.87 -23.61 61.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.3 m-80 -75.62 -24.37 56.49 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.53 -0.731 . . . . 0.0 109.615 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.632 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.6 m-30 -77.83 3.75 13.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.016 -1.052 . . . . 0.0 109.478 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 13.6 m -123.27 69.1 1.01 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 109.794 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 18' ' ' ASN . 17.4 p30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.421 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.498 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.71 HG13 ' N ' ' B' ' 24' ' ' ASN . 1.3 p -95.44 -159.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.213 -0.929 . . . . 0.0 108.603 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.71 ' N ' HG13 ' B' ' 23' ' ' VAL . 6.5 t-20 78.08 30.44 0.44 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.489 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -155.54 162.62 40.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.436 -0.79 . . . . 0.0 109.127 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.538 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -110.74 179.93 3.93 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.686 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -160.24 -168.35 2.16 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.343 -1.473 . . . . 0.0 111.968 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' B' ' 32' ' ' LEU . 0.5 OUTLIER 151.38 147.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.66 -115.58 2.66 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 68.0 m -63.74 -57.58 9.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -1.132 . . . . 0.0 110.047 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' B' ' 30' ' ' SER . 6.6 m-20 -43.83 -36.23 2.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.205 -0.935 . . . . 0.0 109.437 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.88 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -67.85 -76.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.215 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' B' ' 32' ' ' LEU . 3.5 m -44.51 -29.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 108.673 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.53 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 7.1 mt-10 -66.07 -55.58 15.86 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.505 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -55.17 -55.21 33.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.347 -0.846 . . . . 0.0 108.787 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.923 HD13 HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -58.3 -18.44 27.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 108.637 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 23.3 t80 -86.12 -14.49 44.03 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -89.47 -42.11 11.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 108.805 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.75 HG12 HD11 ' A' ' 13' ' ' LEU . 2.3 m -75.62 -20.81 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.485 -0.759 . . . . 0.0 109.261 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' B' ' 39' ' ' VAL . 55.6 m -111.2 6.04 20.4 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.324 -0.86 . . . . 0.0 109.757 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.34 -12.29 83.67 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -82.24 -72.11 0.45 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -1.12 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -175.01 1.84 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.464 -0.772 . . . . 0.0 109.617 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.01 -94.08 1.69 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.94 -119.63 5.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.94 27.42 0.79 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -1.132 . . . . 0.0 109.383 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.63 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.914 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 2' ' ' ILE . 6.7 tt -102.99 -13.14 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.232 -1.158 . . . . 0.0 109.659 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.836 HG12 HD22 ' B' ' 32' ' ' LEU . 10.9 m -99.65 -30.46 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 109.17 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.489 ' O ' ' CG2' ' A' ' 8' ' ' THR . 10.1 mt-10 -82.68 -4.95 58.55 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.308 -0.87 . . . . 0.0 109.958 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.55 -34.93 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -0.991 . . . . 0.0 110.01 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.519 ' CB ' HD11 ' B' ' 27' ' ' LEU . 82.0 m -105.42 -30.31 9.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 110.412 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.558 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 4.5 t -71.57 -6.76 43.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.147 -0.97 . . . . 0.0 109.821 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -119.86 -14.33 8.98 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.234 -0.916 . . . . 0.0 108.815 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.68 ' O ' HD13 ' A' ' 10' ' ' ILE . 68.0 m -136.88 -165.68 1.78 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 9' ' ' SER . 4.6 mm -120.99 92.35 2.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 109.548 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.788 ' O ' HG23 ' B' ' 23' ' ' VAL . 28.0 m -71.66 171.68 11.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.482 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 13' ' ' LEU . 25.4 p -116.12 153.42 31.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.875 . . . . 0.0 108.861 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.707 ' CD1' HG12 ' B' ' 39' ' ' VAL . 0.8 OUTLIER -44.44 -29.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.101 -0.999 . . . . 0.0 109.083 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.32 -50.42 73.68 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.254 -0.904 . . . . 0.0 108.694 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.436 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 3.6 mm-40 -65.45 -35.58 81.34 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.835 ' CD2' HG11 ' B' ' 39' ' ' VAL . 3.4 mp -65.69 -33.91 76.98 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -25.25 63.98 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.88 -34.5 62.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.427 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.72 ' HD2' HD11 ' B' ' 36' ' ' LEU . 1.4 m-30 -59.4 -20.08 52.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 108.78 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.18 54.31 2.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.362 -0.836 . . . . 0.0 109.469 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.479 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.513 ' HA ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 11' ' ' CYS . 1.4 p -82.56 -166.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.422 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.742 ' H ' HG22 ' B' ' 23' ' ' VAL . 8.2 t30 46.47 38.66 5.65 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.559 -0.713 . . . . 0.0 109.308 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.17 169.11 24.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.881 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.538 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 1.1 t60 -125.98 172.01 10.29 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 1.136 HD13 ' CD1' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -161.29 -166.84 1.62 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.327 -1.483 . . . . 0.0 111.639 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 150.78 153.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 123.419 0.688 . . . . 0.0 109.265 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.79 -117.54 2.2 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.446 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.4 OUTLIER -60.84 -57.59 12.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -1.072 . . . . 0.0 110.28 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' B' ' 30' ' ' SER . 13.5 m-20 -42.28 -31.5 0.4 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.236 -0.915 . . . . 0.0 109.68 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 1.136 ' CD1' HD13 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -70.46 -68.46 0.42 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.156 -0.965 . . . . 0.0 108.87 179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.422 HG23 ' N ' ' B' ' 34' ' ' GLU . 33.5 m -51.74 -35.26 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.125 -0.985 . . . . 0.0 108.733 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.536 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 4.7 mt-10 -69.68 -52.94 21.17 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.376 -0.828 . . . . 0.0 108.982 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.539 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -62.99 -42.97 99.99 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.72 HD11 ' HD2' ' A' ' 19' ' ' TYR . 1.6 mm? -60.32 -30.5 69.55 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.894 0.854 . . . . 0.0 108.698 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.414 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 13.3 t80 -77.37 -14.1 59.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.671 -0.643 . . . . 0.0 109.882 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.5 OUTLIER -88.27 -53.7 4.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 108.609 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.835 HG11 ' CD2' ' A' ' 16' ' ' LEU . 2.2 m -54.57 -27.11 17.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . . . . . . . . . 55.7 m -119.61 35.45 4.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.467 -0.771 . . . . 0.0 109.558 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.16 51.2 3.53 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -172.91 -34.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -1.116 . . . . 0.0 109.481 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 44' ' ' GLY . 7.0 ttt85 -92.71 153.13 19.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.493 -0.754 . . . . 0.0 109.311 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' B' ' 43' ' ' ARG . . . -54.67 -106.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.66 145.18 1.05 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.6 -156.24 0.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -1.177 . . . . 0.0 109.632 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 0.0 109.777 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.813 0 N-CA-C 119.313 2.485 . . . . 0.0 119.313 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' B' ' 32' ' ' LEU . 7.9 mt -102.34 -45.66 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -1.16 . . . . 0.0 109.607 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.4 m -49.76 -34.47 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.703 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 3' ' ' VAL . 2.6 mt-10 -77.38 -7.6 56.35 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 109.851 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -40.72 5.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 110.142 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 9' ' ' SER . 69.0 m -99.98 -34.69 9.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 0.0 110.509 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.581 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 6.1 t -71.96 -40.42 68.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.849 -1.157 . . . . 0.0 109.594 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 55.0 p -77.85 -31.9 51.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.114 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.771 ' O ' HD13 ' A' ' 10' ' ' ILE . 2.5 p -124.62 -150.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -0.81 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 9' ' ' SER . 5.5 mm -133.53 112.1 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.143 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.7 m -86.93 170.17 11.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 109.661 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' LEU . 79.4 p -102.76 140.23 37.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 109.383 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.664 HD13 ' CE2' ' B' ' 22' ' ' PHE . 0.8 OUTLIER -42.85 -31.3 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -62.97 -51.19 67.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.94 . . . . 0.0 109.373 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -37.56 74.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.058 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.777 HD23 HD13 ' B' ' 36' ' ' LEU . 6.2 mp -64.93 -38.91 92.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 108.868 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.56 -26.25 63.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -74.87 -32.79 61.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.348 -0.845 . . . . 0.0 108.929 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.591 ' CD2' ' HA ' ' A' ' 16' ' ' LEU . 4.3 m-30 -57.59 -20.58 33.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.31 -0.869 . . . . 0.0 109.219 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.6 m -87.81 50.62 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.55 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.664 ' CE2' HD13 ' A' ' 13' ' ' LEU . 11.8 t80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.4 0.619 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.82 HG13 ' N ' ' B' ' 24' ' ' ASN . 1.1 p -161.8 -153.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.756 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.82 ' N ' HG13 ' B' ' 23' ' ' VAL . 6.2 m-20 81.88 55.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.69 166.44 18.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.63 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -124.97 146.56 49.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.813 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -160.91 145.05 13.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.294 -1.503 . . . . 0.0 112.679 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.46 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -133.91 155.07 50.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.523 -0.736 . . . . 0.0 109.447 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 34.35 -126.12 0.52 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.498 ' O ' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER -39.0 -63.8 0.5 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.937 . . . . 0.0 110.715 -179.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' B' ' 30' ' ' SER . 10.3 m-20 -41.31 -32.14 0.28 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.825 . . . . 0.0 109.354 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.948 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.3 OUTLIER -69.15 -71.69 0.21 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.312 -0.867 . . . . 0.0 108.808 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.498 HG22 ' O ' ' B' ' 30' ' ' SER . 29.0 m -43.05 -39.15 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.262 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.514 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -63.19 -50.44 70.29 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.311 -0.868 . . . . 0.0 108.954 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.722 ' HB2' HD23 ' B' ' 27' ' ' LEU . . . -53.36 -57.69 9.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.458 -0.776 . . . . 0.0 109.443 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.948 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.3 OUTLIER -56.59 -22.73 35.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.047 -1.033 . . . . 0.0 108.526 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 11.1 t80 -82.5 -14.88 54.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.648 -0.657 . . . . 0.0 109.477 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -85.51 -45.31 11.91 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -67.86 -21.63 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.535 -0.728 . . . . 0.0 109.173 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.444 ' HB3' ' O ' ' B' ' 43' ' ' ARG . 96.2 m -113.45 16.02 18.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.404 -0.81 . . . . 0.0 109.353 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -44.04 -39.94 5.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.95 17.0 6.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -1.174 . . . . 0.0 109.422 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' B' ' 40' ' ' CYS . 1.8 tpt85 -132.85 111.37 11.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.323 -0.86 . . . . 0.0 109.367 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.43 -122.88 6.93 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.9 40.11 1.9 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.502 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 29.6 t80 -108.88 -0.88 19.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -1.127 . . . . 0.0 109.507 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . 0.41 ' CE1' HG12 ' B' ' 33' ' ' VAL . 2.3 t80 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.823 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.409 2.523 . . . . 0.0 119.409 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.446 HG23 ' CZ ' ' A' ' 19' ' ' TYR . 62.0 mt -81.49 -32.94 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.265 -1.138 . . . . 0.0 109.65 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.954 HG12 HD22 ' B' ' 32' ' ' LEU . 2.9 m -60.58 -30.33 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.584 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.1 mt-10 -78.73 1.79 21.85 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.565 -0.71 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' SER . 3.0 tp60 -105.24 -40.84 5.72 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.217 -0.927 . . . . 0.0 109.688 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 9' ' ' SER . 85.3 m -106.05 -36.87 6.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 110.667 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.564 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 8.8 t -68.97 -15.28 63.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.876 -1.14 . . . . 0.0 110.076 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 11.2 t -113.34 -27.72 7.84 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 18.2 m -126.65 156.76 40.5 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.482 ' CG2' ' HA ' ' B' ' 24' ' ' ASN . 5.5 mm -81.14 146.61 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.735 -1.228 . . . . 0.0 109.516 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.435 ' HB2' HD11 ' A' ' 16' ' ' LEU . 82.7 m -124.91 -169.19 1.94 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.363 -0.835 . . . . 0.0 109.768 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -137.47 143.1 41.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.653 ' HG ' HG12 ' B' ' 39' ' ' VAL . 0.9 OUTLIER -40.84 -33.32 0.29 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 109.66 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 75.1 t80 -65.93 -50.35 64.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.953 . . . . 0.0 108.616 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -60.98 -36.54 79.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.157 -0.964 . . . . 0.0 108.568 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.835 HD23 HD22 ' B' ' 36' ' ' LEU . 5.2 mp -69.37 -32.47 71.55 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 2.5 mt-10 -56.98 -28.5 62.4 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -31.57 69.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.477 -0.764 . . . . 0.0 109.294 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.629 ' CD2' HD11 ' B' ' 36' ' ' LEU . 23.2 m-30 -58.68 -14.84 9.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -0.963 . . . . 0.0 109.547 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.4 m -99.73 57.64 1.01 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.964 . . . . 0.0 109.532 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.472 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.482 0.658 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.821 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -144.37 -159.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.392 -0.818 . . . . 0.0 109.885 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.821 ' N ' HG13 ' B' ' 23' ' ' VAL . 15.4 t-20 62.08 68.25 0.69 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.399 0.619 . . . . 0.0 109.667 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.27 173.45 11.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.209 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.564 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -121.14 150.86 40.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.76 HD23 ' N ' ' B' ' 27' ' ' LEU . 1.2 pt? -160.98 141.51 11.29 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.223 -1.548 . . . . 0.0 112.85 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.9 OUTLIER -139.54 167.9 21.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 40.71 -121.6 1.94 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.459 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.7 OUTLIER -53.1 -59.35 4.66 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.342 -1.093 . . . . 0.0 110.572 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.614 ' CB ' ' HB2' ' B' ' 27' ' ' LEU . 13.8 m-20 -40.09 -35.92 0.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.873 . . . . 0.0 109.765 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.954 HD22 HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -67.61 -72.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 108.622 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -49.15 -27.98 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.941 . . . . 0.0 108.476 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.52 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -72.38 -56.29 5.7 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.704 ' HB3' ' CD1' ' B' ' 27' ' ' LEU . . . -60.21 -45.53 92.86 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.835 HD22 HD23 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -59.9 -27.09 66.43 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.513 ' O ' ' CA ' ' B' ' 41' ' ' GLY . 76.9 t80 -80.22 -11.9 59.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.75 -0.593 . . . . 0.0 109.822 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.541 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.6 OUTLIER -90.79 -48.51 6.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.979 . . . . 0.0 108.713 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.653 HG12 ' HG ' ' A' ' 13' ' ' LEU . 2.4 m -62.22 -29.47 46.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.484 -0.76 . . . . 0.0 108.963 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . . . . . . . . . 19.1 m -119.49 13.71 12.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.45 -0.781 . . . . 0.0 109.526 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' B' ' 37' ' ' TYR . . . -55.86 -40.87 82.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -105.34 -11.32 16.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.46 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.14 138.31 41.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.601 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.95 -144.29 12.77 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . 0.557 ' C ' ' CG ' ' B' ' 46' ' ' PHE . . . 163.81 165.84 21.67 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.557 ' CG ' ' C ' ' B' ' 45' ' ' GLY . 0.8 OUTLIER 39.29 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.523 -0.987 . . . . 0.0 109.77 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.578 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.738 HG22 HD21 ' B' ' 32' ' ' LEU . 10.5 mt -80.35 -23.13 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -1.111 . . . . 0.0 109.38 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.1 m -60.97 -27.63 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.611 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -83.41 4.74 26.28 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.47 -0.769 . . . . 0.0 109.458 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.75 -49.36 3.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.169 -0.957 . . . . 0.0 110.455 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' SER . 62.0 m -104.97 -34.08 8.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 110.752 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.537 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 4.2 t -61.65 -12.06 14.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.774 -1.204 . . . . 0.0 109.553 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -99.13 -32.81 11.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 108.446 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.582 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 5.7 t -120.71 -156.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' B' ' 24' ' ' ASN . 25.1 mm -109.98 -4.71 10.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.835 -1.166 . . . . 0.0 109.567 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' ILE . 1.5 m 45.41 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 110.24 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.6 p -150.58 149.84 30.42 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.74 -25.33 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.07 -1.019 . . . . 0.0 109.625 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -61.82 -55.05 34.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.162 -0.961 . . . . 0.0 109.173 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 -46.8 84.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.311 -0.868 . . . . 0.0 109.331 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.3 mp -61.47 -35.61 78.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.109 -0.994 . . . . 0.0 108.737 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -56.83 -23.36 43.37 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.96 -25.2 58.69 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.589 -0.695 . . . . 0.0 109.305 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.58 ' CD2' HD11 ' B' ' 36' ' ' LEU . 1.8 m-30 -74.81 -3.77 33.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.943 -1.098 . . . . 0.0 109.183 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.566 ' SG ' HG23 ' B' ' 39' ' ' VAL . 61.0 m -78.38 51.97 1.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.219 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 t30 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.601 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 3.8 p90 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.585 0.707 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.822 HG13 ' N ' ' B' ' 24' ' ' ASN . 1.1 p -160.93 -153.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.579 -0.7 . . . . 0.0 109.422 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.822 ' N ' HG13 ' B' ' 23' ' ' VAL . 28.0 t-20 87.73 74.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.5 0.667 . . . . 0.0 109.558 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -158.24 154.37 27.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.582 ' CE1' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -105.16 174.54 5.83 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.806 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.0 OUTLIER -153.69 -157.17 0.75 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.485 -1.385 . . . . 0.0 111.335 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.653 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.6 OUTLIER 139.24 146.14 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 124.127 0.971 . . . . 0.0 108.53 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.21 -131.02 19.67 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.489 ' HA ' HG22 ' B' ' 33' ' ' VAL . 7.3 m -55.62 -38.95 70.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.718 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.517 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 7.4 m-20 -52.1 -40.04 60.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 109.005 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.795 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -67.17 -72.49 0.16 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 108.96 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.49 HG23 ' N ' ' B' ' 34' ' ' GLU . 27.7 m -42.89 -40.3 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.106 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.543 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -54.67 -51.88 64.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.223 -0.923 . . . . 0.0 109.046 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' B' ' 38' ' ' LEU . . . -59.1 -54.33 48.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.039 -1.038 . . . . 0.0 108.822 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.795 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.8 OUTLIER -54.33 -20.15 6.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.138 -0.976 . . . . 0.0 108.881 179.297 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 33.1 t80 -86.09 -10.61 54.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.408 -0.807 . . . . 0.0 109.373 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -98.68 -40.54 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.038 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.566 HG23 ' SG ' ' A' ' 20' ' ' CYS . 2.3 m -78.86 -27.17 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.422 -0.798 . . . . 0.0 109.409 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.524 ' SG ' HG23 ' B' ' 39' ' ' VAL . 7.4 m -103.98 -1.01 28.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.15 -36.18 51.68 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.78 -15.04 25.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.156 -1.203 . . . . 0.0 109.641 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' B' ' 44' ' ' GLY . 8.5 ttt180 -123.76 161.93 24.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.44 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.525 ' N ' ' HG2' ' B' ' 43' ' ' ARG . . . -48.91 164.94 0.31 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 20' ' ' CYS . . . 116.71 -10.61 16.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' B' ' 45' ' ' GLY . 2.0 t80 -43.16 124.7 3.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -1.088 . . . . 0.0 109.204 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . 0.472 ' OH ' ' O ' ' B' ' 33' ' ' VAL . 4.9 p90 . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.896 0 N-CA-C 119.336 2.494 . . . . 0.0 119.336 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.757 HD13 ' CE2' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -104.91 -9.69 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -1.156 . . . . 0.0 108.997 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.651 HG12 HD22 ' B' ' 32' ' ' LEU . 2.9 m -76.81 -35.3 24.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.359 -0.838 . . . . 0.0 109.893 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' THR . 3.6 mt-10 -61.69 -10.87 9.6 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.707 -0.621 . . . . 0.0 110.641 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -105.46 -34.24 7.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.907 -1.12 . . . . 0.0 110.126 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.3 m -98.76 -18.49 17.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.678 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.543 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 13.3 t -86.2 -34.95 20.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 4' ' ' GLU . 6.2 t -89.67 -30.1 18.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.45 ' OG ' HG23 ' A' ' 8' ' ' THR . 4.5 m -128.71 165.29 21.16 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.566 HG21 ' HA ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -94.23 128.11 45.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.116 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.615 ' HB2' HD11 ' A' ' 16' ' ' LEU . 66.1 m -96.88 175.28 6.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 109.61 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 29.4 p -106.61 148.03 28.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 109.281 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.575 ' HG ' HG12 ' B' ' 39' ' ' VAL . 0.2 OUTLIER -43.42 -30.17 0.52 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.119 -0.988 . . . . 0.0 109.81 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -62.21 -56.57 17.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.366 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.484 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 1.2 mp0 -57.88 -38.33 75.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.184 -0.947 . . . . 0.0 109.128 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.823 ' CB ' HG11 ' B' ' 39' ' ' VAL . 6.8 mp -67.07 -39.97 86.96 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.184 -0.948 . . . . 0.0 108.838 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.54 -25.94 53.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -70.95 -32.18 68.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.468 -0.77 . . . . 0.0 109.095 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.757 ' CE2' HD13 ' A' ' 2' ' ' ILE . 1.6 m-30 -68.71 -31.67 70.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.139 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -60.63 -98.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.988 0.899 . . . . 0.0 109.923 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 . . . . . 0 C--N 1.278 -2.513 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.34 -179.485 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' B' ' 22' ' ' PHE . 2.2 t80 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.393 0.616 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.802 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -160.58 -162.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.239 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.802 ' N ' HG13 ' B' ' 23' ' ' VAL . 0.8 OUTLIER 73.28 68.94 0.11 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.523 -0.736 . . . . 0.0 109.566 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.1 tp60 -141.59 156.24 45.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 109.517 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.543 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -115.21 164.07 14.76 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 1.022 ' HG ' HD12 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -161.41 -156.37 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 119.951 -1.718 . . . . 0.0 112.901 -178.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.592 ' N ' ' HB2' ' B' ' 31' ' ' ASP . 0.3 OUTLIER 150.93 140.78 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.725 0 C-N-CA 123.557 0.743 . . . . 0.0 110.271 -178.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' B' ' 32' ' ' LEU . . . 43.88 -128.99 6.51 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.454 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.3 OUTLIER -47.2 -39.46 14.02 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.156 -1.202 . . . . 0.0 108.821 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.592 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 80.8 m-20 -59.28 -29.83 67.87 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.208 -0.933 . . . . 0.0 108.704 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 1.022 HD12 ' HG ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -68.7 -57.39 5.73 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.6 ' O ' ' CG ' ' B' ' 37' ' ' TYR . 4.8 m -55.63 -35.58 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.538 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -59.58 -59.53 5.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.523 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -61.29 -46.76 88.98 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.599 HD11 ' HD2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -57.89 -33.63 68.94 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.6 ' CG ' ' O ' ' B' ' 33' ' ' VAL . 5.5 m-30 -71.45 -21.94 61.9 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.671 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -81.26 -58.11 3.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 108.895 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.823 HG11 ' CB ' ' A' ' 16' ' ' LEU . 2.5 m -47.27 -32.92 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.49 -0.756 . . . . 0.0 109.416 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' B' ' 43' ' ' ARG . 0.9 OUTLIER -100.09 -27.38 13.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 109.807 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.506 ' O ' ' CG ' ' B' ' 42' ' ' GLU . . . 41.24 65.81 1.04 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' B' ' 41' ' ' GLY . 10.6 pt-20 39.36 29.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -1.008 . . . . 0.0 110.115 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' B' ' 40' ' ' CYS . 0.8 OUTLIER -90.32 135.99 33.33 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.295 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 49.06 66.42 2.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.65 175.91 35.57 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.56 ' HB3' ' CD1' ' B' ' 47' ' ' TYR . 1.7 m-30 -79.75 -100.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.122 -1.223 . . . . 0.0 109.961 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . 0.562 ' CE1' ' OH ' ' B' ' 37' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 120.846 -1.159 . . . . 0.0 109.027 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.809 0 N-CA-C 119.414 2.526 . . . . 0.0 119.414 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.439 HG22 HD21 ' B' ' 32' ' ' LEU . 19.6 mt -89.22 -25.64 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -1.103 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 2.5 m -56.96 -30.55 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 109.724 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -78.37 1.68 21.16 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.496 -0.752 . . . . 0.0 109.706 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -105.63 -42.74 5.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 0.0 109.545 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 9' ' ' SER . 98.7 m -105.65 -39.99 5.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 0.0 110.065 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.595 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 2.2 t -58.28 -54.02 51.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.757 -1.214 . . . . 0.0 108.248 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.1 p -64.03 -68.97 0.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.065 . . . . 0.0 108.368 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 3.3 m -95.27 141.0 29.37 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.3 113.65 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.863 -1.148 . . . . 0.0 109.953 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.7 m -77.96 -168.08 1.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.177 -0.952 . . . . 0.0 109.606 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.608 ' HA ' HG11 ' B' ' 23' ' ' VAL . 6.3 p -122.34 142.1 50.85 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -43.11 -27.2 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.006 . . . . 0.0 109.644 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' SER . 86.9 t80 -62.53 -60.86 2.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.179 -0.951 . . . . 0.0 108.879 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -55.54 -41.71 73.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.305 -0.872 . . . . 0.0 109.044 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.697 ' HB3' HG21 ' B' ' 39' ' ' VAL . 1.6 mp -56.34 -45.99 80.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.186 -0.946 . . . . 0.0 108.787 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.81 -23.86 3.07 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -71.21 -38.67 72.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.57 -0.706 . . . . 0.0 109.159 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.838 ' CD2' HD11 ' B' ' 36' ' ' LEU . 23.1 m-85 -50.91 -32.81 21.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.077 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.441 ' SG ' ' HG3' ' B' ' 43' ' ' ARG . 1.7 m -85.78 52.32 2.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.407 -0.808 . . . . 0.0 109.394 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 t30 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.656 -179.794 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.608 HG11 ' HA ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -79.77 -168.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.242 -0.911 . . . . 0.0 109.679 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 6.6 t30 87.86 -11.07 0.51 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -104.55 144.71 31.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.198 -0.939 . . . . 0.0 109.257 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -91.23 159.5 16.02 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.678 ' O ' HD12 ' B' ' 27' ' ' LEU . 0.3 OUTLIER -160.77 136.54 8.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.28 -1.512 . . . . 0.0 112.27 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.506 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -131.77 145.89 51.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.772 . . . . 0.0 109.009 178.244 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 28.34 -103.35 0.01 OUTLIER Glycine 0 N--CA 1.501 3.006 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.668 ' O ' HG22 ' B' ' 33' ' ' VAL . 16.1 t -41.21 -63.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.434 -1.039 . . . . 0.0 109.881 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.92 -33.74 18.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 108.64 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' B' ' 29' ' ' GLY . 0.3 OUTLIER -60.22 -65.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -0.861 . . . . 0.0 109.045 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.668 HG22 ' O ' ' B' ' 30' ' ' SER . 35.4 m -49.49 -31.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 108.41 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.526 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 7.9 mt-10 -72.69 -59.0 2.93 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.564 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -60.7 -41.88 96.09 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.838 HD11 ' CD2' ' A' ' 19' ' ' TYR . 2.2 mm? -59.51 -30.4 68.55 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -80.12 -13.56 59.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.715 -0.615 . . . . 0.0 110.065 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.544 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -91.04 -47.08 7.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 108.609 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.697 HG21 ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -63.49 -22.06 29.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.445 -0.785 . . . . 0.0 109.138 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' B' ' 43' ' ' ARG . 84.3 m -101.68 -41.63 6.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.26 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.54 -50.18 3.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' B' ' 43' ' ' ARG . 5.3 pt-20 -174.89 34.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -1.223 . . . . 0.0 109.797 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.51 ' HD3' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -43.03 150.03 0.18 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.559 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.93 -26.65 70.6 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.09 103.3 0.99 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.453 ' CG ' ' N ' ' B' ' 47' ' ' TYR . 0.1 OUTLIER -71.88 -156.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -1.127 . . . . 0.0 109.744 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . 0.453 ' N ' ' CG ' ' B' ' 46' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.425 -0.797 . . . . 0.0 109.626 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 1 N--CA 1.529 4.873 0 N-CA-C 119.436 2.534 . . . . 0.0 119.436 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.488 HG22 ' CD2' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -99.64 -27.82 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -1.19 . . . . 0.0 109.145 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 1.4 m -46.69 -29.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.941 . . . . 0.0 108.765 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 1' ' ' GLY . 0.9 OUTLIER -55.18 -19.65 8.43 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.55 -75.48 0.57 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.8 . . . . 0.0 109.795 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 1.046 ' O ' HD11 ' B' ' 32' ' ' LEU . 9.4 m -97.93 96.37 8.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.44 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.706 ' HB2' HD11 ' B' ' 32' ' ' LEU . 8.0 t 161.33 -33.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -3.36 21.97 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.544 ' C ' ' CE1' ' B' ' 26' ' ' HIS . 0.6 OUTLIER -156.06 -173.78 4.66 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.614 HD13 ' ND1' ' B' ' 26' ' ' HIS . 23.3 mm -91.9 142.09 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.019 -1.051 . . . . 0.0 109.396 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.4 -168.87 1.6 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.891 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -145.75 144.8 30.55 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -43.58 -27.44 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 109.655 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -63.51 -53.16 56.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.658 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 4.1 mt-30 -58.48 -32.93 69.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 109.75 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.736 HD23 ' CD1' ' B' ' 36' ' ' LEU . 6.1 mp -67.85 -35.36 78.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.076 -1.015 . . . . 0.0 109.104 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.37 -22.12 62.93 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 25.3 m-80 -74.39 -37.51 63.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.571 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -67.84 -15.57 63.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 109.413 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 m -104.5 51.02 0.78 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.298 -0.876 . . . . 0.0 109.456 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.6 t30 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.462 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.429 ' HB3' HG22 ' B' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.609 0.718 . . . . 0.0 109.393 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.57 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -154.8 173.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 121.645 -0.659 . . . . 0.0 109.562 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 10.0 p-10 153.37 49.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.27 151.59 30.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.41 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.614 ' ND1' HD13 ' A' ' 10' ' ' ILE . 2.2 t60 -72.4 -164.35 0.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.414 -0.804 . . . . 0.0 109.673 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' B' ' 35' ' ' ALA . 0.4 OUTLIER -155.81 -171.38 3.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.687 ' N ' HD12 ' B' ' 32' ' ' LEU . 1.3 m 149.09 139.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.474 0.654 . . . . 0.0 109.792 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 34.57 -126.61 0.57 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.8 m -41.57 -53.43 3.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.405 -1.056 . . . . 0.0 109.71 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.544 ' O ' HD23 ' B' ' 27' ' ' LEU . 17.0 m-20 -44.41 -31.14 0.98 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.897 . . . . 0.0 109.17 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 1.072 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -74.49 -77.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.214 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' B' ' 37' ' ' TYR . 9.4 m -41.6 -35.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.621 -0.674 . . . . 0.0 109.336 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.561 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 2.2 mp0 -70.28 -54.02 14.43 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.832 ' HB2' HD21 ' B' ' 27' ' ' LEU . . . -53.69 -56.41 17.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.16 -0.962 . . . . 0.0 109.462 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 1.072 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.1 OUTLIER -57.08 -20.88 27.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.97 -1.081 . . . . 0.0 108.162 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 89.3 t80 -84.96 -9.96 57.54 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.711 -0.618 . . . . 0.0 109.724 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -97.23 -42.62 7.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.085 -1.009 . . . . 0.0 108.961 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.412 HG23 ' SG ' ' B' ' 40' ' ' CYS . 1.7 m -72.52 -26.01 23.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.507 -0.745 . . . . 0.0 109.662 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.412 ' SG ' HG23 ' B' ' 39' ' ' VAL . 59.3 m -103.33 -11.84 17.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.181 -0.949 . . . . 0.0 109.786 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' B' ' 42' ' ' GLU . . . 49.76 25.44 6.98 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' B' ' 41' ' ' GLY . 0.2 OUTLIER 76.72 10.76 2.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -1.136 . . . . 0.0 109.259 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.12 154.95 5.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 0.0 109.418 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.28 -127.22 7.79 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.77 -91.02 2.2 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.89 -127.52 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -1.183 . . . . 0.0 109.188 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 120.752 -1.217 . . . . 0.0 109.378 179.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.894 0 N-CA-C 119.48 2.552 . . . . 0.0 119.48 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.9 mt -81.8 -46.03 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -1.111 . . . . 0.0 109.604 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.914 HG12 HD22 ' B' ' 32' ' ' LEU . 4.4 m -54.36 -18.82 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.78 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' HG21 ' A' ' 8' ' ' THR . 4.3 mt-10 -92.21 -7.71 47.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.646 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.45 -31.31 9.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.13 -0.982 . . . . 0.0 110.114 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 9' ' ' SER . 83.5 m -105.3 -62.26 1.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.061 -1.025 . . . . 0.0 110.374 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 48.6 t -47.26 -28.58 2.0 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.388 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 4' ' ' GLU . 3.1 t -69.88 -20.17 63.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.972 -1.08 . . . . 0.0 108.92 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.527 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 4.6 t -150.56 -151.24 0.38 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.42 128.32 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.945 -1.097 . . . . 0.0 109.498 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -111.4 164.84 12.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.849 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 13' ' ' LEU . 14.5 p -108.17 141.92 39.18 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.93 HD13 ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -46.14 -28.28 1.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.827 -1.171 . . . . 0.0 109.151 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -53.52 -47.38 69.97 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.439 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 48.5 mm-40 -65.6 -40.86 93.13 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.93 ' HB2' HD13 ' A' ' 13' ' ' LEU . 7.9 mp -63.51 -34.68 78.32 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 4.1 mt-10 -54.95 -32.5 61.46 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -30.29 70.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.862 ' HD2' HD11 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -63.59 -41.92 98.3 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.18 -0.95 . . . . 0.0 108.695 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 m -91.11 53.7 2.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.777 . . . . 0.0 109.652 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.4 t30 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.466 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.919 HG12 ' H ' ' A' ' 13' ' ' LEU . 33.6 m -87.85 -158.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 122.059 0.933 . . . . 0.0 109.802 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.71 64.96 0.97 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.699 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.49 -177.19 5.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 109.233 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.537 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 1.2 t60 -138.02 169.06 18.44 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 1.12 HD13 ' CD1' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -161.13 -137.84 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.716 -1.24 . . . . 0.0 109.644 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.715 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.8 OUTLIER 137.13 134.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 33.54 -113.55 0.09 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.1 OUTLIER -48.27 -56.23 8.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -1.032 . . . . 0.0 109.926 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.568 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 4.1 m-20 -44.36 -33.65 1.71 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -0.932 . . . . 0.0 109.095 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 1.12 ' CD1' HD13 ' B' ' 27' ' ' LEU . 0.8 OUTLIER -65.87 -71.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 108.943 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.416 HG22 ' O ' ' B' ' 30' ' ' SER . 14.3 m -48.83 -24.47 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.518 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 5.4 mt-10 -75.34 -61.85 1.76 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.454 -0.779 . . . . 0.0 108.995 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.535 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.35 -44.0 83.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.862 HD11 ' HD2' ' A' ' 19' ' ' TYR . 2.4 mm? -57.31 -33.32 67.58 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.967 0.889 . . . . 0.0 108.725 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.444 ' CD2' HD23 ' B' ' 38' ' ' LEU . 11.8 t80 -77.3 -16.83 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.248 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.535 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -90.95 -33.55 15.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.111 -0.993 . . . . 0.0 108.904 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.747 HG21 HD11 ' A' ' 13' ' ' LEU . 1.4 m -88.93 -14.48 9.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.505 -0.747 . . . . 0.0 109.443 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 43' ' ' ARG . 93.4 m -114.68 -10.58 12.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.375 -0.828 . . . . 0.0 109.364 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' B' ' 42' ' ' GLU . . . 46.29 67.74 1.27 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 41' ' ' GLY . 2.0 pt-20 37.48 38.98 0.16 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.705 -0.88 . . . . 0.0 110.483 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 40' ' ' CYS . 2.1 ttt85 -64.86 147.55 53.05 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 108.983 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.41 158.82 12.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.77 -1.62 87.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.84 -144.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -1.2 . . . . 0.0 109.388 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 6.8 t80 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 109.282 -179.817 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.816 0 N-CA-C 119.447 2.539 . . . . 0.0 119.447 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.763 HG21 ' CZ ' ' A' ' 19' ' ' TYR . 12.3 mt -89.85 -36.42 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -1.166 . . . . 0.0 109.554 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.691 HG12 HD13 ' B' ' 32' ' ' LEU . 2.4 m -39.19 -31.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.63 -0.669 . . . . 0.0 110.534 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 2' ' ' ILE . 4.8 mt-10 -68.93 -7.68 37.29 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.376 -0.828 . . . . 0.0 110.238 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.75 -35.42 7.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.065 -1.022 . . . . 0.0 110.251 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.666 ' HB3' HD11 ' B' ' 27' ' ' LEU . 96.7 m -105.36 -60.84 1.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.964 -1.085 . . . . 0.0 110.944 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.539 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 2.6 t -40.11 -60.31 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.022 -1.049 . . . . 0.0 109.946 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 7' ' ' CYS . 1.8 t -42.6 -29.31 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.169 -0.957 . . . . 0.0 109.248 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.617 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 18.3 m -142.47 -137.33 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.456 -0.777 . . . . 0.0 108.983 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.48 HG13 ' ND1' ' B' ' 26' ' ' HIS . 1.4 mt -146.85 113.61 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.589 -1.319 . . . . 0.0 109.299 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.451 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . 21.4 m -88.29 -167.26 1.82 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.42 -0.8 . . . . 0.0 110.096 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.546 ' HA ' HG21 ' B' ' 23' ' ' VAL . 39.1 p -115.02 159.28 20.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.098 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.508 HD11 HG12 ' B' ' 39' ' ' VAL . 0.4 OUTLIER -50.85 -23.58 2.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.976 -1.077 . . . . 0.0 109.232 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.473 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 44.4 t80 -65.37 -48.34 73.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 108.812 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.451 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -57.82 -39.14 76.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 108.587 179.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.64 ' CD2' ' HB1' ' B' ' 35' ' ' ALA . 6.2 mp -65.16 -35.69 81.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.376 -0.828 . . . . 0.0 108.8 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 1.8 mm-40 -55.96 -27.53 52.98 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.08 -17.17 60.51 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.496 -0.753 . . . . 0.0 109.318 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.763 ' CZ ' HG21 ' A' ' 2' ' ' ILE . 1.3 m-85 -72.81 -29.75 63.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 108.465 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.9 m -85.89 52.11 2.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 0.0 109.614 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.506 179.878 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.476 ' O ' ' CD2' ' B' ' 22' ' ' PHE . 12.2 p90 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.306 0.574 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.797 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.7 OUTLIER -148.74 -159.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.428 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.797 ' N ' HG13 ' B' ' 23' ' ' VAL . 11.4 t-20 77.74 57.96 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.449 0.642 . . . . 0.0 109.347 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.57 142.92 39.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.323 -0.861 . . . . 0.0 109.299 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.617 ' CE1' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -90.92 144.1 26.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.815 ' O ' HD12 ' B' ' 27' ' ' LEU . 0.4 OUTLIER -154.07 145.7 23.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.348 -1.47 . . . . 0.0 112.133 -178.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' B' ' 32' ' ' LEU . 0.8 OUTLIER -124.92 -162.79 1.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . -37.47 -63.02 0.87 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.212 -0.93 . . . . 0.0 111.679 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.402 ' O ' ' OE1' ' B' ' 34' ' ' GLU . 1.4 p -69.77 -40.29 76.17 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.9 -1.353 . . . . 0.0 111.25 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.568 ' HB2' ' CA ' ' B' ' 27' ' ' LEU . 0.3 OUTLIER -70.71 -20.95 62.61 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.475 -1.391 . . . . 0.0 108.276 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.99 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.6 OUTLIER -69.06 -70.22 0.29 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.549 HG12 ' CE2' ' B' ' 47' ' ' TYR . 33.2 m -43.66 -31.35 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.4 mt-10 -68.94 -54.61 14.49 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.64 ' HB1' ' CD2' ' A' ' 16' ' ' LEU . . . -57.42 -55.06 39.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 108.777 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.99 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -54.21 -21.94 10.22 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.041 -1.037 . . . . 0.0 108.248 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.525 ' O ' ' HA2' ' B' ' 41' ' ' GLY . 13.4 t80 -84.53 -6.43 59.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -105.76 -50.4 3.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.066 -1.021 . . . . 0.0 108.963 179.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.508 HG12 HD11 ' A' ' 13' ' ' LEU . 1.8 m -67.03 -25.76 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.443 -0.786 . . . . 0.0 109.78 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.48 ' O ' ' C ' ' B' ' 41' ' ' GLY . 20.1 m -122.91 -21.13 5.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.921 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' B' ' 37' ' ' TYR . . . 40.52 29.72 0.27 Allowed Glycine 0 N--CA 1.496 2.637 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.539 ' HG2' ' N ' ' B' ' 46' ' ' PHE . 16.4 tp10 49.42 91.74 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.483 -1.01 . . . . 0.0 108.34 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 51.81 0.88 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.645 -0.659 . . . . 0.0 109.707 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.94 63.73 0.01 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . 0.487 ' C ' ' HG2' ' B' ' 42' ' ' GLU . . . 109.07 -140.98 15.85 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.539 ' N ' ' HG2' ' B' ' 42' ' ' GLU . 0.5 OUTLIER -120.15 177.9 4.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -1.191 . . . . 0.0 109.117 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . 0.615 ' OH ' HD23 ' B' ' 36' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.955 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 mm -104.82 -32.14 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -1.208 . . . . 0.0 109.617 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.033 HG12 ' CD2' ' B' ' 32' ' ' LEU . 0.9 OUTLIER -85.41 -41.33 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.614 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 5.9 mt-10 -70.44 -19.86 62.94 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.599 -0.688 . . . . 0.0 110.219 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -89.31 -34.79 16.44 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.125 -0.984 . . . . 0.0 109.48 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.5 m -105.83 -42.43 5.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 110.452 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.556 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 9.1 t -63.14 -18.12 63.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.934 -1.104 . . . . 0.0 110.062 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 4' ' ' GLU . 16.0 p -104.77 -38.5 6.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.077 -1.014 . . . . 0.0 108.516 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.711 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -108.7 -155.89 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 9' ' ' SER . 9.6 mm -129.75 83.34 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.979 -1.076 . . . . 0.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' HB2' HD11 ' A' ' 16' ' ' LEU . 64.1 m -59.71 171.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.291 -0.881 . . . . 0.0 109.61 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.771 ' HA ' HG21 ' B' ' 23' ' ' VAL . 94.5 p -112.99 145.14 41.37 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -43.52 -27.48 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 108.966 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 28.5 t80 -62.54 -46.13 89.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.4 -0.813 . . . . 0.0 108.903 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -66.32 -49.37 67.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 109.007 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.601 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 9.0 mp -56.19 -31.98 63.94 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.311 -0.868 . . . . 0.0 109.118 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' OE1' ' CD ' ' B' ' 43' ' ' ARG . 1.3 mm-40 -58.65 -35.2 72.17 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.87 . . . . 0.0 108.745 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -75.09 -22.76 58.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.437 -0.789 . . . . 0.0 109.291 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.686 ' HD2' HD11 ' B' ' 36' ' ' LEU . 7.3 m-30 -60.28 -14.61 19.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.128 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -91.64 53.64 2.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.927 . . . . 0.0 109.385 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 p30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.417 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.817 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.8 OUTLIER -160.36 -157.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.907 . . . . 0.0 109.697 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.817 ' N ' HG13 ' B' ' 23' ' ' VAL . 37.2 t-20 89.19 79.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.395 0.617 . . . . 0.0 109.835 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -161.0 -176.2 5.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.402 -0.811 . . . . 0.0 109.771 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.556 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -144.59 149.64 36.13 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.783 HD13 HD11 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -162.04 149.83 14.52 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.353 -1.467 . . . . 0.0 112.567 -178.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.505 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -135.38 158.67 43.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.518 -0.739 . . . . 0.0 109.264 177.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 25.49 -119.66 0.03 OUTLIER Glycine 0 N--CA 1.5 2.962 0 CA-C-O 121.62 0.567 . . . . 0.0 112.149 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.579 ' O ' HG22 ' B' ' 33' ' ' VAL . 54.5 m -35.77 -57.5 0.66 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.544 -0.974 . . . . 0.0 110.884 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.7 OUTLIER -45.31 -44.01 11.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.915 -1.116 . . . . 0.0 109.087 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 1.033 ' CD2' HG12 ' A' ' 3' ' ' VAL . 3.1 mp -54.14 -65.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.194 -0.941 . . . . 0.0 108.979 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.579 HG22 ' O ' ' B' ' 30' ' ' SER . 18.1 m -51.36 -25.4 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.121 -0.987 . . . . 0.0 108.746 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.508 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.3 mt-10 -79.26 -58.41 3.24 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.686 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -60.65 -38.77 85.95 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.686 HD11 ' HD2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -61.32 -33.93 74.42 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.933 0.873 . . . . 0.0 108.745 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -74.91 -31.73 61.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.783 -0.573 . . . . 0.0 109.897 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.556 ' N ' HD23 ' B' ' 38' ' ' LEU . 0.2 OUTLIER -70.49 -63.2 1.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.217 -0.927 . . . . 0.0 108.578 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.572 HG13 ' O ' ' B' ' 35' ' ' ALA . 2.5 m -45.41 -27.24 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.45 ' O ' ' C ' ' B' ' 41' ' ' GLY . 1.3 m -118.93 36.56 4.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.739 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' B' ' 40' ' ' CYS . . . -41.35 -63.96 1.46 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -122.66 -22.95 5.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.069 -1.253 . . . . 0.0 109.946 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.493 ' CD ' ' OE1' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -81.53 111.47 17.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.451 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.14 91.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.02 110.06 0.72 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.52 23.4 0.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -1.096 . . . . 0.0 109.406 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.345 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.827 0 N-CA-C 119.433 2.533 . . . . 0.0 119.433 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.671 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -91.74 -26.04 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -1.168 . . . . 0.0 109.182 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.982 HG12 HD22 ' B' ' 32' ' ' LEU . 4.7 m -75.7 -9.35 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.64 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.441 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.9 mt-10 -98.25 -10.89 23.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -105.34 -34.2 7.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.562 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.761 ' HB3' HD11 ' B' ' 27' ' ' LEU . 64.1 m -93.94 -66.23 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 109.704 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 18.6 t -41.42 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 9' ' ' SER . 2.1 t -66.31 135.05 53.85 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.749 ' O ' HD13 ' A' ' 10' ' ' ILE . 1.5 m 75.65 -161.07 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 9' ' ' SER . 39.0 mm -128.5 130.67 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.61 -1.306 . . . . 0.0 110.248 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -166.54 1.62 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.476 -0.765 . . . . 0.0 109.593 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' C ' ' A' ' 13' ' ' LEU . 88.7 p -140.16 129.13 23.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' H ' HG23 ' B' ' 23' ' ' VAL . 0.4 OUTLIER -39.25 -33.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 109.781 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' SER . 27.8 t80 -57.7 -51.63 68.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.17 -0.956 . . . . 0.0 108.95 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.457 ' HG2' ' OG ' ' A' ' 12' ' ' SER . 15.4 mm100 -55.47 -44.96 76.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.873 . . . . 0.0 109.231 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.768 HD23 HD13 ' B' ' 36' ' ' LEU . 6.2 mp -57.05 -48.85 77.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -0.93 . . . . 0.0 109.247 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' OE2' ' HB ' ' B' ' 39' ' ' VAL . 0.9 OUTLIER -52.8 -23.32 6.68 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.108 -0.995 . . . . 0.0 108.399 179.322 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -75.49 -29.81 59.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.484 -0.76 . . . . 0.0 109.005 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.671 ' CE2' HD12 ' A' ' 2' ' ' ILE . 1.7 m-30 -72.63 -11.84 60.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 0.0 109.182 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 m -89.86 51.34 2.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 109.433 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.487 -179.927 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 8.0 p90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.165 0.507 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.837 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -154.99 -158.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.935 . . . . 0.0 109.99 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.837 ' N ' HG13 ' B' ' 23' ' ' VAL . 25.4 m-20 69.64 102.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -153.48 152.22 30.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.702 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 9' ' ' SER . 1.4 t60 -121.69 149.05 43.79 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.975 HD23 ' CB ' ' B' ' 35' ' ' ALA . 0.0 OUTLIER -153.88 -158.59 0.88 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.469 -1.394 . . . . 0.0 110.95 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.563 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 148.77 146.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.77 -134.01 39.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.524 ' HA ' ' CG2' ' B' ' 33' ' ' VAL . 1.3 p -55.99 -46.25 78.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -1.131 . . . . 0.0 109.669 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' B' ' 30' ' ' SER . 9.0 m-20 -45.14 -43.27 9.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 108.555 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.982 HD22 HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -60.1 -72.61 0.1 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.557 HG23 ' N ' ' B' ' 34' ' ' GLU . 14.8 m -45.12 -50.76 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.101 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.557 ' N ' HG23 ' B' ' 33' ' ' VAL . 1.5 mp0 -56.06 -44.42 78.85 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.301 -0.874 . . . . 0.0 109.075 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.975 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -55.12 -58.95 5.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.362 -0.836 . . . . 0.0 109.255 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.948 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -56.0 -24.01 36.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.046 -1.034 . . . . 0.0 108.32 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 72.6 t80 -79.94 -15.78 56.6 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' B' ' 35' ' ' ALA . 1.4 mt -83.74 -54.82 4.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 108.645 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.478 ' HB ' ' OE2' ' A' ' 17' ' ' GLU . 2.5 m -54.16 -40.93 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.485 -0.759 . . . . 0.0 109.115 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.477 ' N ' ' CG2' ' B' ' 39' ' ' VAL . 79.0 m -99.31 17.41 20.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.338 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.06 -10.02 66.88 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -75.56 -26.06 57.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -1.22 . . . . 0.0 109.36 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.25 -172.65 2.31 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.446 -0.783 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.15 130.25 28.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.41 131.59 47.42 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' B' ' 47' ' ' TYR . 0.8 OUTLIER -161.4 -74.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -1.11 . . . . 0.0 109.329 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . 0.465 ' C ' ' O ' ' B' ' 46' ' ' PHE . 53.2 t80 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.577 -0.702 . . . . 0.0 110.267 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.784 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.7 mt -101.61 -17.42 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -1.095 . . . . 0.0 108.997 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 3.5 m -62.12 -11.4 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.491 -0.756 . . . . 0.0 110.502 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -101.94 -4.92 25.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.027 -1.045 . . . . 0.0 110.425 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.448 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 5.3 mm100 -105.33 -42.26 5.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.009 -1.057 . . . . 0.0 110.266 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' THR . 29.0 m -105.66 -57.9 1.98 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.184 -0.948 . . . . 0.0 110.901 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.581 ' HA ' ' CD2' ' B' ' 26' ' ' HIS . 0.9 OUTLIER -37.15 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.218 -0.926 . . . . 0.0 111.411 -178.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.3 t -68.83 -20.14 64.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.662 -1.274 . . . . 0.0 109.328 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.581 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 11.7 t -158.15 -170.69 3.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.709 ' HA ' ' ND1' ' B' ' 26' ' ' HIS . 0.8 OUTLIER -103.26 94.77 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.702 -1.249 . . . . 0.0 110.546 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 67.9 m -55.54 168.75 0.37 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 p -88.2 143.7 26.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.898 -1.126 . . . . 0.0 109.409 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 13' ' ' LEU . 3.0 tt -49.79 -24.09 2.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.978 . . . . 0.0 109.683 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -70.74 -38.79 73.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.182 -0.948 . . . . 0.0 109.072 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -66.6 -48.46 69.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.618 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.893 HD23 HD13 ' B' ' 36' ' ' LEU . 6.5 mp -55.71 -34.12 64.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.098 . . . . 0.0 108.567 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -63.13 -18.79 63.82 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -76.21 -28.87 57.38 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.485 -0.759 . . . . 0.0 109.059 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.9 m-30 -69.81 -5.49 25.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.483 ' HA ' ' HA3' ' B' ' 45' ' ' GLY . 8.3 m -83.89 51.32 2.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -0.965 . . . . 0.0 109.603 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.91 -1.043 . . . . 0.0 109.484 179.874 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.553 0.692 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.798 HG22 ' H ' ' B' ' 24' ' ' ASN . 2.3 p -160.7 -158.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.629 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.798 ' H ' HG22 ' B' ' 23' ' ' VAL . 34.2 m120 109.32 32.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.979 0.895 . . . . 0.0 108.622 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.477 ' O ' HD13 ' A' ' 10' ' ' ILE . 6.2 tp-100 -160.65 160.97 32.24 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.778 ' CE1' HD22 ' B' ' 27' ' ' LEU . 5.3 t60 -126.63 161.92 26.95 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 116.889 -1.924 . . . . 0.0 114.503 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.831 ' C ' HD23 ' B' ' 27' ' ' LEU . 0.1 OUTLIER -97.39 -155.73 0.5 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 113.582 -1.644 . . . . 0.0 110.734 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.587 ' N ' ' HG ' ' B' ' 27' ' ' LEU . 2.2 m 141.05 143.96 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.35 -132.71 49.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 2.9 m -52.5 -46.37 66.59 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.91 -1.347 . . . . 0.0 108.039 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.536 ' HB3' ' HA ' ' B' ' 27' ' ' LEU . 23.3 m-20 -49.39 -31.1 8.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.406 -0.808 . . . . 0.0 109.201 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.978 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.4 OUTLIER -67.8 -68.04 0.42 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.249 -0.907 . . . . 0.0 108.875 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.565 ' HB ' ' CZ ' ' B' ' 47' ' ' TYR . 18.9 m -54.57 -36.64 36.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.365 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.541 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -64.28 -52.19 59.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.521 -0.737 . . . . 0.0 109.405 179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -47.66 -61.28 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.052 . . . . 0.0 109.251 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.978 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -55.39 -21.69 16.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.897 -1.127 . . . . 0.0 108.346 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 84.5 t80 -84.97 -11.26 55.9 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.656 -0.653 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -95.45 -54.29 3.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.147 -0.971 . . . . 0.0 108.582 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.437 HG13 ' H ' ' B' ' 39' ' ' VAL . 2.3 m -59.57 -26.7 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' B' ' 43' ' ' ARG . 3.9 m -124.59 34.85 4.92 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.464 -0.773 . . . . 0.0 109.35 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.3 72.61 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -97.61 -20.52 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -1.214 . . . . 0.0 109.575 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -122.04 117.88 27.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -0.822 . . . . 0.0 109.495 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.39 173.62 19.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 20' ' ' CYS . . . -165.5 -124.55 0.71 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -82.62 -57.98 3.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 109.453 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . 0.565 ' CZ ' ' HB ' ' B' ' 33' ' ' VAL . 10.2 t80 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 109.419 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.818 0 N-CA-C 119.239 2.456 . . . . 0.0 119.239 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.607 HG23 ' CE2' ' A' ' 19' ' ' TYR . 0.5 OUTLIER -76.16 -31.57 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -1.135 . . . . 0.0 109.143 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.603 HG23 ' HG2' ' A' ' 4' ' ' GLU . 4.4 m -66.38 -33.09 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.603 ' HG2' HG23 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -78.63 5.45 11.0 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 109.896 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -104.73 -43.4 5.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.115 -0.991 . . . . 0.0 109.207 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 9' ' ' SER . 89.3 m -105.63 -23.61 12.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 109.966 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.588 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 8.3 t -76.4 -28.37 56.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.902 -1.124 . . . . 0.0 109.262 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 6.9 t -87.01 -32.49 20.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 1.1 t -134.74 147.56 50.06 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' B' ' 25' ' ' GLN . 1.1 mp -79.27 123.1 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.93 -1.106 . . . . 0.0 109.501 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.9 m -90.6 -167.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -0.797 . . . . 0.0 109.704 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.509 ' HA ' HG13 ' B' ' 23' ' ' VAL . 52.5 p -122.68 150.24 42.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.475 -0.766 . . . . 0.0 109.148 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.847 HD12 ' CD2' ' B' ' 22' ' ' PHE . 2.4 tt -44.12 -28.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.895 . . . . 0.0 109.238 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.413 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 10.6 m-85 -64.14 -55.18 23.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.861 . . . . 0.0 109.118 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -41.78 77.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.959 . . . . 0.0 109.071 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.702 HD23 HD22 ' B' ' 36' ' ' LEU . 6.8 mp -61.82 -36.47 81.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.154 -0.966 . . . . 0.0 108.978 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 8.3 mt-10 -56.58 -30.45 63.2 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.249 -0.907 . . . . 0.0 108.641 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.5 -31.13 69.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.607 ' CE2' HG23 ' A' ' 2' ' ' ILE . 2.6 m-85 -54.65 -41.75 70.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 108.668 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.3 50.92 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.47 -0.769 . . . . 0.0 109.387 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.626 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.847 ' CD2' HD12 ' A' ' 13' ' ' LEU . 41.3 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -151.18 -172.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.935 -1.103 . . . . 0.0 109.374 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER 40.07 49.29 2.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 110.049 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLN . . . . . 0.521 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 1.4 mt-30 -160.05 155.75 25.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.8 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' HIS . . . . . 0.547 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -121.34 171.97 8.37 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.926 HD13 HD12 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -160.89 -142.53 0.08 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.351 -1.468 . . . . 0.0 110.863 -179.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 148.4 131.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 123.824 0.85 . . . . 0.0 108.996 -178.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' B' ' 32' ' ' LEU . . . 37.06 -116.9 0.4 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.447 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.3 OUTLIER -43.2 -61.4 1.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.439 -1.036 . . . . 0.0 109.401 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.497 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 7.2 m-20 -45.37 -27.39 0.68 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -0.938 . . . . 0.0 108.984 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.926 HD12 HD13 ' B' ' 27' ' ' LEU . 0.2 OUTLIER -80.34 -72.24 0.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.848 . . . . 0.0 109.328 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' B' ' 30' ' ' SER . 16.8 m -44.66 -29.35 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 108.87 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.533 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.0 OUTLIER -69.79 -60.33 2.38 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.562 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -60.61 -43.37 97.53 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.702 HD22 HD23 ' A' ' 16' ' ' LEU . 3.7 mm? -59.08 -29.27 67.21 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.468 -0.77 . . . . 0.0 109.162 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 37' ' ' TYR . 13.8 t80 -78.76 -10.64 59.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.593 -0.692 . . . . 0.0 109.597 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.562 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -95.24 -36.87 11.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.0 109.253 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 16' ' ' LEU . 3.4 m -72.46 -28.49 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.277 -0.889 . . . . 0.0 109.438 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' CYS . . . . . 0.565 ' HB3' ' CB ' ' B' ' 43' ' ' ARG . 72.5 m -79.84 -37.24 35.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.106 -0.996 . . . . 0.0 109.259 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' GLY . . . . . 0.495 ' C ' ' CG ' ' B' ' 42' ' ' GLU . . . 77.52 98.23 0.2 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.495 ' CG ' ' C ' ' B' ' 41' ' ' GLY . 2.5 pt-20 37.99 37.75 0.16 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.61 -0.935 . . . . 0.0 110.407 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.565 ' CB ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -93.86 -170.97 2.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.085 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 43' ' ' ARG . . . -43.58 112.37 0.55 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.26 -6.3 88.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.41 -168.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.407 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' N ' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 1 N--CA 1.53 4.923 0 N-CA-C 119.457 2.543 . . . . 0.0 119.457 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.685 HG23 ' CE2' ' A' ' 19' ' ' TYR . 12.6 mt -93.29 -34.01 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.129 -1.218 . . . . 0.0 109.577 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.539 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 4.3 m -65.94 -28.01 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.375 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 1' ' ' GLY . 4.9 mt-10 -80.58 2.18 26.63 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.487 -0.758 . . . . 0.0 109.666 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.25 -45.69 4.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.495 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.985 ' HB3' HD11 ' B' ' 27' ' ' LEU . 56.0 m -97.99 -33.11 11.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.912 . . . . 0.0 109.815 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -73.07 -12.97 61.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.947 . . . . 0.0 109.808 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.3 t -100.38 -34.3 10.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.079 -1.013 . . . . 0.0 108.922 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -136.97 159.23 42.49 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.638 HG23 ' O ' ' B' ' 25' ' ' GLN . 23.7 mm -79.41 96.62 2.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 109.513 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.724 ' O ' HG23 ' B' ' 23' ' ' VAL . 9.1 p -76.97 159.58 29.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -0.818 . . . . 0.0 109.794 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.476 ' HA ' HG23 ' B' ' 23' ' ' VAL . 59.1 p -89.03 144.69 25.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 109.338 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.966 HD11 HG12 ' B' ' 39' ' ' VAL . 1.4 tp -46.82 -24.89 0.65 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.283 -0.886 . . . . 0.0 109.108 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 6.5 t80 -71.72 -32.62 67.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -0.927 . . . . 0.0 109.135 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 12' ' ' SER . 5.4 mm100 -66.53 -35.79 81.11 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.188 -0.945 . . . . 0.0 108.456 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.682 HD22 ' N ' ' A' ' 16' ' ' LEU . 3.2 mm? -66.19 -35.17 79.75 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -48.46 -36.21 14.53 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -74.7 -21.51 59.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.428 -0.795 . . . . 0.0 109.329 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.925 ' HD2' HD11 ' B' ' 36' ' ' LEU . 3.2 m-30 -60.04 -19.37 52.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.341 -0.85 . . . . 0.0 109.27 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.3 m -97.44 52.05 1.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.288 -0.882 . . . . 0.0 109.387 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.486 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.468 ' CD1' ' O ' ' B' ' 22' ' ' PHE . 38.5 p90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.226 0.536 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.829 HG22 ' H ' ' B' ' 24' ' ' ASN . 4.7 p -114.08 -170.45 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 108.981 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.829 ' H ' HG22 ' B' ' 23' ' ' VAL . 33.3 m-20 82.84 36.28 0.05 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.697 -0.627 . . . . 0.0 109.495 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.638 ' O ' HG23 ' A' ' 10' ' ' ILE . 2.5 mt-30 -140.95 175.7 9.41 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 6' ' ' CYS . 0.6 OUTLIER -133.54 176.34 8.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.868 -1.145 . . . . 0.0 109.066 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.985 HD11 ' HB3' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -160.28 -164.93 1.35 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.763 -1.21 . . . . 0.0 111.072 -179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 146.16 153.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.45 -119.06 4.54 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.462 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.0 OUTLIER -64.47 -52.47 57.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.3 -1.118 . . . . 0.0 110.115 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' B' ' 30' ' ' SER . 17.1 m-20 -43.55 -38.83 3.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.077 -1.015 . . . . 0.0 109.63 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.494 HD12 HD13 ' B' ' 27' ' ' LEU . 0.2 OUTLIER -67.73 -71.06 0.22 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.096 -1.003 . . . . 0.0 108.956 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.539 HG12 ' OH ' ' B' ' 47' ' ' TYR . 32.2 m -47.9 -27.56 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.098 -1.001 . . . . 0.0 108.602 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.535 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 9.4 mt-10 -74.65 -59.57 2.67 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.505 -0.747 . . . . 0.0 109.087 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.572 ' O ' HG13 ' B' ' 39' ' ' VAL . . . -58.92 -41.96 88.54 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.925 HD11 ' HD2' ' A' ' 19' ' ' TYR . 1.1 mm? -60.27 -29.03 68.54 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.674 0.75 . . . . 0.0 109.027 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.453 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 39.8 t80 -83.09 -13.51 55.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.68 -0.638 . . . . 0.0 110.247 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -90.02 -44.22 10.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.063 -1.023 . . . . 0.0 108.803 179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.966 HG12 HD11 ' A' ' 13' ' ' LEU . 1.9 m -66.27 -37.69 80.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.558 -0.714 . . . . 0.0 109.314 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.421 ' N ' ' CG2' ' B' ' 39' ' ' VAL . 1.3 m -105.5 17.51 23.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.796 . . . . 0.0 109.439 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -56.96 -85.96 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.486 ' HG2' ' N ' ' B' ' 43' ' ' ARG . 28.2 tt0 -55.11 -88.47 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -1.152 . . . . 0.0 109.357 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.486 ' N ' ' HG2' ' B' ' 42' ' ' GLU . 0.4 OUTLIER -46.83 174.33 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.543 -0.723 . . . . 0.0 109.379 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.31 -92.64 1.73 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 30.97 6.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -166.63 -155.0 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -1.143 . . . . 0.0 109.648 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.539 ' OH ' HG12 ' B' ' 33' ' ' VAL . 9.8 t80 -144.64 -93.39 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.344 -0.847 . . . . 0.0 109.526 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.498 ' N ' ' CG ' ' B' ' 47' ' ' TYR . 22.8 m -169.68 -35.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.598 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 tttp 69.14 74.18 0.29 Allowed Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.476 -0.765 . . . . 0.0 109.368 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.514 ' HD3' ' CE2' ' B' ' 47' ' ' TYR . 34.5 Cg_endo -76.87 176.17 10.46 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.696 2.264 . . . . 0.0 110.58 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' B' ' 51' ' ' THR . 20.2 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.489 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.799 0 N-CA-C 119.273 2.469 . . . . 0.0 119.273 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.655 HG22 ' CD2' ' B' ' 32' ' ' LEU . 18.2 mm -78.69 -62.18 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -1.108 . . . . 0.0 109.208 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.792 HG12 HD22 ' B' ' 32' ' ' LEU . 2.4 m -72.3 -13.79 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 109.17 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -89.11 -8.32 54.05 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.637 ' O ' HG22 ' A' ' 8' ' ' THR . 0.5 OUTLIER -97.52 -51.57 4.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.905 . . . . 0.0 109.277 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.628 ' SG ' HD11 ' A' ' 16' ' ' LEU . 17.3 m -85.94 -69.84 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.887 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 2.4 t -41.56 -25.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.048 -1.033 . . . . 0.0 110.724 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 5' ' ' GLN . 3.7 t -72.42 -27.08 62.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.86 -1.15 . . . . 0.0 109.238 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 6' ' ' CYS . 18.0 m -156.61 -157.66 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 mm -107.07 116.02 49.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 120.462 -1.399 . . . . 0.0 109.231 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.463 ' O ' HG21 ' B' ' 23' ' ' VAL . 2.5 p -99.05 172.84 7.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 109.649 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.2 p -106.87 150.78 26.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.806 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -46.52 -28.24 1.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.686 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.47 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 14.9 t80 -61.82 -45.46 93.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.155 -0.966 . . . . 0.0 108.808 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.58 -54.13 47.1 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.368 -0.833 . . . . 0.0 109.418 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 16' ' ' LEU . 1.6 mm? -51.33 -38.64 54.18 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.17 -0.956 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -49.36 -34.06 15.07 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.13 -21.81 58.6 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.884 ' CD2' HD11 ' B' ' 36' ' ' LEU . 3.3 m-85 -68.02 -16.93 64.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 0.0 109.435 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.3 m -82.21 51.26 1.75 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.857 . . . . 0.0 109.564 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.48 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.252 0.548 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.832 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.8 OUTLIER -126.15 -155.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.267 -0.895 . . . . 0.0 109.631 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.832 ' N ' HG13 ' B' ' 23' ' ' VAL . 2.5 t-20 86.68 4.72 0.39 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.287 0.565 . . . . 0.0 109.568 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -121.37 153.77 37.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.822 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.522 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -77.86 164.87 24.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.716 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -161.76 132.93 5.25 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.339 -1.475 . . . . 0.0 112.807 -179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.453 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -138.38 155.9 48.1 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 37.17 -115.2 0.29 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.446 ' O ' HG22 ' B' ' 33' ' ' VAL . 4.1 m -47.75 -65.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.455 -1.027 . . . . 0.0 110.842 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' B' ' 30' ' ' SER . 5.6 m-20 -42.48 -39.11 2.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.238 -0.914 . . . . 0.0 109.418 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.792 HD22 HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -65.99 -73.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 108.945 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.752 HG12 ' CD2' ' B' ' 47' ' ' TYR . 15.9 m -43.86 -28.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.146 -0.971 . . . . 0.0 108.69 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.519 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -78.18 -61.63 1.94 Allowed 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.541 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -56.67 -39.42 73.73 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.884 HD11 ' CD2' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -64.14 -34.13 77.35 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.942 0.877 . . . . 0.0 108.806 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.418 ' O ' ' HA2' ' B' ' 41' ' ' GLY . 20.4 t80 -75.97 -22.33 56.0 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.742 -0.599 . . . . 0.0 110.077 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.537 ' N ' HD23 ' B' ' 38' ' ' LEU . 0.3 OUTLIER -76.5 -53.41 8.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.944 -1.097 . . . . 0.0 108.484 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 16' ' ' LEU . 2.6 m -54.1 -32.24 22.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.534 ' HB3' ' CD ' ' B' ' 43' ' ' ARG . 1.3 m -122.83 39.59 3.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.506 -0.746 . . . . 0.0 109.713 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' B' ' 37' ' ' TYR . . . -53.45 -32.3 45.13 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.73 7.65 9.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -1.181 . . . . 0.0 109.94 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.534 ' CD ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -116.05 139.75 49.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 108.947 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.08 153.73 17.29 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.34 -151.95 6.18 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.22 31.81 0.24 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.233 -1.157 . . . . 0.0 109.636 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.752 ' CD2' HG12 ' B' ' 33' ' ' VAL . 1.2 t80 -56.63 -18.4 11.97 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.447 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 5.8 m -62.19 -27.1 68.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 0.0 109.577 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -154.79 87.51 3.37 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.412 -0.805 . . . . 0.0 109.2 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.28 170.5 19.88 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.705 2.27 . . . . 0.0 110.651 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.49 -179.864 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.338 2.495 . . . . 0.0 119.338 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.751 HG22 HD21 ' B' ' 32' ' ' LEU . 62.2 mt -92.55 -28.94 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -1.077 . . . . 0.0 109.941 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 1.4 m -62.22 -37.41 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.369 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 3.0 mt-10 -76.06 -1.17 24.63 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.362 -0.836 . . . . 0.0 109.644 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -43.4 4.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.108 -0.995 . . . . 0.0 110.045 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 9' ' ' SER . 95.6 m -103.72 -29.35 11.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.103 -0.998 . . . . 0.0 110.093 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.568 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 2.5 t -69.26 -6.98 32.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.042 -1.036 . . . . 0.0 109.349 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -99.6 -31.3 11.66 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.19 -0.943 . . . . 0.0 108.526 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 6' ' ' CYS . 4.2 m -147.45 165.24 30.84 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.486 ' N ' HD13 ' A' ' 10' ' ' ILE . 3.9 mm -80.15 110.42 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.104 -0.997 . . . . 0.0 109.548 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 78.4 m -74.8 -170.71 1.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.662 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 13' ' ' LEU . 87.5 p -121.13 136.04 55.05 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER -42.81 -26.76 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.168 -0.957 . . . . 0.0 109.776 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -62.79 -49.34 75.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.125 -0.984 . . . . 0.0 108.888 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -65.07 -44.94 87.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.224 -0.923 . . . . 0.0 108.865 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.616 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 3.3 mp -55.65 -37.16 67.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.107 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 7.0 mm-40 -54.03 -34.5 60.17 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.286 -0.884 . . . . 0.0 108.749 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.14 -21.98 61.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.414 -0.804 . . . . 0.0 109.485 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.779 ' HD2' HD11 ' B' ' 36' ' ' LEU . 5.0 m-30 -62.44 -29.41 70.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 72.7 m -82.57 53.79 2.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.891 . . . . 0.0 109.276 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.4 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.538 ' O ' ' CD2' ' B' ' 22' ' ' PHE . 52.4 p90 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.592 ' O ' ' HB3' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -143.53 171.15 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.041 -1.037 . . . . 0.0 110.008 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.592 ' HB3' ' O ' ' B' ' 23' ' ' VAL . 2.2 p-10 167.5 -29.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.56 -171.04 3.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.536 -0.728 . . . . 0.0 109.932 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.536 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -118.79 -169.82 1.79 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -0.846 . . . . 0.0 109.022 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' B' ' 28' ' ' CYS . 0.3 OUTLIER -160.77 -159.27 0.66 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.751 -1.218 . . . . 0.0 110.415 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.616 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 145.9 141.9 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 123.558 0.743 . . . . 0.0 109.17 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 35.64 -118.19 0.35 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.1 OUTLIER -42.61 -62.83 0.89 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.427 -1.043 . . . . 0.0 110.177 -179.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' B' ' 31' ' ' ASP . 0.6 OUTLIER -43.99 -31.63 0.95 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.048 -1.033 . . . . 0.0 109.166 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.751 HD21 HG22 ' A' ' 2' ' ' ILE . 0.3 OUTLIER -68.69 -66.9 0.51 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.182 -0.949 . . . . 0.0 109.221 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.452 HG23 ' OE2' ' B' ' 34' ' ' GLU . 30.6 m -51.52 -28.64 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.995 -1.066 . . . . 0.0 108.489 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.503 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.1 mp0 -76.0 -58.77 3.08 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.545 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.55 -47.31 82.38 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.779 HD11 ' HD2' ' A' ' 19' ' ' TYR . 1.1 mm? -56.49 -29.01 61.29 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.781 0.8 . . . . 0.0 108.959 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' B' ' 33' ' ' VAL . 70.7 t80 -82.41 -15.09 53.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.828 -0.545 . . . . 0.0 109.988 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.4 OUTLIER -87.32 -46.64 9.5 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 16' ' ' LEU . 2.7 m -65.95 -21.37 28.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' B' ' 43' ' ' ARG . 1.3 m -119.9 27.09 8.89 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.451 -0.781 . . . . 0.0 109.235 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' B' ' 40' ' ' CYS . . . -43.45 -26.9 0.71 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' B' ' 40' ' ' CYS . 25.9 tt0 -90.92 -23.05 20.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -1.175 . . . . 0.0 109.644 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' B' ' 40' ' ' CYS . 2.0 ttt180 -110.25 159.37 17.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.406 -0.809 . . . . 0.0 109.222 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -178.45 142.57 5.53 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' B' ' 47' ' ' TYR . . . 115.94 -67.59 0.29 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.29 60.06 0.08 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 0.0 109.529 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.506 ' N ' ' O ' ' B' ' 45' ' ' GLY . 72.1 t80 -114.73 -17.36 11.63 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.486 -0.759 . . . . 0.0 110.346 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.532 ' O ' ' HD3' ' B' ' 50' ' ' PRO . 4.3 m -174.27 -18.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.219 -0.925 . . . . 0.0 111.381 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -113.01 85.57 8.11 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.647 -1.283 . . . . 0.0 109.465 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' B' ' 48' ' ' THR . 35.9 Cg_endo -76.42 -179.58 5.44 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.599 2.199 . . . . 0.0 110.695 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' B' ' 50' ' ' PRO . 41.8 p . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.345 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.872 0 N-CA-C 119.369 2.508 . . . . 0.0 119.369 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.566 HG21 ' CE2' ' A' ' 19' ' ' TYR . 22.3 mt -89.06 -31.73 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -1.139 . . . . 0.0 109.399 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.621 HG12 HD22 ' B' ' 32' ' ' LEU . 1.6 m -47.09 -40.14 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.22 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 6.4 mt-10 -56.47 -16.32 5.67 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.641 -0.662 . . . . 0.0 110.103 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -105.34 -31.08 9.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 110.303 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.617 ' HB3' HD11 ' B' ' 27' ' ' LEU . 7.3 m -103.01 -31.2 10.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.039 . . . . 0.0 110.127 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 1.5 m -84.84 -13.82 49.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.32 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.8 -13.29 15.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.037 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.5 m -150.65 158.36 44.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.354 -0.841 . . . . 0.0 109.07 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.414 HD12 HG23 ' A' ' 10' ' ' ILE . 20.4 mm -80.86 97.99 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.149 -0.969 . . . . 0.0 109.622 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' SG ' HD11 ' A' ' 16' ' ' LEU . 3.7 p -82.06 171.46 14.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 0.0 109.373 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.678 ' HA ' HG21 ' B' ' 23' ' ' VAL . 59.3 p -111.03 148.49 32.46 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.239 -0.913 . . . . 0.0 109.828 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.637 ' CD1' HG12 ' B' ' 39' ' ' VAL . 0.6 OUTLIER -45.45 -28.94 0.98 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.058 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -59.08 -53.41 58.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.368 -0.832 . . . . 0.0 109.024 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 19' ' ' TYR . 27.5 mm-40 -61.43 -29.11 69.73 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.286 -0.884 . . . . 0.0 109.048 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.883 HD23 HD13 ' B' ' 36' ' ' LEU . 6.9 mp -71.22 -38.92 72.0 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.258 -0.901 . . . . 0.0 108.7 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.45 -32.75 63.02 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -73.38 -26.87 61.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.433 -0.792 . . . . 0.0 109.277 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.566 ' CE2' HG21 ' A' ' 2' ' ' ILE . 6.2 m-30 -58.79 -19.79 44.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.166 -0.959 . . . . 0.0 108.814 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.67 51.75 1.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -0.768 . . . . 0.0 109.247 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.333 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.397 0.618 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.819 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -157.4 -158.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.368 -0.832 . . . . 0.0 109.865 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.819 ' N ' HG13 ' B' ' 23' ' ' VAL . 30.3 m-20 74.07 30.23 1.27 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -127.86 154.23 45.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.386 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.524 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -100.76 -178.35 3.75 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.782 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -161.0 -159.6 0.68 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.787 -1.195 . . . . 0.0 110.225 -179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.577 ' CB ' ' O ' ' B' ' 27' ' ' LEU . 1.2 m 149.35 150.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.49 -127.86 27.09 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.439 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.9 OUTLIER -58.34 -51.08 71.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.286 -1.126 . . . . 0.0 109.83 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' B' ' 30' ' ' SER . 3.2 m-20 -43.35 -42.87 4.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 109.26 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.853 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -63.09 -76.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.23 -0.918 . . . . 0.0 109.502 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.803 HG12 ' CE1' ' B' ' 47' ' ' TYR . 14.4 m -44.45 -33.93 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.029 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.528 ' O ' ' HG ' ' B' ' 38' ' ' LEU . 2.5 mm-40 -62.97 -52.71 61.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.477 -0.764 . . . . 0.0 109.151 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -55.9 -52.96 62.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.535 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.883 HD13 HD23 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -57.37 -29.96 64.46 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.892 -1.13 . . . . 0.0 107.955 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 86.3 t80 -73.27 -11.95 60.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.567 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -97.06 -51.2 4.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.979 . . . . 0.0 108.74 178.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.815 HG11 ' HB3' ' A' ' 16' ' ' LEU . 2.3 m -48.33 -36.66 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.509 ' CB ' ' HB3' ' B' ' 43' ' ' ARG . 0.9 OUTLIER -93.71 -53.37 4.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.389 -0.819 . . . . 0.0 109.157 179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.72 -50.42 3.58 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -116.86 22.36 12.69 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.186 . . . . 0.0 110.058 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.509 ' HB3' ' CB ' ' B' ' 40' ' ' CYS . 0.2 OUTLIER -56.31 -176.64 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.099 -1.0 . . . . 0.0 109.15 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.68 155.35 49.69 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.12 56.5 4.35 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -147.05 140.2 25.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.527 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.803 ' CE1' HG12 ' B' ' 33' ' ' VAL . 32.4 t80 -175.27 88.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.432 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' B' ' 50' ' ' PRO . 3.1 m -112.04 -50.51 2.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.549 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 2.1 tttp 165.37 -55.5 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.62 0 O-C-N 121.526 -0.734 . . . . 0.0 109.328 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 35.6 Cg_endo -76.45 -177.88 4.05 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.379 2.052 . . . . 0.0 110.744 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.561 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.883 0 N-CA-C 119.388 2.515 . . . . 0.0 119.388 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.7 mt -74.49 -25.98 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 109.567 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.732 HG12 HD22 ' B' ' 32' ' ' LEU . 1.3 m -71.3 -30.58 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.67 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -67.13 -10.73 53.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.619 -0.675 . . . . 0.0 109.807 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.18 -31.3 9.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.868 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.551 ' HB3' HD11 ' B' ' 27' ' ' LEU . 95.5 m -105.01 -34.53 7.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.982 -1.074 . . . . 0.0 110.076 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.538 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 1.8 t -63.44 -10.99 19.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.015 -1.053 . . . . 0.0 109.65 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 9' ' ' SER . 14.6 t -104.99 -37.9 6.8 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.469 ' N ' HG23 ' A' ' 8' ' ' THR . 7.9 m -127.2 147.8 50.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.702 ' CG2' HG22 ' B' ' 23' ' ' VAL . 0.9 OUTLIER -78.87 91.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.993 -1.067 . . . . 0.0 109.212 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.625 ' O ' HG23 ' B' ' 23' ' ' VAL . 59.7 m -54.74 172.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.434 -0.791 . . . . 0.0 109.498 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 13' ' ' LEU . 85.6 p -106.81 155.34 19.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 109.531 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.75 HD11 HG12 ' B' ' 39' ' ' VAL . 0.8 OUTLIER -45.51 -26.81 0.63 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.244 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -67.27 -44.35 79.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 10.0 mt-30 -65.47 -43.35 90.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.923 HD23 HD13 ' B' ' 36' ' ' LEU . 6.8 mp -61.72 -34.03 75.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.014 -1.054 . . . . 0.0 109.081 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -58.87 -23.61 61.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 1.3 m-80 -75.62 -24.37 56.49 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.53 -0.731 . . . . 0.0 109.615 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.632 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.6 m-30 -77.83 3.75 13.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.016 -1.052 . . . . 0.0 109.478 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 13.6 m -123.27 69.1 1.01 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 109.794 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 18' ' ' ASN . 17.4 p30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.421 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.498 ' HA ' HD13 ' A' ' 13' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.71 HG13 ' N ' ' B' ' 24' ' ' ASN . 1.3 p -95.44 -159.51 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.213 -0.929 . . . . 0.0 108.603 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.71 ' N ' HG13 ' B' ' 23' ' ' VAL . 6.5 t-20 78.08 30.44 0.44 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.489 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -155.54 162.62 40.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.436 -0.79 . . . . 0.0 109.127 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.538 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -110.74 179.93 3.93 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.686 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -160.24 -168.35 2.16 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.343 -1.473 . . . . 0.0 111.968 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' B' ' 32' ' ' LEU . 0.5 OUTLIER 151.38 147.72 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.66 -115.58 2.66 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 68.0 m -63.74 -57.58 9.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -1.132 . . . . 0.0 110.047 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' B' ' 30' ' ' SER . 6.6 m-20 -43.83 -36.23 2.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.205 -0.935 . . . . 0.0 109.437 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.88 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -67.85 -76.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.215 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' B' ' 32' ' ' LEU . 3.5 m -44.51 -29.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.32 -0.863 . . . . 0.0 108.673 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.53 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 7.1 mt-10 -66.07 -55.58 15.86 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.505 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -55.17 -55.21 33.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.347 -0.846 . . . . 0.0 108.787 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.923 HD13 HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -58.3 -18.44 27.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 108.637 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 23.3 t80 -86.12 -14.49 44.03 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -89.47 -42.11 11.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 108.805 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.75 HG12 HD11 ' A' ' 13' ' ' LEU . 2.3 m -75.62 -20.81 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.485 -0.759 . . . . 0.0 109.261 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' B' ' 39' ' ' VAL . 55.6 m -111.2 6.04 20.4 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.324 -0.86 . . . . 0.0 109.757 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.34 -12.29 83.67 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -82.24 -72.11 0.45 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -1.12 . . . . 0.0 109.626 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -175.01 1.84 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.464 -0.772 . . . . 0.0 109.617 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.01 -94.08 1.69 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.94 -119.63 5.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' B' ' 51' ' ' THR . 0.7 OUTLIER -149.94 27.42 0.79 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -1.132 . . . . 0.0 109.383 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.19 21.45 2.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.63 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 2.5 m -90.17 -13.97 34.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.375 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.603 ' HB3' ' HD3' ' B' ' 50' ' ' PRO . 2.5 tttt -168.32 -62.23 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.674 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' B' ' 49' ' ' LYS . 33.8 Cg_endo -72.94 172.96 14.36 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.948 1.765 . . . . 0.0 110.504 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.433 ' C ' ' O ' ' B' ' 50' ' ' PRO . 24.2 p . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.612 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.914 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 2' ' ' ILE . 6.7 tt -102.99 -13.14 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.232 -1.158 . . . . 0.0 109.659 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.836 HG12 HD22 ' B' ' 32' ' ' LEU . 10.9 m -99.65 -30.46 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 109.17 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.489 ' O ' ' CG2' ' A' ' 8' ' ' THR . 10.1 mt-10 -82.68 -4.95 58.55 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.308 -0.87 . . . . 0.0 109.958 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -105.55 -34.93 7.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -0.991 . . . . 0.0 110.01 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.519 ' CB ' HD11 ' B' ' 27' ' ' LEU . 82.0 m -105.42 -30.31 9.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.054 -1.029 . . . . 0.0 110.412 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.558 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 4.5 t -71.57 -6.76 43.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.147 -0.97 . . . . 0.0 109.821 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -119.86 -14.33 8.98 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.234 -0.916 . . . . 0.0 108.815 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.68 ' O ' HD13 ' A' ' 10' ' ' ILE . 68.0 m -136.88 -165.68 1.78 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 9' ' ' SER . 4.6 mm -120.99 92.35 2.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 109.548 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.788 ' O ' HG23 ' B' ' 23' ' ' VAL . 28.0 m -71.66 171.68 11.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.482 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 13' ' ' LEU . 25.4 p -116.12 153.42 31.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.875 . . . . 0.0 108.861 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.707 ' CD1' HG12 ' B' ' 39' ' ' VAL . 0.8 OUTLIER -44.44 -29.54 0.71 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.101 -0.999 . . . . 0.0 109.083 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.32 -50.42 73.68 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.254 -0.904 . . . . 0.0 108.694 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.436 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 3.6 mm-40 -65.45 -35.58 81.34 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.835 ' CD2' HG11 ' B' ' 39' ' ' VAL . 3.4 mp -65.69 -33.91 76.98 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -25.25 63.98 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.88 -34.5 62.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.427 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.72 ' HD2' HD11 ' B' ' 36' ' ' LEU . 1.4 m-30 -59.4 -20.08 52.13 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 108.78 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.18 54.31 2.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.362 -0.836 . . . . 0.0 109.469 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.479 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.513 ' HA ' HD12 ' A' ' 13' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 11' ' ' CYS . 1.4 p -82.56 -166.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.422 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.742 ' H ' HG22 ' B' ' 23' ' ' VAL . 8.2 t30 46.47 38.66 5.65 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.559 -0.713 . . . . 0.0 109.308 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.17 169.11 24.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.881 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.538 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 1.1 t60 -125.98 172.01 10.29 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 1.136 HD13 ' CD1' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -161.29 -166.84 1.62 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.327 -1.483 . . . . 0.0 111.639 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 150.78 153.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 123.419 0.688 . . . . 0.0 109.265 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.79 -117.54 2.2 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.446 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.4 OUTLIER -60.84 -57.59 12.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.377 -1.072 . . . . 0.0 110.28 -179.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' B' ' 30' ' ' SER . 13.5 m-20 -42.28 -31.5 0.4 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.236 -0.915 . . . . 0.0 109.68 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 1.136 ' CD1' HD13 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -70.46 -68.46 0.42 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.156 -0.965 . . . . 0.0 108.87 179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.422 HG23 ' N ' ' B' ' 34' ' ' GLU . 33.5 m -51.74 -35.26 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.125 -0.985 . . . . 0.0 108.733 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.536 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 4.7 mt-10 -69.68 -52.94 21.17 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.376 -0.828 . . . . 0.0 108.982 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.539 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -62.99 -42.97 99.99 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.72 HD11 ' HD2' ' A' ' 19' ' ' TYR . 1.6 mm? -60.32 -30.5 69.55 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.894 0.854 . . . . 0.0 108.698 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.414 ' O ' ' CD1' ' B' ' 37' ' ' TYR . 13.3 t80 -77.37 -14.1 59.79 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.671 -0.643 . . . . 0.0 109.882 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.5 OUTLIER -88.27 -53.7 4.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.181 -0.949 . . . . 0.0 108.609 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.835 HG11 ' CD2' ' A' ' 16' ' ' LEU . 2.2 m -54.57 -27.11 17.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . . . . . . . . . 55.7 m -119.61 35.45 4.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.467 -0.771 . . . . 0.0 109.558 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.16 51.2 3.53 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -172.91 -34.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.303 -1.116 . . . . 0.0 109.481 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' B' ' 44' ' ' GLY . 7.0 ttt85 -92.71 153.13 19.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.493 -0.754 . . . . 0.0 109.311 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' B' ' 43' ' ' ARG . . . -54.67 -106.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.66 145.18 1.05 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.6 -156.24 0.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -1.177 . . . . 0.0 109.632 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.58 44.7 0.11 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 0.0 109.777 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.22 -74.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.301 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.37 104.13 0.34 Allowed Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -76.01 157.15 38.64 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.443 2.095 . . . . 0.0 110.666 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 89.0 m . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.439 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.813 0 N-CA-C 119.313 2.485 . . . . 0.0 119.313 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' B' ' 32' ' ' LEU . 7.9 mt -102.34 -45.66 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -1.16 . . . . 0.0 109.607 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.4 m -49.76 -34.47 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.703 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 3' ' ' VAL . 2.6 mt-10 -77.38 -7.6 56.35 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 109.851 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -40.72 5.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 110.142 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.474 ' O ' ' O ' ' A' ' 9' ' ' SER . 69.0 m -99.98 -34.69 9.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 0.0 110.509 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.581 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 6.1 t -71.96 -40.42 68.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.849 -1.157 . . . . 0.0 109.594 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 4' ' ' GLU . 55.0 p -77.85 -31.9 51.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.114 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.771 ' O ' HD13 ' A' ' 10' ' ' ILE . 2.5 p -124.62 -150.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -0.81 . . . . 0.0 109.531 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 9' ' ' SER . 5.5 mm -133.53 112.1 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.143 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.7 m -86.93 170.17 11.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 109.661 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' LEU . 79.4 p -102.76 140.23 37.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.417 -0.802 . . . . 0.0 109.383 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.664 HD13 ' CE2' ' B' ' 22' ' ' PHE . 0.8 OUTLIER -42.85 -31.3 0.48 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -62.97 -51.19 67.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.94 . . . . 0.0 109.373 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -37.56 74.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -0.913 . . . . 0.0 109.058 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.777 HD23 HD13 ' B' ' 36' ' ' LEU . 6.2 mp -64.93 -38.91 92.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 0.0 108.868 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.56 -26.25 63.38 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -74.87 -32.79 61.96 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.348 -0.845 . . . . 0.0 108.929 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.591 ' CD2' ' HA ' ' A' ' 16' ' ' LEU . 4.3 m-30 -57.59 -20.58 33.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.31 -0.869 . . . . 0.0 109.219 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 86.6 m -87.81 50.62 2.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.55 179.963 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.664 ' CE2' HD13 ' A' ' 13' ' ' LEU . 11.8 t80 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.4 0.619 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.82 HG13 ' N ' ' B' ' 24' ' ' ASN . 1.1 p -161.8 -153.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.756 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.82 ' N ' HG13 ' B' ' 23' ' ' VAL . 6.2 m-20 81.88 55.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.69 166.44 18.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.896 . . . . 0.0 109.63 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -124.97 146.56 49.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.813 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -160.91 145.05 13.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.294 -1.503 . . . . 0.0 112.679 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.46 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -133.91 155.07 50.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.523 -0.736 . . . . 0.0 109.447 178.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 34.35 -126.12 0.52 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.498 ' O ' HG22 ' B' ' 33' ' ' VAL . 0.2 OUTLIER -39.0 -63.8 0.5 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.606 -0.937 . . . . 0.0 110.715 -179.026 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' B' ' 30' ' ' SER . 10.3 m-20 -41.31 -32.14 0.28 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.825 . . . . 0.0 109.354 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.948 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.3 OUTLIER -69.15 -71.69 0.21 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.312 -0.867 . . . . 0.0 108.808 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.498 HG22 ' O ' ' B' ' 30' ' ' SER . 29.0 m -43.05 -39.15 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.262 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.514 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -63.19 -50.44 70.29 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.311 -0.868 . . . . 0.0 108.954 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.722 ' HB2' HD23 ' B' ' 27' ' ' LEU . . . -53.36 -57.69 9.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.458 -0.776 . . . . 0.0 109.443 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.948 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.3 OUTLIER -56.59 -22.73 35.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.047 -1.033 . . . . 0.0 108.526 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 11.1 t80 -82.5 -14.88 54.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.648 -0.657 . . . . 0.0 109.477 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -85.51 -45.31 11.91 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -67.86 -21.63 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.535 -0.728 . . . . 0.0 109.173 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.444 ' HB3' ' O ' ' B' ' 43' ' ' ARG . 96.2 m -113.45 16.02 18.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.404 -0.81 . . . . 0.0 109.353 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -44.04 -39.94 5.42 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.95 17.0 6.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -1.174 . . . . 0.0 109.422 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' B' ' 40' ' ' CYS . 1.8 tpt85 -132.85 111.37 11.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.323 -0.86 . . . . 0.0 109.367 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.43 -122.88 6.93 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.9 40.11 1.9 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.502 ' CG ' ' O ' ' B' ' 46' ' ' PHE . 29.6 t80 -108.88 -0.88 19.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -1.127 . . . . 0.0 109.507 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.41 ' CE1' HG12 ' B' ' 33' ' ' VAL . 2.3 t80 -78.69 50.84 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.823 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' B' ' 49' ' ' LYS . 11.4 m -113.21 -70.18 0.82 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.063 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' B' ' 48' ' ' THR . 8.2 tttp 69.5 96.15 0.05 OUTLIER Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.502 -0.748 . . . . 0.0 109.772 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.73 175.36 11.33 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.607 2.204 . . . . 0.0 110.524 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.459 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.409 2.523 . . . . 0.0 119.409 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.446 HG23 ' CZ ' ' A' ' 19' ' ' TYR . 62.0 mt -81.49 -32.94 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.265 -1.138 . . . . 0.0 109.65 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.954 HG12 HD22 ' B' ' 32' ' ' LEU . 2.9 m -60.58 -30.33 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.584 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.1 mt-10 -78.73 1.79 21.85 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.565 -0.71 . . . . 0.0 109.586 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 9' ' ' SER . 3.0 tp60 -105.24 -40.84 5.72 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.217 -0.927 . . . . 0.0 109.688 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 9' ' ' SER . 85.3 m -106.05 -36.87 6.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 110.667 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.564 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 8.8 t -68.97 -15.28 63.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.876 -1.14 . . . . 0.0 110.076 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 11.2 t -113.34 -27.72 7.84 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.493 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 18.2 m -126.65 156.76 40.5 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.482 ' CG2' ' HA ' ' B' ' 24' ' ' ASN . 5.5 mm -81.14 146.61 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.735 -1.228 . . . . 0.0 109.516 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.435 ' HB2' HD11 ' A' ' 16' ' ' LEU . 82.7 m -124.91 -169.19 1.94 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.363 -0.835 . . . . 0.0 109.768 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -137.47 143.1 41.6 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.653 ' HG ' HG12 ' B' ' 39' ' ' VAL . 0.9 OUTLIER -40.84 -33.32 0.29 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 109.66 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 75.1 t80 -65.93 -50.35 64.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.953 . . . . 0.0 108.616 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -60.98 -36.54 79.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.157 -0.964 . . . . 0.0 108.568 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.835 HD23 HD22 ' B' ' 36' ' ' LEU . 5.2 mp -69.37 -32.47 71.55 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' LEU . 2.5 mt-10 -56.98 -28.5 62.4 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -31.57 69.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.477 -0.764 . . . . 0.0 109.294 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.629 ' CD2' HD11 ' B' ' 36' ' ' LEU . 23.2 m-30 -58.68 -14.84 9.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -0.963 . . . . 0.0 109.547 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 84.4 m -99.73 57.64 1.01 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.964 . . . . 0.0 109.532 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.472 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.482 0.658 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.821 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -144.37 -159.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.392 -0.818 . . . . 0.0 109.885 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.821 ' N ' HG13 ' B' ' 23' ' ' VAL . 15.4 t-20 62.08 68.25 0.69 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.399 0.619 . . . . 0.0 109.667 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.27 173.45 11.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.209 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.564 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -121.14 150.86 40.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.76 HD23 ' N ' ' B' ' 27' ' ' LEU . 1.2 pt? -160.98 141.51 11.29 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.223 -1.548 . . . . 0.0 112.85 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.9 OUTLIER -139.54 167.9 21.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 40.71 -121.6 1.94 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.459 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.7 OUTLIER -53.1 -59.35 4.66 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.342 -1.093 . . . . 0.0 110.572 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.614 ' CB ' ' HB2' ' B' ' 27' ' ' LEU . 13.8 m-20 -40.09 -35.92 0.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.873 . . . . 0.0 109.765 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.954 HD22 HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -67.61 -72.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -0.927 . . . . 0.0 108.622 179.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -49.15 -27.98 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.941 . . . . 0.0 108.476 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.52 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -72.38 -56.29 5.7 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.704 ' HB3' ' CD1' ' B' ' 27' ' ' LEU . . . -60.21 -45.53 92.86 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.835 HD22 HD23 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -59.9 -27.09 66.43 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.513 ' O ' ' CA ' ' B' ' 41' ' ' GLY . 76.9 t80 -80.22 -11.9 59.69 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.75 -0.593 . . . . 0.0 109.822 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.541 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.6 OUTLIER -90.79 -48.51 6.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.979 . . . . 0.0 108.713 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.653 HG12 ' HG ' ' A' ' 13' ' ' LEU . 2.4 m -62.22 -29.47 46.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.484 -0.76 . . . . 0.0 108.963 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . . . . . . . . . 19.1 m -119.49 13.71 12.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.45 -0.781 . . . . 0.0 109.526 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' B' ' 37' ' ' TYR . . . -55.86 -40.87 82.43 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -105.34 -11.32 16.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -1.173 . . . . 0.0 109.46 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.14 138.31 41.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.601 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 50.95 -144.29 12.77 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . 0.557 ' C ' ' CG ' ' B' ' 46' ' ' PHE . . . 163.81 165.84 21.67 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.557 ' CG ' ' C ' ' B' ' 45' ' ' GLY . 0.8 OUTLIER 39.29 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.523 -0.987 . . . . 0.0 109.77 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -75.63 3.18 10.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -55.22 -20.55 11.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.067 -1.021 . . . . 0.0 109.349 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt 57.02 92.71 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.417 -0.802 . . . . 0.0 109.671 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.33 158.59 33.14 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.67 2.246 . . . . 0.0 110.56 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 91.5 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.554 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.37 2.508 . . . . 0.0 119.37 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.738 HG22 HD21 ' B' ' 32' ' ' LEU . 10.5 mt -80.35 -23.13 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -1.111 . . . . 0.0 109.38 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 3.1 m -60.97 -27.63 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.611 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -83.41 4.74 26.28 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.47 -0.769 . . . . 0.0 109.458 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.75 -49.36 3.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.169 -0.957 . . . . 0.0 110.455 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 9' ' ' SER . 62.0 m -104.97 -34.08 8.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 110.752 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 4.2 t -61.65 -12.06 14.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.774 -1.204 . . . . 0.0 109.553 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.1 t -99.13 -32.81 11.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 0.0 108.446 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.582 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 5.7 t -120.71 -156.97 0.7 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' B' ' 24' ' ' ASN . 25.1 mm -109.98 -4.71 10.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.835 -1.166 . . . . 0.0 109.567 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.433 ' O ' ' O ' ' A' ' 10' ' ' ILE . 1.5 m 45.41 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.952 . . . . 0.0 110.24 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.6 p -150.58 149.84 30.42 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.74 -25.33 1.2 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.07 -1.019 . . . . 0.0 109.625 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -61.82 -55.05 34.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.162 -0.961 . . . . 0.0 109.173 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 -46.8 84.76 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.311 -0.868 . . . . 0.0 109.331 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 16' ' ' LEU . 8.3 mp -61.47 -35.61 78.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.109 -0.994 . . . . 0.0 108.737 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -56.83 -23.36 43.37 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.96 -25.2 58.69 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.589 -0.695 . . . . 0.0 109.305 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.58 ' CD2' HD11 ' B' ' 36' ' ' LEU . 1.8 m-30 -74.81 -3.77 33.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.943 -1.098 . . . . 0.0 109.183 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.566 ' SG ' HG23 ' B' ' 39' ' ' VAL . 61.0 m -78.38 51.97 1.09 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.219 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 t30 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.601 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 3.8 p90 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.585 0.707 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.822 HG13 ' N ' ' B' ' 24' ' ' ASN . 1.1 p -160.93 -153.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.579 -0.7 . . . . 0.0 109.422 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.822 ' N ' HG13 ' B' ' 23' ' ' VAL . 28.0 t-20 87.73 74.1 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.5 0.667 . . . . 0.0 109.558 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -158.24 154.37 27.14 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.582 ' CE1' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -105.16 174.54 5.83 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.806 HD12 ' N ' ' B' ' 27' ' ' LEU . 0.0 OUTLIER -153.69 -157.17 0.75 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.485 -1.385 . . . . 0.0 111.335 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.653 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.6 OUTLIER 139.24 146.14 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 124.127 0.971 . . . . 0.0 108.53 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.21 -131.02 19.67 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.489 ' HA ' HG22 ' B' ' 33' ' ' VAL . 7.3 m -55.62 -38.95 70.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.718 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.517 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 7.4 m-20 -52.1 -40.04 60.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.058 -1.026 . . . . 0.0 109.005 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.795 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -67.17 -72.49 0.16 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.897 . . . . 0.0 108.96 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.49 HG23 ' N ' ' B' ' 34' ' ' GLU . 27.7 m -42.89 -40.3 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.106 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.543 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.3 OUTLIER -54.67 -51.88 64.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.223 -0.923 . . . . 0.0 109.046 179.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' B' ' 38' ' ' LEU . . . -59.1 -54.33 48.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.039 -1.038 . . . . 0.0 108.822 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.795 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.8 OUTLIER -54.33 -20.15 6.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.138 -0.976 . . . . 0.0 108.881 179.297 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 33.1 t80 -86.09 -10.61 54.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.408 -0.807 . . . . 0.0 109.373 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -98.68 -40.54 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.038 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.566 HG23 ' SG ' ' A' ' 20' ' ' CYS . 2.3 m -78.86 -27.17 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.422 -0.798 . . . . 0.0 109.409 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.524 ' SG ' HG23 ' B' ' 39' ' ' VAL . 7.4 m -103.98 -1.01 28.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.46 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.15 -36.18 51.68 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.78 -15.04 25.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.156 -1.203 . . . . 0.0 109.641 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' B' ' 44' ' ' GLY . 8.5 ttt180 -123.76 161.93 24.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.44 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.525 ' N ' ' HG2' ' B' ' 43' ' ' ARG . . . -48.91 164.94 0.31 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 20' ' ' CYS . . . 116.71 -10.61 16.02 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.425 ' C ' ' O ' ' B' ' 45' ' ' GLY . 2.0 t80 -43.16 124.7 3.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.351 -1.088 . . . . 0.0 109.204 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.518 ' O ' ' CB ' ' B' ' 48' ' ' THR . 4.9 p90 -122.09 -134.48 0.3 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' B' ' 47' ' ' TYR . 1.1 m 162.59 -53.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.312 -0.868 . . . . 0.0 108.837 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -174.14 109.64 0.3 Allowed Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.589 -0.695 . . . . 0.0 109.452 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.3 -178.18 4.24 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.366 2.044 . . . . 0.0 110.455 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 58.9 p . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.495 179.955 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.896 0 N-CA-C 119.336 2.494 . . . . 0.0 119.336 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.757 HD13 ' CE2' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -104.91 -9.69 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.235 -1.156 . . . . 0.0 108.997 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.651 HG12 HD22 ' B' ' 32' ' ' LEU . 2.9 m -76.81 -35.3 24.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.359 -0.838 . . . . 0.0 109.893 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' THR . 3.6 mt-10 -61.69 -10.87 9.6 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.707 -0.621 . . . . 0.0 110.641 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -105.46 -34.24 7.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.907 -1.12 . . . . 0.0 110.126 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.3 m -98.76 -18.49 17.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.678 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.543 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 13.3 t -86.2 -34.95 20.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 4' ' ' GLU . 6.2 t -89.67 -30.1 18.32 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.45 ' OG ' HG23 ' A' ' 8' ' ' THR . 4.5 m -128.71 165.29 21.16 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.566 HG21 ' HA ' ' B' ' 24' ' ' ASN . 0.5 OUTLIER -94.23 128.11 45.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.238 -0.914 . . . . 0.0 109.116 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.615 ' HB2' HD11 ' A' ' 16' ' ' LEU . 66.1 m -96.88 175.28 6.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 109.61 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 29.4 p -106.61 148.03 28.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 109.281 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.575 ' HG ' HG12 ' B' ' 39' ' ' VAL . 0.2 OUTLIER -43.42 -30.17 0.52 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.119 -0.988 . . . . 0.0 109.81 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -62.21 -56.57 17.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.366 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.484 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 1.2 mp0 -57.88 -38.33 75.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.184 -0.947 . . . . 0.0 109.128 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.823 ' CB ' HG11 ' B' ' 39' ' ' VAL . 6.8 mp -67.07 -39.97 86.96 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.184 -0.948 . . . . 0.0 108.838 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.54 -25.94 53.35 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -70.95 -32.18 68.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.468 -0.77 . . . . 0.0 109.095 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.757 ' CE2' HD13 ' A' ' 2' ' ' ILE . 1.6 m-30 -68.71 -31.67 70.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.139 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.6 m -60.63 -98.89 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.988 0.899 . . . . 0.0 109.923 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 . . . . . 0 C--N 1.278 -2.513 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.34 -179.485 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.527 ' CG ' ' O ' ' B' ' 22' ' ' PHE . 2.2 t80 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.393 0.616 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.802 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.3 OUTLIER -160.58 -162.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.239 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.802 ' N ' HG13 ' B' ' 23' ' ' VAL . 0.8 OUTLIER 73.28 68.94 0.11 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.523 -0.736 . . . . 0.0 109.566 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.505 ' O ' HG13 ' A' ' 10' ' ' ILE . 3.1 tp60 -141.59 156.24 45.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 109.517 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.543 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -115.21 164.07 14.76 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 1.022 ' HG ' HD12 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -161.41 -156.37 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 119.951 -1.718 . . . . 0.0 112.901 -178.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.592 ' N ' ' HB2' ' B' ' 31' ' ' ASP . 0.3 OUTLIER 150.93 140.78 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.725 0 C-N-CA 123.557 0.743 . . . . 0.0 110.271 -178.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' B' ' 32' ' ' LEU . . . 43.88 -128.99 6.51 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.454 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.3 OUTLIER -47.2 -39.46 14.02 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.156 -1.202 . . . . 0.0 108.821 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.592 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 80.8 m-20 -59.28 -29.83 67.87 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.208 -0.933 . . . . 0.0 108.704 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 1.022 HD12 ' HG ' ' B' ' 27' ' ' LEU . 0.2 OUTLIER -68.7 -57.39 5.73 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.6 ' O ' ' CG ' ' B' ' 37' ' ' TYR . 4.8 m -55.63 -35.58 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.538 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -59.58 -59.53 5.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.523 ' HA ' ' HG ' ' B' ' 38' ' ' LEU . . . -61.29 -46.76 88.98 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.599 HD11 ' HD2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -57.89 -33.63 68.94 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.6 ' CG ' ' O ' ' B' ' 33' ' ' VAL . 5.5 m-30 -71.45 -21.94 61.9 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.671 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -81.26 -58.11 3.2 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 108.895 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.823 HG11 ' CB ' ' A' ' 16' ' ' LEU . 2.5 m -47.27 -32.92 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.49 -0.756 . . . . 0.0 109.416 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' B' ' 43' ' ' ARG . 0.9 OUTLIER -100.09 -27.38 13.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 109.807 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.506 ' O ' ' CG ' ' B' ' 42' ' ' GLU . . . 41.24 65.81 1.04 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' B' ' 41' ' ' GLY . 10.6 pt-20 39.36 29.85 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -1.008 . . . . 0.0 110.115 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' B' ' 40' ' ' CYS . 0.8 OUTLIER -90.32 135.99 33.33 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.295 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 49.06 66.42 2.2 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.65 175.91 35.57 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.56 ' HB3' ' CD1' ' B' ' 47' ' ' TYR . 1.7 m-30 -79.75 -100.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.122 -1.223 . . . . 0.0 109.961 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.562 ' CE1' ' OH ' ' B' ' 37' ' ' TYR . 0.1 OUTLIER -107.15 -99.25 0.36 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.846 -1.159 . . . . 0.0 109.027 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' B' ' 47' ' ' TYR . 2.7 m -178.26 -50.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.226 -0.922 . . . . 0.0 109.155 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.67 77.38 0.45 Allowed Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.565 -0.709 . . . . 0.0 109.209 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.09 -177.44 3.82 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.803 2.336 . . . . 0.0 110.786 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.341 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.809 0 N-CA-C 119.414 2.526 . . . . 0.0 119.414 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.439 HG22 HD21 ' B' ' 32' ' ' LEU . 19.6 mt -89.22 -25.64 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -1.103 . . . . 0.0 109.49 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 7' ' ' CYS . 2.5 m -56.96 -30.55 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 109.724 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -78.37 1.68 21.16 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.496 -0.752 . . . . 0.0 109.706 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -105.63 -42.74 5.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 0.0 109.545 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 9' ' ' SER . 98.7 m -105.65 -39.99 5.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 0.0 110.065 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.595 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 2.2 t -58.28 -54.02 51.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.757 -1.214 . . . . 0.0 108.248 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.1 p -64.03 -68.97 0.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.065 . . . . 0.0 108.368 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 3.3 m -95.27 141.0 29.37 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.3 113.65 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.863 -1.148 . . . . 0.0 109.953 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.7 m -77.96 -168.08 1.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.177 -0.952 . . . . 0.0 109.606 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.608 ' HA ' HG11 ' B' ' 23' ' ' VAL . 6.3 p -122.34 142.1 50.85 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -43.11 -27.2 0.2 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.006 . . . . 0.0 109.644 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' SER . 86.9 t80 -62.53 -60.86 2.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.179 -0.951 . . . . 0.0 108.879 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -55.54 -41.71 73.6 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.305 -0.872 . . . . 0.0 109.044 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.697 ' HB3' HG21 ' B' ' 39' ' ' VAL . 1.6 mp -56.34 -45.99 80.16 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.186 -0.946 . . . . 0.0 108.787 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.81 -23.86 3.07 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -71.21 -38.67 72.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.57 -0.706 . . . . 0.0 109.159 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.838 ' CD2' HD11 ' B' ' 36' ' ' LEU . 23.1 m-85 -50.91 -32.81 21.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.077 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.441 ' SG ' ' HG3' ' B' ' 43' ' ' ARG . 1.7 m -85.78 52.32 2.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.407 -0.808 . . . . 0.0 109.394 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.9 t30 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.656 -179.794 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.608 HG11 ' HA ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -79.77 -168.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.242 -0.911 . . . . 0.0 109.679 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 6.6 t30 87.86 -11.07 0.51 Allowed 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -104.55 144.71 31.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.198 -0.939 . . . . 0.0 109.257 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -91.23 159.5 16.02 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.678 ' O ' HD12 ' B' ' 27' ' ' LEU . 0.3 OUTLIER -160.77 136.54 8.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.28 -1.512 . . . . 0.0 112.27 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.506 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -131.77 145.89 51.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.772 . . . . 0.0 109.009 178.244 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 28.34 -103.35 0.01 OUTLIER Glycine 0 N--CA 1.501 3.006 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.668 ' O ' HG22 ' B' ' 33' ' ' VAL . 16.1 t -41.21 -63.75 0.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.434 -1.039 . . . . 0.0 109.881 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.92 -33.74 18.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 108.64 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' B' ' 29' ' ' GLY . 0.3 OUTLIER -60.22 -65.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -0.861 . . . . 0.0 109.045 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.668 HG22 ' O ' ' B' ' 30' ' ' SER . 35.4 m -49.49 -31.07 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 108.41 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.526 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 7.9 mt-10 -72.69 -59.0 2.93 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.564 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -60.7 -41.88 96.09 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.838 HD11 ' CD2' ' A' ' 19' ' ' TYR . 2.2 mm? -59.51 -30.4 68.55 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -80.12 -13.56 59.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.715 -0.615 . . . . 0.0 110.065 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.544 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -91.04 -47.08 7.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 108.609 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.697 HG21 ' HB3' ' A' ' 16' ' ' LEU . 2.5 m -63.49 -22.06 29.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.445 -0.785 . . . . 0.0 109.138 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' B' ' 43' ' ' ARG . 84.3 m -101.68 -41.63 6.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.26 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.54 -50.18 3.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' B' ' 43' ' ' ARG . 5.3 pt-20 -174.89 34.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.121 -1.223 . . . . 0.0 109.797 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.51 ' HD3' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -43.03 150.03 0.18 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.559 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.93 -26.65 70.6 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -119.09 103.3 0.99 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.453 ' CG ' ' N ' ' B' ' 47' ' ' TYR . 0.1 OUTLIER -71.88 -156.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -1.127 . . . . 0.0 109.744 -179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.624 ' O ' ' HB ' ' B' ' 48' ' ' THR . 0.7 OUTLIER -42.65 -68.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -0.797 . . . . 0.0 109.626 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.624 ' HB ' ' O ' ' B' ' 47' ' ' TYR . 2.5 m 74.1 -9.2 1.3 Allowed 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.052 0.454 . . . . 0.0 110.464 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.9 ttpp 51.45 90.7 0.08 OUTLIER Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 121.043 -1.036 . . . . 0.0 109.438 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.86 150.14 30.08 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.691 2.261 . . . . 0.0 110.689 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.374 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 4' ' ' GLU . . . . . . . . 1 N--CA 1.529 4.873 0 N-CA-C 119.436 2.534 . . . . 0.0 119.436 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.488 HG22 ' CD2' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -99.64 -27.82 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -1.19 . . . . 0.0 109.145 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 1.4 m -46.69 -29.46 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.941 . . . . 0.0 108.765 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 1' ' ' GLY . 0.9 OUTLIER -55.18 -19.65 8.43 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.55 -75.48 0.57 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.8 . . . . 0.0 109.795 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 1.046 ' O ' HD11 ' B' ' 32' ' ' LEU . 9.4 m -97.93 96.37 8.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.44 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.706 ' HB2' HD11 ' B' ' 32' ' ' LEU . 8.0 t 161.33 -33.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -3.36 21.97 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.544 ' C ' ' CE1' ' B' ' 26' ' ' HIS . 0.6 OUTLIER -156.06 -173.78 4.66 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.614 HD13 ' ND1' ' B' ' 26' ' ' HIS . 23.3 mm -91.9 142.09 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.019 -1.051 . . . . 0.0 109.396 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.4 -168.87 1.6 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.891 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -145.75 144.8 30.55 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -43.58 -27.44 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.0 109.655 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -63.51 -53.16 56.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.658 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 4.1 mt-30 -58.48 -32.93 69.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 109.75 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.736 HD23 ' CD1' ' B' ' 36' ' ' LEU . 6.1 mp -67.85 -35.36 78.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.076 -1.015 . . . . 0.0 109.104 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.37 -22.12 62.93 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 15' ' ' GLN . 25.3 m-80 -74.39 -37.51 63.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.571 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -67.84 -15.57 63.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 109.413 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 m -104.5 51.02 0.78 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.298 -0.876 . . . . 0.0 109.456 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.6 t30 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.462 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.429 ' HB3' HG22 ' B' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.609 0.718 . . . . 0.0 109.393 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.57 ' O ' ' CB ' ' B' ' 24' ' ' ASN . 0.0 OUTLIER -154.8 173.48 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 121.645 -0.659 . . . . 0.0 109.562 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' B' ' 23' ' ' VAL . 10.0 p-10 153.37 49.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.27 151.59 30.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.355 -0.841 . . . . 0.0 109.41 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.614 ' ND1' HD13 ' A' ' 10' ' ' ILE . 2.2 t60 -72.4 -164.35 0.15 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.414 -0.804 . . . . 0.0 109.673 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' B' ' 35' ' ' ALA . 0.4 OUTLIER -155.81 -171.38 3.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.687 ' N ' HD12 ' B' ' 32' ' ' LEU . 1.3 m 149.09 139.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.474 0.654 . . . . 0.0 109.792 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 34.57 -126.61 0.57 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.8 m -41.57 -53.43 3.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.405 -1.056 . . . . 0.0 109.71 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.544 ' O ' HD23 ' B' ' 27' ' ' LEU . 17.0 m-20 -44.41 -31.14 0.98 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.266 -0.897 . . . . 0.0 109.17 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 1.072 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.1 OUTLIER -74.49 -77.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.214 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' B' ' 37' ' ' TYR . 9.4 m -41.6 -35.71 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.621 -0.674 . . . . 0.0 109.336 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.561 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 2.2 mp0 -70.28 -54.02 14.43 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.832 ' HB2' HD21 ' B' ' 27' ' ' LEU . . . -53.69 -56.41 17.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.16 -0.962 . . . . 0.0 109.462 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 1.072 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.1 OUTLIER -57.08 -20.88 27.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.97 -1.081 . . . . 0.0 108.162 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 89.3 t80 -84.96 -9.96 57.54 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.711 -0.618 . . . . 0.0 109.724 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -97.23 -42.62 7.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.085 -1.009 . . . . 0.0 108.961 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.412 HG23 ' SG ' ' B' ' 40' ' ' CYS . 1.7 m -72.52 -26.01 23.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.507 -0.745 . . . . 0.0 109.662 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.412 ' SG ' HG23 ' B' ' 39' ' ' VAL . 59.3 m -103.33 -11.84 17.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.181 -0.949 . . . . 0.0 109.786 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' B' ' 42' ' ' GLU . . . 49.76 25.44 6.98 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' B' ' 41' ' ' GLY . 0.2 OUTLIER 76.72 10.76 2.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -1.136 . . . . 0.0 109.259 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.12 154.95 5.1 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 0.0 109.418 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.28 -127.22 7.79 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.77 -91.02 2.2 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.89 -127.52 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -1.183 . . . . 0.0 109.188 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.66 -88.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.752 -1.217 . . . . 0.0 109.378 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 94.1 m -111.82 -77.06 0.59 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.364 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 59.57 93.71 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 109.615 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.38 146.09 24.44 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.614 2.209 . . . . 0.0 110.552 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.4 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.894 0 N-CA-C 119.48 2.552 . . . . 0.0 119.48 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.9 mt -81.8 -46.03 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -1.111 . . . . 0.0 109.604 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.914 HG12 HD22 ' B' ' 32' ' ' LEU . 4.4 m -54.36 -18.82 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.78 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' HG21 ' A' ' 8' ' ' THR . 4.3 mt-10 -92.21 -7.71 47.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.646 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.45 -31.31 9.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.13 -0.982 . . . . 0.0 110.114 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' O ' ' N ' ' A' ' 9' ' ' SER . 83.5 m -105.3 -62.26 1.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.061 -1.025 . . . . 0.0 110.374 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 48.6 t -47.26 -28.58 2.0 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.939 -1.101 . . . . 0.0 109.388 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.405 HG21 ' O ' ' A' ' 4' ' ' GLU . 3.1 t -69.88 -20.17 63.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.972 -1.08 . . . . 0.0 108.92 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.527 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 4.6 t -150.56 -151.24 0.38 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.42 128.32 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.945 -1.097 . . . . 0.0 109.498 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.2 m -111.4 164.84 12.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.849 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 13' ' ' LEU . 14.5 p -108.17 141.92 39.18 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.93 HD13 ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -46.14 -28.28 1.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.827 -1.171 . . . . 0.0 109.151 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -53.52 -47.38 69.97 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.439 ' O ' ' CE1' ' A' ' 19' ' ' TYR . 48.5 mm-40 -65.6 -40.86 93.13 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.93 ' HB2' HD13 ' A' ' 13' ' ' LEU . 7.9 mp -63.51 -34.68 78.32 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 4.1 mt-10 -54.95 -32.5 61.46 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -30.29 70.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.862 ' HD2' HD11 ' B' ' 36' ' ' LEU . 1.0 OUTLIER -63.59 -41.92 98.3 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.18 -0.95 . . . . 0.0 108.695 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 48.8 m -91.11 53.7 2.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.777 . . . . 0.0 109.652 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.4 t30 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.466 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.919 HG12 ' H ' ' A' ' 13' ' ' LEU . 33.6 m -87.85 -158.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 122.059 0.933 . . . . 0.0 109.802 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.71 64.96 0.97 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.699 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.49 -177.19 5.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 109.233 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.537 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 1.2 t60 -138.02 169.06 18.44 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 1.12 HD13 ' CD1' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -161.13 -137.84 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.716 -1.24 . . . . 0.0 109.644 179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.715 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.8 OUTLIER 137.13 134.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . 33.54 -113.55 0.09 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.443 ' O ' ' C ' ' B' ' 31' ' ' ASP . 0.1 OUTLIER -48.27 -56.23 8.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.445 -1.032 . . . . 0.0 109.926 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.568 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 4.1 m-20 -44.36 -33.65 1.71 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.208 -0.932 . . . . 0.0 109.095 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 1.12 ' CD1' HD13 ' B' ' 27' ' ' LEU . 0.8 OUTLIER -65.87 -71.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 108.943 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.416 HG22 ' O ' ' B' ' 30' ' ' SER . 14.3 m -48.83 -24.47 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.518 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 5.4 mt-10 -75.34 -61.85 1.76 Allowed 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.454 -0.779 . . . . 0.0 108.995 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.535 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -57.35 -44.0 83.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.862 HD11 ' HD2' ' A' ' 19' ' ' TYR . 2.4 mm? -57.31 -33.32 67.58 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.967 0.889 . . . . 0.0 108.725 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.444 ' CD2' HD23 ' B' ' 38' ' ' LEU . 11.8 t80 -77.3 -16.83 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.248 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.535 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -90.95 -33.55 15.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.111 -0.993 . . . . 0.0 108.904 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.747 HG21 HD11 ' A' ' 13' ' ' LEU . 1.4 m -88.93 -14.48 9.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.505 -0.747 . . . . 0.0 109.443 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 43' ' ' ARG . 93.4 m -114.68 -10.58 12.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.375 -0.828 . . . . 0.0 109.364 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' B' ' 42' ' ' GLU . . . 46.29 67.74 1.27 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' B' ' 41' ' ' GLY . 2.0 pt-20 37.48 38.98 0.16 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.705 -0.88 . . . . 0.0 110.483 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 40' ' ' CYS . 2.1 ttt85 -64.86 147.55 53.05 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 108.983 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.41 158.82 12.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.77 -1.62 87.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -127.84 -144.05 0.29 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.161 -1.2 . . . . 0.0 109.388 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -115.67 -16.4 11.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 109.282 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 89.7 m -159.4 -39.56 0.06 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.403 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -118.44 86.33 28.04 Favored Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 121.501 -0.75 . . . . 0.0 109.164 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.71 175.25 11.61 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.692 2.262 . . . . 0.0 110.696 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.444 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.816 0 N-CA-C 119.447 2.539 . . . . 0.0 119.447 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.763 HG21 ' CZ ' ' A' ' 19' ' ' TYR . 12.3 mt -89.85 -36.42 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -1.166 . . . . 0.0 109.554 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.691 HG12 HD13 ' B' ' 32' ' ' LEU . 2.4 m -39.19 -31.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.63 -0.669 . . . . 0.0 110.534 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 2' ' ' ILE . 4.8 mt-10 -68.93 -7.68 37.29 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.376 -0.828 . . . . 0.0 110.238 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.75 -35.42 7.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.065 -1.022 . . . . 0.0 110.251 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.666 ' HB3' HD11 ' B' ' 27' ' ' LEU . 96.7 m -105.36 -60.84 1.56 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.964 -1.085 . . . . 0.0 110.944 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.539 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 2.6 t -40.11 -60.31 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.022 -1.049 . . . . 0.0 109.946 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 7' ' ' CYS . 1.8 t -42.6 -29.31 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.169 -0.957 . . . . 0.0 109.248 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.617 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 18.3 m -142.47 -137.33 0.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.456 -0.777 . . . . 0.0 108.983 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.48 HG13 ' ND1' ' B' ' 26' ' ' HIS . 1.4 mt -146.85 113.61 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.589 -1.319 . . . . 0.0 109.299 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.451 ' HB3' ' OE1' ' A' ' 15' ' ' GLN . 21.4 m -88.29 -167.26 1.82 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.42 -0.8 . . . . 0.0 110.096 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.546 ' HA ' HG21 ' B' ' 23' ' ' VAL . 39.1 p -115.02 159.28 20.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.098 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.508 HD11 HG12 ' B' ' 39' ' ' VAL . 0.4 OUTLIER -50.85 -23.58 2.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.976 -1.077 . . . . 0.0 109.232 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.473 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 44.4 t80 -65.37 -48.34 73.26 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 108.812 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.451 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 0.1 OUTLIER -57.82 -39.14 76.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 108.587 179.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.64 ' CD2' ' HB1' ' B' ' 35' ' ' ALA . 6.2 mp -65.16 -35.69 81.88 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.376 -0.828 . . . . 0.0 108.8 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 1.8 mm-40 -55.96 -27.53 52.98 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -75.08 -17.17 60.51 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.496 -0.753 . . . . 0.0 109.318 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.763 ' CZ ' HG21 ' A' ' 2' ' ' ILE . 1.3 m-85 -72.81 -29.75 63.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 108.465 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.9 m -85.89 52.11 2.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 0.0 109.614 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.506 179.878 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.476 ' O ' ' CD2' ' B' ' 22' ' ' PHE . 12.2 p90 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.306 0.574 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.797 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.7 OUTLIER -148.74 -159.8 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.428 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.797 ' N ' HG13 ' B' ' 23' ' ' VAL . 11.4 t-20 77.74 57.96 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.449 0.642 . . . . 0.0 109.347 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.57 142.92 39.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.323 -0.861 . . . . 0.0 109.299 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.617 ' CE1' ' O ' ' A' ' 9' ' ' SER . 0.8 OUTLIER -90.92 144.1 26.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.815 ' O ' HD12 ' B' ' 27' ' ' LEU . 0.4 OUTLIER -154.07 145.7 23.26 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.348 -1.47 . . . . 0.0 112.133 -178.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' B' ' 32' ' ' LEU . 0.8 OUTLIER -124.92 -162.79 1.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' B' ' 28' ' ' CYS . . . -37.47 -63.02 0.87 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.212 -0.93 . . . . 0.0 111.679 -179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.402 ' O ' ' OE1' ' B' ' 34' ' ' GLU . 1.4 p -69.77 -40.29 76.17 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.9 -1.353 . . . . 0.0 111.25 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.568 ' HB2' ' CA ' ' B' ' 27' ' ' LEU . 0.3 OUTLIER -70.71 -20.95 62.61 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.475 -1.391 . . . . 0.0 108.276 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.99 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.6 OUTLIER -69.06 -70.22 0.29 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.549 HG12 ' CE2' ' B' ' 47' ' ' TYR . 33.2 m -43.66 -31.35 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.532 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.4 mt-10 -68.94 -54.61 14.49 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.64 ' HB1' ' CD2' ' A' ' 16' ' ' LEU . . . -57.42 -55.06 39.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 108.777 179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.99 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -54.21 -21.94 10.22 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.041 -1.037 . . . . 0.0 108.248 179.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.525 ' O ' ' HA2' ' B' ' 41' ' ' GLY . 13.4 t80 -84.53 -6.43 59.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -105.76 -50.4 3.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.066 -1.021 . . . . 0.0 108.963 179.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.508 HG12 HD11 ' A' ' 13' ' ' LEU . 1.8 m -67.03 -25.76 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.443 -0.786 . . . . 0.0 109.78 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.48 ' O ' ' C ' ' B' ' 41' ' ' GLY . 20.1 m -122.91 -21.13 5.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.0 109.921 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' B' ' 37' ' ' TYR . . . 40.52 29.72 0.27 Allowed Glycine 0 N--CA 1.496 2.637 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.539 ' HG2' ' N ' ' B' ' 46' ' ' PHE . 16.4 tp10 49.42 91.74 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.483 -1.01 . . . . 0.0 108.34 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.3 51.81 0.88 Allowed 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.645 -0.659 . . . . 0.0 109.707 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.94 63.73 0.01 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . 0.487 ' C ' ' HG2' ' B' ' 42' ' ' GLU . . . 109.07 -140.98 15.85 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.539 ' N ' ' HG2' ' B' ' 42' ' ' GLU . 0.5 OUTLIER -120.15 177.9 4.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.175 -1.191 . . . . 0.0 109.117 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.639 ' O ' ' HB ' ' B' ' 48' ' ' THR . 0.1 OUTLIER -40.37 -75.86 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 109.65 -179.345 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.639 ' HB ' ' O ' ' B' ' 47' ' ' TYR . 86.5 m 85.59 -22.73 0.18 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.418 0.628 . . . . 0.0 110.201 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.469 ' HG2' ' HD2' ' B' ' 50' ' ' PRO . 2.3 tttt 177.16 129.35 0.19 Allowed Pre-proline 0 C--N 1.292 -1.896 0 O-C-N 121.48 -0.762 . . . . 0.0 109.032 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.541 ' HA ' ' CE2' ' B' ' 47' ' ' TYR . 36.4 Cg_endo -77.05 143.29 22.7 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.276 1.984 . . . . 0.0 110.523 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.593 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.955 0 N-CA-C 119.385 2.514 . . . . 0.0 119.385 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.2 mm -104.82 -32.14 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -1.208 . . . . 0.0 109.617 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.033 HG12 ' CD2' ' B' ' 32' ' ' LEU . 0.9 OUTLIER -85.41 -41.33 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.614 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 3' ' ' VAL . 5.9 mt-10 -70.44 -19.86 62.94 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.599 -0.688 . . . . 0.0 110.219 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -89.31 -34.79 16.44 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.125 -0.984 . . . . 0.0 109.48 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.5 m -105.83 -42.43 5.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 0.0 110.452 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.556 ' O ' ' NE2' ' B' ' 26' ' ' HIS . 9.1 t -63.14 -18.12 63.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.934 -1.104 . . . . 0.0 110.062 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 4' ' ' GLU . 16.0 p -104.77 -38.5 6.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.077 -1.014 . . . . 0.0 108.516 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.711 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -108.7 -155.89 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.711 HD13 ' O ' ' A' ' 9' ' ' SER . 9.6 mm -129.75 83.34 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.979 -1.076 . . . . 0.0 109.57 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' HB2' HD11 ' A' ' 16' ' ' LEU . 64.1 m -59.71 171.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.291 -0.881 . . . . 0.0 109.61 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.771 ' HA ' HG21 ' B' ' 23' ' ' VAL . 94.5 p -112.99 145.14 41.37 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -43.52 -27.48 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 108.966 -179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 28.5 t80 -62.54 -46.13 89.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.4 -0.813 . . . . 0.0 108.903 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -66.32 -49.37 67.22 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 109.007 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.601 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 9.0 mp -56.19 -31.98 63.94 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.311 -0.868 . . . . 0.0 109.118 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' OE1' ' CD ' ' B' ' 43' ' ' ARG . 1.3 mm-40 -58.65 -35.2 72.17 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.309 -0.87 . . . . 0.0 108.745 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -75.09 -22.76 58.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.437 -0.789 . . . . 0.0 109.291 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.686 ' HD2' HD11 ' B' ' 36' ' ' LEU . 7.3 m-30 -60.28 -14.61 19.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.128 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.5 m -91.64 53.64 2.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.927 . . . . 0.0 109.385 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.5 p30 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.417 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.817 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.8 OUTLIER -160.36 -157.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.907 . . . . 0.0 109.697 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.817 ' N ' HG13 ' B' ' 23' ' ' VAL . 37.2 t-20 89.19 79.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.395 0.617 . . . . 0.0 109.835 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -161.0 -176.2 5.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.402 -0.811 . . . . 0.0 109.771 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.556 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -144.59 149.64 36.13 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.783 HD13 HD11 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -162.04 149.83 14.52 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.353 -1.467 . . . . 0.0 112.567 -178.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.505 ' O ' ' C ' ' B' ' 29' ' ' GLY . 0.8 OUTLIER -135.38 158.67 43.78 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.518 -0.739 . . . . 0.0 109.264 177.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' B' ' 32' ' ' LEU . . . 25.49 -119.66 0.03 OUTLIER Glycine 0 N--CA 1.5 2.962 0 CA-C-O 121.62 0.567 . . . . 0.0 112.149 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.579 ' O ' HG22 ' B' ' 33' ' ' VAL . 54.5 m -35.77 -57.5 0.66 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.544 -0.974 . . . . 0.0 110.884 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' B' ' 31' ' ' ASP . 0.7 OUTLIER -45.31 -44.01 11.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.915 -1.116 . . . . 0.0 109.087 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 1.033 ' CD2' HG12 ' A' ' 3' ' ' VAL . 3.1 mp -54.14 -65.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.194 -0.941 . . . . 0.0 108.979 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.579 HG22 ' O ' ' B' ' 30' ' ' SER . 18.1 m -51.36 -25.4 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.121 -0.987 . . . . 0.0 108.746 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.508 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.3 mt-10 -79.26 -58.41 3.24 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.686 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -60.65 -38.77 85.95 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.686 HD11 ' HD2' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -61.32 -33.93 74.42 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.933 0.873 . . . . 0.0 108.745 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -74.91 -31.73 61.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.783 -0.573 . . . . 0.0 109.897 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.556 ' N ' HD23 ' B' ' 38' ' ' LEU . 0.2 OUTLIER -70.49 -63.2 1.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.217 -0.927 . . . . 0.0 108.578 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.572 HG13 ' O ' ' B' ' 35' ' ' ALA . 2.5 m -45.41 -27.24 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.45 ' O ' ' C ' ' B' ' 41' ' ' GLY . 1.3 m -118.93 36.56 4.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.739 . . . . 0.0 109.552 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' B' ' 40' ' ' CYS . . . -41.35 -63.96 1.46 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -122.66 -22.95 5.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.069 -1.253 . . . . 0.0 109.946 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.493 ' CD ' ' OE1' ' A' ' 17' ' ' GLU . 0.9 OUTLIER -81.53 111.47 17.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.202 -0.936 . . . . 0.0 109.451 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.14 91.41 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.02 110.06 0.72 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -160.52 23.4 0.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -1.096 . . . . 0.0 109.406 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -76.46 -16.71 59.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.345 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' B' ' 49' ' ' LYS . 40.0 m -162.16 -73.9 0.05 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.701 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' B' ' 48' ' ' THR . 2.9 tptt 178.28 97.88 0.15 Allowed Pre-proline 0 C--N 1.298 -1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.5 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.49 150.29 31.78 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.539 2.159 . . . . 0.0 110.531 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.556 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.827 0 N-CA-C 119.433 2.533 . . . . 0.0 119.433 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.671 HD12 ' CE2' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -91.74 -26.04 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -1.168 . . . . 0.0 109.182 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.982 HG12 HD22 ' B' ' 32' ' ' LEU . 4.7 m -75.7 -9.35 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.64 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.441 ' O ' ' CG2' ' A' ' 8' ' ' THR . 1.9 mt-10 -98.25 -10.89 23.28 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.406 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -105.34 -34.2 7.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.562 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.761 ' HB3' HD11 ' B' ' 27' ' ' LEU . 64.1 m -93.94 -66.23 0.93 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 109.704 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.589 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 18.6 t -41.42 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 9' ' ' SER . 2.1 t -66.31 135.05 53.85 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.749 ' O ' HD13 ' A' ' 10' ' ' ILE . 1.5 m 75.65 -161.07 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 9' ' ' SER . 39.0 mm -128.5 130.67 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.61 -1.306 . . . . 0.0 110.248 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -166.54 1.62 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.476 -0.765 . . . . 0.0 109.593 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' C ' ' A' ' 13' ' ' LEU . 88.7 p -140.16 129.13 23.44 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' H ' HG23 ' B' ' 23' ' ' VAL . 0.4 OUTLIER -39.25 -33.47 0.14 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 109.781 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' SER . 27.8 t80 -57.7 -51.63 68.74 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.17 -0.956 . . . . 0.0 108.95 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.457 ' HG2' ' OG ' ' A' ' 12' ' ' SER . 15.4 mm100 -55.47 -44.96 76.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.873 . . . . 0.0 109.231 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.768 HD23 HD13 ' B' ' 36' ' ' LEU . 6.2 mp -57.05 -48.85 77.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.212 -0.93 . . . . 0.0 109.247 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' OE2' ' HB ' ' B' ' 39' ' ' VAL . 0.9 OUTLIER -52.8 -23.32 6.68 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.108 -0.995 . . . . 0.0 108.399 179.322 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -75.49 -29.81 59.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.484 -0.76 . . . . 0.0 109.005 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.671 ' CE2' HD12 ' A' ' 2' ' ' ILE . 1.7 m-30 -72.63 -11.84 60.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 0.0 109.182 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.4 m -89.86 51.34 2.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 109.433 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.487 -179.927 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 8.0 p90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.165 0.507 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.837 HG13 ' N ' ' B' ' 24' ' ' ASN . 0.4 OUTLIER -154.99 -158.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.203 -0.935 . . . . 0.0 109.99 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.837 ' N ' HG13 ' B' ' 23' ' ' VAL . 25.4 m-20 69.64 102.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -153.48 152.22 30.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.702 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.557 ' CE1' ' O ' ' A' ' 9' ' ' SER . 1.4 t60 -121.69 149.05 43.79 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.975 HD23 ' CB ' ' B' ' 35' ' ' ALA . 0.0 OUTLIER -153.88 -158.59 0.88 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.469 -1.394 . . . . 0.0 110.95 -179.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.563 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 148.77 146.28 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.77 -134.01 39.77 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.524 ' HA ' ' CG2' ' B' ' 33' ' ' VAL . 1.3 p -55.99 -46.25 78.75 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -1.131 . . . . 0.0 109.669 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' B' ' 30' ' ' SER . 9.0 m-20 -45.14 -43.27 9.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 108.555 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.982 HD22 HG12 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -60.1 -72.61 0.1 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.557 HG23 ' N ' ' B' ' 34' ' ' GLU . 14.8 m -45.12 -50.76 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.101 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.557 ' N ' HG23 ' B' ' 33' ' ' VAL . 1.5 mp0 -56.06 -44.42 78.85 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.301 -0.874 . . . . 0.0 109.075 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.975 ' CB ' HD23 ' B' ' 27' ' ' LEU . . . -55.12 -58.95 5.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.362 -0.836 . . . . 0.0 109.255 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.948 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.4 OUTLIER -56.0 -24.01 36.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.046 -1.034 . . . . 0.0 108.32 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 72.6 t80 -79.94 -15.78 56.6 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' B' ' 35' ' ' ALA . 1.4 mt -83.74 -54.82 4.64 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 108.645 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.478 ' HB ' ' OE2' ' A' ' 17' ' ' GLU . 2.5 m -54.16 -40.93 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.485 -0.759 . . . . 0.0 109.115 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.477 ' N ' ' CG2' ' B' ' 39' ' ' VAL . 79.0 m -99.31 17.41 20.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.338 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.06 -10.02 66.88 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -75.56 -26.06 57.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -1.22 . . . . 0.0 109.36 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.25 -172.65 2.31 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.446 -0.783 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -50.15 130.25 28.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.41 131.59 47.42 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' B' ' 47' ' ' TYR . 0.8 OUTLIER -161.4 -74.37 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -1.11 . . . . 0.0 109.329 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.465 ' C ' ' O ' ' B' ' 46' ' ' PHE . 53.2 t80 37.0 61.91 0.85 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.577 -0.702 . . . . 0.0 110.267 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' B' ' 46' ' ' PHE . 3.4 m -160.87 -54.62 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 109.642 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.478 ' N ' ' HD3' ' B' ' 50' ' ' PRO . 1.3 mttm -145.94 64.19 9.89 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.557 -0.714 . . . . 0.0 109.451 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' B' ' 49' ' ' LYS . 34.3 Cg_endo -76.95 -171.51 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.768 2.312 . . . . 0.0 110.683 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.456 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.784 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.7 mt -101.61 -17.42 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.339 -1.095 . . . . 0.0 108.997 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 3.5 m -62.12 -11.4 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.491 -0.756 . . . . 0.0 110.502 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -101.94 -4.92 25.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.027 -1.045 . . . . 0.0 110.425 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.448 ' HA ' ' OE1' ' A' ' 5' ' ' GLN . 5.3 mm100 -105.33 -42.26 5.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.009 -1.057 . . . . 0.0 110.266 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 8' ' ' THR . 29.0 m -105.66 -57.9 1.98 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.184 -0.948 . . . . 0.0 110.901 -178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.581 ' HA ' ' CD2' ' B' ' 26' ' ' HIS . 0.9 OUTLIER -37.15 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.218 -0.926 . . . . 0.0 111.411 -178.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' CYS . 3.3 t -68.83 -20.14 64.29 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.662 -1.274 . . . . 0.0 109.328 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.581 ' O ' ' CE1' ' B' ' 26' ' ' HIS . 11.7 t -158.15 -170.69 3.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.709 ' HA ' ' ND1' ' B' ' 26' ' ' HIS . 0.8 OUTLIER -103.26 94.77 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.702 -1.249 . . . . 0.0 110.546 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 67.9 m -55.54 168.75 0.37 Allowed 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 p -88.2 143.7 26.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.898 -1.126 . . . . 0.0 109.409 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 13' ' ' LEU . 3.0 tt -49.79 -24.09 2.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.978 . . . . 0.0 109.683 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -70.74 -38.79 73.55 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.182 -0.948 . . . . 0.0 109.072 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -66.6 -48.46 69.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -0.926 . . . . 0.0 109.618 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.893 HD23 HD13 ' B' ' 36' ' ' LEU . 6.5 mp -55.71 -34.12 64.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.944 -1.098 . . . . 0.0 108.567 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -63.13 -18.79 63.82 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -76.21 -28.87 57.38 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.485 -0.759 . . . . 0.0 109.059 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.611 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.9 m-30 -69.81 -5.49 25.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.483 ' HA ' ' HA3' ' B' ' 45' ' ' GLY . 8.3 m -83.89 51.32 2.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -0.965 . . . . 0.0 109.603 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.91 -1.043 . . . . 0.0 109.484 179.874 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.553 0.692 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.798 HG22 ' H ' ' B' ' 24' ' ' ASN . 2.3 p -160.7 -158.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.629 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.798 ' H ' HG22 ' B' ' 23' ' ' VAL . 34.2 m120 109.32 32.17 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.979 0.895 . . . . 0.0 108.622 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.477 ' O ' HD13 ' A' ' 10' ' ' ILE . 6.2 tp-100 -160.65 160.97 32.24 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.778 ' CE1' HD22 ' B' ' 27' ' ' LEU . 5.3 t60 -126.63 161.92 26.95 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 116.889 -1.924 . . . . 0.0 114.503 -178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.831 ' C ' HD23 ' B' ' 27' ' ' LEU . 0.1 OUTLIER -97.39 -155.73 0.5 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 113.582 -1.644 . . . . 0.0 110.734 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.587 ' N ' ' HG ' ' B' ' 27' ' ' LEU . 2.2 m 141.05 143.96 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.35 -132.71 49.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.294 -1.923 . . . . 0.0 108.294 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 2.9 m -52.5 -46.37 66.59 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.91 -1.347 . . . . 0.0 108.039 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.536 ' HB3' ' HA ' ' B' ' 27' ' ' LEU . 23.3 m-20 -49.39 -31.1 8.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.406 -0.808 . . . . 0.0 109.201 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.978 ' O ' HD22 ' B' ' 36' ' ' LEU . 0.4 OUTLIER -67.8 -68.04 0.42 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.249 -0.907 . . . . 0.0 108.875 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.565 ' HB ' ' CZ ' ' B' ' 47' ' ' TYR . 18.9 m -54.57 -36.64 36.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.365 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.541 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 0.1 OUTLIER -64.28 -52.19 59.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.521 -0.737 . . . . 0.0 109.405 179.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -47.66 -61.28 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.017 -1.052 . . . . 0.0 109.251 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.978 HD22 ' O ' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -55.39 -21.69 16.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.897 -1.127 . . . . 0.0 108.346 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' B' ' 34' ' ' GLU . 84.5 t80 -84.97 -11.26 55.9 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.656 -0.653 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' B' ' 34' ' ' GLU . 0.3 OUTLIER -95.45 -54.29 3.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.147 -0.971 . . . . 0.0 108.582 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.437 HG13 ' H ' ' B' ' 39' ' ' VAL . 2.3 m -59.57 -26.7 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' B' ' 43' ' ' ARG . 3.9 m -124.59 34.85 4.92 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.464 -0.773 . . . . 0.0 109.35 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.3 72.61 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -97.61 -20.52 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -1.214 . . . . 0.0 109.575 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -122.04 117.88 27.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -0.822 . . . . 0.0 109.495 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.39 173.62 19.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 20' ' ' CYS . . . -165.5 -124.55 0.71 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -82.62 -57.98 3.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -1.139 . . . . 0.0 109.453 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . 0.63 ' O ' ' HB ' ' B' ' 48' ' ' THR . 10.2 t80 -43.99 -83.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 109.419 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' B' ' 47' ' ' TYR . 11.6 m 78.35 -14.66 0.83 Allowed 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 121.123 0.487 . . . . 0.0 110.61 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.556 ' HA ' ' CZ ' ' B' ' 47' ' ' TYR . 15.1 tttp 57.47 96.48 0.04 OUTLIER Pre-proline 0 C--N 1.299 -1.608 0 O-C-N 121.052 -1.03 . . . . 0.0 109.293 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.54 172.62 15.96 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.475 2.116 . . . . 0.0 110.429 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.534 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.818 0 N-CA-C 119.239 2.456 . . . . 0.0 119.239 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.607 HG23 ' CE2' ' A' ' 19' ' ' TYR . 0.5 OUTLIER -76.16 -31.57 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.27 -1.135 . . . . 0.0 109.143 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.603 HG23 ' HG2' ' A' ' 4' ' ' GLU . 4.4 m -66.38 -33.09 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.603 ' HG2' HG23 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -78.63 5.45 11.0 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.487 -0.758 . . . . 0.0 109.896 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -104.73 -43.4 5.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.115 -0.991 . . . . 0.0 109.207 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 9' ' ' SER . 89.3 m -105.63 -23.61 12.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 109.966 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.588 ' SG ' ' O ' ' B' ' 27' ' ' LEU . 8.3 t -76.4 -28.37 56.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.902 -1.124 . . . . 0.0 109.262 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 4' ' ' GLU . 6.9 t -87.01 -32.49 20.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 1.1 t -134.74 147.56 50.06 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.521 ' CG1' ' O ' ' B' ' 25' ' ' GLN . 1.1 mp -79.27 123.1 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.93 -1.106 . . . . 0.0 109.501 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.9 m -90.6 -167.87 1.94 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -0.797 . . . . 0.0 109.704 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.509 ' HA ' HG13 ' B' ' 23' ' ' VAL . 52.5 p -122.68 150.24 42.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.475 -0.766 . . . . 0.0 109.148 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.847 HD12 ' CD2' ' B' ' 22' ' ' PHE . 2.4 tt -44.12 -28.64 0.52 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.895 . . . . 0.0 109.238 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.413 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 10.6 m-85 -64.14 -55.18 23.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.861 . . . . 0.0 109.118 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -41.78 77.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.959 . . . . 0.0 109.071 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.702 HD23 HD22 ' B' ' 36' ' ' LEU . 6.8 mp -61.82 -36.47 81.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.154 -0.966 . . . . 0.0 108.978 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 8.3 mt-10 -56.58 -30.45 63.2 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.249 -0.907 . . . . 0.0 108.641 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.5 -31.13 69.2 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.607 ' CE2' HG23 ' A' ' 2' ' ' ILE . 2.6 m-85 -54.65 -41.75 70.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 108.668 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 m -80.3 50.92 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.47 -0.769 . . . . 0.0 109.387 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.497 ' O ' ' HG3' ' B' ' 50' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.626 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.847 ' CD2' HD12 ' A' ' 13' ' ' LEU . 41.3 m-85 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -151.18 -172.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.935 -1.103 . . . . 0.0 109.374 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER 40.07 49.29 2.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 110.049 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLN . . . . . 0.521 ' O ' ' CG1' ' A' ' 10' ' ' ILE . 1.4 mt-30 -160.05 155.75 25.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.8 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' HIS . . . . . 0.547 ' NE2' ' O ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -121.34 171.97 8.37 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.926 HD13 HD12 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -160.89 -142.53 0.08 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.351 -1.468 . . . . 0.0 110.863 -179.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' B' ' 27' ' ' LEU . 0.5 OUTLIER 148.4 131.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 123.824 0.85 . . . . 0.0 108.996 -178.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' B' ' 32' ' ' LEU . . . 37.06 -116.9 0.4 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.447 ' HA ' HG22 ' B' ' 33' ' ' VAL . 0.3 OUTLIER -43.2 -61.4 1.34 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.439 -1.036 . . . . 0.0 109.401 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.497 ' HB2' ' N ' ' B' ' 28' ' ' CYS . 7.2 m-20 -45.37 -27.39 0.68 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -0.938 . . . . 0.0 108.984 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.926 HD12 HD13 ' B' ' 27' ' ' LEU . 0.2 OUTLIER -80.34 -72.24 0.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.848 . . . . 0.0 109.328 179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' B' ' 30' ' ' SER . 16.8 m -44.66 -29.35 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.188 -0.945 . . . . 0.0 108.87 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.533 ' O ' ' CD2' ' B' ' 38' ' ' LEU . 1.0 OUTLIER -69.79 -60.33 2.38 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.562 ' HA ' ' CD1' ' B' ' 38' ' ' LEU . . . -60.61 -43.37 97.53 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.702 HD22 HD23 ' A' ' 16' ' ' LEU . 3.7 mm? -59.08 -29.27 67.21 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.468 -0.77 . . . . 0.0 109.162 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.416 ' O ' ' CG ' ' B' ' 37' ' ' TYR . 13.8 t80 -78.76 -10.64 59.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.593 -0.692 . . . . 0.0 109.597 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.562 ' CD1' ' HA ' ' B' ' 35' ' ' ALA . 0.3 OUTLIER -95.24 -36.87 11.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.0 109.253 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 16' ' ' LEU . 3.4 m -72.46 -28.49 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.277 -0.889 . . . . 0.0 109.438 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' CYS . . . . . 0.565 ' HB3' ' CB ' ' B' ' 43' ' ' ARG . 72.5 m -79.84 -37.24 35.42 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.106 -0.996 . . . . 0.0 109.259 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . 0.495 ' C ' ' CG ' ' B' ' 42' ' ' GLU . . . 77.52 98.23 0.2 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.495 ' CG ' ' C ' ' B' ' 41' ' ' GLY . 2.5 pt-20 37.99 37.75 0.16 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.61 -0.935 . . . . 0.0 110.407 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.565 ' CB ' ' HB3' ' B' ' 40' ' ' CYS . 0.0 OUTLIER -93.86 -170.97 2.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.085 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' B' ' 43' ' ' ARG . . . -43.58 112.37 0.55 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.26 -6.3 88.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.41 -168.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.65 43.06 1.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.407 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 99.0 m -148.45 -37.45 0.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.867 . . . . 0.0 109.777 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.506 ' O ' ' CG ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER -167.21 116.65 0.7 Allowed Pre-proline 0 C--N 1.3 -1.566 0 O-C-N 121.315 -0.866 . . . . 0.0 109.572 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.497 ' HG3' ' O ' ' A' ' 21' ' ' ASN . 34.5 Cg_endo -77.5 -170.09 0.87 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.227 1.952 . . . . 0.0 110.261 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 29.2 p . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.471 -179.901 . . . . . . . . 0 0 . 1 stop_ save_